data_1x68_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x68 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.997 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -43.0 118.49 1.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 116.197 -1.859 . . . . 0.0 110.423 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.15 -31.36 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 121.753 2.069 . . . . 0.0 112.025 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.68 -5.37 59.31 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -157.95 -7.66 0.08 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 0.1 OUTLIER 61.77 14.34 6.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 130.164 3.386 . . . . 0.0 114.914 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -78.25 147.04 71.97 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 120.453 -1.404 . . . . 0.0 108.646 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.16 120.32 6.93 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.259 2.639 . . . . 0.0 110.07 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mm -66.53 140.45 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.237 0.419 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.58 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.9 tttm . . . . . 0 C--O 1.237 0.433 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -134.43 164.28 27.8 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.499 0.72 . . . . 0.0 110.514 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mm -122.43 145.96 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 127.271 2.229 . . . . 0.0 106.283 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -126.83 102.82 7.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -121.95 127.62 50.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 52.85 43.59 31.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.968 0.907 . . . . 0.0 108.781 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 56.91 0.51 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.007 2.523 . . . . 0.0 114.41 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 m -85.39 156.46 20.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.932 1.693 . . . . 0.0 107.831 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.99 130.31 51.63 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -132.3 145.09 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.647 1.179 . . . . 0.0 109.026 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -98.39 161.26 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 p -53.09 -55.02 27.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.938 0.895 . . . . 0.0 111.651 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.29 -4.05 9.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.054 1.341 . . . . 0.0 112.98 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.48 14.87 11.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.911 1.284 . . . . 0.0 113.298 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -107.41 101.3 10.67 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -157.2 167.04 31.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.4 t -64.86 120.83 13.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 117.111 -1.423 . . . . 0.0 109.799 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.04 -28.66 58.56 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.917 1.235 . . . . 0.0 114.396 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -81.04 -19.86 42.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.6 p -139.71 -23.05 0.87 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t 87.76 7.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.356 1.863 . . . . 0.0 114.467 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.94 135.23 27.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -60.21 132.34 53.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -98.21 -1.6 41.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 108.946 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.06 109.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 -65.93 0.31 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 126.069 1.795 . . . . 0.0 109.072 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -66.65 157.08 33.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.049 0.94 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.06 20.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -106.59 168.77 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.215 1.006 . . . . 0.0 109.187 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.95 152.28 42.66 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.868 1.667 . . . . 0.0 108.365 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 p -134.23 114.85 13.49 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.535 1.134 . . . . 0.0 110.6 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.402 ' HG2' HD21 ' A' ' 54' ' ' ASN . 31.8 tt0 -142.64 143.23 32.28 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.622 1.569 . . . . 0.0 106.907 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.402 HD21 ' HG2' ' A' ' 53' ' ' GLN . 8.8 m-80 53.76 25.32 5.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.873 0.869 . . . . 0.0 111.493 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt 73.15 3.61 4.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.119 1.768 . . . . 0.0 111.127 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.7 153.18 18.41 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.289 1.436 . . . . 0.0 109.825 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.75 122.46 55.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 109.931 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -137.13 166.49 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.795 1.283 . . . . 0.0 111.848 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.24 163.6 19.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -55.74 -55.51 31.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.052 1.341 . . . . 0.0 111.306 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -52.71 -48.87 66.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.361 -0.837 . . . . 0.0 112.886 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 m -68.62 -44.59 73.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.349 0.66 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 22.59 7.65 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 120.939 -1.1 . . . . 0.0 113.759 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 CA--C 1.53 0.178 0 CA-C-N 119.369 1.585 . . . . 0.0 107.441 179.325 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.522 0 N-CA-C 115.149 0.82 . . . . 0.0 115.149 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.404 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.6 t -60.71 113.56 2.54 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 117.243 -1.36 . . . . 0.0 110.21 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.6 t -57.83 -20.36 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 120.091 1.314 . . . . 0.0 110.438 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.6 -3.76 58.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.072 1.349 . . . . 0.0 114.078 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 p -155.44 -10.53 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.408 1.913 . . . . 0.0 115.673 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m 55.17 53.32 10.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.331 2.252 . . . . 0.0 112.589 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -113.7 137.3 22.18 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 108.61 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.92 3.08 . . . . 0.0 110.113 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.44 129.83 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 122.69 0.396 . . . . 0.0 111.819 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.482 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.286 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -137.89 166.77 23.23 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.406 1.882 . . . . 0.0 109.991 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.2 mm -125.25 114.87 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 p -104.41 117.29 33.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.139 1.776 . . . . 0.0 107.525 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -145.58 143.48 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.209 1.004 . . . . 0.0 109.218 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 31.52 60.37 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.872 2.469 . . . . 0.0 114.372 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 65.19 5.36 3.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.916 2.487 . . . . 0.0 114.972 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -116.09 161.85 18.3 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 0.0 111.079 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -125.72 141.1 52.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.462 1.125 . . . . 0.0 110.168 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -132.58 152.42 51.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.225 1.41 . . . . 0.0 109.555 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -86.15 141.57 29.27 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.67 -55.79 4.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.021 1.328 . . . . 0.0 111.071 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -65.56 -12.68 55.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -118.15 16.56 14.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.411 0.685 . . . . 0.0 111.869 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -106.92 101.56 10.99 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.88 176.34 12.28 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.9 t -58.11 118.93 5.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 117.088 -1.434 . . . . 0.0 109.731 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.07 -11.51 12.23 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 123.968 0.793 . . . . 0.0 114.787 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -102.74 -21.52 14.06 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.093 1.357 . . . . 0.0 114.595 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.68 -14.21 0.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.993 2.59 . . . . 0.0 117.993 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 t 81.62 27.46 0.18 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.833 1.652 . . . . 0.0 114.725 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.75 128.49 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -51.3 136.51 24.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.141 1.377 . . . . 0.0 111.691 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.1 mt -112.41 3.74 17.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.561 1.144 . . . . 0.0 110.215 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.81 105.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 126.594 1.958 . . . . 0.0 108.641 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.45 36.13 92.08 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.517 -0.602 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -132.99 160.97 35.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.483 1.141 . . . . 0.0 107.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.44 124.82 30.29 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.7 171.08 14.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.125 . . . . 0.0 109.243 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 60' ' ' GLN . 5.1 mp -136.13 156.84 48.11 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.271 1.828 . . . . 0.0 106.442 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.4 p -137.46 115.4 11.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -142.48 145.79 34.07 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 48.42 41.92 17.54 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.909 1.283 . . . . 0.0 111.465 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.397 5.0 ptpp? 61.43 7.87 1.95 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.189 2.995 . . . . 0.0 114.62 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.95 178.07 5.4 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.368 1.44 . . . . 0.0 110.889 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.31 122.81 60.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 109.535 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.14 160.14 35.61 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.667 -1.27 . . . . 0.0 112.811 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.91 162.43 16.91 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.422 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.28 -52.73 60.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.041 1.291 . . . . 0.0 111.372 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -40.28 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.145 1.339 . . . . 0.0 113.302 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -78.46 -29.05 46.65 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.715 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.47 13.76 61.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.108 1.813 . . . . 0.0 113.342 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.702 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 t -58.56 125.4 23.24 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 117.619 -1.182 . . . . 0.0 108.943 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.3 -17.01 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 124.731 1.213 . . . . 0.0 112.052 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.85 9.43 22.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.239 2.216 . . . . 0.0 115.083 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.1 -5.3 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.426 -1.421 . . . . 0.0 114.351 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t 62.15 0.6 0.59 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.381 1.872 . . . . 0.0 113.755 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -82.58 156.4 68.21 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 122.359 2.345 . . . . 0.0 112.271 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.23 122.82 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.452 2.101 . . . . 0.0 108.837 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -76.33 151.26 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.235 0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.292 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 tptm . . . . . 0 C--O 1.238 0.473 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -137.41 164.65 28.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.538 1.535 . . . . 0.0 108.844 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.29 140.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -131.47 132.94 44.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.731 2.012 . . . . 0.0 106.272 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -145.57 102.74 3.73 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.703 1.601 . . . . 0.0 108.587 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.5 64.68 1.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 109.796 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 49.8 t0 42.66 67.32 0.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.468 2.707 . . . . 0.0 113.245 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.8 p -134.99 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 130.103 3.361 . . . . 0.0 106.951 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -142.53 118.06 10.34 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -131.55 131.61 43.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.305 1.042 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -66.45 154.97 38.83 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -53.03 -43.41 66.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.157 0.98 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.62 -2.69 33.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -121.12 18.68 11.61 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 0.0 114.442 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -112.38 100.08 8.51 Favored 'General case' 0 C--O 1.235 0.333 1 N-CA-C 100.193 -4.002 . . . . 0.0 100.193 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.63 160.53 40.12 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.7 t -58.9 124.23 19.15 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.444 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.88 -28.06 72.15 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 118.425 0.557 . . . . 0.0 113.362 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -78.83 -28.63 44.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.78 -10.84 1.02 Allowed 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t 72.62 87.77 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.907 1.337 . . . . 0.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.98 143.29 18.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 127.556 2.342 . . . . 0.0 104.801 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.7 t -65.55 142.71 58.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.252 1.025 . . . . 0.0 109.867 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.32 13.15 11.87 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.044 1.738 . . . . 0.0 109.658 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.9 t -76.97 -63.49 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 119.035 0.834 . . . . 0.0 108.761 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.61 11.9 6.6 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.206 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.97 159.1 44.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.665 1.732 . . . . 0.0 109.897 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.65 159.14 52.41 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -132.46 167.4 20.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.697 1.599 . . . . 0.0 108.425 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -125.29 159.02 32.7 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -126.72 107.84 10.53 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.991 1.716 . . . . 0.0 109.489 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -142.44 155.21 45.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m120 47.66 41.53 13.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.873 1.269 . . . . 0.0 112.197 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt 50.74 19.75 0.65 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.931 2.092 . . . . 0.0 113.882 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -123.82 176.26 6.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.494 1.918 . . . . 0.0 109.389 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.6 pt -112.92 131.67 63.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.674 1.189 . . . . 0.0 111.511 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.0 165.51 25.5 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.51 1.148 . . . . 0.0 113.69 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.72 156.64 20.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -54.9 -52.38 63.06 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.532 1.133 . . . . 0.0 109.554 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -55.07 -26.14 35.67 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.219 -1.551 . . . . 0.0 114.558 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.21 -22.97 16.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.731 1.612 . . . . 0.0 112.808 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.3 -4.38 55.13 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.492 1.044 . . . . 0.0 113.529 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.451 -0.423 0 C-N-CA 125.914 1.686 . . . . 0.0 108.023 -179.774 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.429 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -49.54 124.67 9.84 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.203 2.002 . . . . 0.0 108.32 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.23 -8.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 120.581 1.537 . . . . 0.0 110.964 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.07 7.16 27.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.703 2.001 . . . . 0.0 113.159 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.9 p -167.66 -5.34 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 121.225 1.829 . . . . 0.0 115.774 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.368 0.1 OUTLIER 56.06 18.79 3.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.128 2.171 . . . . 0.0 114.666 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -82.82 144.45 48.27 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.34 128.51 14.67 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.648 2.232 . . . . 0.0 110.239 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.8 mt -78.87 162.18 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.6 mttm . . . . . 0 C--O 1.237 0.441 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -119.24 158.53 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.85 131.67 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.08 116.11 22.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.117 2.167 . . . . 0.0 107.549 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -145.76 131.25 18.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.233 1.813 . . . . 0.0 107.172 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 36.32 63.13 0.65 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.669 1.988 . . . . 0.0 111.918 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 60.19 -3.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 128.035 2.534 . . . . 0.0 115.749 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -80.45 160.63 25.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.492 1.117 . . . . 0.0 108.179 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -136.69 113.87 10.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -118.91 149.95 40.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.584 1.154 . . . . 0.0 111.021 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -86.56 147.37 25.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.0 t -49.39 -52.78 26.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.613 1.097 . . . . 0.0 110.669 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -57.76 -31.07 66.13 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.49 -4.92 52.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -80.93 99.36 8.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.38 161.76 37.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.086 1.355 . . . . 0.0 112.563 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.68 145.7 55.23 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.099 1.36 . . . . 0.0 112.701 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.39 -49.27 15.74 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 123.797 0.686 . . . . 0.0 111.915 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -75.53 -23.14 56.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -133.57 -7.43 2.87 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 m 72.49 -0.75 3.19 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -71.06 147.03 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 121.038 1.744 . . . . 0.0 111.251 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -71.81 149.59 45.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.583 0.628 . . . . 0.0 111.968 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.13 -6.56 13.66 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.985 0.803 . . . . 0.0 112.412 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.65 95.83 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.58 11.56 24.81 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.877 1.227 . . . . 0.0 113.175 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -127.55 141.01 51.76 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.498 1.149 . . . . 0.0 108.305 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.95 88.78 0.66 Allowed Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -85.44 168.07 14.92 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.766 0.783 . . . . 0.0 110.296 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 mp -117.68 158.89 23.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.224 1.809 . . . . 0.0 106.918 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.3 p -128.71 122.6 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -143.51 153.21 42.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 m120 47.06 36.99 4.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm 58.89 30.4 20.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.327 1.051 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -129.19 166.64 18.96 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.913 1.685 . . . . 0.0 108.921 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.82 120.8 63.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.128 1.771 . . . . 0.0 108.487 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -131.31 139.48 49.58 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.007 -1.683 . . . . 0.0 113.054 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.58 144.52 31.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 114.521 -2.657 . . . . 0.0 106.024 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -30.06 -53.16 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.791 3.236 . . . . 0.0 112.304 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -47.83 -40.31 20.86 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.953 0.797 . . . . 0.0 112.296 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 29.2 m -80.14 -44.13 20.44 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.02 14.97 5.59 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 120.954 -1.091 . . . . 0.0 113.6 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.445 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.576 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.1 t -61.28 117.24 5.37 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 116.31 -1.805 . . . . 0.0 107.761 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.0 t -52.3 -30.54 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 121.067 1.758 . . . . 0.0 112.161 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.83 -12.02 58.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.49 -13.51 1.14 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.733 1.606 . . . . 0.0 113.413 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m 52.77 56.04 8.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 128.396 2.679 . . . . 0.0 111.665 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -124.86 149.23 62.21 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 117.773 -1.108 . . . . 0.0 108.748 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.87 114.74 3.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.606 2.204 . . . . 0.0 109.042 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.76 138.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 107.542 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 CA--C 1.535 0.392 0 CA-C-N 118.544 0.611 . . . . 0.0 111.079 179.345 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 121.944 0.878 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.58 165.26 18.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.559 1.544 . . . . 0.0 109.523 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 mt -130.19 152.94 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 126.218 1.807 . . . . 0.0 106.611 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 t -131.8 131.72 43.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.557 1.543 . . . . 0.0 108.399 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -146.42 136.24 23.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.116 1.366 . . . . 0.0 107.811 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 48.15 38.12 9.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 65.51 6.47 3.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.374 1.469 . . . . 0.0 112.959 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.4 m -102.08 160.98 14.04 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.426 2.29 . . . . 0.0 105.73 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -132.14 144.86 50.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 119.936 -1.728 . . . . 0.0 113.363 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -133.43 145.08 49.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.238 1.015 . . . . 0.0 111.327 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -80.68 157.69 25.83 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 p -53.62 -49.77 67.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.867 0.867 . . . . 0.0 111.846 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -12.64 60.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.75 4.77 24.06 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.277 1.831 . . . . 0.0 113.714 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -101.28 99.89 10.33 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -155.24 166.41 33.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -58.48 119.77 7.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 116.821 -1.561 . . . . 0.0 112.45 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.27 49.81 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.453 1.024 . . . . 0.0 112.225 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -92.0 -17.52 24.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -148.72 -4.96 0.43 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m 74.47 1.14 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.77 134.61 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.9 t -59.38 145.52 43.22 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 124.242 0.964 . . . . 0.0 110.472 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -118.33 4.6 11.85 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.137 1.775 . . . . 0.0 110.058 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.91 91.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.964 . . . . 0.0 110.524 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.51 -58.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 125.875 1.702 . . . . 0.0 111.668 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.64 148.42 42.58 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.352 0.576 . . . . 0.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.42 115.03 7.36 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 105.52 -3.032 . . . . 0.0 105.52 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -85.16 170.38 12.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 109.137 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.7 160.74 32.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.693 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.7 p -137.72 104.5 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 110.247 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -141.16 153.57 45.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.89 1.676 . . . . 0.0 107.246 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.89 31.6 3.3 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.272 1.029 . . . . 0.0 113.396 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm 60.37 21.46 11.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.005 1.722 . . . . 0.0 112.007 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -125.43 174.83 7.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.49 1.516 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -117.31 122.7 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.977 1.311 . . . . 0.0 111.037 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.78 148.23 50.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.382 1.087 . . . . 0.0 113.586 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 162.68 29.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -50.22 -52.94 31.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.586 1.085 . . . . 0.0 112.39 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.46 -45.24 69.48 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.64 1.109 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.22 -59.44 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.5 29.92 1.71 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.139 1.352 . . . . 0.0 112.959 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 107.642 -179.278 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.757 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -57.67 120.72 8.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.418 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.76 -2.4 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 125.605 1.562 . . . . 0.0 112.337 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.99 6.09 10.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.957 2.103 . . . . 0.0 113.022 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.7 p -159.02 -7.37 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 119.282 -2.136 . . . . 0.0 114.625 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.8 m 58.38 12.94 2.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.63 1.572 . . . . 0.0 114.036 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -81.31 148.75 63.95 Favored Pre-proline 0 C--N 1.346 0.435 0 O-C-N 120.117 -1.614 . . . . 0.0 108.138 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.59 117.54 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.901 3.067 . . . . 0.0 109.122 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.2 mt -74.65 139.51 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.614 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 7.1 mmpt? . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.267 0.556 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.99 164.13 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.484 1.514 . . . . 0.0 107.877 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.23 137.78 52.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.14 112.15 18.32 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.265 1.826 . . . . 0.0 106.751 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -146.47 150.23 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 42.04 32.88 0.33 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.6 t70 56.68 40.67 29.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 123.699 1.714 . . . . 0.0 111.454 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.407 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 56.5 m -131.73 164.37 26.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 130.525 3.53 . . . . 0.0 106.804 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -132.65 133.77 44.0 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.327 1.051 . . . . 0.0 111.858 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.407 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 30.6 m-90 -132.38 161.54 33.34 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.527 1.131 . . . . 0.0 109.419 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -97.28 166.7 11.43 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.1 p -55.92 -30.76 62.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.338 1.055 . . . . 0.0 112.282 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -103.57 4.8 36.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.251 1.42 . . . . 0.0 112.256 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.01 6.59 9.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.313 1.045 . . . . 0.0 112.349 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -101.85 100.28 10.59 Favored 'General case' 0 N--CA 1.453 -0.298 1 N-CA-C 99.524 -4.25 . . . . 0.0 99.524 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -145.04 157.41 44.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 t -51.53 118.28 3.22 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -27.3 38.67 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 119.849 1.204 . . . . 0.0 112.872 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.6 -22.59 26.14 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.4 p -143.45 -6.72 0.8 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m 76.92 10.31 2.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.71 141.36 15.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.1 t -66.11 151.33 47.13 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.4 mt -118.18 -1.72 11.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.433 1.093 . . . . 0.0 111.374 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.29 -57.43 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.445 1.098 . . . . 0.0 112.286 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.76 17.15 2.85 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.05 -0.861 . . . . 0.0 113.947 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -150.92 -167.66 2.88 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.437 1.618 . . . . 0.0 110.722 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.96 165.31 21.92 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -140.82 171.48 14.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 109.766 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.53 165.53 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.407 1.083 . . . . 0.0 109.291 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 p -137.65 111.51 8.28 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.983 0.513 . . . . 0.0 109.735 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -142.46 148.36 37.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.161 1.784 . . . . 0.0 106.48 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 46.08 33.98 1.9 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.093 2.157 . . . . 0.0 112.478 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp 59.7 9.99 1.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.752 1.621 . . . . 0.0 113.039 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -93.41 -173.56 3.25 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.769 2.028 . . . . 0.0 107.466 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.2 pt -135.75 124.05 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.06 1.744 . . . . 0.0 109.397 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -135.38 148.04 49.25 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 120.745 -1.222 . . . . 0.0 114.183 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.72 155.68 39.66 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -51.36 -52.75 42.87 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.934 1.243 . . . . 0.0 110.263 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -56.83 -25.79 56.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.2 m -97.51 -18.23 19.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 114.075 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.62 -5.63 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.536 0.41 0 C-N-CA 128.032 2.533 . . . . 0.0 105.963 178.737 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.2 t -66.53 106.89 1.9 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.743 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -50.55 -35.16 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.784 1.174 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.39 1.0 50.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.227 2.211 . . . . 0.0 116.427 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.16 -12.98 0.15 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.101 1.773 . . . . 0.0 112.798 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m 55.41 51.13 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 131.169 3.788 . . . . 0.0 113.388 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.59 149.18 44.47 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.71 1.204 . . . . 0.0 110.098 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.4 122.6 6.62 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 123.306 2.671 . . . . 0.0 112.097 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.8 mt -80.72 163.04 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.621 2.368 . . . . 0.0 105.2 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.116 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -131.59 163.97 26.89 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.659 0.784 . . . . 0.0 111.477 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.18 138.66 53.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.877 2.071 . . . . 0.0 105.892 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.6 121.0 23.64 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.12 1.368 . . . . 0.0 107.584 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -145.31 130.74 18.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 53.16 39.27 29.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.125 0.97 . . . . 0.0 111.532 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 68.26 -0.72 2.06 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.879 1.672 . . . . 0.0 113.039 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 t -73.91 165.75 24.58 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.103 2.161 . . . . 0.0 110.059 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -132.81 110.69 10.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.662 0.785 . . . . 0.0 112.141 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -118.03 129.81 55.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.61 154.47 40.74 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -49.87 -49.85 47.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.425 1.09 . . . . 0.0 110.967 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.35 -4.76 41.16 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.207 -1.558 . . . . 0.0 114.224 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.0 m -121.56 17.71 11.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.96 101.54 9.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.14 166.44 30.81 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.0 t -55.83 112.15 1.1 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.247 -1.359 . . . . 0.0 109.548 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.04 -25.3 30.99 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.208 0.909 . . . . 0.0 114.921 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -90.35 -20.96 22.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.35 -22.8 1.5 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m 77.47 78.51 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.251 1.024 . . . . 0.0 109.738 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.34 134.68 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 t -54.2 135.43 44.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.933 1.293 . . . . 0.0 112.461 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.39 9.72 15.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.547 1.939 . . . . 0.0 109.222 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.19 111.23 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 126.11 1.764 . . . . 0.0 112.711 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.47 43.4 94.03 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-O 119.331 -0.705 . . . . 0.0 113.666 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -139.07 153.21 48.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 134.34 46.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.99 171.77 9.0 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.144 1.378 . . . . 0.0 108.058 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.99 155.31 30.49 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 112.88 6.49 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -143.12 150.26 39.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 54.72 23.08 4.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.134 0.879 . . . . 0.0 112.528 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 70.54 8.45 6.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.792 2.437 . . . . 0.0 113.065 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.81 150.94 25.83 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.431 1.092 . . . . 0.0 108.587 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.8 pt -102.63 129.87 53.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.226 1.411 . . . . 0.0 110.025 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.92 160.69 36.9 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.669 -1.269 . . . . 0.0 112.444 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 161.39 19.69 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -51.98 -51.55 56.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.21 1.368 . . . . 0.0 111.57 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -53.49 -38.59 63.82 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.419 -0.8 . . . . 0.0 112.402 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -75.59 -53.26 8.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.27 1.04 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.548 1.07 . . . . 0.0 113.924 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.361 0 CA-C-N 119.134 1.467 . . . . 0.0 111.303 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.796 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.5 t -79.13 121.97 25.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.96 -23.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.249 0.931 . . . . 0.0 111.61 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.2 1.28 57.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.804 1.642 . . . . 0.0 115.207 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.1 p -162.6 -7.79 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.776 1.625 . . . . 0.0 115.128 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.28 97.1 p 53.83 26.82 6.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.103 2.561 . . . . 0.0 114.149 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -83.88 154.16 64.29 Favored Pre-proline 0 C--O 1.237 0.436 0 O-C-N 120.765 -1.21 . . . . 0.0 108.459 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.34 120.12 5.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.366 2.71 . . . . 0.0 107.185 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -70.55 144.07 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 C--O 1.234 0.282 0 C-N-CA 123.429 0.692 . . . . 0.0 111.212 -179.847 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -145.06 164.95 29.64 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 126.039 1.736 . . . . 0.0 108.721 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.27 134.73 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -111.22 131.35 55.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.185 0.994 . . . . 0.0 108.834 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -146.15 138.1 25.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.091 1.756 . . . . 0.0 106.666 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 45.33 43.11 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.273 1.429 . . . . 0.0 112.235 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 69.45 -17.55 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 129.766 3.226 . . . . 0.0 113.616 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.6 m -73.94 164.15 26.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.325 1.45 . . . . 0.0 108.969 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.21 135.94 52.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.082 1.353 . . . . 0.0 111.115 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -132.89 131.43 40.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.359 0.664 . . . . 0.0 111.664 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -65.48 154.38 38.73 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 p -49.58 -53.19 25.18 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.298 1.408 . . . . 0.0 112.613 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.49 -26.38 67.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.05 1.06 56.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 116.955 -1.498 . . . . 0.0 114.162 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -100.74 100.4 11.07 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 102.406 -3.183 . . . . 0.0 102.406 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -153.19 166.09 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 t -61.13 120.11 9.68 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-O 117.329 -1.319 . . . . 0.0 109.99 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.08 -24.38 54.53 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 121.989 0.772 . . . . 0.0 113.412 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -85.81 -18.83 31.82 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.16 -8.81 0.34 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 82.63 -0.99 1.33 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.474 1.488 . . . . 0.0 114.791 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.44 136.13 26.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 121.246 1.839 . . . . 0.0 108.024 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -54.35 136.2 43.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.082 1.353 . . . . 0.0 109.609 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.1 -0.37 15.65 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.773 0.829 . . . . 0.0 110.686 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.8 t -54.18 116.51 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 127.409 2.284 . . . . 0.0 109.505 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.68 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.532 1.152 0 C-N-CA 128.776 3.084 . . . . 0.0 117.617 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -9.38 56.96 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.23 147.09 16.94 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -146.34 172.26 13.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.575 1.55 . . . . 0.0 110.563 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.13 154.95 32.45 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.9 p -130.11 102.46 6.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.241 0.963 . . . . 0.0 109.213 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.61 155.66 48.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.323 1.849 . . . . 0.0 107.595 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 52.35 21.77 1.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.004 1.321 . . . . 0.0 112.935 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt 62.49 22.02 12.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.038 1.735 . . . . 0.0 112.047 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -112.95 -169.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.893 2.477 . . . . 0.0 108.691 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.1 123.82 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 120.423 -1.423 . . . . 0.0 110.003 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -131.95 152.01 51.36 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 122.92 1.343 . . . . 0.0 114.607 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.76 150.28 42.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -46.23 -51.83 13.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.337 1.426 . . . . 0.0 110.502 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -51.53 61.47 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.135 0.879 . . . . 0.0 111.017 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.78 -29.01 68.85 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.35 -25.28 51.83 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.021 -1.433 . . . . 0.0 111.535 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 C--N 1.343 0.283 0 CA-C-N 118.936 1.368 . . . . 0.0 109.802 179.636 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.426 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 t -53.26 127.54 24.9 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.178 -1.391 . . . . 0.0 107.954 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -51.51 -24.64 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 120.048 1.294 . . . . 0.0 113.883 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.67 9.29 25.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.493 1.917 . . . . 0.0 115.126 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.2 -11.07 0.14 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.96 -1.712 . . . . 0.0 114.132 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 p 58.99 2.93 0.28 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.057 2.543 . . . . 0.0 114.812 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -72.04 147.69 91.19 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 120.597 -1.315 . . . . 0.0 110.684 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.55 113.65 3.7 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.355 2.703 . . . . 0.0 110.58 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.63 149.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm . . . . . 0 C--O 1.239 0.531 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -135.44 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.827 2.051 . . . . 0.0 111.807 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.0 mm -120.05 147.37 23.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.89 117.9 19.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.375 1.07 . . . . 0.0 109.603 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.82 138.74 25.89 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 48.57 42.74 19.51 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.727 1.611 . . . . 0.0 110.597 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 61.87 2.45 0.76 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.272 2.229 . . . . 0.0 112.545 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.6 m -84.35 164.84 18.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.631 1.572 . . . . 0.0 108.875 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 117.83 24.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.403 1.081 . . . . 0.0 111.47 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -120.72 136.73 54.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.26 155.52 28.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.1 t -57.34 -46.03 83.69 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.341 0.973 . . . . 0.0 108.487 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -1.24 3.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.64 -6.47 6.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.913 1.285 . . . . 0.0 113.275 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -89.99 100.29 13.13 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -149.08 176.5 10.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.5 t -65.53 119.93 11.97 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.49 -1.243 . . . . 0.0 112.694 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.07 -10.8 16.14 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.468 1.508 . . . . 0.0 112.977 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -106.05 -23.49 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.133 1.466 . . . . 0.0 114.525 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.41 -3.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.294 15.4 m 70.83 15.44 6.85 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.64 134.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 t -58.0 139.63 54.09 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.802 0.728 . . . . 0.0 110.679 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -111.06 3.55 18.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.045 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.32 122.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.52 29.47 69.82 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.622 -1.099 . . . . 0.0 112.438 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -139.8 150.45 44.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.356 1.578 . . . . 0.0 110.958 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.28 108.35 2.54 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.506 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -102.83 171.85 7.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.363 1.865 . . . . 0.0 108.945 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.15 163.61 25.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.117 1.767 . . . . 0.0 107.256 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.9 p -135.39 117.4 15.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.396 0.544 . . . . 0.0 111.567 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -143.7 156.49 44.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.301 1.84 . . . . 0.0 107.386 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.5 m120 57.3 29.08 16.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.925 0.89 . . . . 0.0 112.018 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm 64.18 16.09 9.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.437 1.495 . . . . 0.0 110.57 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -120.1 177.97 4.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.993 1.717 . . . . 0.0 106.994 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.5 pt -115.63 149.55 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -145.84 155.73 43.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.096 1.771 . . . . 0.0 111.482 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.3 156.42 38.46 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -57.12 -50.61 72.27 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.197 1.362 . . . . 0.0 110.871 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -55.42 -24.91 33.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.516 1.126 . . . . 0.0 113.847 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.382 85.7 m -97.24 -17.07 20.06 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.572 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.02 -20.29 18.94 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.387 -1.229 . . . . 0.0 111.54 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.533 0.294 0 C-N-CA 127.081 2.152 . . . . 0.0 113.518 -179.409 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.9 t -62.57 119.55 9.42 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.358 -1.782 . . . . 0.0 108.607 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.7 t -54.55 -25.84 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 121.113 1.779 . . . . 0.0 111.165 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.66 -1.77 58.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.294 1.837 . . . . 0.0 115.284 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.4 p -158.88 -2.54 0.08 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 121.235 1.834 . . . . 0.0 114.481 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 p 58.35 7.27 0.66 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.838 3.255 . . . . 0.0 114.071 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -70.38 136.68 86.36 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.11 122.67 10.5 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 123.066 2.51 . . . . 0.0 108.504 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.51 151.98 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.542 0.65 0 O-C-N 121.067 -1.021 . . . . 0.0 109.115 179.649 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.627 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -145.67 165.16 29.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.744 1.617 . . . . 0.0 107.125 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.89 122.38 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 126.984 2.114 . . . . 0.0 106.202 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -106.05 106.79 17.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.97 139.85 38.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 48.86 43.92 21.74 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.379 0.672 . . . . 0.0 109.591 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 42.87 43.32 3.43 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.086 2.555 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -134.16 149.77 51.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.898 1.679 . . . . 0.0 108.712 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.07 118.81 32.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -131.36 123.23 27.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -66.24 145.34 55.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -45.04 -54.76 6.27 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.422 1.489 . . . . 0.0 111.376 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -67.29 -17.57 64.83 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.09 17.55 20.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.73 101.39 12.78 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -139.48 165.05 28.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.95 113.59 2.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.077 1.751 . . . . 0.0 109.009 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.83 -24.92 21.26 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 120.167 1.349 . . . . 0.0 115.539 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -84.92 -20.33 30.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 114.762 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.71 -25.88 0.68 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.298 5.6 p 91.57 17.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.671 2.388 . . . . 0.0 115.596 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.47 143.72 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 120.582 -1.324 . . . . 0.0 108.043 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -59.35 140.65 55.89 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.821 0.848 . . . . 0.0 110.631 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.22 -1.01 10.35 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.252 1.421 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.1 t -49.69 115.93 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 126.33 1.852 . . . . 0.0 110.402 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -3.74 27.24 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.043 -1.421 . . . . 0.0 115.33 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -89.34 162.1 15.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.948 2.374 . . . . 0.0 110.179 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.87 1.54 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -85.38 171.88 11.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.916 0.887 . . . . 0.0 109.762 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.53 126.7 52.56 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.911 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -95.55 107.35 19.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.787 2.035 . . . . 0.0 110.15 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -144.17 155.04 43.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 44.99 46.18 9.05 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.173 1.389 . . . . 0.0 112.333 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.346 7.5 ptmm? 48.97 24.99 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.709 2.004 . . . . 0.0 114.321 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -127.23 177.94 6.36 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.977 1.711 . . . . 0.0 107.781 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.04 123.62 65.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 125.611 1.564 . . . . 0.0 110.984 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.42 152.01 51.03 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.948 0.88 . . . . 0.0 113.31 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.9 163.36 27.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -53.91 -55.87 22.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 110.854 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -55.28 -27.08 44.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.672 1.189 . . . . 0.0 113.468 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.91 -19.29 18.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.724 1.21 . . . . 0.0 113.077 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.49 -3.61 56.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.088 1.804 . . . . 0.0 112.015 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 124.741 1.217 . . . . 0.0 107.952 178.631 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.871 0 CA-C-O 121.383 0.435 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -71.48 109.58 5.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.858 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -43.73 -39.93 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 121.539 1.972 . . . . 0.0 111.743 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -8.47 53.11 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -156.96 -4.88 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.098 1.317 . . . . 0.0 114.326 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 p 62.92 8.01 2.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 130.815 3.646 . . . . 0.0 114.597 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -70.64 152.93 95.21 Favored Pre-proline 0 N--CA 1.468 0.454 0 O-C-N 120.38 -1.45 . . . . 0.0 109.892 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.24 127.63 16.15 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.84 1.694 . . . . 0.0 109.054 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.97 142.96 16.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 CA--C 1.537 0.455 0 C-N-CA 123.734 0.814 . . . . 0.0 109.898 -179.856 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.6 mptt . . . . . 0 C--O 1.237 0.406 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -134.05 120.44 20.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 mm -83.46 152.73 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -130.01 107.02 9.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.671 1.588 . . . . 0.0 108.897 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -128.22 123.82 35.17 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.815 1.246 . . . . 0.0 108.803 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 50.69 15.48 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.264 1.026 . . . . 0.0 109.001 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 62.62 -6.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 127.57 2.348 . . . . 0.0 115.97 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.3 t -89.06 149.68 23.11 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -116.04 136.45 53.02 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.474 0.709 . . . . 0.0 111.548 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -130.26 138.56 50.58 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.776 1.23 . . . . 0.0 108.35 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -71.09 152.32 43.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -43.87 -62.48 1.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.751 1.22 . . . . 0.0 113.101 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 21.0 mp0 -61.34 -22.46 64.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.887 2.075 . . . . 0.0 114.164 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 m -90.5 -28.27 18.66 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.026 1.331 . . . . 0.0 112.725 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -72.09 101.73 2.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.456 1.48 . . . . 0.0 108.703 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -139.87 164.02 31.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.294 1.038 . . . . 0.0 112.95 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 35.2 t -59.15 116.74 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 116.287 -1.816 . . . . 0.0 108.474 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.42 34.01 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 120.865 1.666 . . . . 0.0 114.132 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -84.93 -18.66 33.94 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.43 -13.74 1.0 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.358 86.9 p 62.46 60.04 1.44 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.65 137.01 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -58.38 125.56 23.83 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 124.037 0.836 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.1 mt -101.91 14.71 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.172 1.389 . . . . 0.0 109.111 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.64 126.9 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.21 -49.77 1.55 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 126.049 1.785 . . . . 0.0 115.987 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -63.23 154.18 32.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.904 0.882 . . . . 0.0 112.238 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.09 161.59 54.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.59 163.29 36.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.935 1.294 . . . . 0.0 109.778 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.03 152.7 29.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.695 1.998 . . . . 0.0 106.573 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.3 p -129.77 123.16 30.32 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -144.17 154.72 43.44 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.583 0.753 . . . . 0.0 109.183 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 41.89 42.31 2.2 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.783 1.174 . . . . 0.0 111.649 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 62.42 7.12 2.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.552 1.941 . . . . 0.0 114.805 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -106.31 173.12 6.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.861 2.064 . . . . 0.0 111.088 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.8 135.12 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.588 1.955 . . . . 0.0 110.737 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -139.65 155.35 47.46 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 120.787 -1.195 . . . . 0.0 113.256 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 157.49 32.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -52.31 -54.47 31.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.241 1.017 . . . . 0.0 110.161 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -52.67 -46.35 67.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.124 0.875 . . . . 0.0 111.256 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.332 1.3 m -61.29 -41.27 96.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.381 0.992 . . . . 0.0 111.73 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.49 -4.14 89.42 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.582 1.083 . . . . 0.0 113.553 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.236 0.373 0 C-N-CA 126.326 1.85 . . . . 0.0 110.592 -179.344 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.753 0 CA-C-O 121.395 0.442 . . . . 0.0 113.063 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -58.61 112.36 1.58 Allowed 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 115.794 -2.051 . . . . 0.0 108.282 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.9 t -41.81 -36.33 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 122.312 2.324 . . . . 0.0 112.785 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.55 -13.93 58.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.77 -3.62 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 120.877 1.671 . . . . 0.0 115.431 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 m 59.49 8.03 1.12 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 130.18 3.392 . . . . 0.0 115.083 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -58.79 153.09 44.43 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 120.0 1.273 . . . . 0.0 110.315 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.0 122.9 9.21 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.82 1.68 . . . . 0.0 108.526 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mm -74.12 144.13 12.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 123.121 0.568 . . . . 0.0 110.842 179.791 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -129.5 165.18 22.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.407 1.883 . . . . 0.0 108.675 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.0 mm -116.37 151.46 18.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 m -131.27 117.83 19.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -145.43 130.6 18.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 55.66 23.62 6.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 111.231 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . 0.272 2.3 m-20 72.49 -0.68 3.21 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 130.004 3.322 . . . . 0.0 113.482 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -81.8 164.01 21.96 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.02 135.15 51.95 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.382 -1.448 . . . . 0.0 114.153 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.505 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 3.6 m-90 -132.07 125.91 32.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -73.84 154.54 39.44 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -49.97 -55.08 16.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.598 1.09 . . . . 0.0 109.178 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -65.66 -3.28 4.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.97 1.708 . . . . 0.0 115.554 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . 0.282 1.7 m -119.31 -3.01 10.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.58 -1.676 . . . . 0.0 114.369 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -91.04 102.54 15.3 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.181 1.392 . . . . 0.0 108.583 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -154.12 172.13 18.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.5 122.81 18.05 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 117.019 -1.467 . . . . 0.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -27.1 65.12 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.762 1.164 . . . . 0.0 113.524 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -75.81 -20.51 58.14 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.17 -12.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.272 18.0 m 85.92 10.6 0.25 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.726 1.61 . . . . 0.0 115.119 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.67 131.95 32.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 m -56.63 136.09 54.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.552 1.141 . . . . 0.0 111.611 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.1 mt -103.21 -1.11 29.48 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.79 142.04 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 20.85 73.63 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.628 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -152.94 148.21 26.85 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.039 1.419 . . . . 0.0 109.768 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.0 152.71 44.3 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -135.73 171.65 14.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.92 1.36 . . . . 0.0 111.652 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.08 145.45 24.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.1 p -134.45 103.39 5.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.619 1.168 . . . . 0.0 109.47 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -140.58 152.36 45.41 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 53.23 17.15 0.94 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.05 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.3 mttt 86.56 -0.1 0.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 129.313 3.045 . . . . 0.0 112.282 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -89.55 -179.04 5.71 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.504 1.521 . . . . 0.0 109.619 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.0 pt -131.44 136.01 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.512 2.325 . . . . 0.0 106.509 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -148.56 157.26 43.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 123.126 1.441 . . . . 0.0 113.199 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 153.81 39.79 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -66.34 -38.38 87.5 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.918 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -54.24 -26.74 30.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.25 1.42 . . . . 0.0 113.916 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.0 m -97.29 -45.08 6.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.208 1.803 . . . . 0.0 109.123 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.03 11.4 57.54 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 CA-C-N 118.969 1.385 . . . . 0.0 108.524 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.032 0 CA-C-O 121.639 0.577 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.9 t -59.87 121.4 11.66 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 117.275 -1.345 . . . . 0.0 108.636 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -52.21 -29.76 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.727 1.148 . . . . 0.0 111.346 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.4 -4.05 59.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 p -153.48 -7.08 0.17 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.156 1.343 . . . . 0.0 114.084 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 54.02 37.83 27.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.435 2.294 . . . . 0.0 112.642 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -100.05 151.91 37.66 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.47 137.57 30.87 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 O-C-N 124.554 1.818 . . . . 0.0 108.55 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.94 121.22 60.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 123.094 0.558 . . . . 0.0 110.48 -179.868 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.433 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.73 164.22 30.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.03 0.443 . . . . 0.0 111.85 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.2 mm -121.3 125.81 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.3 m -103.39 102.93 12.88 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -124.9 136.92 54.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 40.38 46.23 1.99 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.401 1.881 . . . . 0.0 112.697 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 51.05 35.63 13.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.075 1.75 . . . . 0.0 113.127 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -126.09 164.73 20.25 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 126.419 1.888 . . . . 0.0 107.206 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -109.73 131.57 54.94 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -132.21 133.14 43.82 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 108.324 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -73.76 147.1 43.81 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -49.21 -55.5 12.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.936 1.244 . . . . 0.0 110.189 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.92 -5.18 2.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.928 1.291 . . . . 0.0 113.994 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 m -118.65 -1.26 11.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 113.566 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -94.59 100.78 12.68 Favored 'General case' 0 N--CA 1.45 -0.46 1 N-CA-C 99.417 -4.29 . . . . 0.0 99.417 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -145.59 164.3 32.13 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.709 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.9 t -58.12 122.03 12.1 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 116.795 -1.574 . . . . 0.0 108.975 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.89 -25.56 30.82 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 123.985 0.803 . . . . 0.0 113.816 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -90.87 -18.37 24.93 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -143.87 -15.95 0.61 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.3 1.1 p 84.78 8.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.2 142.55 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 120.54 1.518 . . . . 0.0 110.158 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -64.81 105.16 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.514 1.925 . . . . 0.0 107.429 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.3 mt -88.54 -9.0 53.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.0 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.1 t -42.56 111.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.404 1.882 . . . . 0.0 112.4 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 12.51 63.02 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.28 -1.845 . . . . 0.0 117.304 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -110.39 167.73 9.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 121.432 2.616 . . . . 0.0 112.161 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 136.2 46.13 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -144.42 171.17 14.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.242 1.017 . . . . 0.0 110.905 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.42 160.66 33.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.954 0.902 . . . . 0.0 110.793 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 p -132.58 104.83 6.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.995 0.918 . . . . 0.0 109.653 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -142.37 152.45 42.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.18 31.89 7.3 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.499 1.52 . . . . 0.0 112.77 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.17 6.67 3.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.369 2.267 . . . . 0.0 113.014 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -108.53 176.84 4.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.698 1.599 . . . . 0.0 109.8 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -112.68 121.46 65.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.64 138.26 52.09 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 157.24 37.1 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -46.39 -54.43 9.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.353 1.061 . . . . 0.0 111.654 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -58.96 -31.33 68.63 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.1 -12.46 21.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 113.656 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.91 -24.31 20.49 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 101.91 -3.366 . . . . 0.0 101.91 177.666 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.95 0 CA-C-O 119.095 -0.836 . . . . 0.0 112.955 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 t -44.61 120.47 2.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.824 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.03 -32.31 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 120.63 1.559 . . . . 0.0 110.685 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.92 2.66 37.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 p -166.24 -3.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 119.19 -2.194 . . . . 0.0 114.707 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.54 10.21 2.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.763 3.225 . . . . 0.0 114.238 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -67.36 145.66 98.55 Favored Pre-proline 0 N--CA 1.47 0.565 0 O-C-N 120.122 -1.611 . . . . 0.0 109.402 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 137.68 45.45 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 O-C-N 124.35 1.711 . . . . 0.0 109.149 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -87.98 157.09 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.719 1.608 . . . . 0.0 107.216 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.233 0.215 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -178.27 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt . . . . . 0 C--O 1.238 0.449 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -145.77 146.73 31.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mm -88.77 120.74 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 p -107.38 110.22 22.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -139.46 137.77 35.86 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 42.4 54.91 4.24 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.842 1.657 . . . . 0.0 112.114 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.92 13.89 0.61 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.851 1.661 . . . . 0.0 114.111 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -113.03 163.74 14.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.945 2.098 . . . . 0.0 108.949 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -120.95 131.94 54.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.938 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -124.61 138.28 54.32 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.113 1.365 . . . . 0.0 107.535 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -76.0 144.74 40.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.5 t -51.53 -51.53 54.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -61.9 -11.24 12.05 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 114.156 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.2 m -123.66 11.31 9.13 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.624 1.17 . . . . 0.0 113.382 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.99 101.16 13.19 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 101.231 -3.618 . . . . 0.0 101.231 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -141.35 168.82 18.86 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.89 121.04 13.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 116.424 -1.751 . . . . 0.0 108.287 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.82 -32.26 58.83 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 120.919 1.69 . . . . 0.0 113.45 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -82.67 -22.32 34.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.38 -7.92 1.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.393 83.7 p 66.64 29.94 8.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -86.9 147.07 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -58.06 134.96 56.88 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 111.484 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 mt -112.12 1.69 16.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.708 1.203 . . . . 0.0 110.818 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.82 107.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.342 2.657 . . . . 0.0 110.636 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.69 -17.57 3.44 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.968 1.747 . . . . 0.0 115.482 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 112.62 22.77 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -40.88 142.06 0.87 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.243 1.401 . . . . 0.0 111.149 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -135.66 170.55 15.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.04 162.12 13.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.287 1.435 . . . . 0.0 108.052 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 p -141.92 102.92 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -130.33 154.94 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 m120 48.95 36.02 7.7 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.852 1.261 . . . . 0.0 112.728 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm 55.76 21.76 4.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.491 1.116 . . . . 0.0 112.181 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -117.36 -178.54 3.48 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.165 1.786 . . . . 0.0 109.609 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 pt -123.34 122.7 65.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.805 1.642 . . . . 0.0 110.461 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -136.16 140.02 43.3 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.205 -0.934 . . . . 0.0 111.486 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.79 163.33 27.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -42.84 -62.79 0.92 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.226 1.81 . . . . 0.0 111.975 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -52.63 -41.03 63.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.877 0.871 . . . . 0.0 112.825 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.4 -46.99 58.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.551 0.614 . . . . 0.0 110.068 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.57 -3.01 46.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.987 0.803 . . . . 0.0 113.506 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.544 0.74 0 C-N-CA 126.973 2.109 . . . . 0.0 112.588 179.756 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.35 124.54 18.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.291 -1.814 . . . . 0.0 107.989 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -7.96 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 120.694 1.588 . . . . 0.0 112.319 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.28 4.96 25.19 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.026 1.73 . . . . 0.0 114.076 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 p -166.22 -4.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.286 61.6 p 54.83 12.83 0.63 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.6 3.16 . . . . 0.0 114.824 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.07 150.28 97.54 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.71 125.5 11.71 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.484 1.456 . . . . 0.0 108.665 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mm -68.32 148.19 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.13 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 pttm . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -145.15 164.96 29.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.932 2.093 . . . . 0.0 107.177 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -115.15 139.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 p -130.89 120.08 23.11 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.475 1.51 . . . . 0.0 107.921 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -145.37 150.53 36.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.303 1.841 . . . . 0.0 106.526 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 36.04 50.52 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.111 2.165 . . . . 0.0 114.081 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t0 53.89 39.74 30.77 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 113.189 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.6 t -134.22 164.71 26.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.07 1.748 . . . . 0.0 109.972 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -119.11 124.1 46.03 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.89 1.676 . . . . 0.0 111.605 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -130.71 123.99 30.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.796 1.284 . . . . 0.0 110.296 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -68.49 155.5 39.8 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -53.51 30.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.106 1.363 . . . . 0.0 112.589 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.1 -30.49 71.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.597 1.09 . . . . 0.0 113.607 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -84.81 0.08 52.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 117.416 -1.278 . . . . 0.0 113.457 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -98.77 100.5 11.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -155.85 170.28 22.45 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.0 115.42 4.05 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 115.713 -2.089 . . . . 0.0 106.493 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.11 -29.34 51.9 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 121.444 1.929 . . . . 0.0 112.902 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -75.55 -22.49 57.0 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.87 -13.9 0.83 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 118.621 2.823 . . . . 0.0 118.621 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.276 3.0 m 79.67 12.22 1.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.92 136.09 26.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.1 t -58.59 138.36 56.92 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.446 0.641 . . . . 0.0 109.87 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.47 2.04 20.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.577 1.551 . . . . 0.0 110.079 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.82 109.57 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.05 1.34 . . . . 0.0 110.441 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.19 -44.66 2.96 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.749 2.118 . . . . 0.0 113.409 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -64.76 160.93 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.854 1.327 . . . . 0.0 111.864 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.58 123.55 16.53 Favored Glycine 0 C--O 1.241 0.531 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -110.16 166.1 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.762 1.225 . . . . 0.0 109.561 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.82 147.98 47.12 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.45 103.82 6.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.956 1.302 . . . . 0.0 107.659 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -142.75 156.4 44.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 127.096 2.159 . . . . 0.0 106.441 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 57.86 21.68 7.83 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 62.81 23.08 13.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.045 1.338 . . . . 0.0 109.72 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -126.75 -178.84 4.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 127.443 2.297 . . . . 0.0 107.614 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 pt -130.56 134.5 62.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.986 0.898 . . . . 0.0 109.868 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -134.24 162.43 32.18 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 123.012 1.387 . . . . 0.0 114.138 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.23 161.51 23.93 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -54.16 -54.87 33.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.02 0.827 . . . . 0.0 111.08 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -56.41 -27.7 57.23 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.527 -1.358 . . . . 0.0 114.553 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 m -97.59 -18.4 18.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.612 1.165 . . . . 0.0 113.297 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.31 -23.85 10.05 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.815 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 t . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 125.823 1.649 . . . . 0.0 108.571 179.722 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 CA-C-O 119.728 -0.485 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -57.75 116.44 3.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.62 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.42 -14.0 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.783 0.833 . . . . 0.0 112.241 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.95 -0.71 38.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.368 1.467 . . . . 0.0 113.678 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -152.62 -11.21 0.17 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.792 -1.818 . . . . 0.0 114.917 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 2.9 p 49.91 53.51 12.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.615 1.966 . . . . 0.0 112.667 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -114.81 140.3 25.25 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.37 124.32 12.74 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.986 2.457 . . . . 0.0 110.454 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.74 135.76 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.007 1.723 . . . . 0.0 106.538 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 123.966 0.907 . . . . 0.0 109.816 179.608 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 C--O 1.24 0.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.29 164.57 31.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.482 1.513 . . . . 0.0 109.495 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.73 102.12 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.364 1.465 . . . . 0.0 109.061 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.3 m -82.19 114.67 20.86 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -145.83 147.7 32.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.279 0.945 . . . . 0.0 108.638 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 36.96 58.08 1.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.096 1.759 . . . . 0.0 111.537 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 p30 48.62 25.03 0.87 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.105 1.762 . . . . 0.0 114.968 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 t -128.49 165.46 20.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 127.911 2.484 . . . . 0.0 108.524 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.9 109.77 11.54 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.516 -0.74 . . . . 0.0 110.632 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -103.54 150.96 23.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.343 1.068 . . . . 0.0 108.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -82.5 152.5 26.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -57.52 -37.02 72.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.781 1.173 . . . . 0.0 108.923 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.8 -17.4 63.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 112.763 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.45 27.82 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -113.1 100.31 8.51 Favored 'General case' 0 C--O 1.237 0.436 1 N-CA-C 99.023 -4.436 . . . . 0.0 99.023 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -145.38 173.11 12.28 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.16 107.39 1.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.457 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.2 -31.34 26.5 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 119.57 1.077 . . . . 0.0 115.413 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -77.4 -23.86 50.59 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.26 -23.68 1.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t 74.37 85.13 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.632 1.573 . . . . 0.0 109.909 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -151.57 136.59 10.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 129.872 3.269 . . . . 0.0 104.682 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -54.54 146.45 16.31 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.659 1.219 . . . . 0.0 113.045 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -120.01 1.94 10.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 109.098 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.36 103.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 125.659 1.583 . . . . 0.0 107.178 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 5.89 86.87 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.272 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -112.86 87.7 2.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.249 1.524 . . . . 0.0 107.969 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -20.67 109.79 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 128.501 2.953 . . . . 0.0 113.139 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -111.14 165.02 12.25 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.378 1.071 . . . . 0.0 112.752 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.58 151.15 24.69 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.913 1.685 . . . . 0.0 107.734 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -124.4 109.05 12.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.103 1.361 . . . . 0.0 108.677 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -142.49 152.76 43.01 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 45.78 32.52 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.479 1.912 . . . . 0.0 111.354 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.06 -9.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.782 2.833 . . . . 0.0 112.813 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.97 -176.02 5.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.971 2.108 . . . . 0.0 110.747 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.05 126.18 21.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 127.619 2.368 . . . . 0.0 110.589 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -139.58 155.77 47.27 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.464 -1.397 . . . . 0.0 113.689 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.17 154.67 41.64 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -53.15 -51.69 61.16 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.248 1.019 . . . . 0.0 111.283 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -52.54 -46.06 66.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.018 1.281 . . . . 0.0 111.272 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.5 m -65.45 -47.03 77.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.469 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -17.08 73.43 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.041 0.837 . . . . 0.0 112.743 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.445 -0.7 0 C-N-CA 125.229 1.412 . . . . 0.0 108.44 179.919 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.8 125.3 24.39 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 116.732 -1.604 . . . . 0.0 107.39 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -57.94 -27.28 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 120.841 1.655 . . . . 0.0 109.015 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.22 12.12 14.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.982 2.913 . . . . 0.0 116.831 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -171.7 -7.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 118.609 -2.557 . . . . 0.0 114.229 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 58.28 9.85 1.13 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.644 2.778 . . . . 0.0 114.658 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -72.74 154.92 91.19 Favored Pre-proline 0 CA--C 1.517 -0.299 0 O-C-N 120.868 -1.145 . . . . 0.0 110.662 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.61 146.34 84.18 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.364 2.042 . . . . 0.0 108.871 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.4 mt -109.32 122.0 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.772 2.429 . . . . 0.0 106.772 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m . . . . . 0 N--CA 1.445 -0.683 0 C-N-CA 124.494 1.118 . . . . 0.0 108.603 -179.873 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--O 1.239 0.517 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.28 165.35 28.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 111.297 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -128.99 146.28 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.808 1.643 . . . . 0.0 107.765 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -132.81 119.06 19.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.75 143.89 48.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 37.2 56.14 1.31 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.07 1.748 . . . . 0.0 114.178 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t0 55.14 24.59 6.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.678 1.191 . . . . 0.0 112.806 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 14.7 m -127.69 131.49 49.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.777 1.631 . . . . 0.0 109.949 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -90.73 130.28 36.74 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.393 0.677 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 2.6 m-90 -131.09 133.32 45.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.501 1.143 . . . . 0.0 110.873 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.39 154.35 41.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 p -61.22 -36.24 79.39 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -74.07 4.25 5.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.746 1.618 . . . . 0.0 113.12 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -139.97 21.75 2.45 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.445 1.021 . . . . 0.0 113.002 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -109.34 99.76 8.96 Favored 'General case' 0 C--O 1.237 0.443 1 N-CA-C 98.356 -4.683 . . . . 0.0 98.356 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -152.63 176.16 12.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.467 ' C ' ' H ' ' A' ' 40' ' ' LYS . 20.8 t -59.69 111.64 1.51 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.891 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.82 13.22 0.09 OUTLIER Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.165 1.84 . . . . 0.0 115.348 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 38' ' ' CYS . 62.8 mttt -128.03 -18.64 4.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.411 2.684 . . . . 0.0 112.757 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 -17.43 0.82 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 m 84.36 1.43 0.87 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.224 1.81 . . . . 0.0 115.463 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.81 126.44 28.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 t -52.05 142.81 15.22 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.475 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -115.81 -2.5 12.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.809 1.244 . . . . 0.0 110.924 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.17 126.12 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.647 0.779 . . . . 0.0 109.356 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.36 69.48 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.016 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -131.45 167.25 19.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 121.128 2.464 . . . . 0.0 112.547 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.97 127.73 33.45 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.01 171.49 14.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.732 1.213 . . . . 0.0 110.015 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -121.52 156.55 32.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.885 1.674 . . . . 0.0 109.188 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 p -137.45 102.59 4.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.28 147.64 47.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 108.757 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 52.81 23.78 2.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.775 2.03 . . . . 0.0 114.322 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? 78.61 12.4 1.52 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.043 2.137 . . . . 0.0 111.784 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -105.78 -178.39 3.64 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.748 -1.22 . . . . 0.0 109.4 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -128.45 122.17 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.714 1.606 . . . . 0.0 108.395 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -138.08 157.28 46.65 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 123.111 1.434 . . . . 0.0 114.794 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.45 155.52 37.93 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -47.26 -52.92 14.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.765 0.711 . . . . 0.0 111.557 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -58.57 7.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.534 0.734 . . . . 0.0 112.171 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.11 -23.11 44.71 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.619 -1.181 . . . . 0.0 113.728 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.36 -24.13 10.53 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 120.213 1.37 . . . . 0.0 112.355 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 179.776 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.681 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.428 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 11.6 t -61.89 126.04 25.94 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.89 -20.23 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 119.336 0.971 . . . . 0.0 111.493 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.73 3.62 45.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 115.487 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -155.94 -9.69 0.11 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.023 -1.673 . . . . 0.0 113.723 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m 53.38 29.06 8.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.533 1.933 . . . . 0.0 111.675 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -89.41 151.09 45.82 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.802 -1.186 . . . . 0.0 108.178 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 118.37 5.64 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.273 1.982 . . . . 0.0 110.027 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mm -65.29 162.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.514 1.526 . . . . 0.0 107.632 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm . . . . . 0 C--O 1.24 0.554 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -142.32 164.51 29.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.558 1.943 . . . . 0.0 106.644 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.59 130.34 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.234 1.814 . . . . 0.0 106.427 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.7 124.11 38.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.05 122.56 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 40.92 59.02 2.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.998 1.719 . . . . 0.0 112.848 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 63.66 12.23 6.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.265 2.226 . . . . 0.0 114.913 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 158.51 28.79 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.547 -1.346 . . . . 0.0 110.629 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.24 133.26 56.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.588 0.709 . . . . 0.0 110.855 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -123.88 126.8 47.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -67.08 148.79 51.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.11 -51.64 23.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.098 0.863 . . . . 0.0 112.438 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.22 -13.33 61.87 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -102.64 -12.68 17.53 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -80.43 101.52 9.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.24 168.57 19.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.2 t -65.23 114.91 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 116.663 -1.637 . . . . 0.0 110.049 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.82 -18.62 25.96 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.498 1.045 . . . . 0.0 115.528 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.13 -17.37 23.85 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.0 -20.21 0.5 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 118.601 2.815 . . . . 0.0 118.601 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 m 77.14 80.54 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.536 1.062 . . . . 0.0 109.888 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.64 141.57 18.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 126.832 2.053 . . . . 0.0 105.749 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -58.56 121.7 11.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.79 1.306 . . . . 0.0 113.626 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.4 mt -99.37 1.73 44.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.072 0.949 . . . . 0.0 109.659 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.68 140.71 19.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 -62.19 3.84 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.252 1.406 . . . . 0.0 112.777 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 164.81 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.849 0.859 . . . . 0.0 112.494 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.3 156.44 39.39 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -137.93 168.48 19.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.586 1.154 . . . . 0.0 107.946 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.61 161.01 24.56 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.7 p -127.41 115.82 19.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.247 1.419 . . . . 0.0 107.607 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -143.17 150.59 39.6 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 51.39 24.72 2.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.896 1.678 . . . . 0.0 114.107 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt 73.79 9.99 4.76 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.751 2.02 . . . . 0.0 111.277 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -110.68 -178.01 3.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.06 2.144 . . . . 0.0 110.136 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.3 pt -123.96 126.99 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.892 0.877 . . . . 0.0 110.465 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -130.28 163.32 27.04 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.468 -1.395 . . . . 0.0 113.254 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.21 156.98 19.44 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -57.36 -47.05 82.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 119.257 0.935 . . . . 0.0 110.136 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -52.25 -37.43 55.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.75 -1.219 . . . . 0.0 113.541 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.77 -35.6 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.234 1.014 . . . . 0.0 110.622 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.79 33.32 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.104 1.335 . . . . 0.0 110.005 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.449 -0.522 0 CA-C-N 118.783 1.291 . . . . 0.0 110.739 -177.895 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 N-CA-C 115.325 0.89 . . . . 0.0 115.325 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.0 t -50.52 117.28 2.34 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.582 -1.199 . . . . 0.0 107.948 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -54.97 -27.34 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 120.94 1.7 . . . . 0.0 110.83 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.86 -3.69 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.673 1.989 . . . . 0.0 115.175 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -152.62 -10.25 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.446 1.476 . . . . 0.0 114.24 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m 60.3 10.32 2.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.517 3.527 . . . . 0.0 115.642 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -75.67 151.54 84.84 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 120.911 1.687 . . . . 0.0 112.403 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -66.94 139.43 51.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.817 2.344 . . . . 0.0 109.019 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.76 156.71 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.415 2.286 . . . . 0.0 108.68 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 124.321 1.049 . . . . 0.0 111.146 178.523 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 C--O 1.236 0.362 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -130.83 164.58 24.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.51 0.724 . . . . 0.0 111.077 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 mm -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 128.837 2.855 . . . . 0.0 105.932 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.34 102.96 15.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -135.49 127.22 29.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.403 1.002 . . . . 0.0 110.632 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 50.24 45.44 25.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.38 1.072 . . . . 0.0 109.227 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.91 -17.55 0.25 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 129.735 3.214 . . . . 0.0 114.325 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 m -73.64 164.53 26.52 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.133 0.879 . . . . 0.0 109.3 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -128.95 107.73 9.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -109.05 125.57 52.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 111.12 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -60.47 150.08 32.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -55.33 -42.42 73.77 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.72 -3.82 20.56 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.2 -1.46 11.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 128.959 2.904 . . . . 0.0 113.909 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.98 102.57 15.14 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -152.77 174.59 13.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.27 120.47 11.63 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 117.264 -1.35 . . . . 0.0 110.075 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.14 -12.27 29.8 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.627 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.37 -19.67 16.18 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.98 -10.59 0.88 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 81.11 1.22 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.23 138.9 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.218 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -55.33 134.25 50.01 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.313 1.045 . . . . 0.0 111.773 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 mt -117.99 4.75 12.09 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.69 -1.148 . . . . 0.0 109.695 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 t -36.76 103.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.482 1.913 . . . . 0.0 112.525 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 -25.17 0.9 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 129.064 3.221 . . . . 0.0 115.928 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -55.0 138.27 44.21 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.662 1.985 . . . . 0.0 112.128 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.14 121.73 27.14 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -116.36 172.6 7.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.866 2.067 . . . . 0.0 111.719 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.01 148.12 33.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.0 p -126.52 117.26 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.11 143.93 32.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 50.6 28.74 3.64 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.981 1.264 . . . . 0.0 113.958 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm 64.85 22.72 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.734 1.214 . . . . 0.0 111.145 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -110.2 178.57 4.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.129 2.172 . . . . 0.0 106.751 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.81 122.95 55.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 109.532 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -131.55 154.58 48.67 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 122.893 1.33 . . . . 0.0 113.197 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 164.51 19.75 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -59.02 -54.44 47.1 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.925 0.784 . . . . 0.0 111.135 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -50.52 -30.18 12.33 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.4 m -93.96 -30.72 14.6 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.231 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.55 7.53 59.67 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.96 1.255 . . . . 0.0 115.356 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.234 0.246 0 CA-C-N 119.455 1.628 . . . . 0.0 113.276 -179.05 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 CA-C-O 120.127 -0.263 . . . . 0.0 112.743 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 12.4 t -52.13 115.38 1.68 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.737 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.2 t -54.94 -24.36 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 121.287 1.858 . . . . 0.0 112.481 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.96 -0.57 56.81 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.666 1.186 . . . . 0.0 113.841 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.8 p -156.71 -11.37 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.268 1.849 . . . . 0.0 115.075 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t 52.44 57.63 6.23 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.004 2.522 . . . . 0.0 111.598 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -117.84 147.11 40.46 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.883 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.55 114.03 2.94 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.013 3.142 . . . . 0.0 113.537 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -82.95 162.09 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 CA--C 1.529 0.159 0 O-C-N 120.69 -1.256 . . . . 0.0 110.657 179.171 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.39 165.72 26.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.544 1.938 . . . . 0.0 109.294 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mm -116.52 150.37 18.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -131.38 135.08 46.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -145.21 111.38 5.61 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.43 56.81 6.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.143 0.973 . . . . 0.0 109.682 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 -16.89 0.09 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 130.013 3.325 . . . . 0.0 115.191 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.7 m -80.08 145.64 32.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -119.87 141.69 49.34 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.976 0.893 . . . . 0.0 112.528 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.8 m-90 -132.86 162.9 30.33 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.145 1.378 . . . . 0.0 111.143 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -79.78 148.43 31.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.4 t -60.55 -8.94 3.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.728 2.011 . . . . 0.0 115.042 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.96 -36.74 5.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.001 1.721 . . . . 0.0 108.83 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.26 18.28 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.866 1.667 . . . . 0.0 114.913 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -113.2 101.35 9.34 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -148.57 174.72 11.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -61.19 121.05 11.56 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.503 1.521 . . . . 0.0 109.779 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.49 -25.75 58.55 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 118.133 0.424 . . . . 0.0 113.069 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -87.45 -18.8 29.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.63 -9.92 0.41 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 119.082 2.993 . . . . 0.0 119.082 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 83.44 3.23 0.94 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.37 133.69 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.445 1.475 . . . . 0.0 107.303 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.0 t -57.36 144.67 35.2 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.684 0.754 . . . . 0.0 109.852 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.21 -6.56 14.1 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.325 . . . . 0.0 110.197 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.82 120.24 10.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.73 84.83 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 116.163 -2.465 . . . . 0.0 115.923 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -135.21 169.47 17.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.635 2.717 . . . . 0.0 112.204 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.25 123.54 25.92 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -116.62 167.88 10.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.19 159.81 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.8 p -132.3 112.06 11.9 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.919 0.762 . . . . 0.0 109.504 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -142.7 156.12 44.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.632 1.573 . . . . 0.0 107.341 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.9 m120 52.5 30.73 8.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.349 1.06 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.7 27.43 14.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.03 1.332 . . . . 0.0 110.708 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -125.63 175.55 7.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.192 2.197 . . . . 0.0 110.24 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.39 126.4 69.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 127.715 2.406 . . . . 0.0 110.021 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -134.03 163.52 29.37 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 161.2 16.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -50.23 -56.39 11.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.772 1.229 . . . . 0.0 111.215 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -49.8 -33.63 17.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 113.249 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.2 -54.85 5.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.369 0.668 . . . . 0.0 109.319 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.72 26.62 4.62 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 115.621 1.008 . . . . 0.0 115.621 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.734 0 CA-C-N 119.578 1.689 . . . . 0.0 112.776 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.959 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m -62.73 -6.22 3.44 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -71.07 -13.57 62.02 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.85 -178.96 48.81 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 120.544 1.52 . . . . 0.0 112.061 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.7 t -108.76 175.56 5.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.394 1.478 . . . . 0.0 109.012 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -158.69 179.46 9.09 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.451 1.5 . . . . 0.0 110.876 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.76 176.53 19.43 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.752 1.644 . . . . 0.0 110.488 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -43.0 118.49 1.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 116.197 -1.859 . . . . 0.0 110.423 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.15 -31.36 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 121.753 2.069 . . . . 0.0 112.025 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.68 -5.37 59.31 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -157.95 -7.66 0.08 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 0.1 OUTLIER 61.77 14.34 6.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 130.164 3.386 . . . . 0.0 114.914 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -78.25 147.04 71.97 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 120.453 -1.404 . . . . 0.0 108.646 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.16 120.32 6.93 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.259 2.639 . . . . 0.0 110.07 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mm -66.53 140.45 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 p -82.23 79.56 8.68 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 14.29 -101.55 0.01 OUTLIER Glycine 0 C--N 1.335 0.507 1 C-N-CA 131.118 4.199 . . . . 0.0 114.388 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mp -127.11 30.14 5.48 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.218 1.807 . . . . 0.0 107.176 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.1 m -67.12 -7.35 22.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.216 1.806 . . . . 0.0 113.123 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.98 9.88 15.16 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.045 -1.034 . . . . 0.0 113.735 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.71 159.69 30.84 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.791 1.296 . . . . 0.0 109.461 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -97.11 109.09 21.92 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -134.43 164.28 27.8 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.499 0.72 . . . . 0.0 110.514 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mm -122.43 145.96 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 127.271 2.229 . . . . 0.0 106.283 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -126.83 102.82 7.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -121.95 127.62 50.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 52.85 43.59 31.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.968 0.907 . . . . 0.0 108.781 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 56.91 0.51 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.007 2.523 . . . . 0.0 114.41 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 m -85.39 156.46 20.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.932 1.693 . . . . 0.0 107.831 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.99 130.31 51.63 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -132.3 145.09 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.647 1.179 . . . . 0.0 109.026 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -98.39 161.26 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 p -53.09 -55.02 27.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.938 0.895 . . . . 0.0 111.651 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.29 -4.05 9.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.054 1.341 . . . . 0.0 112.98 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.48 14.87 11.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.911 1.284 . . . . 0.0 113.298 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -107.41 101.3 10.67 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -157.2 167.04 31.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.4 t -64.86 120.83 13.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 117.111 -1.423 . . . . 0.0 109.799 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.04 -28.66 58.56 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.917 1.235 . . . . 0.0 114.396 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -81.04 -19.86 42.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.6 p -139.71 -23.05 0.87 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t 87.76 7.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.356 1.863 . . . . 0.0 114.467 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.94 135.23 27.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -60.21 132.34 53.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -98.21 -1.6 41.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 108.946 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.06 109.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 -65.93 0.31 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 126.069 1.795 . . . . 0.0 109.072 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -66.65 157.08 33.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.049 0.94 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.06 20.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -106.59 168.77 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.215 1.006 . . . . 0.0 109.187 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.95 152.28 42.66 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.868 1.667 . . . . 0.0 108.365 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 p -134.23 114.85 13.49 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.535 1.134 . . . . 0.0 110.6 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.402 ' HG2' HD21 ' A' ' 54' ' ' ASN . 31.8 tt0 -142.64 143.23 32.28 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.622 1.569 . . . . 0.0 106.907 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.402 HD21 ' HG2' ' A' ' 53' ' ' GLN . 8.8 m-80 53.76 25.32 5.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.873 0.869 . . . . 0.0 111.493 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt 73.15 3.61 4.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.119 1.768 . . . . 0.0 111.127 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.7 153.18 18.41 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.289 1.436 . . . . 0.0 109.825 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.75 122.46 55.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 109.931 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -137.13 166.49 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.795 1.283 . . . . 0.0 111.848 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.24 163.6 19.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -55.74 -55.51 31.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.052 1.341 . . . . 0.0 111.306 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -52.71 -48.87 66.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.361 -0.837 . . . . 0.0 112.886 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 m -68.62 -44.59 73.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.349 0.66 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 22.59 7.65 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 120.939 -1.1 . . . . 0.0 113.759 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m -75.3 92.62 2.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.369 1.585 . . . . 0.0 107.441 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.93 56.25 3.52 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.53 1.538 . . . . 0.0 111.612 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.76 132.96 52.57 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -85.34 63.0 7.84 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.0 p -59.35 -66.54 0.49 Allowed 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.502 -0.749 . . . . 0.0 111.863 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.04 167.79 28.38 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.598 2.359 . . . . 0.0 109.719 -176.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -92.48 6.22 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.731 1.612 . . . . 0.0 112.551 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.2 t -152.81 151.63 30.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.26 -74.49 0.44 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 106.751 -2.539 . . . . 0.0 106.751 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.3 62.06 6.8 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.9 3.067 . . . . 0.0 110.628 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 m -162.78 179.26 7.78 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.858 2.863 . . . . 0.0 107.564 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.4 100.49 5.99 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 N-CA-C 105.634 -2.987 . . . . 0.0 105.634 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.762 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -71.35 130.38 41.21 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.7 -9.98 35.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.806 0.842 . . . . 0.0 110.856 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.71 -174.27 30.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.6 p -113.55 1.1 14.87 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.152 -1.404 . . . . 0.0 113.139 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 m 3.71 89.81 0.01 OUTLIER 'General case' 0 C--O 1.24 0.579 0 C-N-CA 130.237 3.415 . . . . 0.0 112.522 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.25 -168.85 23.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.492 -0.861 . . . . 0.0 115.149 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.404 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.6 t -60.71 113.56 2.54 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 117.243 -1.36 . . . . 0.0 110.21 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.6 t -57.83 -20.36 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 120.091 1.314 . . . . 0.0 110.438 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.6 -3.76 58.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.072 1.349 . . . . 0.0 114.078 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 p -155.44 -10.53 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.408 1.913 . . . . 0.0 115.673 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m 55.17 53.32 10.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.331 2.252 . . . . 0.0 112.589 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -113.7 137.3 22.18 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 108.61 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.92 3.08 . . . . 0.0 110.113 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.44 129.83 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.65 173.56 1.25 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.69 0.396 . . . . 0.0 111.819 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 19' ' ' THR . . . -64.53 -174.06 3.67 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.22 19.97 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.045 1.338 . . . . 0.0 114.604 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 17' ' ' GLY . 11.1 t -72.8 32.19 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.444 3.098 . . . . 0.0 111.494 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.25 2.63 57.89 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.583 -1.323 . . . . 0.0 113.638 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 105.96 0.73 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.335 1.067 . . . . 0.0 109.684 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.482 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -74.46 117.61 16.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -137.89 166.77 23.23 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.406 1.882 . . . . 0.0 109.991 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.2 mm -125.25 114.87 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 p -104.41 117.29 33.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.139 1.776 . . . . 0.0 107.525 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -145.58 143.48 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.209 1.004 . . . . 0.0 109.218 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 31.52 60.37 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.872 2.469 . . . . 0.0 114.372 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 65.19 5.36 3.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.916 2.487 . . . . 0.0 114.972 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -116.09 161.85 18.3 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 0.0 111.079 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -125.72 141.1 52.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.462 1.125 . . . . 0.0 110.168 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -132.58 152.42 51.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.225 1.41 . . . . 0.0 109.555 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -86.15 141.57 29.27 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.67 -55.79 4.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.021 1.328 . . . . 0.0 111.071 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -65.56 -12.68 55.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -118.15 16.56 14.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.411 0.685 . . . . 0.0 111.869 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -106.92 101.56 10.99 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.88 176.34 12.28 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.9 t -58.11 118.93 5.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 117.088 -1.434 . . . . 0.0 109.731 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.07 -11.51 12.23 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 123.968 0.793 . . . . 0.0 114.787 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -102.74 -21.52 14.06 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.093 1.357 . . . . 0.0 114.595 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.68 -14.21 0.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.993 2.59 . . . . 0.0 117.993 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 t 81.62 27.46 0.18 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.833 1.652 . . . . 0.0 114.725 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.75 128.49 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -51.3 136.51 24.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.141 1.377 . . . . 0.0 111.691 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.1 mt -112.41 3.74 17.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.561 1.144 . . . . 0.0 110.215 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.81 105.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 126.594 1.958 . . . . 0.0 108.641 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.45 36.13 92.08 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.517 -0.602 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -132.99 160.97 35.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.483 1.141 . . . . 0.0 107.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.44 124.82 30.29 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.7 171.08 14.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.125 . . . . 0.0 109.243 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 60' ' ' GLN . 5.1 mp -136.13 156.84 48.11 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.271 1.828 . . . . 0.0 106.442 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.4 p -137.46 115.4 11.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -142.48 145.79 34.07 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 48.42 41.92 17.54 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.909 1.283 . . . . 0.0 111.465 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.397 5.0 ptpp? 61.43 7.87 1.95 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.189 2.995 . . . . 0.0 114.62 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.95 178.07 5.4 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.368 1.44 . . . . 0.0 110.889 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.31 122.81 60.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 109.535 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.14 160.14 35.61 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.667 -1.27 . . . . 0.0 112.811 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.91 162.43 16.91 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.422 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.28 -52.73 60.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.041 1.291 . . . . 0.0 111.372 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -40.28 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.145 1.339 . . . . 0.0 113.302 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -78.46 -29.05 46.65 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.715 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.47 13.76 61.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.108 1.813 . . . . 0.0 113.342 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -84.17 79.73 9.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.6 156.21 4.83 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.4 ttm -145.22 120.03 9.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -120.82 94.81 4.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.2 t -161.1 -22.35 0.05 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.55 0.74 . . . . 0.0 112.53 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -156.31 110.04 2.72 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.9 mt -77.28 72.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.4 m -71.84 64.19 0.48 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 128.186 2.594 . . . . 0.0 109.086 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.08 73.59 0.32 Allowed Glycine 0 C--N 1.334 0.447 0 CA-C-O 117.949 -1.473 . . . . 0.0 114.344 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.6 22.7 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.28 2.653 . . . . 0.0 111.949 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.4 p -55.71 -45.4 77.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.126 1.77 . . . . 0.0 109.312 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.6 m -142.02 179.78 6.68 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 128.268 2.627 . . . . 0.0 107.443 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 N-CA-C 105.574 -3.01 . . . . 0.0 105.574 -179.851 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 t -114.57 164.95 13.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -161.77 168.66 22.79 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.133 1.373 . . . . 0.0 107.764 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.46 60.05 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 m -125.7 116.35 21.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.242 1.017 . . . . 0.0 108.72 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 m -67.4 88.56 0.2 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.32 1.448 . . . . 0.0 109.898 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.79 -165.77 38.23 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 126.291 1.901 . . . . 0.0 108.368 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 t -58.56 125.4 23.24 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 117.619 -1.182 . . . . 0.0 108.943 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.3 -17.01 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 124.731 1.213 . . . . 0.0 112.052 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.85 9.43 22.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.239 2.216 . . . . 0.0 115.083 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.1 -5.3 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.426 -1.421 . . . . 0.0 114.351 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t 62.15 0.6 0.59 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.381 1.872 . . . . 0.0 113.755 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -82.58 156.4 68.21 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 122.359 2.345 . . . . 0.0 112.271 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.23 122.82 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.452 2.101 . . . . 0.0 108.837 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -76.33 151.26 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -66.17 139.33 58.12 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.44 -176.08 10.91 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.09 37.9 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.215 2.606 . . . . 0.0 116.274 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 t -99.0 32.08 2.79 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.702 2.401 . . . . 0.0 107.52 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.19 38.73 7.15 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 124.553 1.073 . . . . 0.0 110.566 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.94 107.58 20.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.396 1.479 . . . . 0.0 112.625 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -64.6 110.77 2.45 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.23 1.012 . . . . 0.0 110.187 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -137.41 164.65 28.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.538 1.535 . . . . 0.0 108.844 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.29 140.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -131.47 132.94 44.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.731 2.012 . . . . 0.0 106.272 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -145.57 102.74 3.73 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.703 1.601 . . . . 0.0 108.587 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.5 64.68 1.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 109.796 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 49.8 t0 42.66 67.32 0.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.468 2.707 . . . . 0.0 113.245 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.8 p -134.99 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 130.103 3.361 . . . . 0.0 106.951 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -142.53 118.06 10.34 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -131.55 131.61 43.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.305 1.042 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -66.45 154.97 38.83 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -53.03 -43.41 66.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.157 0.98 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.62 -2.69 33.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -121.12 18.68 11.61 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 0.0 114.442 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -112.38 100.08 8.51 Favored 'General case' 0 C--O 1.235 0.333 1 N-CA-C 100.193 -4.002 . . . . 0.0 100.193 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.63 160.53 40.12 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.7 t -58.9 124.23 19.15 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.444 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.88 -28.06 72.15 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 118.425 0.557 . . . . 0.0 113.362 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -78.83 -28.63 44.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.78 -10.84 1.02 Allowed 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t 72.62 87.77 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.907 1.337 . . . . 0.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.98 143.29 18.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 127.556 2.342 . . . . 0.0 104.801 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.7 t -65.55 142.71 58.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.252 1.025 . . . . 0.0 109.867 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.32 13.15 11.87 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.044 1.738 . . . . 0.0 109.658 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.9 t -76.97 -63.49 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 119.035 0.834 . . . . 0.0 108.761 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.61 11.9 6.6 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.206 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.97 159.1 44.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.665 1.732 . . . . 0.0 109.897 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.65 159.14 52.41 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -132.46 167.4 20.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.697 1.599 . . . . 0.0 108.425 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -125.29 159.02 32.7 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -126.72 107.84 10.53 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.991 1.716 . . . . 0.0 109.489 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -142.44 155.21 45.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m120 47.66 41.53 13.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.873 1.269 . . . . 0.0 112.197 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt 50.74 19.75 0.65 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.931 2.092 . . . . 0.0 113.882 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -123.82 176.26 6.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.494 1.918 . . . . 0.0 109.389 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.6 pt -112.92 131.67 63.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.674 1.189 . . . . 0.0 111.511 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.0 165.51 25.5 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.51 1.148 . . . . 0.0 113.69 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.72 156.64 20.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -54.9 -52.38 63.06 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.532 1.133 . . . . 0.0 109.554 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -55.07 -26.14 35.67 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.219 -1.551 . . . . 0.0 114.558 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.21 -22.97 16.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.731 1.612 . . . . 0.0 112.808 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.3 -4.38 55.13 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.492 1.044 . . . . 0.0 113.529 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.1 t -61.9 107.56 0.87 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.914 1.686 . . . . 0.0 108.023 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.47 -173.62 26.65 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 126.163 1.84 . . . . 0.0 108.999 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.24 -30.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.01 1.324 . . . . 0.0 110.114 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.6 13.42 7.28 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.608 1.963 . . . . 0.0 113.915 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 t -146.36 145.85 30.45 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.523 1.056 . . . . 0.0 108.528 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -72.75 -7.29 49.85 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.776 2.03 . . . . 0.0 115.684 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 48.3 pt -64.98 153.46 8.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 122.273 1.035 . . . . 0.0 111.492 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.4 p -125.59 55.67 1.41 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.455 1.902 . . . . 0.0 106.985 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.51 156.22 39.36 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.76 124.73 9.94 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.851 1.701 . . . . 0.0 107.851 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 p -167.24 154.34 8.68 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 127.138 2.175 . . . . 0.0 105.556 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 p -159.84 100.07 1.41 Allowed 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.634 -0.667 . . . . 0.0 111.127 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 178.542 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.516 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 t -129.76 127.45 40.41 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.986 0.914 . . . . 0.0 109.581 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 t -77.84 -30.88 51.24 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.28 178.36 47.48 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 125.671 1.605 . . . . 0.0 114.154 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -133.86 154.37 51.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.16 2.584 . . . . 0.0 104.293 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 55.65 64.42 1.75 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.822 1.192 . . . . 0.0 111.346 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.79 -171.49 42.11 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -49.54 124.67 9.84 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.203 2.002 . . . . 0.0 108.32 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.23 -8.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 120.581 1.537 . . . . 0.0 110.964 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.07 7.16 27.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.703 2.001 . . . . 0.0 113.159 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.9 p -167.66 -5.34 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 121.225 1.829 . . . . 0.0 115.774 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.368 0.1 OUTLIER 56.06 18.79 3.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.128 2.171 . . . . 0.0 114.666 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -82.82 144.45 48.27 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.34 128.51 14.67 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.648 2.232 . . . . 0.0 110.239 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.8 mt -78.87 162.18 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t -107.97 88.33 2.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.73 169.17 52.63 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.0 tp 48.54 28.32 1.71 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.264 1.425 . . . . 0.0 112.399 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.4 m -125.83 -12.15 6.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.79 1.236 . . . . 0.0 113.204 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.07 30.67 19.53 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.12 154.76 40.45 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.656 0.782 . . . . 0.0 111.322 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -85.99 75.22 9.99 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -119.24 158.53 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.85 131.67 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.08 116.11 22.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.117 2.167 . . . . 0.0 107.549 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -145.76 131.25 18.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.233 1.813 . . . . 0.0 107.172 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 36.32 63.13 0.65 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.669 1.988 . . . . 0.0 111.918 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 60.19 -3.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 128.035 2.534 . . . . 0.0 115.749 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -80.45 160.63 25.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.492 1.117 . . . . 0.0 108.179 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -136.69 113.87 10.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -118.91 149.95 40.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.584 1.154 . . . . 0.0 111.021 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -86.56 147.37 25.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.0 t -49.39 -52.78 26.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.613 1.097 . . . . 0.0 110.669 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -57.76 -31.07 66.13 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.49 -4.92 52.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -80.93 99.36 8.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.38 161.76 37.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.086 1.355 . . . . 0.0 112.563 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.68 145.7 55.23 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.099 1.36 . . . . 0.0 112.701 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.39 -49.27 15.74 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 123.797 0.686 . . . . 0.0 111.915 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -75.53 -23.14 56.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -133.57 -7.43 2.87 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 m 72.49 -0.75 3.19 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -71.06 147.03 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 121.038 1.744 . . . . 0.0 111.251 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -71.81 149.59 45.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.583 0.628 . . . . 0.0 111.968 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.13 -6.56 13.66 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.985 0.803 . . . . 0.0 112.412 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.65 95.83 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.58 11.56 24.81 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.877 1.227 . . . . 0.0 113.175 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -127.55 141.01 51.76 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.498 1.149 . . . . 0.0 108.305 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.95 88.78 0.66 Allowed Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -85.44 168.07 14.92 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.766 0.783 . . . . 0.0 110.296 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 mp -117.68 158.89 23.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.224 1.809 . . . . 0.0 106.918 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.3 p -128.71 122.6 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -143.51 153.21 42.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 m120 47.06 36.99 4.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm 58.89 30.4 20.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.327 1.051 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -129.19 166.64 18.96 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.913 1.685 . . . . 0.0 108.921 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.82 120.8 63.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.128 1.771 . . . . 0.0 108.487 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -131.31 139.48 49.58 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.007 -1.683 . . . . 0.0 113.054 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.58 144.52 31.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 114.521 -2.657 . . . . 0.0 106.024 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -30.06 -53.16 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.791 3.236 . . . . 0.0 112.304 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -47.83 -40.31 20.86 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.953 0.797 . . . . 0.0 112.296 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 29.2 m -80.14 -44.13 20.44 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.02 14.97 5.59 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 120.954 -1.091 . . . . 0.0 113.6 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.3 t -82.61 53.99 2.51 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.65 -83.51 0.9 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 94.3 mmm -134.94 146.26 48.95 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.085 1.754 . . . . 0.0 107.923 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.96 52.78 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.038 2.135 . . . . 0.0 108.116 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.9 t -60.98 144.94 52.31 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.82 -1.175 . . . . 0.0 109.287 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.05 -177.27 6.19 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 128.355 2.662 . . . . 0.0 107.224 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.1 pt -78.05 152.15 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.1 t -71.72 -43.38 65.98 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.19 177.52 25.1 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.385 0.993 . . . . 0.0 111.544 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -76.29 -177.89 4.03 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 124.096 3.197 . . . . 0.0 109.055 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -60.4 143.14 53.89 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.6 p -63.67 122.86 17.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 109.783 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 N-CA-C 105.707 -2.957 . . . . 0.0 105.707 179.333 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.838 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 p -72.89 -84.27 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.237 1.815 . . . . 0.0 108.805 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.64 95.43 0.86 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.468 1.907 . . . . 0.0 107.747 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.93 156.84 27.11 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -84.27 102.8 12.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.841 1.257 . . . . 0.0 108.546 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.8 m -55.98 153.15 9.18 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.49 179.88 31.13 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.213 1.387 . . . . 0.0 109.753 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.1 t -61.28 117.24 5.37 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 116.31 -1.805 . . . . 0.0 107.761 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.0 t -52.3 -30.54 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 121.067 1.758 . . . . 0.0 112.161 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.83 -12.02 58.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.49 -13.51 1.14 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.733 1.606 . . . . 0.0 113.413 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m 52.77 56.04 8.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 128.396 2.679 . . . . 0.0 111.665 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -124.86 149.23 62.21 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 117.773 -1.108 . . . . 0.0 108.748 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.87 114.74 3.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.606 2.204 . . . . 0.0 109.042 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.76 138.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 107.542 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -66.1 150.87 48.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.544 0.611 . . . . 0.0 111.079 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.41 146.82 18.76 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp 39.17 48.89 1.62 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.064 2.146 . . . . 0.0 113.749 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.31 11.92 5.95 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.669 -1.269 . . . . 0.0 111.863 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.55 17.77 79.63 Favored Glycine 0 CA--C 1.537 1.448 0 O-C-N 121.072 -1.017 . . . . 0.0 111.058 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 110.83 3.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -71.74 71.13 0.73 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.944 0.878 . . . . 0.0 112.086 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.58 165.26 18.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.559 1.544 . . . . 0.0 109.523 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 mt -130.19 152.94 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 126.218 1.807 . . . . 0.0 106.611 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 t -131.8 131.72 43.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.557 1.543 . . . . 0.0 108.399 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -146.42 136.24 23.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.116 1.366 . . . . 0.0 107.811 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 48.15 38.12 9.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 65.51 6.47 3.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.374 1.469 . . . . 0.0 112.959 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.4 m -102.08 160.98 14.04 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.426 2.29 . . . . 0.0 105.73 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -132.14 144.86 50.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 119.936 -1.728 . . . . 0.0 113.363 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -133.43 145.08 49.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.238 1.015 . . . . 0.0 111.327 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -80.68 157.69 25.83 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 p -53.62 -49.77 67.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.867 0.867 . . . . 0.0 111.846 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -12.64 60.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.75 4.77 24.06 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.277 1.831 . . . . 0.0 113.714 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -101.28 99.89 10.33 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -155.24 166.41 33.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -58.48 119.77 7.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 116.821 -1.561 . . . . 0.0 112.45 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.27 49.81 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.453 1.024 . . . . 0.0 112.225 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -92.0 -17.52 24.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -148.72 -4.96 0.43 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m 74.47 1.14 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.77 134.61 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.9 t -59.38 145.52 43.22 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 124.242 0.964 . . . . 0.0 110.472 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -118.33 4.6 11.85 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.137 1.775 . . . . 0.0 110.058 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.91 91.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.964 . . . . 0.0 110.524 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.51 -58.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 125.875 1.702 . . . . 0.0 111.668 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.64 148.42 42.58 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.352 0.576 . . . . 0.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.42 115.03 7.36 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 105.52 -3.032 . . . . 0.0 105.52 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -85.16 170.38 12.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 109.137 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.7 160.74 32.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.693 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.7 p -137.72 104.5 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 110.247 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -141.16 153.57 45.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.89 1.676 . . . . 0.0 107.246 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.89 31.6 3.3 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.272 1.029 . . . . 0.0 113.396 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm 60.37 21.46 11.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.005 1.722 . . . . 0.0 112.007 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -125.43 174.83 7.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.49 1.516 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -117.31 122.7 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.977 1.311 . . . . 0.0 111.037 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.78 148.23 50.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.382 1.087 . . . . 0.0 113.586 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 162.68 29.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -50.22 -52.94 31.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.586 1.085 . . . . 0.0 112.39 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.46 -45.24 69.48 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.64 1.109 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.22 -59.44 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.5 29.92 1.71 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.139 1.352 . . . . 0.0 112.959 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.2 t -64.95 104.08 0.81 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 107.642 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.0 115.08 2.83 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 127.843 2.639 . . . . 0.0 111.545 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -146.47 166.9 25.02 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.424 2.69 . . . . 0.0 105.811 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -128.05 87.2 2.57 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -79.98 69.26 6.31 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -133.99 84.8 2.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.541 1.136 . . . . 0.0 108.155 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.11 -46.31 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.9 t -78.51 -95.46 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.811 1.645 . . . . 0.0 107.513 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.8 120.69 0.54 Allowed Glycine 0 CA--C 1.526 0.755 0 O-C-N 120.632 -1.293 . . . . 0.0 110.86 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -80.01 -4.65 13.41 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.229 2.619 . . . . 0.0 114.019 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t -68.4 170.92 8.05 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 120.191 1.36 . . . . 0.0 111.909 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 p -151.73 163.75 38.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.858 1.663 . . . . 0.0 108.428 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 N-CA-C 105.947 -2.861 . . . . 0.0 105.947 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.4 m -59.42 108.26 0.69 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.799 1.64 . . . . 0.0 111.0 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m -80.94 -15.48 56.15 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.156 0.435 . . . . 0.0 109.85 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.53 -178.08 48.19 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.209 2.338 . . . . 0.0 108.116 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 p -59.15 114.8 2.79 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.737 1.215 . . . . 0.0 110.056 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.4 t -151.85 131.56 13.17 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.61 167.01 11.66 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.453 1.501 . . . . 0.0 111.174 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 t -57.67 120.72 8.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.418 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.76 -2.4 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 125.605 1.562 . . . . 0.0 112.337 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.99 6.09 10.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.957 2.103 . . . . 0.0 113.022 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.7 p -159.02 -7.37 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 119.282 -2.136 . . . . 0.0 114.625 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.8 m 58.38 12.94 2.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.63 1.572 . . . . 0.0 114.036 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -81.31 148.75 63.95 Favored Pre-proline 0 C--N 1.346 0.435 0 O-C-N 120.117 -1.614 . . . . 0.0 108.138 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.59 117.54 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.901 3.067 . . . . 0.0 109.122 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.2 mt -74.65 139.51 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -53.65 -41.1 66.42 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.55 -90.87 0.31 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -43.03 -41.83 3.61 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 128.612 2.765 . . . . 0.0 114.215 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 m -66.59 -17.51 64.86 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.22 21.56 54.51 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 120.691 -1.256 . . . . 0.0 112.628 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.35 153.2 12.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.873 0.869 . . . . 0.0 109.987 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 7.1 mmpt? -76.88 111.07 12.03 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.684 -0.635 . . . . 0.0 111.233 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.99 164.13 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.484 1.514 . . . . 0.0 107.877 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.23 137.78 52.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.14 112.15 18.32 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.265 1.826 . . . . 0.0 106.751 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -146.47 150.23 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 42.04 32.88 0.33 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.6 t70 56.68 40.67 29.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 123.699 1.714 . . . . 0.0 111.454 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.407 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 56.5 m -131.73 164.37 26.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 130.525 3.53 . . . . 0.0 106.804 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -132.65 133.77 44.0 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.327 1.051 . . . . 0.0 111.858 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.407 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 30.6 m-90 -132.38 161.54 33.34 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.527 1.131 . . . . 0.0 109.419 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -97.28 166.7 11.43 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.1 p -55.92 -30.76 62.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.338 1.055 . . . . 0.0 112.282 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -103.57 4.8 36.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.251 1.42 . . . . 0.0 112.256 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.01 6.59 9.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.313 1.045 . . . . 0.0 112.349 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -101.85 100.28 10.59 Favored 'General case' 0 N--CA 1.453 -0.298 1 N-CA-C 99.524 -4.25 . . . . 0.0 99.524 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -145.04 157.41 44.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 t -51.53 118.28 3.22 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -27.3 38.67 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 119.849 1.204 . . . . 0.0 112.872 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.6 -22.59 26.14 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.4 p -143.45 -6.72 0.8 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m 76.92 10.31 2.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.71 141.36 15.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.1 t -66.11 151.33 47.13 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.4 mt -118.18 -1.72 11.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.433 1.093 . . . . 0.0 111.374 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.29 -57.43 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.445 1.098 . . . . 0.0 112.286 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.76 17.15 2.85 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.05 -0.861 . . . . 0.0 113.947 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -150.92 -167.66 2.88 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.437 1.618 . . . . 0.0 110.722 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.96 165.31 21.92 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -140.82 171.48 14.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 109.766 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.53 165.53 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.407 1.083 . . . . 0.0 109.291 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 p -137.65 111.51 8.28 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.983 0.513 . . . . 0.0 109.735 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -142.46 148.36 37.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.161 1.784 . . . . 0.0 106.48 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 46.08 33.98 1.9 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.093 2.157 . . . . 0.0 112.478 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp 59.7 9.99 1.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.752 1.621 . . . . 0.0 113.039 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -93.41 -173.56 3.25 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.769 2.028 . . . . 0.0 107.466 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.2 pt -135.75 124.05 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.06 1.744 . . . . 0.0 109.397 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -135.38 148.04 49.25 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 120.745 -1.222 . . . . 0.0 114.183 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.72 155.68 39.66 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -51.36 -52.75 42.87 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.934 1.243 . . . . 0.0 110.263 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -56.83 -25.79 56.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.2 m -97.51 -18.23 19.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 114.075 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.62 -5.63 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t -59.98 112.24 1.8 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.032 2.533 . . . . 0.0 105.963 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.95 -77.42 1.21 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -158.92 165.81 33.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.911 1.684 . . . . 0.0 108.323 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -115.92 0.7 13.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.976 1.31 . . . . 0.0 108.752 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.298 2.0 p 61.46 10.13 3.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.307 2.243 . . . . 0.0 113.2 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -93.98 133.42 37.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 mt -120.92 8.37 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.809 1.243 . . . . 0.0 109.321 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m -65.12 152.69 42.92 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -2.05 82.73 0.0 OUTLIER Glycine 0 CA--C 1.532 1.155 0 C-N-CA 128.509 2.956 . . . . 0.0 114.427 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -57.93 108.34 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.204 2.603 . . . . 0.0 110.874 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.4 t -124.8 -168.23 1.79 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.083 1.753 . . . . 0.0 108.274 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 65.7 p -132.13 -172.25 2.84 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.853 1.261 . . . . 0.0 110.423 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.951 0 N-CA-C 106.304 -2.718 . . . . 0.0 106.304 179.044 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.444 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 m -152.45 160.49 43.26 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.897 1.279 . . . . 0.0 107.979 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 t -112.89 104.12 12.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.78 -81.79 1.24 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . 0.263 31.4 p 51.17 29.49 4.86 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.961 1.705 . . . . 0.0 111.629 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -72.48 -173.76 1.21 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.938 2.495 . . . . 0.0 108.979 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -142.4 -119.85 1.51 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.2 t -66.53 106.89 1.9 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.743 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -50.55 -35.16 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.784 1.174 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.39 1.0 50.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.227 2.211 . . . . 0.0 116.427 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.16 -12.98 0.15 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.101 1.773 . . . . 0.0 112.798 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m 55.41 51.13 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 131.169 3.788 . . . . 0.0 113.388 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.59 149.18 44.47 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.71 1.204 . . . . 0.0 110.098 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.4 122.6 6.62 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 123.306 2.671 . . . . 0.0 112.097 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.8 mt -80.72 163.04 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.621 2.368 . . . . 0.0 105.2 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -65.93 -80.04 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.27 84.58 0.19 Allowed Glycine 0 C--N 1.338 0.691 0 O-C-N 120.616 -1.303 . . . . 0.0 110.79 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.1 mt 58.95 11.74 2.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.502 1.521 . . . . 0.0 112.84 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 m -67.38 -15.45 63.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.939 2.096 . . . . 0.0 113.706 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.28 6.15 18.46 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.27 161.2 27.77 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.599 1.2 . . . . 0.0 109.207 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -85.93 106.5 17.17 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -131.59 163.97 26.89 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.659 0.784 . . . . 0.0 111.477 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.18 138.66 53.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.877 2.071 . . . . 0.0 105.892 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.6 121.0 23.64 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.12 1.368 . . . . 0.0 107.584 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -145.31 130.74 18.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 53.16 39.27 29.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.125 0.97 . . . . 0.0 111.532 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 68.26 -0.72 2.06 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.879 1.672 . . . . 0.0 113.039 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 t -73.91 165.75 24.58 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.103 2.161 . . . . 0.0 110.059 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -132.81 110.69 10.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.662 0.785 . . . . 0.0 112.141 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -118.03 129.81 55.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.61 154.47 40.74 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -49.87 -49.85 47.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.425 1.09 . . . . 0.0 110.967 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.35 -4.76 41.16 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.207 -1.558 . . . . 0.0 114.224 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.0 m -121.56 17.71 11.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.96 101.54 9.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.14 166.44 30.81 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.0 t -55.83 112.15 1.1 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.247 -1.359 . . . . 0.0 109.548 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.04 -25.3 30.99 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.208 0.909 . . . . 0.0 114.921 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -90.35 -20.96 22.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.35 -22.8 1.5 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m 77.47 78.51 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.251 1.024 . . . . 0.0 109.738 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.34 134.68 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 t -54.2 135.43 44.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.933 1.293 . . . . 0.0 112.461 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.39 9.72 15.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.547 1.939 . . . . 0.0 109.222 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.19 111.23 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 126.11 1.764 . . . . 0.0 112.711 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.47 43.4 94.03 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-O 119.331 -0.705 . . . . 0.0 113.666 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -139.07 153.21 48.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 134.34 46.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.99 171.77 9.0 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.144 1.378 . . . . 0.0 108.058 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.99 155.31 30.49 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 112.88 6.49 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -143.12 150.26 39.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 54.72 23.08 4.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.134 0.879 . . . . 0.0 112.528 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 70.54 8.45 6.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.792 2.437 . . . . 0.0 113.065 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.81 150.94 25.83 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.431 1.092 . . . . 0.0 108.587 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.8 pt -102.63 129.87 53.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.226 1.411 . . . . 0.0 110.025 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.92 160.69 36.9 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.669 -1.269 . . . . 0.0 112.444 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 161.39 19.69 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -51.98 -51.55 56.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.21 1.368 . . . . 0.0 111.57 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -53.49 -38.59 63.82 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.419 -0.8 . . . . 0.0 112.402 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -75.59 -53.26 8.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.27 1.04 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.548 1.07 . . . . 0.0 113.924 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -30.69 70.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.134 1.467 . . . . 0.0 111.303 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.32 -178.23 39.92 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.405 ' HG3' ' H ' ' A' ' 67' ' ' ASP . 22.8 ptt? -125.48 -60.21 1.34 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.418 1.487 . . . . 0.0 108.05 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.405 ' H ' ' HG3' ' A' ' 66' ' ' MET . 67.5 m-20 48.35 27.47 1.37 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.022 2.529 . . . . 0.0 112.882 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 p -66.09 113.73 4.7 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.977 2.111 . . . . 0.0 110.555 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -81.92 149.39 28.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.007 2.123 . . . . 0.0 110.498 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.1 pt -150.76 159.71 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 127.47 2.308 . . . . 0.0 108.388 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -80.28 179.5 7.64 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.718 0.807 . . . . 0.0 109.252 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.75 149.68 17.15 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.31 4.46 1.98 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.035 2.49 . . . . 0.0 113.754 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -125.26 -0.15 7.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.858 2.463 . . . . 0.0 111.009 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.8 t -168.29 84.61 0.18 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.855 0 CA-C-O 116.108 -2.495 . . . . 0.0 108.274 -179.466 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.979 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -85.57 108.01 17.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.657 1.583 . . . . 0.0 108.255 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -136.86 130.7 32.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.4 1.0 . . . . 0.0 111.808 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.56 -111.18 2.9 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.519 2.009 . . . . 0.0 110.695 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 t -104.9 112.51 25.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.032 1.333 . . . . 0.0 111.462 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.2 m -155.6 74.54 0.88 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.36 1.864 . . . . 0.0 110.469 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.33 178.39 15.3 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.464 1.03 . . . . 0.0 110.709 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.5 t -79.13 121.97 25.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.96 -23.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.249 0.931 . . . . 0.0 111.61 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.2 1.28 57.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.804 1.642 . . . . 0.0 115.207 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.1 p -162.6 -7.79 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.776 1.625 . . . . 0.0 115.128 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.28 97.1 p 53.83 26.82 6.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.103 2.561 . . . . 0.0 114.149 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -83.88 154.16 64.29 Favored Pre-proline 0 C--O 1.237 0.436 0 O-C-N 120.765 -1.21 . . . . 0.0 108.459 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.34 120.12 5.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.366 2.71 . . . . 0.0 107.185 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -70.55 144.07 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 p -76.8 176.4 8.54 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.429 0.692 . . . . 0.0 111.212 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.47 -179.08 43.98 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.27 19.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.789 2.036 . . . . 0.0 115.175 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 t -67.26 32.55 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 129.202 3.001 . . . . 0.0 114.2 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.26 1.61 55.77 Favored Glycine 0 CA--C 1.522 0.5 0 O-C-N 119.884 -1.76 . . . . 0.0 112.41 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.23 160.99 11.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.473 0.709 . . . . 0.0 109.8 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 127.31 20.68 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -145.06 164.95 29.64 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 126.039 1.736 . . . . 0.0 108.721 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.27 134.73 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -111.22 131.35 55.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.185 0.994 . . . . 0.0 108.834 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -146.15 138.1 25.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.091 1.756 . . . . 0.0 106.666 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 45.33 43.11 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.273 1.429 . . . . 0.0 112.235 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 69.45 -17.55 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 129.766 3.226 . . . . 0.0 113.616 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.6 m -73.94 164.15 26.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.325 1.45 . . . . 0.0 108.969 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.21 135.94 52.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.082 1.353 . . . . 0.0 111.115 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -132.89 131.43 40.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.359 0.664 . . . . 0.0 111.664 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -65.48 154.38 38.73 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 p -49.58 -53.19 25.18 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.298 1.408 . . . . 0.0 112.613 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.49 -26.38 67.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.05 1.06 56.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 116.955 -1.498 . . . . 0.0 114.162 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -100.74 100.4 11.07 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 102.406 -3.183 . . . . 0.0 102.406 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -153.19 166.09 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 t -61.13 120.11 9.68 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-O 117.329 -1.319 . . . . 0.0 109.99 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.08 -24.38 54.53 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 121.989 0.772 . . . . 0.0 113.412 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -85.81 -18.83 31.82 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.16 -8.81 0.34 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 82.63 -0.99 1.33 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.474 1.488 . . . . 0.0 114.791 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.44 136.13 26.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 121.246 1.839 . . . . 0.0 108.024 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -54.35 136.2 43.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.082 1.353 . . . . 0.0 109.609 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.1 -0.37 15.65 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.773 0.829 . . . . 0.0 110.686 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.8 t -54.18 116.51 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 127.409 2.284 . . . . 0.0 109.505 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.68 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.532 1.152 0 C-N-CA 128.776 3.084 . . . . 0.0 117.617 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -9.38 56.96 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.23 147.09 16.94 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -146.34 172.26 13.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.575 1.55 . . . . 0.0 110.563 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.0 mp -119.13 154.95 32.45 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.9 p -130.11 102.46 6.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.241 0.963 . . . . 0.0 109.213 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.61 155.66 48.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.323 1.849 . . . . 0.0 107.595 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 52.35 21.77 1.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.004 1.321 . . . . 0.0 112.935 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt 62.49 22.02 12.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.038 1.735 . . . . 0.0 112.047 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -112.95 -169.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.893 2.477 . . . . 0.0 108.691 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.1 123.82 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 120.423 -1.423 . . . . 0.0 110.003 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -131.95 152.01 51.36 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 122.92 1.343 . . . . 0.0 114.607 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.76 150.28 42.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -46.23 -51.83 13.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.337 1.426 . . . . 0.0 110.502 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -51.53 61.47 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.135 0.879 . . . . 0.0 111.017 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.78 -29.01 68.85 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.35 -25.28 51.83 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.021 -1.433 . . . . 0.0 111.535 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m -61.97 -51.79 66.64 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.936 1.368 . . . . 0.0 109.802 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.59 -166.74 53.52 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.3 mmt -146.44 76.76 1.45 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -69.73 4.73 1.78 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.909 0.484 . . . . 0.0 112.12 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.3 p 56.92 49.1 14.63 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 128.027 2.531 . . . . 0.0 111.059 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -63.05 148.46 47.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.84 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.1 pt -115.85 18.69 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.849 1.659 . . . . 0.0 111.456 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -28.65 69.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.914 0.886 . . . . 0.0 113.029 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 112.8 -86.78 0.43 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.412 -1.216 . . . . 0.0 112.409 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.23 134.67 23.4 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.586 2.191 . . . . 0.0 112.646 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.4 t -158.58 162.49 37.35 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.923 1.289 . . . . 0.0 107.829 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.7 p -72.77 88.47 1.31 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.093 -1.005 . . . . 0.0 109.025 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.793 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m -147.44 126.99 13.25 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 t -135.09 76.93 1.65 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.51 -4.02 2.73 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.285 1.421 . . . . 0.0 112.691 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t -139.13 155.02 48.18 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.799 1.64 . . . . 0.0 107.751 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.3 p -140.79 -8.95 1.05 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.514 1.926 . . . . 0.0 112.7 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.45 -149.56 8.96 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 125.92 1.724 . . . . 0.0 109.856 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 t -53.26 127.54 24.9 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.178 -1.391 . . . . 0.0 107.954 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -51.51 -24.64 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 120.048 1.294 . . . . 0.0 113.883 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.67 9.29 25.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.493 1.917 . . . . 0.0 115.126 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.2 -11.07 0.14 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.96 -1.712 . . . . 0.0 114.132 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 p 58.99 2.93 0.28 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.057 2.543 . . . . 0.0 114.812 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -72.04 147.69 91.19 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 120.597 -1.315 . . . . 0.0 110.684 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.55 113.65 3.7 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.355 2.703 . . . . 0.0 110.58 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.63 149.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.46 21.38 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.18 -175.71 31.77 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.749 1.194 . . . . 0.0 112.11 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.56 15.82 0.17 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.722 1.609 . . . . 0.0 113.605 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -66.89 -0.14 2.87 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.833 1.653 . . . . 0.0 112.827 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.57 11.65 11.39 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 120.559 -1.338 . . . . 0.0 115.04 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.13 146.05 55.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.881 1.341 . . . . 0.0 107.659 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -78.7 106.22 10.54 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -135.44 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.827 2.051 . . . . 0.0 111.807 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.0 mm -120.05 147.37 23.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.89 117.9 19.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.375 1.07 . . . . 0.0 109.603 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.82 138.74 25.89 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 48.57 42.74 19.51 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.727 1.611 . . . . 0.0 110.597 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 61.87 2.45 0.76 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.272 2.229 . . . . 0.0 112.545 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.6 m -84.35 164.84 18.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.631 1.572 . . . . 0.0 108.875 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 117.83 24.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.403 1.081 . . . . 0.0 111.47 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -120.72 136.73 54.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.26 155.52 28.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.1 t -57.34 -46.03 83.69 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.341 0.973 . . . . 0.0 108.487 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -1.24 3.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.64 -6.47 6.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.913 1.285 . . . . 0.0 113.275 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -89.99 100.29 13.13 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -149.08 176.5 10.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.5 t -65.53 119.93 11.97 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.49 -1.243 . . . . 0.0 112.694 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.07 -10.8 16.14 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.468 1.508 . . . . 0.0 112.977 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -106.05 -23.49 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.133 1.466 . . . . 0.0 114.525 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.41 -3.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.294 15.4 m 70.83 15.44 6.85 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.64 134.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 t -58.0 139.63 54.09 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.802 0.728 . . . . 0.0 110.679 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -111.06 3.55 18.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.045 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.32 122.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.52 29.47 69.82 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.622 -1.099 . . . . 0.0 112.438 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -139.8 150.45 44.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.356 1.578 . . . . 0.0 110.958 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.28 108.35 2.54 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.506 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -102.83 171.85 7.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.363 1.865 . . . . 0.0 108.945 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.15 163.61 25.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.117 1.767 . . . . 0.0 107.256 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.9 p -135.39 117.4 15.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.396 0.544 . . . . 0.0 111.567 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -143.7 156.49 44.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.301 1.84 . . . . 0.0 107.386 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.5 m120 57.3 29.08 16.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.925 0.89 . . . . 0.0 112.018 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm 64.18 16.09 9.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.437 1.495 . . . . 0.0 110.57 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -120.1 177.97 4.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.993 1.717 . . . . 0.0 106.994 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.5 pt -115.63 149.55 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -145.84 155.73 43.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.096 1.771 . . . . 0.0 111.482 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.3 156.42 38.46 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -57.12 -50.61 72.27 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.197 1.362 . . . . 0.0 110.871 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -55.42 -24.91 33.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.516 1.126 . . . . 0.0 113.847 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.382 85.7 m -97.24 -17.07 20.06 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.572 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.02 -20.29 18.94 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.387 -1.229 . . . . 0.0 111.54 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 m -39.88 110.24 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.081 2.152 . . . . 0.0 113.518 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.36 -175.55 44.25 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 106.167 -2.773 . . . . 0.0 106.167 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.2 132.86 4.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -123.76 14.95 9.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.2 p -57.26 -34.07 68.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.021 0.928 . . . . 0.0 109.261 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -166.83 176.97 6.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.152 2.181 . . . . 0.0 107.801 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.7 mt -131.48 -43.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 129.791 3.237 . . . . 0.0 106.613 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.99 167.03 3.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.916 2.086 . . . . 0.0 111.977 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -98.23 175.43 29.53 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.29 10.99 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.883 3.055 . . . . 0.0 113.308 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.0 p -147.1 131.98 18.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.742 1.617 . . . . 0.0 107.483 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -146.06 135.63 23.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.894 0 N-CA-C 106.677 -2.569 . . . . 0.0 106.677 -179.263 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.851 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -146.02 91.21 2.05 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m -74.19 92.07 2.19 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.36 88.03 0.07 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 m -68.14 -16.07 63.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.14 1.776 . . . . 0.0 113.212 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.0 m -127.43 169.99 13.03 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.374 1.47 . . . . 0.0 107.301 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.16 -175.69 54.99 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.9 t -62.57 119.55 9.42 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.358 -1.782 . . . . 0.0 108.607 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.7 t -54.55 -25.84 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 121.113 1.779 . . . . 0.0 111.165 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.66 -1.77 58.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.294 1.837 . . . . 0.0 115.284 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.4 p -158.88 -2.54 0.08 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 121.235 1.834 . . . . 0.0 114.481 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 p 58.35 7.27 0.66 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.838 3.255 . . . . 0.0 114.071 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -70.38 136.68 86.36 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.11 122.67 10.5 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 123.066 2.51 . . . . 0.0 108.504 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.51 151.98 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.0 t -70.3 165.78 21.57 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.067 -1.021 . . . . 0.0 109.115 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.14 -140.41 6.32 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.764 1.173 . . . . 0.0 111.111 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 tt -75.53 71.34 2.45 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 123.468 1.604 . . . . 0.0 107.66 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.6 m -128.04 -5.16 5.6 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 127.067 2.147 . . . . 0.0 109.498 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.62 39.22 10.91 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.07 111.45 2.2 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.684 1.193 . . . . 0.0 108.564 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 108.25 12.45 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -145.67 165.16 29.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.744 1.617 . . . . 0.0 107.125 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.89 122.38 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 126.984 2.114 . . . . 0.0 106.202 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -106.05 106.79 17.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.97 139.85 38.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 48.86 43.92 21.74 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.379 0.672 . . . . 0.0 109.591 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 42.87 43.32 3.43 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.086 2.555 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -134.16 149.77 51.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.898 1.679 . . . . 0.0 108.712 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.07 118.81 32.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -131.36 123.23 27.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -66.24 145.34 55.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -45.04 -54.76 6.27 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.422 1.489 . . . . 0.0 111.376 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -67.29 -17.57 64.83 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.09 17.55 20.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.73 101.39 12.78 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -139.48 165.05 28.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.95 113.59 2.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.077 1.751 . . . . 0.0 109.009 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.83 -24.92 21.26 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 120.167 1.349 . . . . 0.0 115.539 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -84.92 -20.33 30.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 114.762 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.71 -25.88 0.68 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.298 5.6 p 91.57 17.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.671 2.388 . . . . 0.0 115.596 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.47 143.72 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 120.582 -1.324 . . . . 0.0 108.043 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -59.35 140.65 55.89 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.821 0.848 . . . . 0.0 110.631 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.22 -1.01 10.35 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.252 1.421 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.1 t -49.69 115.93 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 126.33 1.852 . . . . 0.0 110.402 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -3.74 27.24 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.043 -1.421 . . . . 0.0 115.33 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -89.34 162.1 15.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.948 2.374 . . . . 0.0 110.179 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.87 1.54 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -85.38 171.88 11.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.916 0.887 . . . . 0.0 109.762 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.53 126.7 52.56 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.911 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -95.55 107.35 19.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.787 2.035 . . . . 0.0 110.15 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -144.17 155.04 43.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 44.99 46.18 9.05 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.173 1.389 . . . . 0.0 112.333 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.346 7.5 ptmm? 48.97 24.99 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.709 2.004 . . . . 0.0 114.321 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -127.23 177.94 6.36 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.977 1.711 . . . . 0.0 107.781 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.04 123.62 65.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 125.611 1.564 . . . . 0.0 110.984 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.42 152.01 51.03 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.948 0.88 . . . . 0.0 113.31 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.9 163.36 27.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -53.91 -55.87 22.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 110.854 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -55.28 -27.08 44.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.672 1.189 . . . . 0.0 113.468 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.91 -19.29 18.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.724 1.21 . . . . 0.0 113.077 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.49 -3.61 56.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.088 1.804 . . . . 0.0 112.015 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 t -68.72 177.39 2.54 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.741 1.217 . . . . 0.0 107.952 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.97 -65.72 0.09 OUTLIER Glycine 0 C--N 1.333 0.379 0 CA-C-O 119.176 -0.791 . . . . 0.0 112.269 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 23.1 mmt -104.78 88.67 2.96 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 117.794 0.797 . . . . 0.0 109.485 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.2 91.67 3.2 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -158.53 172.51 18.17 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.318 2.247 . . . . 0.0 108.231 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -82.13 -177.93 6.82 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 126.181 1.792 . . . . 0.0 111.033 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -85.19 167.72 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 120.867 -1.146 . . . . 0.0 109.469 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.7 t -117.24 7.69 13.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.653 1.181 . . . . 0.0 112.5 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.36 144.45 15.77 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.64 137.26 62.9 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.835 1.69 . . . . 0.0 110.043 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -164.42 179.34 6.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.655 1.582 . . . . 0.0 107.331 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.5 m -79.83 81.32 6.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 179.511 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.633 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -130.47 81.67 2.02 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.201 1.001 . . . . 0.0 108.398 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.6 t -82.99 -32.44 26.99 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.848 1.659 . . . . 0.0 109.553 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.78 -178.89 28.78 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 p -149.68 49.85 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.08 1.44 . . . . 0.0 114.401 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.6 p -107.48 68.5 0.72 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -111.97 -167.56 17.97 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.44 1.495 . . . . 0.0 112.627 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -71.48 109.58 5.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.858 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -43.73 -39.93 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 121.539 1.972 . . . . 0.0 111.743 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -8.47 53.11 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -156.96 -4.88 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.098 1.317 . . . . 0.0 114.326 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 p 62.92 8.01 2.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 130.815 3.646 . . . . 0.0 114.597 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -70.64 152.93 95.21 Favored Pre-proline 0 N--CA 1.468 0.454 0 O-C-N 120.38 -1.45 . . . . 0.0 109.892 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.24 127.63 16.15 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.84 1.694 . . . . 0.0 109.054 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.97 142.96 16.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.9 m -59.94 154.0 19.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.734 0.814 . . . . 0.0 109.898 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.08 -81.79 0.82 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.916 0.77 . . . . 0.0 111.333 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 tt -145.55 77.31 1.51 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.486 1.114 . . . . 0.0 108.343 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.7 t -129.67 20.22 5.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.985 0.914 . . . . 0.0 112.961 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.01 5.52 84.96 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.457 -1.191 . . . . 0.0 114.25 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.63 154.0 37.7 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.305 1.042 . . . . 0.0 109.336 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -103.43 117.24 34.02 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.118 0.967 . . . . 0.0 109.469 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -134.05 120.44 20.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 mm -83.46 152.73 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -130.01 107.02 9.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.671 1.588 . . . . 0.0 108.897 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -128.22 123.82 35.17 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.815 1.246 . . . . 0.0 108.803 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 50.69 15.48 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.264 1.026 . . . . 0.0 109.001 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 62.62 -6.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 127.57 2.348 . . . . 0.0 115.97 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.3 t -89.06 149.68 23.11 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -116.04 136.45 53.02 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.474 0.709 . . . . 0.0 111.548 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -130.26 138.56 50.58 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.776 1.23 . . . . 0.0 108.35 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -71.09 152.32 43.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -43.87 -62.48 1.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.751 1.22 . . . . 0.0 113.101 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 21.0 mp0 -61.34 -22.46 64.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.887 2.075 . . . . 0.0 114.164 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 m -90.5 -28.27 18.66 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.026 1.331 . . . . 0.0 112.725 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -72.09 101.73 2.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.456 1.48 . . . . 0.0 108.703 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -139.87 164.02 31.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.294 1.038 . . . . 0.0 112.95 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 35.2 t -59.15 116.74 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 116.287 -1.816 . . . . 0.0 108.474 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.42 34.01 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 120.865 1.666 . . . . 0.0 114.132 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -84.93 -18.66 33.94 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.43 -13.74 1.0 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.358 86.9 p 62.46 60.04 1.44 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.65 137.01 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -58.38 125.56 23.83 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 124.037 0.836 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.1 mt -101.91 14.71 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.172 1.389 . . . . 0.0 109.111 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.64 126.9 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.21 -49.77 1.55 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 126.049 1.785 . . . . 0.0 115.987 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -63.23 154.18 32.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.904 0.882 . . . . 0.0 112.238 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.09 161.59 54.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.59 163.29 36.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.935 1.294 . . . . 0.0 109.778 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.03 152.7 29.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.695 1.998 . . . . 0.0 106.573 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.3 p -129.77 123.16 30.32 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -144.17 154.72 43.44 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.583 0.753 . . . . 0.0 109.183 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 41.89 42.31 2.2 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.783 1.174 . . . . 0.0 111.649 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 62.42 7.12 2.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.552 1.941 . . . . 0.0 114.805 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -106.31 173.12 6.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.861 2.064 . . . . 0.0 111.088 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.8 135.12 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.588 1.955 . . . . 0.0 110.737 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -139.65 155.35 47.46 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 120.787 -1.195 . . . . 0.0 113.256 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 157.49 32.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -52.31 -54.47 31.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.241 1.017 . . . . 0.0 110.161 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -52.67 -46.35 67.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.124 0.875 . . . . 0.0 111.256 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.332 1.3 m -61.29 -41.27 96.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.381 0.992 . . . . 0.0 111.73 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.49 -4.14 89.42 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.582 1.083 . . . . 0.0 113.553 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t -70.55 92.29 0.83 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.326 1.85 . . . . 0.0 110.592 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.98 -162.52 28.34 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -151.13 150.23 30.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -102.37 115.77 31.25 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.85 161.13 27.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.428 0.691 . . . . 0.0 112.329 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -117.24 27.7 8.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.099 2.56 . . . . 0.0 112.13 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.2 mt -66.04 110.05 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.701 1.6 . . . . 0.0 107.543 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 m -62.32 -6.2 3.02 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.6 93.63 1.34 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.302 0.956 . . . . 0.0 111.442 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.32 150.65 71.15 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 119.559 1.679 . . . . 0.0 109.44 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 t -71.52 92.68 1.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 t -151.8 -175.21 5.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.039 1.736 . . . . 0.0 107.769 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.263 1.916 1 C-N-CA 133.132 5.158 . . . . 0.0 103.504 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.747 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 p -149.01 99.07 2.92 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -73.8 79.66 1.59 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.482 1.113 . . . . 0.0 110.297 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.83 169.98 20.7 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 123.756 0.693 . . . . 0.0 112.305 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -153.59 80.06 1.16 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.376 1.07 . . . . 0.0 110.204 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -53.02 -62.36 1.71 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.794 1.238 . . . . 0.0 111.933 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.98 -175.38 52.29 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.644 0.64 . . . . 0.0 113.063 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -58.61 112.36 1.58 Allowed 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 115.794 -2.051 . . . . 0.0 108.282 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.9 t -41.81 -36.33 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 122.312 2.324 . . . . 0.0 112.785 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.55 -13.93 58.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.77 -3.62 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 120.877 1.671 . . . . 0.0 115.431 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 m 59.49 8.03 1.12 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 130.18 3.392 . . . . 0.0 115.083 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -58.79 153.09 44.43 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 120.0 1.273 . . . . 0.0 110.315 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.0 122.9 9.21 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.82 1.68 . . . . 0.0 108.526 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mm -74.12 144.13 12.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -64.43 169.61 4.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.121 0.568 . . . . 0.0 110.842 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.12 -137.72 9.71 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.4 mt -76.08 80.32 2.92 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.676 0.79 . . . . 0.0 108.892 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 t -128.7 -16.35 4.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.51 1.124 . . . . 0.0 112.253 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.98 34.07 7.43 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 160.24 29.72 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -110.11 95.19 5.43 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -129.5 165.18 22.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.407 1.883 . . . . 0.0 108.675 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.0 mm -116.37 151.46 18.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 m -131.27 117.83 19.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -145.43 130.6 18.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 55.66 23.62 6.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 111.231 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . 0.272 2.3 m-20 72.49 -0.68 3.21 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 130.004 3.322 . . . . 0.0 113.482 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -81.8 164.01 21.96 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.02 135.15 51.95 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.382 -1.448 . . . . 0.0 114.153 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.505 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 3.6 m-90 -132.07 125.91 32.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -73.84 154.54 39.44 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -49.97 -55.08 16.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.598 1.09 . . . . 0.0 109.178 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -65.66 -3.28 4.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.97 1.708 . . . . 0.0 115.554 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . 0.282 1.7 m -119.31 -3.01 10.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.58 -1.676 . . . . 0.0 114.369 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -91.04 102.54 15.3 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.181 1.392 . . . . 0.0 108.583 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -154.12 172.13 18.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.5 122.81 18.05 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 117.019 -1.467 . . . . 0.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -27.1 65.12 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.762 1.164 . . . . 0.0 113.524 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -75.81 -20.51 58.14 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.17 -12.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.272 18.0 m 85.92 10.6 0.25 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.726 1.61 . . . . 0.0 115.119 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.67 131.95 32.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 m -56.63 136.09 54.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.552 1.141 . . . . 0.0 111.611 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.1 mt -103.21 -1.11 29.48 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.79 142.04 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 20.85 73.63 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.628 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -152.94 148.21 26.85 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.039 1.419 . . . . 0.0 109.768 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.0 152.71 44.3 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -135.73 171.65 14.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.92 1.36 . . . . 0.0 111.652 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.08 145.45 24.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.1 p -134.45 103.39 5.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.619 1.168 . . . . 0.0 109.47 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -140.58 152.36 45.41 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 53.23 17.15 0.94 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.05 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.3 mttt 86.56 -0.1 0.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 129.313 3.045 . . . . 0.0 112.282 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -89.55 -179.04 5.71 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.504 1.521 . . . . 0.0 109.619 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.0 pt -131.44 136.01 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.512 2.325 . . . . 0.0 106.509 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -148.56 157.26 43.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 123.126 1.441 . . . . 0.0 113.199 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 153.81 39.79 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -66.34 -38.38 87.5 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.918 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -54.24 -26.74 30.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.25 1.42 . . . . 0.0 113.916 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.0 m -97.29 -45.08 6.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.208 1.803 . . . . 0.0 109.123 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.03 11.4 57.54 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.99 153.69 24.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.969 1.385 . . . . 0.0 108.524 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.42 6.86 56.3 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.892 -0.949 . . . . 0.0 112.971 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.1 mtt -64.26 86.31 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.054 2.542 . . . . 0.0 112.749 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.19 66.09 6.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.144 2.577 . . . . 0.0 105.205 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.7 t -79.4 -3.04 44.52 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.2 170.83 9.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.881 0.764 . . . . 0.0 109.213 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.5 mt -79.19 84.83 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 101.449 -3.537 . . . . 0.0 101.449 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.5 t -98.58 -167.43 1.5 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 129.095 2.958 . . . . 0.0 110.443 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.21 -73.31 0.03 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.156 1.836 . . . . 0.0 108.987 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.18 78.74 2.19 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.162 3.241 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.3 p -61.49 -31.0 70.96 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 127.187 2.195 . . . . 0.0 111.601 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 4.82 81.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 131.367 3.867 . . . . 0.0 113.875 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 -179.656 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.643 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -66.49 168.22 9.46 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.492 0.717 . . . . 0.0 110.839 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.5 -61.0 1.29 Allowed 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.8 131.87 1.41 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -160.35 92.4 0.98 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -64.7 -61.0 2.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.82 -167.99 14.66 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 121.733 -0.604 . . . . 0.0 112.362 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.9 t -59.87 121.4 11.66 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 117.275 -1.345 . . . . 0.0 108.636 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -52.21 -29.76 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.727 1.148 . . . . 0.0 111.346 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.4 -4.05 59.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 p -153.48 -7.08 0.17 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.156 1.343 . . . . 0.0 114.084 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 54.02 37.83 27.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.435 2.294 . . . . 0.0 112.642 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -100.05 151.91 37.66 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.47 137.57 30.87 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 O-C-N 124.554 1.818 . . . . 0.0 108.55 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.94 121.22 60.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 t -58.64 -44.49 90.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.094 0.558 . . . . 0.0 110.48 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.74 -75.03 1.89 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 pp -45.36 -31.57 1.69 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.703 2.801 . . . . 0.0 114.974 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.8 t -67.76 -10.44 52.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.393 0.677 . . . . 0.0 110.604 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.95 37.29 13.17 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.34 147.71 20.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.228 1.411 . . . . 0.0 110.935 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -80.41 115.57 20.01 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.73 164.22 30.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.03 0.443 . . . . 0.0 111.85 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.2 mm -121.3 125.81 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.3 m -103.39 102.93 12.88 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -124.9 136.92 54.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 40.38 46.23 1.99 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.401 1.881 . . . . 0.0 112.697 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 51.05 35.63 13.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.075 1.75 . . . . 0.0 113.127 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -126.09 164.73 20.25 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 126.419 1.888 . . . . 0.0 107.206 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -109.73 131.57 54.94 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -132.21 133.14 43.82 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 108.324 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -73.76 147.1 43.81 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -49.21 -55.5 12.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.936 1.244 . . . . 0.0 110.189 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.92 -5.18 2.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.928 1.291 . . . . 0.0 113.994 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 m -118.65 -1.26 11.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 113.566 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -94.59 100.78 12.68 Favored 'General case' 0 N--CA 1.45 -0.46 1 N-CA-C 99.417 -4.29 . . . . 0.0 99.417 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -145.59 164.3 32.13 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.709 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.9 t -58.12 122.03 12.1 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 116.795 -1.574 . . . . 0.0 108.975 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.89 -25.56 30.82 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 123.985 0.803 . . . . 0.0 113.816 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -90.87 -18.37 24.93 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -143.87 -15.95 0.61 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.3 1.1 p 84.78 8.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.2 142.55 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 120.54 1.518 . . . . 0.0 110.158 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -64.81 105.16 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.514 1.925 . . . . 0.0 107.429 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.3 mt -88.54 -9.0 53.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.0 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.1 t -42.56 111.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.404 1.882 . . . . 0.0 112.4 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 12.51 63.02 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.28 -1.845 . . . . 0.0 117.304 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -110.39 167.73 9.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 121.432 2.616 . . . . 0.0 112.161 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 136.2 46.13 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -144.42 171.17 14.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.242 1.017 . . . . 0.0 110.905 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.42 160.66 33.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.954 0.902 . . . . 0.0 110.793 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 p -132.58 104.83 6.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.995 0.918 . . . . 0.0 109.653 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -142.37 152.45 42.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.18 31.89 7.3 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.499 1.52 . . . . 0.0 112.77 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.17 6.67 3.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.369 2.267 . . . . 0.0 113.014 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -108.53 176.84 4.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.698 1.599 . . . . 0.0 109.8 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -112.68 121.46 65.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.64 138.26 52.09 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 157.24 37.1 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -46.39 -54.43 9.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.353 1.061 . . . . 0.0 111.654 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -58.96 -31.33 68.63 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.1 -12.46 21.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 113.656 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.91 -24.31 20.49 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -81.16 99.29 8.47 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 101.91 -3.366 . . . . 0.0 101.91 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.96 -169.45 36.57 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 56.3 mtp 46.73 46.6 15.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.434 1.094 . . . . 0.0 110.835 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.98 44.08 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.668 2.787 . . . . 0.0 113.201 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.1 t -136.53 171.76 14.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.071 1.748 . . . . 0.0 108.566 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -138.06 8.19 2.72 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.088 2.155 . . . . 0.0 109.409 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.2 pt -135.9 151.61 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.292 1.037 . . . . 0.0 109.199 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.2 m -117.78 34.13 5.3 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.064 1.345 . . . . 0.0 109.27 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.73 95.99 1.02 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.06 -17.77 28.0 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.338 2.025 . . . . 0.0 112.833 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.7 p -158.67 171.19 20.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.846 2.458 . . . . 0.0 106.836 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 m -136.46 3.53 2.81 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.31 1.444 . . . . 0.0 110.908 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.635 1 C-N-CA 130.918 4.104 . . . . 0.0 105.717 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.36 -69.93 0.73 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 p -155.34 157.16 36.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.93 157.06 10.53 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.7 t -144.2 121.78 11.79 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 t -161.86 -71.15 0.06 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.2 162.3 43.58 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.095 -0.836 . . . . 0.0 112.955 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 t -44.61 120.47 2.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.824 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.03 -32.31 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 120.63 1.559 . . . . 0.0 110.685 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.92 2.66 37.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 p -166.24 -3.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 119.19 -2.194 . . . . 0.0 114.707 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.54 10.21 2.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.763 3.225 . . . . 0.0 114.238 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -67.36 145.66 98.55 Favored Pre-proline 0 N--CA 1.47 0.565 0 O-C-N 120.122 -1.611 . . . . 0.0 109.402 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 137.68 45.45 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 O-C-N 124.35 1.711 . . . . 0.0 109.149 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -87.98 157.09 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.719 1.608 . . . . 0.0 107.216 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m -70.75 -25.31 62.85 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.05 -118.65 7.63 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.287 0.949 . . . . 0.0 111.708 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.402 ' CD2' ' H ' ' A' ' 18' ' ' LEU . 1.4 pt? -69.27 53.16 0.1 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.639 2.376 . . . . 0.0 115.524 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -130.05 -30.09 2.02 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.873 0.869 . . . . 0.0 111.491 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.12 0.33 25.36 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.336 0.969 . . . . 0.0 114.437 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.47 151.44 32.73 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.056 1.342 . . . . 0.0 113.093 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -80.2 120.37 24.21 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.004 0.921 . . . . 0.0 109.584 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -145.77 146.73 31.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mm -88.77 120.74 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 p -107.38 110.22 22.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -139.46 137.77 35.86 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 42.4 54.91 4.24 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.842 1.657 . . . . 0.0 112.114 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.92 13.89 0.61 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.851 1.661 . . . . 0.0 114.111 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -113.03 163.74 14.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.945 2.098 . . . . 0.0 108.949 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -120.95 131.94 54.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.938 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -124.61 138.28 54.32 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.113 1.365 . . . . 0.0 107.535 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -76.0 144.74 40.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.5 t -51.53 -51.53 54.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -61.9 -11.24 12.05 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 114.156 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.2 m -123.66 11.31 9.13 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.624 1.17 . . . . 0.0 113.382 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.99 101.16 13.19 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 101.231 -3.618 . . . . 0.0 101.231 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -141.35 168.82 18.86 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.89 121.04 13.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 116.424 -1.751 . . . . 0.0 108.287 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.82 -32.26 58.83 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 120.919 1.69 . . . . 0.0 113.45 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -82.67 -22.32 34.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.38 -7.92 1.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.393 83.7 p 66.64 29.94 8.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -86.9 147.07 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -58.06 134.96 56.88 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 111.484 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 mt -112.12 1.69 16.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.708 1.203 . . . . 0.0 110.818 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.82 107.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.342 2.657 . . . . 0.0 110.636 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.69 -17.57 3.44 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.968 1.747 . . . . 0.0 115.482 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 112.62 22.77 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -40.88 142.06 0.87 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.243 1.401 . . . . 0.0 111.149 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -135.66 170.55 15.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.04 162.12 13.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.287 1.435 . . . . 0.0 108.052 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 p -141.92 102.92 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -130.33 154.94 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 m120 48.95 36.02 7.7 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.852 1.261 . . . . 0.0 112.728 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm 55.76 21.76 4.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.491 1.116 . . . . 0.0 112.181 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -117.36 -178.54 3.48 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.165 1.786 . . . . 0.0 109.609 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 pt -123.34 122.7 65.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.805 1.642 . . . . 0.0 110.461 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -136.16 140.02 43.3 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.205 -0.934 . . . . 0.0 111.486 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.79 163.33 27.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -42.84 -62.79 0.92 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.226 1.81 . . . . 0.0 111.975 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -52.63 -41.03 63.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.877 0.871 . . . . 0.0 112.825 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.4 -46.99 58.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.551 0.614 . . . . 0.0 110.068 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.57 -3.01 46.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.987 0.803 . . . . 0.0 113.506 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 t -66.54 8.99 0.19 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.973 2.109 . . . . 0.0 112.588 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.98 68.75 3.44 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.0 tpt -71.71 127.83 33.84 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -63.57 8.28 0.08 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.119 1.368 . . . . 0.0 114.325 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -66.17 -31.18 71.87 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.014 1.326 . . . . 0.0 112.352 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -68.08 164.08 21.0 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.2 mt -38.34 117.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 128.78 2.832 . . . . 0.0 110.737 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 p -73.24 175.19 7.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.104 1.362 . . . . 0.0 110.813 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.39 171.15 47.49 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.46 130.82 31.36 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.465 2.11 . . . . 0.0 110.52 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 m -92.0 -158.09 0.56 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.399 1.479 . . . . 0.0 109.199 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.4 m -69.35 -2.8 11.83 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.292 -0.88 . . . . 0.0 111.361 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 1 C-N-CA 133.074 5.131 . . . . 0.0 105.213 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.049 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 p -124.86 167.02 15.23 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.361 1.08 . . . . 0.0 109.596 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 p -122.75 159.59 27.7 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.433 0.693 . . . . 0.0 109.943 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.24 10.45 86.2 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.469 -0.628 . . . . 0.0 112.88 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.7 p -70.92 30.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.736 1.614 . . . . 0.0 113.658 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.4 t -141.07 5.04 1.89 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.523 -1.361 . . . . 0.0 111.231 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.62 -166.92 37.58 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 119.551 1.069 . . . . 0.0 110.483 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.35 124.54 18.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.291 -1.814 . . . . 0.0 107.989 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -7.96 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 120.694 1.588 . . . . 0.0 112.319 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.28 4.96 25.19 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.026 1.73 . . . . 0.0 114.076 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 p -166.22 -4.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.286 61.6 p 54.83 12.83 0.63 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.6 3.16 . . . . 0.0 114.824 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.07 150.28 97.54 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.71 125.5 11.71 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.484 1.456 . . . . 0.0 108.665 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mm -68.32 148.19 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 135.97 45.45 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.29 -119.87 0.19 Allowed Glycine 0 CA--C 1.523 0.588 0 O-C-N 124.801 1.313 . . . . 0.0 111.763 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.67 69.78 6.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.105 0.962 . . . . 0.0 108.686 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 m -128.21 -4.39 5.55 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.71 2.404 . . . . 0.0 112.135 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.54 26.14 64.13 Favored Glycine 0 CA--C 1.535 1.304 0 O-C-N 120.343 -1.473 . . . . 0.0 114.005 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.72 158.56 33.98 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.237 1.015 . . . . 0.0 109.924 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -95.04 122.61 37.87 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -145.15 164.96 29.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.932 2.093 . . . . 0.0 107.177 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -115.15 139.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 p -130.89 120.08 23.11 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.475 1.51 . . . . 0.0 107.921 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -145.37 150.53 36.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.303 1.841 . . . . 0.0 106.526 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 36.04 50.52 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.111 2.165 . . . . 0.0 114.081 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t0 53.89 39.74 30.77 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 113.189 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.6 t -134.22 164.71 26.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.07 1.748 . . . . 0.0 109.972 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -119.11 124.1 46.03 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.89 1.676 . . . . 0.0 111.605 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -130.71 123.99 30.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.796 1.284 . . . . 0.0 110.296 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -68.49 155.5 39.8 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -53.51 30.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.106 1.363 . . . . 0.0 112.589 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.1 -30.49 71.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.597 1.09 . . . . 0.0 113.607 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -84.81 0.08 52.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 117.416 -1.278 . . . . 0.0 113.457 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -98.77 100.5 11.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -155.85 170.28 22.45 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.0 115.42 4.05 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 115.713 -2.089 . . . . 0.0 106.493 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.11 -29.34 51.9 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 121.444 1.929 . . . . 0.0 112.902 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -75.55 -22.49 57.0 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.87 -13.9 0.83 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 118.621 2.823 . . . . 0.0 118.621 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.276 3.0 m 79.67 12.22 1.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.92 136.09 26.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.1 t -58.59 138.36 56.92 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.446 0.641 . . . . 0.0 109.87 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.47 2.04 20.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.577 1.551 . . . . 0.0 110.079 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.82 109.57 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.05 1.34 . . . . 0.0 110.441 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.19 -44.66 2.96 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.749 2.118 . . . . 0.0 113.409 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -64.76 160.93 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.854 1.327 . . . . 0.0 111.864 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.58 123.55 16.53 Favored Glycine 0 C--O 1.241 0.531 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -110.16 166.1 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.762 1.225 . . . . 0.0 109.561 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.82 147.98 47.12 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.45 103.82 6.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.956 1.302 . . . . 0.0 107.659 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -142.75 156.4 44.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 127.096 2.159 . . . . 0.0 106.441 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 57.86 21.68 7.83 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 62.81 23.08 13.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.045 1.338 . . . . 0.0 109.72 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -126.75 -178.84 4.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 127.443 2.297 . . . . 0.0 107.614 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 pt -130.56 134.5 62.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.986 0.898 . . . . 0.0 109.868 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -134.24 162.43 32.18 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 123.012 1.387 . . . . 0.0 114.138 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.23 161.51 23.93 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -54.16 -54.87 33.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.02 0.827 . . . . 0.0 111.08 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -56.41 -27.7 57.23 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.527 -1.358 . . . . 0.0 114.553 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 m -97.59 -18.4 18.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.612 1.165 . . . . 0.0 113.297 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.31 -23.85 10.05 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.815 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 t -57.83 117.64 4.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.823 1.649 . . . . 0.0 108.571 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.67 144.69 16.7 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 107.204 -2.358 . . . . 0.0 107.204 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.1 mtm -147.12 147.56 30.69 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -59.92 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.242 1.817 . . . . 0.0 110.671 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.91 160.02 22.2 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.135 1.774 . . . . 0.0 109.045 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -70.68 159.09 35.08 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 122.252 -0.28 . . . . 0.0 111.539 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.58 173.12 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.181 0.993 . . . . 0.0 110.221 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.2 t -73.85 0.91 11.83 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.21 100.49 0.34 Allowed Glycine 0 C--O 1.224 -0.493 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.39 20.57 0.1 OUTLIER 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 124.496 3.464 . . . . 0.0 115.61 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 t -80.27 67.32 6.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 t -116.95 78.42 1.21 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.245 0 C-N-CA 126.676 2.084 . . . . 0.0 108.168 -179.6 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.548 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t -159.63 171.71 19.1 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.765 0.826 . . . . 0.0 109.5 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 m -158.43 174.42 15.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.279 2.232 . . . . 0.0 107.46 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.63 165.28 14.53 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.587 1.089 . . . . 0.0 111.597 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -92.34 156.95 16.9 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.619 1.568 . . . . 0.0 110.724 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.4 t -69.78 139.37 53.24 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.23 -150.34 19.98 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 121.193 -0.942 . . . . 0.0 112.419 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -57.75 116.44 3.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.62 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.42 -14.0 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.783 0.833 . . . . 0.0 112.241 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.95 -0.71 38.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.368 1.467 . . . . 0.0 113.678 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -152.62 -11.21 0.17 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.792 -1.818 . . . . 0.0 114.917 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 2.9 p 49.91 53.51 12.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.615 1.966 . . . . 0.0 112.667 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -114.81 140.3 25.25 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.37 124.32 12.74 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.986 2.457 . . . . 0.0 110.454 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.74 135.76 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.007 1.723 . . . . 0.0 106.538 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t -78.59 178.81 7.52 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.966 0.907 . . . . 0.0 109.816 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.25 179.56 53.17 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.2 10.32 0.12 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.508 1.523 . . . . 0.0 112.734 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 t -69.84 22.72 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.36 2.264 . . . . 0.0 112.575 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.95 2.4 23.7 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 125.404 1.478 . . . . 0.0 111.875 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 100.67 12.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.926 1.863 . . . . 0.0 106.515 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -73.47 131.7 42.09 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.29 164.57 31.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.482 1.513 . . . . 0.0 109.495 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.73 102.12 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.364 1.465 . . . . 0.0 109.061 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.3 m -82.19 114.67 20.86 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -145.83 147.7 32.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.279 0.945 . . . . 0.0 108.638 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 36.96 58.08 1.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.096 1.759 . . . . 0.0 111.537 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 p30 48.62 25.03 0.87 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.105 1.762 . . . . 0.0 114.968 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 t -128.49 165.46 20.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 127.911 2.484 . . . . 0.0 108.524 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.9 109.77 11.54 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.516 -0.74 . . . . 0.0 110.632 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -103.54 150.96 23.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.343 1.068 . . . . 0.0 108.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -82.5 152.5 26.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -57.52 -37.02 72.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.781 1.173 . . . . 0.0 108.923 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.8 -17.4 63.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 112.763 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.45 27.82 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -113.1 100.31 8.51 Favored 'General case' 0 C--O 1.237 0.436 1 N-CA-C 99.023 -4.436 . . . . 0.0 99.023 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -145.38 173.11 12.28 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.16 107.39 1.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.457 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.2 -31.34 26.5 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 119.57 1.077 . . . . 0.0 115.413 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -77.4 -23.86 50.59 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.26 -23.68 1.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t 74.37 85.13 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.632 1.573 . . . . 0.0 109.909 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 p -151.57 136.59 10.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 129.872 3.269 . . . . 0.0 104.682 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -54.54 146.45 16.31 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.659 1.219 . . . . 0.0 113.045 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -120.01 1.94 10.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 109.098 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.36 103.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 125.659 1.583 . . . . 0.0 107.178 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 5.89 86.87 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.272 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -112.86 87.7 2.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.249 1.524 . . . . 0.0 107.969 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -20.67 109.79 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 128.501 2.953 . . . . 0.0 113.139 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -111.14 165.02 12.25 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.378 1.071 . . . . 0.0 112.752 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.58 151.15 24.69 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.913 1.685 . . . . 0.0 107.734 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -124.4 109.05 12.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.103 1.361 . . . . 0.0 108.677 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -142.49 152.76 43.01 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 45.78 32.52 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.479 1.912 . . . . 0.0 111.354 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.06 -9.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.782 2.833 . . . . 0.0 112.813 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.97 -176.02 5.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.971 2.108 . . . . 0.0 110.747 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.05 126.18 21.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 127.619 2.368 . . . . 0.0 110.589 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -139.58 155.77 47.27 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.464 -1.397 . . . . 0.0 113.689 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.17 154.67 41.64 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -53.15 -51.69 61.16 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.248 1.019 . . . . 0.0 111.283 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -52.54 -46.06 66.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.018 1.281 . . . . 0.0 111.272 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.5 m -65.45 -47.03 77.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.469 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -17.08 73.43 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.041 0.837 . . . . 0.0 112.743 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t -85.59 63.63 8.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.229 1.412 . . . . 0.0 108.44 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.25 175.54 22.71 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 124.891 1.234 . . . . 0.0 110.058 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.0 ptm -71.64 119.94 16.52 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -65.83 130.04 41.87 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.2 p -133.24 -27.25 1.61 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -85.52 87.66 7.42 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 120.426 1.467 . . . . 0.0 107.249 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.6 pt -69.73 -4.87 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 118.096 -0.955 . . . . 0.0 112.379 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.6 p -79.42 143.8 34.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 120.113 1.324 . . . . 0.0 111.049 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 148.33 92.7 0.11 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-O 118.575 -1.125 . . . . 0.0 111.172 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.98 164.21 36.53 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 119.977 1.888 . . . . 0.0 109.89 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 m -86.19 116.02 24.12 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.1 m -135.95 164.72 27.33 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 N-CA-C 107.333 -2.307 . . . . 0.0 107.333 178.731 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.486 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -102.66 170.29 8.11 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.307 1.043 . . . . 0.0 110.965 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.92 135.82 1.45 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.943 1.697 . . . . 0.0 107.06 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.14 91.06 1.69 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 105.866 -2.894 . . . . 0.0 105.866 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.8 m -71.63 61.29 0.36 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.342 1.857 . . . . 0.0 111.844 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.38 125.99 28.4 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 121.447 -0.783 . . . . 0.0 109.579 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.08 -177.24 17.63 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.268 1.413 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.8 125.3 24.39 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 116.732 -1.604 . . . . 0.0 107.39 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -57.94 -27.28 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 120.841 1.655 . . . . 0.0 109.015 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.22 12.12 14.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.982 2.913 . . . . 0.0 116.831 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -171.7 -7.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 118.609 -2.557 . . . . 0.0 114.229 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 58.28 9.85 1.13 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.644 2.778 . . . . 0.0 114.658 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -72.74 154.92 91.19 Favored Pre-proline 0 CA--C 1.517 -0.299 0 O-C-N 120.868 -1.145 . . . . 0.0 110.662 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.61 146.34 84.18 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.364 2.042 . . . . 0.0 108.871 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.4 mt -109.32 122.0 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.772 2.429 . . . . 0.0 106.772 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m -112.18 114.33 27.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.494 1.118 . . . . 0.0 108.603 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.64 89.16 0.49 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 105.278 -3.129 . . . . 0.0 105.278 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.5 tp -156.99 -50.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.661 1.584 . . . . 0.0 109.526 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 m -73.81 -23.23 59.64 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.357 -0.839 . . . . 0.0 110.486 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.62 36.13 1.47 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.924 1.249 . . . . 0.0 112.01 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.12 118.78 8.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.098 0.959 . . . . 0.0 109.264 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -65.8 132.08 47.85 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.28 165.35 28.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 111.297 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -128.99 146.28 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.808 1.643 . . . . 0.0 107.765 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -132.81 119.06 19.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.75 143.89 48.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 37.2 56.14 1.31 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.07 1.748 . . . . 0.0 114.178 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t0 55.14 24.59 6.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.678 1.191 . . . . 0.0 112.806 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 14.7 m -127.69 131.49 49.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.777 1.631 . . . . 0.0 109.949 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -90.73 130.28 36.74 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.393 0.677 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 2.6 m-90 -131.09 133.32 45.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.501 1.143 . . . . 0.0 110.873 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.39 154.35 41.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 p -61.22 -36.24 79.39 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -74.07 4.25 5.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.746 1.618 . . . . 0.0 113.12 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -139.97 21.75 2.45 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.445 1.021 . . . . 0.0 113.002 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -109.34 99.76 8.96 Favored 'General case' 0 C--O 1.237 0.443 1 N-CA-C 98.356 -4.683 . . . . 0.0 98.356 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -152.63 176.16 12.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.467 ' C ' ' H ' ' A' ' 40' ' ' LYS . 20.8 t -59.69 111.64 1.51 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.891 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.82 13.22 0.09 OUTLIER Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.165 1.84 . . . . 0.0 115.348 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 38' ' ' CYS . 62.8 mttt -128.03 -18.64 4.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.411 2.684 . . . . 0.0 112.757 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 -17.43 0.82 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 m 84.36 1.43 0.87 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.224 1.81 . . . . 0.0 115.463 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.81 126.44 28.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 t -52.05 142.81 15.22 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.475 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -115.81 -2.5 12.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.809 1.244 . . . . 0.0 110.924 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.17 126.12 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.647 0.779 . . . . 0.0 109.356 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.36 69.48 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.016 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -131.45 167.25 19.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 121.128 2.464 . . . . 0.0 112.547 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.97 127.73 33.45 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.01 171.49 14.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.732 1.213 . . . . 0.0 110.015 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 mp -121.52 156.55 32.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.885 1.674 . . . . 0.0 109.188 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 p -137.45 102.59 4.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.28 147.64 47.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 108.757 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 52.81 23.78 2.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.775 2.03 . . . . 0.0 114.322 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? 78.61 12.4 1.52 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.043 2.137 . . . . 0.0 111.784 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -105.78 -178.39 3.64 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.748 -1.22 . . . . 0.0 109.4 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -128.45 122.17 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.714 1.606 . . . . 0.0 108.395 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -138.08 157.28 46.65 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 123.111 1.434 . . . . 0.0 114.794 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.45 155.52 37.93 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -47.26 -52.92 14.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.765 0.711 . . . . 0.0 111.557 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -58.57 7.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.534 0.734 . . . . 0.0 112.171 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.11 -23.11 44.71 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.619 -1.181 . . . . 0.0 113.728 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.36 -24.13 10.53 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 120.213 1.37 . . . . 0.0 112.355 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.0 t -86.95 89.07 7.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.93 87.32 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.3 mmt -78.45 89.18 4.42 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -81.11 71.61 8.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 p -128.54 71.24 1.39 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.775 1.23 . . . . 0.0 110.975 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.52 -11.61 59.12 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.797 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.8 mt -67.01 92.53 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 129.348 3.059 . . . . 0.0 106.913 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.3 t -150.8 165.06 34.68 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.718 1.207 . . . . 0.0 108.609 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.25 65.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.464 2.459 . . . . 0.0 107.952 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.91 166.78 26.63 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.483 2.122 . . . . 0.0 111.609 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.4 p -144.4 177.9 8.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.709 1.604 . . . . 0.0 108.351 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.5 t -79.29 -178.35 6.17 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.263 1.911 1 C-N-CA 133.197 5.189 . . . . 0.0 103.458 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.983 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -71.78 97.94 1.87 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.8 m -144.55 168.6 19.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.402 1.481 . . . . 0.0 109.174 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.47 -6.49 57.51 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 117.769 -1.573 . . . . 0.0 116.444 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 p -172.35 111.21 0.26 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-N 120.442 2.121 . . . . 0.0 111.579 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.1 m -61.2 126.96 29.24 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.99 -174.0 32.37 Favored Glycine 0 N--CA 1.446 -0.681 0 O-C-N 121.761 -0.587 . . . . 0.0 112.552 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.428 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 11.6 t -61.89 126.04 25.94 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.89 -20.23 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 119.336 0.971 . . . . 0.0 111.493 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.73 3.62 45.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 115.487 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -155.94 -9.69 0.11 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.023 -1.673 . . . . 0.0 113.723 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m 53.38 29.06 8.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.533 1.933 . . . . 0.0 111.675 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -89.41 151.09 45.82 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.802 -1.186 . . . . 0.0 108.178 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 118.37 5.64 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.273 1.982 . . . . 0.0 110.027 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mm -65.29 162.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.514 1.526 . . . . 0.0 107.632 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.32 147.34 37.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.83 -21.67 0.63 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.554 1.55 . . . . 0.0 113.065 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.34 -46.71 83.0 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.431 2.115 . . . . 0.0 109.02 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.3 m -73.44 7.43 2.32 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.578 1.951 . . . . 0.0 112.17 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.9 38.12 82.46 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 120.367 -1.458 . . . . 0.0 111.679 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 141.45 58.04 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.161 0.584 . . . . 0.0 111.898 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -72.74 110.32 6.99 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.348 1.059 . . . . 0.0 111.939 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -142.32 164.51 29.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.558 1.943 . . . . 0.0 106.644 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.59 130.34 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.234 1.814 . . . . 0.0 106.427 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.7 124.11 38.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.05 122.56 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 40.92 59.02 2.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.998 1.719 . . . . 0.0 112.848 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 63.66 12.23 6.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.265 2.226 . . . . 0.0 114.913 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 158.51 28.79 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.547 -1.346 . . . . 0.0 110.629 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.24 133.26 56.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.588 0.709 . . . . 0.0 110.855 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -123.88 126.8 47.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -67.08 148.79 51.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.11 -51.64 23.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.098 0.863 . . . . 0.0 112.438 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.22 -13.33 61.87 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -102.64 -12.68 17.53 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -80.43 101.52 9.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.24 168.57 19.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.2 t -65.23 114.91 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 116.663 -1.637 . . . . 0.0 110.049 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.82 -18.62 25.96 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.498 1.045 . . . . 0.0 115.528 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.13 -17.37 23.85 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.0 -20.21 0.5 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 118.601 2.815 . . . . 0.0 118.601 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 m 77.14 80.54 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.536 1.062 . . . . 0.0 109.888 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.64 141.57 18.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 126.832 2.053 . . . . 0.0 105.749 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -58.56 121.7 11.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.79 1.306 . . . . 0.0 113.626 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.4 mt -99.37 1.73 44.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.072 0.949 . . . . 0.0 109.659 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.68 140.71 19.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 -62.19 3.84 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.252 1.406 . . . . 0.0 112.777 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 164.81 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.849 0.859 . . . . 0.0 112.494 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.3 156.44 39.39 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -137.93 168.48 19.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.586 1.154 . . . . 0.0 107.946 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.61 161.01 24.56 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.7 p -127.41 115.82 19.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.247 1.419 . . . . 0.0 107.607 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -143.17 150.59 39.6 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 51.39 24.72 2.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.896 1.678 . . . . 0.0 114.107 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt 73.79 9.99 4.76 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.751 2.02 . . . . 0.0 111.277 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -110.68 -178.01 3.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.06 2.144 . . . . 0.0 110.136 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.3 pt -123.96 126.99 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.892 0.877 . . . . 0.0 110.465 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -130.28 163.32 27.04 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.468 -1.395 . . . . 0.0 113.254 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.21 156.98 19.44 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -57.36 -47.05 82.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 119.257 0.935 . . . . 0.0 110.136 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -52.25 -37.43 55.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.75 -1.219 . . . . 0.0 113.541 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.77 -35.6 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.234 1.014 . . . . 0.0 110.622 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.79 33.32 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.104 1.335 . . . . 0.0 110.005 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -64.99 141.21 58.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 118.783 1.291 . . . . 0.0 110.739 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.22 178.2 20.86 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 69.1 mtm -88.11 -27.74 21.73 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.013 0.525 . . . . 0.0 109.688 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.05 33.98 13.1 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.414 1.885 . . . . 0.0 111.615 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 t -160.36 176.51 11.6 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.595 2.358 . . . . 0.0 104.882 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 35.02 48.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 127.999 2.519 . . . . 0.0 113.623 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 70' ' ' ILE . 3.9 mp -61.97 -18.7 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.472 1.509 . . . . 0.0 110.892 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 m -157.81 118.57 3.48 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.041 -1.662 . . . . 0.0 109.002 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.94 173.24 15.01 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.747 1.642 . . . . 0.0 109.795 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.09 43.8 1.46 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.489 3.46 . . . . 0.0 112.279 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.9 m 54.67 41.79 31.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.499 1.12 . . . . 0.0 111.029 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.6 m -50.57 -36.19 33.46 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.463 2.305 . . . . 0.0 115.465 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -179.552 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.65 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.3 m -60.97 126.3 26.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 117.378 0.589 . . . . 0.0 109.426 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -52.14 138.51 25.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.626 1.17 . . . . 0.0 110.41 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.09 116.94 9.46 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 124.432 1.015 . . . . 0.0 111.636 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -31.93 72.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.248 1.019 . . . . 0.0 111.743 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -168.33 169.27 10.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.715 2.006 . . . . 0.0 107.256 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.67 -167.53 42.62 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 115.325 0.89 . . . . 0.0 115.325 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.0 t -50.52 117.28 2.34 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.582 -1.199 . . . . 0.0 107.948 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -54.97 -27.34 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 120.94 1.7 . . . . 0.0 110.83 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.86 -3.69 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.673 1.989 . . . . 0.0 115.175 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -152.62 -10.25 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.446 1.476 . . . . 0.0 114.24 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m 60.3 10.32 2.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.517 3.527 . . . . 0.0 115.642 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -75.67 151.54 84.84 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 120.911 1.687 . . . . 0.0 112.403 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -66.94 139.43 51.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.817 2.344 . . . . 0.0 109.019 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.76 156.71 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.415 2.286 . . . . 0.0 108.68 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -98.13 -9.3 26.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.321 1.049 . . . . 0.0 111.146 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.02 -122.41 11.7 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.017 1.77 . . . . 0.0 112.813 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.9 mt -53.22 -16.17 1.16 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.629 1.972 . . . . 0.0 114.293 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 m -66.89 -8.89 32.44 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.103 0.961 . . . . 0.0 110.279 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.8 28.91 2.78 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.33 1.443 . . . . 0.0 113.053 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.64 147.05 37.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.343 1.071 . . . . 0.0 108.279 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -86.0 82.0 8.28 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -130.83 164.58 24.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.51 0.724 . . . . 0.0 111.077 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 mm -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 128.837 2.855 . . . . 0.0 105.932 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.34 102.96 15.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -135.49 127.22 29.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.403 1.002 . . . . 0.0 110.632 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 50.24 45.44 25.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.38 1.072 . . . . 0.0 109.227 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.91 -17.55 0.25 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 129.735 3.214 . . . . 0.0 114.325 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 m -73.64 164.53 26.52 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.133 0.879 . . . . 0.0 109.3 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -128.95 107.73 9.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -109.05 125.57 52.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 111.12 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -60.47 150.08 32.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -55.33 -42.42 73.77 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.72 -3.82 20.56 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.2 -1.46 11.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 128.959 2.904 . . . . 0.0 113.909 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.98 102.57 15.14 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -152.77 174.59 13.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.27 120.47 11.63 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 117.264 -1.35 . . . . 0.0 110.075 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.14 -12.27 29.8 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.627 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.37 -19.67 16.18 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.98 -10.59 0.88 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 81.11 1.22 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.23 138.9 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.218 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -55.33 134.25 50.01 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.313 1.045 . . . . 0.0 111.773 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 mt -117.99 4.75 12.09 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.69 -1.148 . . . . 0.0 109.695 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 t -36.76 103.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.482 1.913 . . . . 0.0 112.525 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 -25.17 0.9 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 129.064 3.221 . . . . 0.0 115.928 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -55.0 138.27 44.21 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.662 1.985 . . . . 0.0 112.128 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.14 121.73 27.14 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -116.36 172.6 7.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.866 2.067 . . . . 0.0 111.719 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.01 148.12 33.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.0 p -126.52 117.26 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.11 143.93 32.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 50.6 28.74 3.64 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.981 1.264 . . . . 0.0 113.958 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm 64.85 22.72 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.734 1.214 . . . . 0.0 111.145 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -110.2 178.57 4.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.129 2.172 . . . . 0.0 106.751 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.81 122.95 55.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 109.532 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -131.55 154.58 48.67 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 122.893 1.33 . . . . 0.0 113.197 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 164.51 19.75 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -59.02 -54.44 47.1 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.925 0.784 . . . . 0.0 111.135 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -50.52 -30.18 12.33 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.4 m -93.96 -30.72 14.6 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.231 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.55 7.53 59.67 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.96 1.255 . . . . 0.0 115.356 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -53.53 -38.64 63.98 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.455 1.628 . . . . 0.0 113.276 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.04 178.22 30.25 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.5 ptp -132.02 169.55 16.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -143.71 58.85 1.38 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.5 p -75.67 -11.33 59.98 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.963 1.305 . . . . 0.0 111.616 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -67.94 163.47 22.05 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.1 mt 53.52 54.94 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -70.54 92.58 0.85 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.27 2.228 . . . . 0.0 108.254 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.43 113.1 0.24 Allowed Glycine 0 CA--C 1.531 1.041 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.39 47.05 1.96 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 123.726 2.951 . . . . 0.0 112.102 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.2 m -142.79 142.44 31.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.97 2.908 . . . . 0.0 106.518 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.1 m -91.12 86.98 6.37 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 CA-C-O 117.931 -1.483 . . . . 0.0 110.052 -179.831 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.896 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -142.03 -174.12 4.01 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.985 -0.715 . . . . 0.0 110.76 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 t 65.19 10.61 6.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.065 1.746 . . . . 0.0 113.73 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.84 175.75 19.86 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.967 1.258 . . . . 0.0 111.634 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 m -114.06 164.7 13.48 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.531 1.133 . . . . 0.0 110.498 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 m -146.97 156.63 43.2 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.761 1.225 . . . . 0.0 109.225 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.87 178.3 52.31 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.103 1.335 . . . . 0.0 112.743 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 12.4 t -52.13 115.38 1.68 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.737 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.2 t -54.94 -24.36 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 121.287 1.858 . . . . 0.0 112.481 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.96 -0.57 56.81 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.666 1.186 . . . . 0.0 113.841 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.8 p -156.71 -11.37 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.268 1.849 . . . . 0.0 115.075 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t 52.44 57.63 6.23 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.004 2.522 . . . . 0.0 111.598 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -117.84 147.11 40.46 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.883 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.55 114.03 2.94 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.013 3.142 . . . . 0.0 113.537 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -82.95 162.09 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -64.71 154.2 37.38 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 120.69 -1.256 . . . . 0.0 110.657 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.5 54.33 3.25 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 124.563 1.078 . . . . 0.0 114.524 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mp 58.98 5.53 0.53 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.839 2.456 . . . . 0.0 115.875 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 t -67.33 17.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 127.483 2.313 . . . . 0.0 115.87 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.64 22.73 5.31 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 119.624 -1.922 . . . . 0.0 113.859 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.73 161.02 30.02 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.737 -0.861 . . . . 0.0 109.712 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -104.2 100.92 10.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.39 165.72 26.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.544 1.938 . . . . 0.0 109.294 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mm -116.52 150.37 18.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -131.38 135.08 46.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -145.21 111.38 5.61 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.43 56.81 6.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.143 0.973 . . . . 0.0 109.682 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 -16.89 0.09 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 130.013 3.325 . . . . 0.0 115.191 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.7 m -80.08 145.64 32.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -119.87 141.69 49.34 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.976 0.893 . . . . 0.0 112.528 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.8 m-90 -132.86 162.9 30.33 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.145 1.378 . . . . 0.0 111.143 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -79.78 148.43 31.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.4 t -60.55 -8.94 3.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.728 2.011 . . . . 0.0 115.042 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.96 -36.74 5.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.001 1.721 . . . . 0.0 108.83 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.26 18.28 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.866 1.667 . . . . 0.0 114.913 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -113.2 101.35 9.34 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -148.57 174.72 11.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -61.19 121.05 11.56 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.503 1.521 . . . . 0.0 109.779 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.49 -25.75 58.55 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 118.133 0.424 . . . . 0.0 113.069 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -87.45 -18.8 29.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.63 -9.92 0.41 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 119.082 2.993 . . . . 0.0 119.082 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 83.44 3.23 0.94 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.37 133.69 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.445 1.475 . . . . 0.0 107.303 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.0 t -57.36 144.67 35.2 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.684 0.754 . . . . 0.0 109.852 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.21 -6.56 14.1 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.325 . . . . 0.0 110.197 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.82 120.24 10.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.73 84.83 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 116.163 -2.465 . . . . 0.0 115.923 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -135.21 169.47 17.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.635 2.717 . . . . 0.0 112.204 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.25 123.54 25.92 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -116.62 167.88 10.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.19 159.81 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.8 p -132.3 112.06 11.9 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.919 0.762 . . . . 0.0 109.504 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -142.7 156.12 44.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.632 1.573 . . . . 0.0 107.341 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.9 m120 52.5 30.73 8.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.349 1.06 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.7 27.43 14.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.03 1.332 . . . . 0.0 110.708 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -125.63 175.55 7.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.192 2.197 . . . . 0.0 110.24 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.39 126.4 69.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 127.715 2.406 . . . . 0.0 110.021 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -134.03 163.52 29.37 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 161.2 16.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -50.23 -56.39 11.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.772 1.229 . . . . 0.0 111.215 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -49.8 -33.63 17.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 113.249 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.2 -54.85 5.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.369 0.668 . . . . 0.0 109.319 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.72 26.62 4.62 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 115.621 1.008 . . . . 0.0 115.621 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.16 29.39 0.08 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.578 1.689 . . . . 0.0 112.776 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.21 -172.63 30.94 Favored Glycine 0 CA--C 1.522 0.525 0 O-C-N 120.804 -1.185 . . . . 0.0 111.458 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -71.25 168.16 17.89 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.332 2.253 . . . . 0.0 110.34 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -81.95 60.42 4.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.222 1.011 . . . . 0.0 110.532 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.3 p -64.15 98.3 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.654 1.582 . . . . 0.0 110.118 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -153.75 150.58 28.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.4 mm -84.25 88.11 2.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 m -58.78 155.42 12.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.935 0.398 . . . . 0.0 110.452 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.09 -176.66 14.62 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.85 -14.3 43.25 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.179 1.919 . . . . 0.0 112.44 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.4 m -63.68 98.92 0.2 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.667 1.187 . . . . 0.0 109.518 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 t -124.09 -177.0 3.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.375 1.87 . . . . 0.0 110.464 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.425 0 C-N-CA 126.412 1.958 . . . . 0.0 108.918 179.844 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.997 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -43.0 118.49 1.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 116.197 -1.859 . . . . 0.0 110.423 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.15 -31.36 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 121.753 2.069 . . . . 0.0 112.025 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.68 -5.37 59.31 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -157.95 -7.66 0.08 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 0.1 OUTLIER 61.77 14.34 6.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 130.164 3.386 . . . . 0.0 114.914 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -78.25 147.04 71.97 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 120.453 -1.404 . . . . 0.0 108.646 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.16 120.32 6.93 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.259 2.639 . . . . 0.0 110.07 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mm -66.53 140.45 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.237 0.419 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.58 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.9 tttm . . . . . 0 C--O 1.237 0.433 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -134.43 164.28 27.8 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.499 0.72 . . . . 0.0 110.514 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mm -122.43 145.96 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 127.271 2.229 . . . . 0.0 106.283 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -126.83 102.82 7.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -121.95 127.62 50.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 52.85 43.59 31.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.968 0.907 . . . . 0.0 108.781 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 56.91 0.51 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.007 2.523 . . . . 0.0 114.41 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 m -85.39 156.46 20.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.932 1.693 . . . . 0.0 107.831 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.99 130.31 51.63 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -132.3 145.09 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.647 1.179 . . . . 0.0 109.026 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -98.39 161.26 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 p -53.09 -55.02 27.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.938 0.895 . . . . 0.0 111.651 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.29 -4.05 9.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.054 1.341 . . . . 0.0 112.98 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.48 14.87 11.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.911 1.284 . . . . 0.0 113.298 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -107.41 101.3 10.67 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -157.2 167.04 31.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.4 t -64.86 120.83 13.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 117.111 -1.423 . . . . 0.0 109.799 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.04 -28.66 58.56 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.917 1.235 . . . . 0.0 114.396 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -81.04 -19.86 42.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.6 p -139.71 -23.05 0.87 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t 87.76 7.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.356 1.863 . . . . 0.0 114.467 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.94 135.23 27.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -60.21 132.34 53.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -98.21 -1.6 41.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 108.946 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.06 109.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 -65.93 0.31 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 126.069 1.795 . . . . 0.0 109.072 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -66.65 157.08 33.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.049 0.94 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.06 20.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -106.59 168.77 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.215 1.006 . . . . 0.0 109.187 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.95 152.28 42.66 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.868 1.667 . . . . 0.0 108.365 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 p -134.23 114.85 13.49 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.535 1.134 . . . . 0.0 110.6 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -142.64 143.23 32.28 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.622 1.569 . . . . 0.0 106.907 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 m120 53.76 25.32 5.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.873 0.869 . . . . 0.0 111.493 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt 73.15 3.61 4.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.119 1.768 . . . . 0.0 111.127 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.7 153.18 18.41 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.289 1.436 . . . . 0.0 109.825 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.75 122.46 55.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 109.931 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -137.13 166.49 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.795 1.283 . . . . 0.0 111.848 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.24 163.6 19.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -55.74 -55.51 31.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.052 1.341 . . . . 0.0 111.306 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -52.71 -48.87 66.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.361 -0.837 . . . . 0.0 112.886 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 m -68.62 -44.59 73.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.349 0.66 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 22.59 7.65 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 120.939 -1.1 . . . . 0.0 113.759 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 CA--C 1.53 0.178 0 CA-C-N 119.369 1.585 . . . . 0.0 107.441 179.325 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.522 0 N-CA-C 115.149 0.82 . . . . 0.0 115.149 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.6 t -60.71 113.56 2.54 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 117.243 -1.36 . . . . 0.0 110.21 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.6 t -57.83 -20.36 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 120.091 1.314 . . . . 0.0 110.438 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.6 -3.76 58.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.072 1.349 . . . . 0.0 114.078 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 p -155.44 -10.53 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.408 1.913 . . . . 0.0 115.673 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m 55.17 53.32 10.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.331 2.252 . . . . 0.0 112.589 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -113.7 137.3 22.18 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 108.61 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.92 3.08 . . . . 0.0 110.113 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.44 129.83 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 122.69 0.396 . . . . 0.0 111.819 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.286 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -137.89 166.77 23.23 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.406 1.882 . . . . 0.0 109.991 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.2 mm -125.25 114.87 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 p -104.41 117.29 33.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.139 1.776 . . . . 0.0 107.525 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -145.58 143.48 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.209 1.004 . . . . 0.0 109.218 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 31.52 60.37 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.872 2.469 . . . . 0.0 114.372 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 65.19 5.36 3.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.916 2.487 . . . . 0.0 114.972 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -116.09 161.85 18.3 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 0.0 111.079 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -125.72 141.1 52.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.462 1.125 . . . . 0.0 110.168 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -132.58 152.42 51.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.225 1.41 . . . . 0.0 109.555 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -86.15 141.57 29.27 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.67 -55.79 4.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.021 1.328 . . . . 0.0 111.071 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -65.56 -12.68 55.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -118.15 16.56 14.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.411 0.685 . . . . 0.0 111.869 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -106.92 101.56 10.99 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.88 176.34 12.28 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.9 t -58.11 118.93 5.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 117.088 -1.434 . . . . 0.0 109.731 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.07 -11.51 12.23 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 123.968 0.793 . . . . 0.0 114.787 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -102.74 -21.52 14.06 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.093 1.357 . . . . 0.0 114.595 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.68 -14.21 0.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.993 2.59 . . . . 0.0 117.993 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 t 81.62 27.46 0.18 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.833 1.652 . . . . 0.0 114.725 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.75 128.49 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -51.3 136.51 24.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.141 1.377 . . . . 0.0 111.691 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.1 mt -112.41 3.74 17.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.561 1.144 . . . . 0.0 110.215 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.81 105.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 126.594 1.958 . . . . 0.0 108.641 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.45 36.13 92.08 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.517 -0.602 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -132.99 160.97 35.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.483 1.141 . . . . 0.0 107.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.44 124.82 30.29 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.7 171.08 14.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.125 . . . . 0.0 109.243 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 60' ' ' GLN . 5.1 mp -136.13 156.84 48.11 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.271 1.828 . . . . 0.0 106.442 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.4 p -137.46 115.4 11.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -142.48 145.79 34.07 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 48.42 41.92 17.54 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.909 1.283 . . . . 0.0 111.465 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.397 5.0 ptpp? 61.43 7.87 1.95 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.189 2.995 . . . . 0.0 114.62 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.95 178.07 5.4 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.368 1.44 . . . . 0.0 110.889 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.31 122.81 60.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 109.535 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.14 160.14 35.61 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.667 -1.27 . . . . 0.0 112.811 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.91 162.43 16.91 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.654 ' HA ' HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.28 -52.73 60.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.041 1.291 . . . . 0.0 111.372 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -40.28 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.145 1.339 . . . . 0.0 113.302 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -78.46 -29.05 46.65 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.715 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.47 13.76 61.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.108 1.813 . . . . 0.0 113.342 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.702 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 11.4 t -58.56 125.4 23.24 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 117.619 -1.182 . . . . 0.0 108.943 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.3 -17.01 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 124.731 1.213 . . . . 0.0 112.052 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.85 9.43 22.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.239 2.216 . . . . 0.0 115.083 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -161.1 -5.3 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.426 -1.421 . . . . 0.0 114.351 178.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t 62.15 0.6 0.59 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.381 1.872 . . . . 0.0 113.755 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -82.58 156.4 68.21 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 122.359 2.345 . . . . 0.0 112.271 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.23 122.82 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.452 2.101 . . . . 0.0 108.837 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -76.33 151.26 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.235 0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.292 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 tptm . . . . . 0 C--O 1.238 0.473 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -137.41 164.65 28.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.538 1.535 . . . . 0.0 108.844 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.29 140.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -131.47 132.94 44.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.731 2.012 . . . . 0.0 106.272 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -145.57 102.74 3.73 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.703 1.601 . . . . 0.0 108.587 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.5 64.68 1.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 109.796 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 49.8 t0 42.66 67.32 0.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.468 2.707 . . . . 0.0 113.245 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.8 p -134.99 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 130.103 3.361 . . . . 0.0 106.951 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -142.53 118.06 10.34 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -131.55 131.61 43.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.305 1.042 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -66.45 154.97 38.83 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -53.03 -43.41 66.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.157 0.98 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.62 -2.69 33.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -121.12 18.68 11.61 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 0.0 114.442 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -112.38 100.08 8.51 Favored 'General case' 0 C--O 1.235 0.333 1 N-CA-C 100.193 -4.002 . . . . 0.0 100.193 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.63 160.53 40.12 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.7 t -58.9 124.23 19.15 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.444 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.88 -28.06 72.15 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 118.425 0.557 . . . . 0.0 113.362 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -78.83 -28.63 44.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.78 -10.84 1.02 Allowed 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t 72.62 87.77 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.907 1.337 . . . . 0.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.98 143.29 18.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 127.556 2.342 . . . . 0.0 104.801 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.7 t -65.55 142.71 58.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.252 1.025 . . . . 0.0 109.867 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.32 13.15 11.87 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.044 1.738 . . . . 0.0 109.658 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.9 t -76.97 -63.49 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 119.035 0.834 . . . . 0.0 108.761 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.61 11.9 6.6 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.206 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.97 159.1 44.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.665 1.732 . . . . 0.0 109.897 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.65 159.14 52.41 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -132.46 167.4 20.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.697 1.599 . . . . 0.0 108.425 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 60' ' ' GLN . 10.3 mp -125.29 159.02 32.7 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -126.72 107.84 10.53 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.991 1.716 . . . . 0.0 109.489 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -142.44 155.21 45.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m120 47.66 41.53 13.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.873 1.269 . . . . 0.0 112.197 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt 50.74 19.75 0.65 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.931 2.092 . . . . 0.0 113.882 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -123.82 176.26 6.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.494 1.918 . . . . 0.0 109.389 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.6 pt -112.92 131.67 63.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.674 1.189 . . . . 0.0 111.511 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.0 165.51 25.5 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.51 1.148 . . . . 0.0 113.69 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.72 156.64 20.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.472 ' HA ' HD13 ' A' ' 51' ' ' LEU . 74.6 mt-30 -54.9 -52.38 63.06 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.532 1.133 . . . . 0.0 109.554 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -55.07 -26.14 35.67 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.219 -1.551 . . . . 0.0 114.558 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.21 -22.97 16.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.731 1.612 . . . . 0.0 112.808 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.3 -4.38 55.13 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.492 1.044 . . . . 0.0 113.529 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.451 -0.423 0 C-N-CA 125.914 1.686 . . . . 0.0 108.023 -179.774 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.429 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 18.0 t -49.54 124.67 9.84 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.203 2.002 . . . . 0.0 108.32 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.23 -8.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 120.581 1.537 . . . . 0.0 110.964 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.07 7.16 27.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.703 2.001 . . . . 0.0 113.159 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.9 p -167.66 -5.34 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 121.225 1.829 . . . . 0.0 115.774 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.368 0.1 OUTLIER 56.06 18.79 3.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.128 2.171 . . . . 0.0 114.666 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -82.82 144.45 48.27 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.34 128.51 14.67 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.648 2.232 . . . . 0.0 110.239 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.8 mt -78.87 162.18 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.699 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.6 mttm . . . . . 0 C--O 1.237 0.441 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -119.24 158.53 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.405 HG21 ' CE1' ' A' ' 36' ' ' PHE . 3.9 mp -118.85 131.67 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.08 116.11 22.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.117 2.167 . . . . 0.0 107.549 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -145.76 131.25 18.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.233 1.813 . . . . 0.0 107.172 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 36.32 63.13 0.65 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.669 1.988 . . . . 0.0 111.918 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 60.19 -3.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 128.035 2.534 . . . . 0.0 115.749 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -80.45 160.63 25.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.492 1.117 . . . . 0.0 108.179 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -136.69 113.87 10.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -118.91 149.95 40.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.584 1.154 . . . . 0.0 111.021 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -86.56 147.37 25.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.0 t -49.39 -52.78 26.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.613 1.097 . . . . 0.0 110.669 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -57.76 -31.07 66.13 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.49 -4.92 52.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.405 ' CE1' HG21 ' A' ' 24' ' ' ILE . 47.8 t80 -80.93 99.36 8.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.38 161.76 37.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.086 1.355 . . . . 0.0 112.563 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.68 145.7 55.23 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.099 1.36 . . . . 0.0 112.701 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.39 -49.27 15.74 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 123.797 0.686 . . . . 0.0 111.915 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -75.53 -23.14 56.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -133.57 -7.43 2.87 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -178.454 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 m 72.49 -0.75 3.19 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 41' ' ' CYS . 4.0 p -71.06 147.03 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 121.038 1.744 . . . . 0.0 111.251 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -71.81 149.59 45.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.583 0.628 . . . . 0.0 111.968 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.13 -6.56 13.66 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.985 0.803 . . . . 0.0 112.412 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.65 95.83 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.58 11.56 24.81 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.877 1.227 . . . . 0.0 113.175 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -127.55 141.01 51.76 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.498 1.149 . . . . 0.0 108.305 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.95 88.78 0.66 Allowed Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -85.44 168.07 14.92 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.766 0.783 . . . . 0.0 110.296 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 mp -117.68 158.89 23.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.224 1.809 . . . . 0.0 106.918 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.3 p -128.71 122.6 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -143.51 153.21 42.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 m120 47.06 36.99 4.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm 58.89 30.4 20.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.327 1.051 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -129.19 166.64 18.96 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.913 1.685 . . . . 0.0 108.921 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.82 120.8 63.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.128 1.771 . . . . 0.0 108.487 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -131.31 139.48 49.58 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.007 -1.683 . . . . 0.0 113.054 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.58 144.52 31.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 114.521 -2.657 . . . . 0.0 106.024 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -30.06 -53.16 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.791 3.236 . . . . 0.0 112.304 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -47.83 -40.31 20.86 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.953 0.797 . . . . 0.0 112.296 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 29.2 m -80.14 -44.13 20.44 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.02 14.97 5.59 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 120.954 -1.091 . . . . 0.0 113.6 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.445 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.576 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 18.1 t -61.28 117.24 5.37 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 116.31 -1.805 . . . . 0.0 107.761 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 29' ' ' SER . 88.0 t -52.3 -30.54 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 121.067 1.758 . . . . 0.0 112.161 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.83 -12.02 58.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 1.8 p -139.49 -13.51 1.14 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.733 1.606 . . . . 0.0 113.413 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m 52.77 56.04 8.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 128.396 2.679 . . . . 0.0 111.665 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -124.86 149.23 62.21 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 117.773 -1.108 . . . . 0.0 108.748 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.87 114.74 3.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.606 2.204 . . . . 0.0 109.042 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.76 138.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 107.542 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 CA--C 1.535 0.392 0 CA-C-N 118.544 0.611 . . . . 0.0 111.079 179.345 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 121.944 0.878 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.58 165.26 18.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.559 1.544 . . . . 0.0 109.523 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 mt -130.19 152.94 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 126.218 1.807 . . . . 0.0 106.611 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 t -131.8 131.72 43.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.557 1.543 . . . . 0.0 108.399 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -146.42 136.24 23.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.116 1.366 . . . . 0.0 107.811 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 48.15 38.12 9.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 65.51 6.47 3.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.374 1.469 . . . . 0.0 112.959 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 9' ' ' VAL . 15.4 m -102.08 160.98 14.04 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.426 2.29 . . . . 0.0 105.73 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -132.14 144.86 50.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 119.936 -1.728 . . . . 0.0 113.363 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -133.43 145.08 49.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.238 1.015 . . . . 0.0 111.327 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -80.68 157.69 25.83 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 p -53.62 -49.77 67.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.867 0.867 . . . . 0.0 111.846 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -12.64 60.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.75 4.77 24.06 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.277 1.831 . . . . 0.0 113.714 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -101.28 99.89 10.33 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -155.24 166.41 33.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -58.48 119.77 7.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 116.821 -1.561 . . . . 0.0 112.45 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.27 49.81 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.453 1.024 . . . . 0.0 112.225 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -92.0 -17.52 24.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -148.72 -4.96 0.43 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m 74.47 1.14 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.77 134.61 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.9 t -59.38 145.52 43.22 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 124.242 0.964 . . . . 0.0 110.472 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -118.33 4.6 11.85 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.137 1.775 . . . . 0.0 110.058 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.91 91.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.964 . . . . 0.0 110.524 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.51 -58.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 125.875 1.702 . . . . 0.0 111.668 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.64 148.42 42.58 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.352 0.576 . . . . 0.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.42 115.03 7.36 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 105.52 -3.032 . . . . 0.0 105.52 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -85.16 170.38 12.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 109.137 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.7 160.74 32.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.693 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.7 p -137.72 104.5 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 110.247 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -141.16 153.57 45.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.89 1.676 . . . . 0.0 107.246 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.89 31.6 3.3 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.272 1.029 . . . . 0.0 113.396 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm 60.37 21.46 11.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.005 1.722 . . . . 0.0 112.007 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -125.43 174.83 7.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.49 1.516 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -117.31 122.7 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.977 1.311 . . . . 0.0 111.037 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.78 148.23 50.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.382 1.087 . . . . 0.0 113.586 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 162.68 29.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -50.22 -52.94 31.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.586 1.085 . . . . 0.0 112.39 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.46 -45.24 69.48 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.64 1.109 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.22 -59.44 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.5 29.92 1.71 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.139 1.352 . . . . 0.0 112.959 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 107.642 -179.278 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.757 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 10.2 t -57.67 120.72 8.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.418 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.76 -2.4 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 125.605 1.562 . . . . 0.0 112.337 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.99 6.09 10.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.957 2.103 . . . . 0.0 113.022 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.7 p -159.02 -7.37 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 119.282 -2.136 . . . . 0.0 114.625 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.8 m 58.38 12.94 2.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.63 1.572 . . . . 0.0 114.036 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -81.31 148.75 63.95 Favored Pre-proline 0 C--N 1.346 0.435 0 O-C-N 120.117 -1.614 . . . . 0.0 108.138 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.59 117.54 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.901 3.067 . . . . 0.0 109.122 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.2 mt -74.65 139.51 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.614 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 7.1 mmpt? . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.267 0.556 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.99 164.13 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.484 1.514 . . . . 0.0 107.877 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.23 137.78 52.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.14 112.15 18.32 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.265 1.826 . . . . 0.0 106.751 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -146.47 150.23 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 42.04 32.88 0.33 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.6 t70 56.68 40.67 29.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 123.699 1.714 . . . . 0.0 111.454 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 56.5 m -131.73 164.37 26.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 130.525 3.53 . . . . 0.0 106.804 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -132.65 133.77 44.0 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.327 1.051 . . . . 0.0 111.858 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 30.6 m-90 -132.38 161.54 33.34 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.527 1.131 . . . . 0.0 109.419 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -97.28 166.7 11.43 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.1 p -55.92 -30.76 62.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.338 1.055 . . . . 0.0 112.282 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -103.57 4.8 36.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.251 1.42 . . . . 0.0 112.256 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.01 6.59 9.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.313 1.045 . . . . 0.0 112.349 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -101.85 100.28 10.59 Favored 'General case' 0 N--CA 1.453 -0.298 1 N-CA-C 99.524 -4.25 . . . . 0.0 99.524 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -145.04 157.41 44.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 t -51.53 118.28 3.22 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -27.3 38.67 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 119.849 1.204 . . . . 0.0 112.872 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.6 -22.59 26.14 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.4 p -143.45 -6.72 0.8 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m 76.92 10.31 2.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.71 141.36 15.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.1 t -66.11 151.33 47.13 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.4 mt -118.18 -1.72 11.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.433 1.093 . . . . 0.0 111.374 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.29 -57.43 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.445 1.098 . . . . 0.0 112.286 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.76 17.15 2.85 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.05 -0.861 . . . . 0.0 113.947 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -150.92 -167.66 2.88 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.437 1.618 . . . . 0.0 110.722 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.96 165.31 21.92 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -140.82 171.48 14.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 109.766 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 60' ' ' GLN . 6.7 mp -129.53 165.53 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.407 1.083 . . . . 0.0 109.291 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 p -137.65 111.51 8.28 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.983 0.513 . . . . 0.0 109.735 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -142.46 148.36 37.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.161 1.784 . . . . 0.0 106.48 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 46.08 33.98 1.9 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.093 2.157 . . . . 0.0 112.478 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp 59.7 9.99 1.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.752 1.621 . . . . 0.0 113.039 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -93.41 -173.56 3.25 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.769 2.028 . . . . 0.0 107.466 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.2 pt -135.75 124.05 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.06 1.744 . . . . 0.0 109.397 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -135.38 148.04 49.25 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 120.745 -1.222 . . . . 0.0 114.183 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.72 155.68 39.66 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HA ' HD13 ' A' ' 51' ' ' LEU . 56.6 mt-30 -51.36 -52.75 42.87 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.934 1.243 . . . . 0.0 110.263 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -56.83 -25.79 56.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.2 m -97.51 -18.23 19.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 114.075 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.62 -5.63 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.536 0.41 0 C-N-CA 128.032 2.533 . . . . 0.0 105.963 178.737 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 49.2 t -66.53 106.89 1.9 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.743 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -50.55 -35.16 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.784 1.174 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.39 1.0 50.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.227 2.211 . . . . 0.0 116.427 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -153.16 -12.98 0.15 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.101 1.773 . . . . 0.0 112.798 178.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m 55.41 51.13 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 131.169 3.788 . . . . 0.0 113.388 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.59 149.18 44.47 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.71 1.204 . . . . 0.0 110.098 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.4 122.6 6.62 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 123.306 2.671 . . . . 0.0 112.097 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.8 mt -80.72 163.04 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.621 2.368 . . . . 0.0 105.2 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.116 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -131.59 163.97 26.89 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.659 0.784 . . . . 0.0 111.477 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.18 138.66 53.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.877 2.071 . . . . 0.0 105.892 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.6 121.0 23.64 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.12 1.368 . . . . 0.0 107.584 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -145.31 130.74 18.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 53.16 39.27 29.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.125 0.97 . . . . 0.0 111.532 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 68.26 -0.72 2.06 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.879 1.672 . . . . 0.0 113.039 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 t -73.91 165.75 24.58 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.103 2.161 . . . . 0.0 110.059 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -132.81 110.69 10.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.662 0.785 . . . . 0.0 112.141 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -118.03 129.81 55.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.61 154.47 40.74 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -49.87 -49.85 47.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.425 1.09 . . . . 0.0 110.967 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.35 -4.76 41.16 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.207 -1.558 . . . . 0.0 114.224 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.0 m -121.56 17.71 11.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.96 101.54 9.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.14 166.44 30.81 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.0 t -55.83 112.15 1.1 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.247 -1.359 . . . . 0.0 109.548 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.04 -25.3 30.99 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.208 0.909 . . . . 0.0 114.921 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -90.35 -20.96 22.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.35 -22.8 1.5 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m 77.47 78.51 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.251 1.024 . . . . 0.0 109.738 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.34 134.68 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 t -54.2 135.43 44.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.933 1.293 . . . . 0.0 112.461 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.39 9.72 15.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.547 1.939 . . . . 0.0 109.222 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.19 111.23 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 126.11 1.764 . . . . 0.0 112.711 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.47 43.4 94.03 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-O 119.331 -0.705 . . . . 0.0 113.666 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -139.07 153.21 48.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 134.34 46.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.99 171.77 9.0 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.144 1.378 . . . . 0.0 108.058 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.99 155.31 30.49 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 112.88 6.49 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -143.12 150.26 39.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 54.72 23.08 4.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.134 0.879 . . . . 0.0 112.528 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 70.54 8.45 6.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.792 2.437 . . . . 0.0 113.065 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.81 150.94 25.83 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.431 1.092 . . . . 0.0 108.587 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.8 pt -102.63 129.87 53.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.226 1.411 . . . . 0.0 110.025 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.92 160.69 36.9 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.669 -1.269 . . . . 0.0 112.444 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 161.39 19.69 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -51.98 -51.55 56.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.21 1.368 . . . . 0.0 111.57 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -53.49 -38.59 63.82 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.419 -0.8 . . . . 0.0 112.402 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -75.59 -53.26 8.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.27 1.04 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.548 1.07 . . . . 0.0 113.924 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.361 0 CA-C-N 119.134 1.467 . . . . 0.0 111.303 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.796 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.489 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.5 t -79.13 121.97 25.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.96 -23.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.249 0.931 . . . . 0.0 111.61 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.2 1.28 57.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.804 1.642 . . . . 0.0 115.207 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.1 p -162.6 -7.79 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.776 1.625 . . . . 0.0 115.128 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.28 97.1 p 53.83 26.82 6.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.103 2.561 . . . . 0.0 114.149 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -83.88 154.16 64.29 Favored Pre-proline 0 C--O 1.237 0.436 0 O-C-N 120.765 -1.21 . . . . 0.0 108.459 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.34 120.12 5.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.366 2.71 . . . . 0.0 107.185 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -70.55 144.07 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 C--O 1.234 0.282 0 C-N-CA 123.429 0.692 . . . . 0.0 111.212 -179.847 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -145.06 164.95 29.64 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 126.039 1.736 . . . . 0.0 108.721 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.27 134.73 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -111.22 131.35 55.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.185 0.994 . . . . 0.0 108.834 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -146.15 138.1 25.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.091 1.756 . . . . 0.0 106.666 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 45.33 43.11 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.273 1.429 . . . . 0.0 112.235 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 69.45 -17.55 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 129.766 3.226 . . . . 0.0 113.616 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 56.6 m -73.94 164.15 26.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.325 1.45 . . . . 0.0 108.969 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.21 135.94 52.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.082 1.353 . . . . 0.0 111.115 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 18.3 m-90 -132.89 131.43 40.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.359 0.664 . . . . 0.0 111.664 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -65.48 154.38 38.73 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 p -49.58 -53.19 25.18 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.298 1.408 . . . . 0.0 112.613 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.49 -26.38 67.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.05 1.06 56.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 116.955 -1.498 . . . . 0.0 114.162 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -100.74 100.4 11.07 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 102.406 -3.183 . . . . 0.0 102.406 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -153.19 166.09 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 t -61.13 120.11 9.68 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-O 117.329 -1.319 . . . . 0.0 109.99 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.08 -24.38 54.53 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 121.989 0.772 . . . . 0.0 113.412 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -85.81 -18.83 31.82 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.16 -8.81 0.34 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 82.63 -0.99 1.33 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.474 1.488 . . . . 0.0 114.791 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.44 136.13 26.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 121.246 1.839 . . . . 0.0 108.024 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -54.35 136.2 43.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.082 1.353 . . . . 0.0 109.609 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.1 -0.37 15.65 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.773 0.829 . . . . 0.0 110.686 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.8 t -54.18 116.51 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 127.409 2.284 . . . . 0.0 109.505 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.68 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.532 1.152 0 C-N-CA 128.776 3.084 . . . . 0.0 117.617 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -9.38 56.96 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.23 147.09 16.94 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -146.34 172.26 13.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.575 1.55 . . . . 0.0 110.563 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.0 mp -119.13 154.95 32.45 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.9 p -130.11 102.46 6.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.241 0.963 . . . . 0.0 109.213 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.61 155.66 48.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.323 1.849 . . . . 0.0 107.595 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 52.35 21.77 1.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.004 1.321 . . . . 0.0 112.935 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt 62.49 22.02 12.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.038 1.735 . . . . 0.0 112.047 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -112.95 -169.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.893 2.477 . . . . 0.0 108.691 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.1 123.82 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 120.423 -1.423 . . . . 0.0 110.003 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -131.95 152.01 51.36 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 122.92 1.343 . . . . 0.0 114.607 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.76 150.28 42.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.545 ' HA ' HD13 ' A' ' 51' ' ' LEU . 5.0 mt-30 -46.23 -51.83 13.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.337 1.426 . . . . 0.0 110.502 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -51.53 61.47 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.135 0.879 . . . . 0.0 111.017 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.78 -29.01 68.85 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.35 -25.28 51.83 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.021 -1.433 . . . . 0.0 111.535 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 C--N 1.343 0.283 0 CA-C-N 118.936 1.368 . . . . 0.0 109.802 179.636 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.426 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 8.0 t -53.26 127.54 24.9 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.178 -1.391 . . . . 0.0 107.954 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -51.51 -24.64 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 120.048 1.294 . . . . 0.0 113.883 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.67 9.29 25.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.493 1.917 . . . . 0.0 115.126 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -154.2 -11.07 0.14 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.96 -1.712 . . . . 0.0 114.132 179.026 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 p 58.99 2.93 0.28 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.057 2.543 . . . . 0.0 114.812 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -72.04 147.69 91.19 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 120.597 -1.315 . . . . 0.0 110.684 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.55 113.65 3.7 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.355 2.703 . . . . 0.0 110.58 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.63 149.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm . . . . . 0 C--O 1.239 0.531 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -135.44 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.827 2.051 . . . . 0.0 111.807 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.0 mm -120.05 147.37 23.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.89 117.9 19.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.375 1.07 . . . . 0.0 109.603 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.82 138.74 25.89 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 48.57 42.74 19.51 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.727 1.611 . . . . 0.0 110.597 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 61.87 2.45 0.76 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.272 2.229 . . . . 0.0 112.545 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.6 m -84.35 164.84 18.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.631 1.572 . . . . 0.0 108.875 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 117.83 24.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.403 1.081 . . . . 0.0 111.47 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -120.72 136.73 54.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.26 155.52 28.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.1 t -57.34 -46.03 83.69 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.341 0.973 . . . . 0.0 108.487 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -1.24 3.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.64 -6.47 6.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.913 1.285 . . . . 0.0 113.275 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -89.99 100.29 13.13 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -149.08 176.5 10.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.5 t -65.53 119.93 11.97 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.49 -1.243 . . . . 0.0 112.694 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.07 -10.8 16.14 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.468 1.508 . . . . 0.0 112.977 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -106.05 -23.49 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.133 1.466 . . . . 0.0 114.525 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.433 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -141.41 -3.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.294 15.4 m 70.83 15.44 6.85 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.433 HG12 ' SG ' ' A' ' 41' ' ' CYS . 7.5 p -73.64 134.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 t -58.0 139.63 54.09 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.802 0.728 . . . . 0.0 110.679 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -111.06 3.55 18.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.045 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.32 122.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.52 29.47 69.82 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.622 -1.099 . . . . 0.0 112.438 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -139.8 150.45 44.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.356 1.578 . . . . 0.0 110.958 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.28 108.35 2.54 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.506 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -102.83 171.85 7.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.363 1.865 . . . . 0.0 108.945 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -129.15 163.61 25.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.117 1.767 . . . . 0.0 107.256 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.479 HG22 HG22 ' A' ' 57' ' ' ILE . 21.9 p -135.39 117.4 15.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.396 0.544 . . . . 0.0 111.567 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -143.7 156.49 44.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.301 1.84 . . . . 0.0 107.386 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.5 m120 57.3 29.08 16.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.925 0.89 . . . . 0.0 112.018 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm 64.18 16.09 9.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.437 1.495 . . . . 0.0 110.57 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -120.1 177.97 4.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.993 1.717 . . . . 0.0 106.994 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 52' ' ' THR . 18.5 pt -115.63 149.55 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -145.84 155.73 43.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.096 1.771 . . . . 0.0 111.482 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.3 156.42 38.46 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -57.12 -50.61 72.27 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.197 1.362 . . . . 0.0 110.871 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -55.42 -24.91 33.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.516 1.126 . . . . 0.0 113.847 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.382 85.7 m -97.24 -17.07 20.06 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.572 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.02 -20.29 18.94 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.387 -1.229 . . . . 0.0 111.54 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.533 0.294 0 C-N-CA 127.081 2.152 . . . . 0.0 113.518 -179.409 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 8.9 t -62.57 119.55 9.42 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.358 -1.782 . . . . 0.0 108.607 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.7 t -54.55 -25.84 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 121.113 1.779 . . . . 0.0 111.165 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.66 -1.77 58.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.294 1.837 . . . . 0.0 115.284 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 6.4 p -158.88 -2.54 0.08 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 121.235 1.834 . . . . 0.0 114.481 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 p 58.35 7.27 0.66 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.838 3.255 . . . . 0.0 114.071 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -70.38 136.68 86.36 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.11 122.67 10.5 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 123.066 2.51 . . . . 0.0 108.504 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.51 151.98 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.542 0.65 0 O-C-N 121.067 -1.021 . . . . 0.0 109.115 179.649 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.627 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -145.67 165.16 29.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.744 1.617 . . . . 0.0 107.125 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.89 122.38 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 126.984 2.114 . . . . 0.0 106.202 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -106.05 106.79 17.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.97 139.85 38.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 48.86 43.92 21.74 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.379 0.672 . . . . 0.0 109.591 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 42.87 43.32 3.43 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.086 2.555 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 50.7 m -134.16 149.77 51.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.898 1.679 . . . . 0.0 108.712 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.07 118.81 32.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.419 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 2.7 m-90 -131.36 123.23 27.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -66.24 145.34 55.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -45.04 -54.76 6.27 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.422 1.489 . . . . 0.0 111.376 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -67.29 -17.57 64.83 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.09 17.55 20.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.73 101.39 12.78 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -139.48 165.05 28.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.95 113.59 2.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.077 1.751 . . . . 0.0 109.009 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.83 -24.92 21.26 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 120.167 1.349 . . . . 0.0 115.539 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -84.92 -20.33 30.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 114.762 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.71 -25.88 0.68 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.298 5.6 p 91.57 17.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.671 2.388 . . . . 0.0 115.596 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.47 143.72 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 120.582 -1.324 . . . . 0.0 108.043 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -59.35 140.65 55.89 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.821 0.848 . . . . 0.0 110.631 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.22 -1.01 10.35 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.252 1.421 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.1 t -49.69 115.93 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 126.33 1.852 . . . . 0.0 110.402 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -3.74 27.24 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.043 -1.421 . . . . 0.0 115.33 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -89.34 162.1 15.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.948 2.374 . . . . 0.0 110.179 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.87 1.54 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -85.38 171.88 11.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.916 0.887 . . . . 0.0 109.762 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.53 126.7 52.56 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.911 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -95.55 107.35 19.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.787 2.035 . . . . 0.0 110.15 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -144.17 155.04 43.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 44.99 46.18 9.05 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.173 1.389 . . . . 0.0 112.333 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.346 7.5 ptmm? 48.97 24.99 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.709 2.004 . . . . 0.0 114.321 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -127.23 177.94 6.36 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.977 1.711 . . . . 0.0 107.781 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.04 123.62 65.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 125.611 1.564 . . . . 0.0 110.984 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.42 152.01 51.03 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.948 0.88 . . . . 0.0 113.31 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.9 163.36 27.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -53.91 -55.87 22.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 110.854 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -55.28 -27.08 44.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.672 1.189 . . . . 0.0 113.468 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.91 -19.29 18.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.724 1.21 . . . . 0.0 113.077 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.49 -3.61 56.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.088 1.804 . . . . 0.0 112.015 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 124.741 1.217 . . . . 0.0 107.952 178.631 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.871 0 CA-C-O 121.383 0.435 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -71.48 109.58 5.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.858 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -43.73 -39.93 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 121.539 1.972 . . . . 0.0 111.743 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -8.47 53.11 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -156.96 -4.88 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.098 1.317 . . . . 0.0 114.326 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 p 62.92 8.01 2.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 130.815 3.646 . . . . 0.0 114.597 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -70.64 152.93 95.21 Favored Pre-proline 0 N--CA 1.468 0.454 0 O-C-N 120.38 -1.45 . . . . 0.0 109.892 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.24 127.63 16.15 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.84 1.694 . . . . 0.0 109.054 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.97 142.96 16.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 CA--C 1.537 0.455 0 C-N-CA 123.734 0.814 . . . . 0.0 109.898 -179.856 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.6 mptt . . . . . 0 C--O 1.237 0.406 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -134.05 120.44 20.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 mm -83.46 152.73 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -130.01 107.02 9.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.671 1.588 . . . . 0.0 108.897 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -128.22 123.82 35.17 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.815 1.246 . . . . 0.0 108.803 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 50.69 15.48 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.264 1.026 . . . . 0.0 109.001 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 62.62 -6.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 127.57 2.348 . . . . 0.0 115.97 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.3 t -89.06 149.68 23.11 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -116.04 136.45 53.02 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.474 0.709 . . . . 0.0 111.548 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -130.26 138.56 50.58 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.776 1.23 . . . . 0.0 108.35 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -71.09 152.32 43.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -43.87 -62.48 1.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.751 1.22 . . . . 0.0 113.101 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 21.0 mp0 -61.34 -22.46 64.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.887 2.075 . . . . 0.0 114.164 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 m -90.5 -28.27 18.66 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.026 1.331 . . . . 0.0 112.725 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -72.09 101.73 2.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.456 1.48 . . . . 0.0 108.703 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 4.6 m-80 -139.87 164.02 31.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.294 1.038 . . . . 0.0 112.95 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 35.2 t -59.15 116.74 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 116.287 -1.816 . . . . 0.0 108.474 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.42 34.01 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 120.865 1.666 . . . . 0.0 114.132 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -84.93 -18.66 33.94 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 38' ' ' CYS . 0.8 OUTLIER -140.43 -13.74 1.0 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -177.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' HB3' ' A' ' 37' ' ' ASN 0.358 86.9 p 62.46 60.04 1.44 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.203 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 ' SG ' ' A' ' 41' ' ' CYS . 10.0 p -117.65 137.01 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -58.38 125.56 23.83 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 124.037 0.836 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.1 mt -101.91 14.71 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.172 1.389 . . . . 0.0 109.111 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.64 126.9 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.21 -49.77 1.55 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 126.049 1.785 . . . . 0.0 115.987 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -63.23 154.18 32.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.904 0.882 . . . . 0.0 112.238 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.09 161.59 54.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.59 163.29 36.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.935 1.294 . . . . 0.0 109.778 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.03 152.7 29.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.695 1.998 . . . . 0.0 106.573 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.3 p -129.77 123.16 30.32 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -144.17 154.72 43.44 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.583 0.753 . . . . 0.0 109.183 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 41.89 42.31 2.2 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.783 1.174 . . . . 0.0 111.649 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 62.42 7.12 2.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.552 1.941 . . . . 0.0 114.805 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -106.31 173.12 6.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.861 2.064 . . . . 0.0 111.088 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.8 135.12 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.588 1.955 . . . . 0.0 110.737 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -139.65 155.35 47.46 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 120.787 -1.195 . . . . 0.0 113.256 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 157.49 32.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -52.31 -54.47 31.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.241 1.017 . . . . 0.0 110.161 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -52.67 -46.35 67.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.124 0.875 . . . . 0.0 111.256 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.332 1.3 m -61.29 -41.27 96.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.381 0.992 . . . . 0.0 111.73 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.49 -4.14 89.42 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.582 1.083 . . . . 0.0 113.553 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.236 0.373 0 C-N-CA 126.326 1.85 . . . . 0.0 110.592 -179.344 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.753 0 CA-C-O 121.395 0.442 . . . . 0.0 113.063 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -58.61 112.36 1.58 Allowed 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 115.794 -2.051 . . . . 0.0 108.282 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.9 t -41.81 -36.33 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 122.312 2.324 . . . . 0.0 112.785 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.55 -13.93 58.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.77 -3.62 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 120.877 1.671 . . . . 0.0 115.431 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 m 59.49 8.03 1.12 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 130.18 3.392 . . . . 0.0 115.083 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -58.79 153.09 44.43 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 120.0 1.273 . . . . 0.0 110.315 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.0 122.9 9.21 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.82 1.68 . . . . 0.0 108.526 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mm -74.12 144.13 12.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 123.121 0.568 . . . . 0.0 110.842 179.791 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -129.5 165.18 22.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.407 1.883 . . . . 0.0 108.675 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.0 mm -116.37 151.46 18.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 m -131.27 117.83 19.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -145.43 130.6 18.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 55.66 23.62 6.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 111.231 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . 0.272 2.3 m-20 72.49 -0.68 3.21 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 130.004 3.322 . . . . 0.0 113.482 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -81.8 164.01 21.96 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.02 135.15 51.95 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.382 -1.448 . . . . 0.0 114.153 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 3.6 m-90 -132.07 125.91 32.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -73.84 154.54 39.44 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -49.97 -55.08 16.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.598 1.09 . . . . 0.0 109.178 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -65.66 -3.28 4.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.97 1.708 . . . . 0.0 115.554 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . 0.282 1.7 m -119.31 -3.01 10.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.58 -1.676 . . . . 0.0 114.369 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -91.04 102.54 15.3 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.181 1.392 . . . . 0.0 108.583 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -154.12 172.13 18.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.5 122.81 18.05 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 117.019 -1.467 . . . . 0.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -27.1 65.12 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.762 1.164 . . . . 0.0 113.524 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -75.81 -20.51 58.14 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.17 -12.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.272 18.0 m 85.92 10.6 0.25 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.726 1.61 . . . . 0.0 115.119 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.67 131.95 32.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 m -56.63 136.09 54.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.552 1.141 . . . . 0.0 111.611 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.1 mt -103.21 -1.11 29.48 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.79 142.04 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 20.85 73.63 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.628 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -152.94 148.21 26.85 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.039 1.419 . . . . 0.0 109.768 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.0 152.71 44.3 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -135.73 171.65 14.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.92 1.36 . . . . 0.0 111.652 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.08 145.45 24.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.1 p -134.45 103.39 5.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.619 1.168 . . . . 0.0 109.47 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -140.58 152.36 45.41 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 53.23 17.15 0.94 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.05 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.3 mttt 86.56 -0.1 0.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 129.313 3.045 . . . . 0.0 112.282 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -89.55 -179.04 5.71 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.504 1.521 . . . . 0.0 109.619 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.0 pt -131.44 136.01 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.512 2.325 . . . . 0.0 106.509 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -148.56 157.26 43.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 123.126 1.441 . . . . 0.0 113.199 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 153.81 39.79 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -66.34 -38.38 87.5 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.918 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -54.24 -26.74 30.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.25 1.42 . . . . 0.0 113.916 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.0 m -97.29 -45.08 6.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.208 1.803 . . . . 0.0 109.123 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.03 11.4 57.54 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 CA-C-N 118.969 1.385 . . . . 0.0 108.524 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.032 0 CA-C-O 121.639 0.577 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.9 t -59.87 121.4 11.66 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 117.275 -1.345 . . . . 0.0 108.636 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -52.21 -29.76 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.727 1.148 . . . . 0.0 111.346 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.4 -4.05 59.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 p -153.48 -7.08 0.17 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.156 1.343 . . . . 0.0 114.084 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 54.02 37.83 27.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.435 2.294 . . . . 0.0 112.642 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -100.05 151.91 37.66 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.47 137.57 30.87 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 O-C-N 124.554 1.818 . . . . 0.0 108.55 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.94 121.22 60.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 123.094 0.558 . . . . 0.0 110.48 -179.868 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.433 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.73 164.22 30.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.03 0.443 . . . . 0.0 111.85 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.2 mm -121.3 125.81 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.3 m -103.39 102.93 12.88 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -124.9 136.92 54.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 40.38 46.23 1.99 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.401 1.881 . . . . 0.0 112.697 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 51.05 35.63 13.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.075 1.75 . . . . 0.0 113.127 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -126.09 164.73 20.25 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 126.419 1.888 . . . . 0.0 107.206 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -109.73 131.57 54.94 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -132.21 133.14 43.82 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 108.324 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -73.76 147.1 43.81 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -49.21 -55.5 12.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.936 1.244 . . . . 0.0 110.189 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.92 -5.18 2.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.928 1.291 . . . . 0.0 113.994 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 m -118.65 -1.26 11.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 113.566 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -94.59 100.78 12.68 Favored 'General case' 0 N--CA 1.45 -0.46 1 N-CA-C 99.417 -4.29 . . . . 0.0 99.417 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 75.5 m-20 -145.59 164.3 32.13 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.709 -177.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.9 t -58.12 122.03 12.1 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 116.795 -1.574 . . . . 0.0 108.975 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.89 -25.56 30.82 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 123.985 0.803 . . . . 0.0 113.816 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -90.87 -18.37 24.93 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -143.87 -15.95 0.61 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 37' ' ' ASN 0.3 1.1 p 84.78 8.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.2 142.55 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 120.54 1.518 . . . . 0.0 110.158 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -64.81 105.16 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.514 1.925 . . . . 0.0 107.429 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.3 mt -88.54 -9.0 53.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.0 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.1 t -42.56 111.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.404 1.882 . . . . 0.0 112.4 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 12.51 63.02 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.28 -1.845 . . . . 0.0 117.304 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -110.39 167.73 9.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 121.432 2.616 . . . . 0.0 112.161 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 136.2 46.13 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -144.42 171.17 14.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.242 1.017 . . . . 0.0 110.905 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.42 160.66 33.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.954 0.902 . . . . 0.0 110.793 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 p -132.58 104.83 6.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.995 0.918 . . . . 0.0 109.653 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -142.37 152.45 42.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.18 31.89 7.3 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.499 1.52 . . . . 0.0 112.77 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.17 6.67 3.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.369 2.267 . . . . 0.0 113.014 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -108.53 176.84 4.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.698 1.599 . . . . 0.0 109.8 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -112.68 121.46 65.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.64 138.26 52.09 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 157.24 37.1 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -46.39 -54.43 9.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.353 1.061 . . . . 0.0 111.654 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -58.96 -31.33 68.63 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.1 -12.46 21.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 113.656 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.91 -24.31 20.49 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 101.91 -3.366 . . . . 0.0 101.91 177.666 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.95 0 CA-C-O 119.095 -0.836 . . . . 0.0 112.955 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 t -44.61 120.47 2.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.824 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.03 -32.31 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 120.63 1.559 . . . . 0.0 110.685 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.92 2.66 37.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 p -166.24 -3.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 119.19 -2.194 . . . . 0.0 114.707 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.54 10.21 2.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.763 3.225 . . . . 0.0 114.238 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -67.36 145.66 98.55 Favored Pre-proline 0 N--CA 1.47 0.565 0 O-C-N 120.122 -1.611 . . . . 0.0 109.402 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 137.68 45.45 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 O-C-N 124.35 1.711 . . . . 0.0 109.149 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -87.98 157.09 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.719 1.608 . . . . 0.0 107.216 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.233 0.215 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -178.27 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt . . . . . 0 C--O 1.238 0.449 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -145.77 146.73 31.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mm -88.77 120.74 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 p -107.38 110.22 22.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -139.46 137.77 35.86 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 42.4 54.91 4.24 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.842 1.657 . . . . 0.0 112.114 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.92 13.89 0.61 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.851 1.661 . . . . 0.0 114.111 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -113.03 163.74 14.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.945 2.098 . . . . 0.0 108.949 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -120.95 131.94 54.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.938 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -124.61 138.28 54.32 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.113 1.365 . . . . 0.0 107.535 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -76.0 144.74 40.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.5 t -51.53 -51.53 54.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -61.9 -11.24 12.05 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 114.156 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.2 m -123.66 11.31 9.13 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.624 1.17 . . . . 0.0 113.382 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.99 101.16 13.19 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 101.231 -3.618 . . . . 0.0 101.231 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -141.35 168.82 18.86 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.89 121.04 13.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 116.424 -1.751 . . . . 0.0 108.287 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.82 -32.26 58.83 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 120.919 1.69 . . . . 0.0 113.45 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -82.67 -22.32 34.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.38 -7.92 1.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.393 83.7 p 66.64 29.94 8.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -86.9 147.07 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -58.06 134.96 56.88 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 111.484 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 mt -112.12 1.69 16.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.708 1.203 . . . . 0.0 110.818 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.82 107.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.342 2.657 . . . . 0.0 110.636 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.69 -17.57 3.44 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.968 1.747 . . . . 0.0 115.482 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 112.62 22.77 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -40.88 142.06 0.87 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.243 1.401 . . . . 0.0 111.149 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -135.66 170.55 15.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.04 162.12 13.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.287 1.435 . . . . 0.0 108.052 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 p -141.92 102.92 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -130.33 154.94 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 m120 48.95 36.02 7.7 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.852 1.261 . . . . 0.0 112.728 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm 55.76 21.76 4.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.491 1.116 . . . . 0.0 112.181 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -117.36 -178.54 3.48 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.165 1.786 . . . . 0.0 109.609 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 pt -123.34 122.7 65.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.805 1.642 . . . . 0.0 110.461 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -136.16 140.02 43.3 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.205 -0.934 . . . . 0.0 111.486 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.79 163.33 27.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -42.84 -62.79 0.92 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.226 1.81 . . . . 0.0 111.975 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -52.63 -41.03 63.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.877 0.871 . . . . 0.0 112.825 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.4 -46.99 58.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.551 0.614 . . . . 0.0 110.068 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.57 -3.01 46.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.987 0.803 . . . . 0.0 113.506 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.544 0.74 0 C-N-CA 126.973 2.109 . . . . 0.0 112.588 179.756 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.35 124.54 18.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.291 -1.814 . . . . 0.0 107.989 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -7.96 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 120.694 1.588 . . . . 0.0 112.319 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.28 4.96 25.19 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.026 1.73 . . . . 0.0 114.076 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 p -166.22 -4.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.286 61.6 p 54.83 12.83 0.63 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.6 3.16 . . . . 0.0 114.824 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.07 150.28 97.54 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.71 125.5 11.71 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.484 1.456 . . . . 0.0 108.665 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mm -68.32 148.19 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.13 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 pttm . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -145.15 164.96 29.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.932 2.093 . . . . 0.0 107.177 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -115.15 139.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 p -130.89 120.08 23.11 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.475 1.51 . . . . 0.0 107.921 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -145.37 150.53 36.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.303 1.841 . . . . 0.0 106.526 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 36.04 50.52 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.111 2.165 . . . . 0.0 114.081 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t0 53.89 39.74 30.77 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 113.189 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' ' CZ3' ' A' ' 31' ' ' TRP . 27.6 t -134.22 164.71 26.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.07 1.748 . . . . 0.0 109.972 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -119.11 124.1 46.03 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.89 1.676 . . . . 0.0 111.605 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' A' ' 29' ' ' SER . 9.6 m-90 -130.71 123.99 30.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.796 1.284 . . . . 0.0 110.296 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -68.49 155.5 39.8 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -53.51 30.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.106 1.363 . . . . 0.0 112.589 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.1 -30.49 71.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.597 1.09 . . . . 0.0 113.607 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -84.81 0.08 52.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 117.416 -1.278 . . . . 0.0 113.457 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -98.77 100.5 11.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -155.85 170.28 22.45 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.0 115.42 4.05 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 115.713 -2.089 . . . . 0.0 106.493 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.11 -29.34 51.9 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 121.444 1.929 . . . . 0.0 112.902 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -75.55 -22.49 57.0 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.87 -13.9 0.83 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 118.621 2.823 . . . . 0.0 118.621 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.276 3.0 m 79.67 12.22 1.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.92 136.09 26.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.1 t -58.59 138.36 56.92 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.446 0.641 . . . . 0.0 109.87 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.47 2.04 20.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.577 1.551 . . . . 0.0 110.079 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.82 109.57 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.05 1.34 . . . . 0.0 110.441 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.19 -44.66 2.96 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.749 2.118 . . . . 0.0 113.409 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -64.76 160.93 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.854 1.327 . . . . 0.0 111.864 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.58 123.55 16.53 Favored Glycine 0 C--O 1.241 0.531 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -110.16 166.1 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.762 1.225 . . . . 0.0 109.561 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.82 147.98 47.12 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.45 103.82 6.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.956 1.302 . . . . 0.0 107.659 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -142.75 156.4 44.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 127.096 2.159 . . . . 0.0 106.441 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 57.86 21.68 7.83 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 62.81 23.08 13.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.045 1.338 . . . . 0.0 109.72 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -126.75 -178.84 4.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 127.443 2.297 . . . . 0.0 107.614 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 pt -130.56 134.5 62.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.986 0.898 . . . . 0.0 109.868 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -134.24 162.43 32.18 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 123.012 1.387 . . . . 0.0 114.138 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.23 161.51 23.93 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -54.16 -54.87 33.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.02 0.827 . . . . 0.0 111.08 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -56.41 -27.7 57.23 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.527 -1.358 . . . . 0.0 114.553 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 m -97.59 -18.4 18.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.612 1.165 . . . . 0.0 113.297 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.31 -23.85 10.05 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.815 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 t . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 125.823 1.649 . . . . 0.0 108.571 179.722 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 CA-C-O 119.728 -0.485 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 4.6 t -57.75 116.44 3.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.62 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.42 -14.0 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.783 0.833 . . . . 0.0 112.241 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.95 -0.71 38.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.368 1.467 . . . . 0.0 113.678 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -152.62 -11.21 0.17 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.792 -1.818 . . . . 0.0 114.917 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 2.9 p 49.91 53.51 12.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.615 1.966 . . . . 0.0 112.667 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -114.81 140.3 25.25 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.37 124.32 12.74 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.986 2.457 . . . . 0.0 110.454 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.74 135.76 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.007 1.723 . . . . 0.0 106.538 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 123.966 0.907 . . . . 0.0 109.816 179.608 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 C--O 1.24 0.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.29 164.57 31.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.482 1.513 . . . . 0.0 109.495 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.73 102.12 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.364 1.465 . . . . 0.0 109.061 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.3 m -82.19 114.67 20.86 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -145.83 147.7 32.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.279 0.945 . . . . 0.0 108.638 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 36.96 58.08 1.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.096 1.759 . . . . 0.0 111.537 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 p30 48.62 25.03 0.87 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.105 1.762 . . . . 0.0 114.968 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 t -128.49 165.46 20.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 127.911 2.484 . . . . 0.0 108.524 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.9 109.77 11.54 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.516 -0.74 . . . . 0.0 110.632 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -103.54 150.96 23.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.343 1.068 . . . . 0.0 108.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' A' ' 8' ' ' CYS . 25.9 m170 -82.5 152.5 26.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -57.52 -37.02 72.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.781 1.173 . . . . 0.0 108.923 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.8 -17.4 63.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 112.763 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.45 27.82 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -113.1 100.31 8.51 Favored 'General case' 0 C--O 1.237 0.436 1 N-CA-C 99.023 -4.436 . . . . 0.0 99.023 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -145.38 173.11 12.28 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.16 107.39 1.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.457 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.2 -31.34 26.5 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 119.57 1.077 . . . . 0.0 115.413 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -77.4 -23.86 50.59 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.42 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -135.26 -23.68 1.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -178.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t 74.37 85.13 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.632 1.573 . . . . 0.0 109.909 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.42 HG12 ' SG ' ' A' ' 41' ' ' CYS . 11.1 p -151.57 136.59 10.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 129.872 3.269 . . . . 0.0 104.682 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -54.54 146.45 16.31 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.659 1.219 . . . . 0.0 113.045 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -120.01 1.94 10.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 109.098 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.36 103.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 125.659 1.583 . . . . 0.0 107.178 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 5.89 86.87 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.272 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -112.86 87.7 2.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.249 1.524 . . . . 0.0 107.969 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -20.67 109.79 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 128.501 2.953 . . . . 0.0 113.139 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -111.14 165.02 12.25 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.378 1.071 . . . . 0.0 112.752 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.9 mp -105.58 151.15 24.69 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.913 1.685 . . . . 0.0 107.734 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -124.4 109.05 12.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.103 1.361 . . . . 0.0 108.677 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -142.49 152.76 43.01 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m120 45.78 32.52 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.479 1.912 . . . . 0.0 111.354 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.06 -9.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.782 2.833 . . . . 0.0 112.813 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.97 -176.02 5.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.971 2.108 . . . . 0.0 110.747 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.05 126.18 21.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 127.619 2.368 . . . . 0.0 110.589 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -139.58 155.77 47.27 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.464 -1.397 . . . . 0.0 113.689 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.17 154.67 41.64 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.554 ' HA ' HD13 ' A' ' 51' ' ' LEU . 25.2 tm0? -53.15 -51.69 61.16 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.248 1.019 . . . . 0.0 111.283 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -52.54 -46.06 66.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.018 1.281 . . . . 0.0 111.272 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.5 m -65.45 -47.03 77.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.469 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -17.08 73.43 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.041 0.837 . . . . 0.0 112.743 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.445 -0.7 0 C-N-CA 125.229 1.412 . . . . 0.0 108.44 179.919 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.8 125.3 24.39 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 116.732 -1.604 . . . . 0.0 107.39 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -57.94 -27.28 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 120.841 1.655 . . . . 0.0 109.015 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.22 12.12 14.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.982 2.913 . . . . 0.0 116.831 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -171.7 -7.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 118.609 -2.557 . . . . 0.0 114.229 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 58.28 9.85 1.13 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.644 2.778 . . . . 0.0 114.658 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -72.74 154.92 91.19 Favored Pre-proline 0 CA--C 1.517 -0.299 0 O-C-N 120.868 -1.145 . . . . 0.0 110.662 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.61 146.34 84.18 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.364 2.042 . . . . 0.0 108.871 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.4 mt -109.32 122.0 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.772 2.429 . . . . 0.0 106.772 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m . . . . . 0 N--CA 1.445 -0.683 0 C-N-CA 124.494 1.118 . . . . 0.0 108.603 -179.873 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--O 1.239 0.517 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.28 165.35 28.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 111.297 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -128.99 146.28 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.808 1.643 . . . . 0.0 107.765 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -132.81 119.06 19.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.75 143.89 48.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 37.2 56.14 1.31 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.07 1.748 . . . . 0.0 114.178 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t0 55.14 24.59 6.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.678 1.191 . . . . 0.0 112.806 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 14.7 m -127.69 131.49 49.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.777 1.631 . . . . 0.0 109.949 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -90.73 130.28 36.74 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.393 0.677 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 2.6 m-90 -131.09 133.32 45.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.501 1.143 . . . . 0.0 110.873 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.39 154.35 41.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 p -61.22 -36.24 79.39 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -74.07 4.25 5.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.746 1.618 . . . . 0.0 113.12 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -139.97 21.75 2.45 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.445 1.021 . . . . 0.0 113.002 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -109.34 99.76 8.96 Favored 'General case' 0 C--O 1.237 0.443 1 N-CA-C 98.356 -4.683 . . . . 0.0 98.356 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -152.63 176.16 12.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.8 t -59.69 111.64 1.51 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.891 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.82 13.22 0.09 OUTLIER Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.165 1.84 . . . . 0.0 115.348 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -128.03 -18.64 4.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.411 2.684 . . . . 0.0 112.757 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 -17.43 0.82 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 m 84.36 1.43 0.87 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.224 1.81 . . . . 0.0 115.463 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.81 126.44 28.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 t -52.05 142.81 15.22 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.475 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -115.81 -2.5 12.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.809 1.244 . . . . 0.0 110.924 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.17 126.12 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.647 0.779 . . . . 0.0 109.356 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.36 69.48 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.016 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -131.45 167.25 19.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 121.128 2.464 . . . . 0.0 112.547 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.97 127.73 33.45 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.01 171.49 14.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.732 1.213 . . . . 0.0 110.015 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.7 mp -121.52 156.55 32.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.885 1.674 . . . . 0.0 109.188 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 p -137.45 102.59 4.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.28 147.64 47.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 108.757 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.7 m120 52.81 23.78 2.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.775 2.03 . . . . 0.0 114.322 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? 78.61 12.4 1.52 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.043 2.137 . . . . 0.0 111.784 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -105.78 -178.39 3.64 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.748 -1.22 . . . . 0.0 109.4 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -128.45 122.17 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.714 1.606 . . . . 0.0 108.395 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -138.08 157.28 46.65 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 123.111 1.434 . . . . 0.0 114.794 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.45 155.52 37.93 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.539 ' HA ' HD13 ' A' ' 51' ' ' LEU . 12.6 tt0 -47.26 -52.92 14.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.765 0.711 . . . . 0.0 111.557 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -58.57 7.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.534 0.734 . . . . 0.0 112.171 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.11 -23.11 44.71 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.619 -1.181 . . . . 0.0 113.728 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.36 -24.13 10.53 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 120.213 1.37 . . . . 0.0 112.355 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 179.776 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.681 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 11.6 t -61.89 126.04 25.94 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.89 -20.23 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 119.336 0.971 . . . . 0.0 111.493 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.73 3.62 45.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 115.487 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -155.94 -9.69 0.11 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.023 -1.673 . . . . 0.0 113.723 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m 53.38 29.06 8.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.533 1.933 . . . . 0.0 111.675 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -89.41 151.09 45.82 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.802 -1.186 . . . . 0.0 108.178 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 118.37 5.64 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.273 1.982 . . . . 0.0 110.027 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mm -65.29 162.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.514 1.526 . . . . 0.0 107.632 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm . . . . . 0 C--O 1.24 0.554 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -142.32 164.51 29.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.558 1.943 . . . . 0.0 106.644 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.59 130.34 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.234 1.814 . . . . 0.0 106.427 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.7 124.11 38.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.05 122.56 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 40.92 59.02 2.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.998 1.719 . . . . 0.0 112.848 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 63.66 12.23 6.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.265 2.226 . . . . 0.0 114.913 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 158.51 28.79 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.547 -1.346 . . . . 0.0 110.629 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.24 133.26 56.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.588 0.709 . . . . 0.0 110.855 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -123.88 126.8 47.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -67.08 148.79 51.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.11 -51.64 23.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.098 0.863 . . . . 0.0 112.438 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.22 -13.33 61.87 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -102.64 -12.68 17.53 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -80.43 101.52 9.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.24 168.57 19.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.2 t -65.23 114.91 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 116.663 -1.637 . . . . 0.0 110.049 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.82 -18.62 25.96 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.498 1.045 . . . . 0.0 115.528 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.13 -17.37 23.85 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.0 -20.21 0.5 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 118.601 2.815 . . . . 0.0 118.601 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 m 77.14 80.54 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.536 1.062 . . . . 0.0 109.888 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.64 141.57 18.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 126.832 2.053 . . . . 0.0 105.749 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -58.56 121.7 11.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.79 1.306 . . . . 0.0 113.626 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.4 mt -99.37 1.73 44.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.072 0.949 . . . . 0.0 109.659 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.68 140.71 19.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 -62.19 3.84 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.252 1.406 . . . . 0.0 112.777 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 164.81 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.849 0.859 . . . . 0.0 112.494 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.3 156.44 39.39 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.433 ' C ' HD12 ' A' ' 51' ' ' LEU . 30.9 p90 -137.93 168.48 19.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.586 1.154 . . . . 0.0 107.946 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.433 HD12 ' C ' ' A' ' 50' ' ' PHE . 6.8 mp -122.61 161.01 24.56 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.7 p -127.41 115.82 19.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.247 1.419 . . . . 0.0 107.607 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -143.17 150.59 39.6 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 51.39 24.72 2.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.896 1.678 . . . . 0.0 114.107 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt 73.79 9.99 4.76 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.751 2.02 . . . . 0.0 111.277 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -110.68 -178.01 3.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.06 2.144 . . . . 0.0 110.136 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.3 pt -123.96 126.99 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.892 0.877 . . . . 0.0 110.465 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -130.28 163.32 27.04 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.468 -1.395 . . . . 0.0 113.254 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.21 156.98 19.44 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -57.36 -47.05 82.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 119.257 0.935 . . . . 0.0 110.136 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -52.25 -37.43 55.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.75 -1.219 . . . . 0.0 113.541 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.77 -35.6 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.234 1.014 . . . . 0.0 110.622 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.79 33.32 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.104 1.335 . . . . 0.0 110.005 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.449 -0.522 0 CA-C-N 118.783 1.291 . . . . 0.0 110.739 -177.895 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 N-CA-C 115.325 0.89 . . . . 0.0 115.325 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 15.0 t -50.52 117.28 2.34 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.582 -1.199 . . . . 0.0 107.948 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -54.97 -27.34 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 120.94 1.7 . . . . 0.0 110.83 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.86 -3.69 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.673 1.989 . . . . 0.0 115.175 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -152.62 -10.25 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.446 1.476 . . . . 0.0 114.24 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m 60.3 10.32 2.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.517 3.527 . . . . 0.0 115.642 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -75.67 151.54 84.84 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 120.911 1.687 . . . . 0.0 112.403 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -66.94 139.43 51.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.817 2.344 . . . . 0.0 109.019 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.76 156.71 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.415 2.286 . . . . 0.0 108.68 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 124.321 1.049 . . . . 0.0 111.146 178.523 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 C--O 1.236 0.362 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -130.83 164.58 24.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.51 0.724 . . . . 0.0 111.077 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 mm -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 128.837 2.855 . . . . 0.0 105.932 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.34 102.96 15.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -135.49 127.22 29.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.403 1.002 . . . . 0.0 110.632 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 50.24 45.44 25.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.38 1.072 . . . . 0.0 109.227 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.91 -17.55 0.25 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 129.735 3.214 . . . . 0.0 114.325 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 m -73.64 164.53 26.52 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.133 0.879 . . . . 0.0 109.3 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -128.95 107.73 9.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -109.05 125.57 52.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 111.12 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -60.47 150.08 32.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -55.33 -42.42 73.77 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.72 -3.82 20.56 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.2 -1.46 11.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 128.959 2.904 . . . . 0.0 113.909 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.98 102.57 15.14 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -152.77 174.59 13.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.27 120.47 11.63 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 117.264 -1.35 . . . . 0.0 110.075 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.14 -12.27 29.8 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.627 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.37 -19.67 16.18 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.52 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -141.98 -10.59 0.88 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 81.11 1.22 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.52 HG12 ' SG ' ' A' ' 41' ' ' CYS . 11.8 p -65.23 138.9 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.218 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -55.33 134.25 50.01 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.313 1.045 . . . . 0.0 111.773 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 mt -117.99 4.75 12.09 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.69 -1.148 . . . . 0.0 109.695 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 46' ' ' VAL . 22.9 t -36.76 103.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.482 1.913 . . . . 0.0 112.525 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 -25.17 0.9 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 129.064 3.221 . . . . 0.0 115.928 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -55.0 138.27 44.21 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.662 1.985 . . . . 0.0 112.128 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.14 121.73 27.14 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -116.36 172.6 7.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.866 2.067 . . . . 0.0 111.719 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.01 148.12 33.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.0 p -126.52 117.26 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.11 143.93 32.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 50.6 28.74 3.64 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.981 1.264 . . . . 0.0 113.958 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm 64.85 22.72 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.734 1.214 . . . . 0.0 111.145 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -110.2 178.57 4.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.129 2.172 . . . . 0.0 106.751 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.81 122.95 55.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 109.532 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -131.55 154.58 48.67 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 122.893 1.33 . . . . 0.0 113.197 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 164.51 19.75 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -59.02 -54.44 47.1 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.925 0.784 . . . . 0.0 111.135 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -50.52 -30.18 12.33 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.4 m -93.96 -30.72 14.6 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.231 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.55 7.53 59.67 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.96 1.255 . . . . 0.0 115.356 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.234 0.246 0 CA-C-N 119.455 1.628 . . . . 0.0 113.276 -179.05 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 CA-C-O 120.127 -0.263 . . . . 0.0 112.743 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 12.4 t -52.13 115.38 1.68 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.737 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 29' ' ' SER . 80.2 t -54.94 -24.36 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 121.287 1.858 . . . . 0.0 112.481 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.96 -0.57 56.81 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.666 1.186 . . . . 0.0 113.841 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.8 p -156.71 -11.37 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.268 1.849 . . . . 0.0 115.075 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t 52.44 57.63 6.23 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.004 2.522 . . . . 0.0 111.598 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -117.84 147.11 40.46 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.883 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.55 114.03 2.94 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.013 3.142 . . . . 0.0 113.537 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -82.95 162.09 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 CA--C 1.529 0.159 0 O-C-N 120.69 -1.256 . . . . 0.0 110.657 179.171 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.39 165.72 26.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.544 1.938 . . . . 0.0 109.294 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mm -116.52 150.37 18.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -131.38 135.08 46.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -145.21 111.38 5.61 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.43 56.81 6.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.143 0.973 . . . . 0.0 109.682 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 -16.89 0.09 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 130.013 3.325 . . . . 0.0 115.191 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' HG21 ' A' ' 9' ' ' VAL . 72.7 m -80.08 145.64 32.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -119.87 141.69 49.34 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.976 0.893 . . . . 0.0 112.528 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.8 m-90 -132.86 162.9 30.33 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.145 1.378 . . . . 0.0 111.143 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -79.78 148.43 31.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.4 t -60.55 -8.94 3.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.728 2.011 . . . . 0.0 115.042 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.96 -36.74 5.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.001 1.721 . . . . 0.0 108.83 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.26 18.28 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.866 1.667 . . . . 0.0 114.913 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -113.2 101.35 9.34 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -148.57 174.72 11.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -61.19 121.05 11.56 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.503 1.521 . . . . 0.0 109.779 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.49 -25.75 58.55 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 118.133 0.424 . . . . 0.0 113.069 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -87.45 -18.8 29.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.63 -9.92 0.41 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 119.082 2.993 . . . . 0.0 119.082 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 83.44 3.23 0.94 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.37 133.69 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.445 1.475 . . . . 0.0 107.303 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.0 t -57.36 144.67 35.2 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.684 0.754 . . . . 0.0 109.852 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.21 -6.56 14.1 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.325 . . . . 0.0 110.197 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.82 120.24 10.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.73 84.83 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 116.163 -2.465 . . . . 0.0 115.923 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -135.21 169.47 17.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.635 2.717 . . . . 0.0 112.204 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.25 123.54 25.92 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -116.62 167.88 10.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.19 159.81 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.8 p -132.3 112.06 11.9 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.919 0.762 . . . . 0.0 109.504 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -142.7 156.12 44.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.632 1.573 . . . . 0.0 107.341 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.9 m120 52.5 30.73 8.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.349 1.06 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.7 27.43 14.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.03 1.332 . . . . 0.0 110.708 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -125.63 175.55 7.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.192 2.197 . . . . 0.0 110.24 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.39 126.4 69.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 127.715 2.406 . . . . 0.0 110.021 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -134.03 163.52 29.37 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 161.2 16.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -50.23 -56.39 11.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.772 1.229 . . . . 0.0 111.215 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -49.8 -33.63 17.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 113.249 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.2 -54.85 5.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.369 0.668 . . . . 0.0 109.319 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.72 26.62 4.62 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 115.621 1.008 . . . . 0.0 115.621 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.734 0 CA-C-N 119.578 1.689 . . . . 0.0 112.776 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.959 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m -62.73 -6.22 3.44 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -71.07 -13.57 62.02 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.85 -178.96 48.81 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 120.544 1.52 . . . . 0.0 112.061 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.7 t -108.76 175.56 5.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.394 1.478 . . . . 0.0 109.012 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -158.69 179.46 9.09 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.451 1.5 . . . . 0.0 110.876 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.76 176.53 19.43 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.752 1.644 . . . . 0.0 110.488 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -43.0 118.49 1.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 116.197 -1.859 . . . . 0.0 110.423 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.15 -31.36 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 121.753 2.069 . . . . 0.0 112.025 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.68 -5.37 59.31 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -157.95 -7.66 0.08 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 0.1 OUTLIER 61.77 14.34 6.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 130.164 3.386 . . . . 0.0 114.914 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -78.25 147.04 71.97 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 120.453 -1.404 . . . . 0.0 108.646 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.16 120.32 6.93 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.259 2.639 . . . . 0.0 110.07 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mm -66.53 140.45 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 p -82.23 79.56 8.68 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 14.29 -101.55 0.01 OUTLIER Glycine 0 C--N 1.335 0.507 1 C-N-CA 131.118 4.199 . . . . 0.0 114.388 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mp -127.11 30.14 5.48 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.218 1.807 . . . . 0.0 107.176 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.1 m -67.12 -7.35 22.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.216 1.806 . . . . 0.0 113.123 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.98 9.88 15.16 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.045 -1.034 . . . . 0.0 113.735 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.71 159.69 30.84 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.791 1.296 . . . . 0.0 109.461 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -97.11 109.09 21.92 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -134.43 164.28 27.8 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.499 0.72 . . . . 0.0 110.514 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mm -122.43 145.96 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 127.271 2.229 . . . . 0.0 106.283 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -126.83 102.82 7.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -121.95 127.62 50.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 52.85 43.59 31.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.968 0.907 . . . . 0.0 108.781 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 56.91 0.51 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.007 2.523 . . . . 0.0 114.41 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 m -85.39 156.46 20.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.932 1.693 . . . . 0.0 107.831 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.99 130.31 51.63 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -132.3 145.09 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.647 1.179 . . . . 0.0 109.026 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -98.39 161.26 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 p -53.09 -55.02 27.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.938 0.895 . . . . 0.0 111.651 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.29 -4.05 9.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.054 1.341 . . . . 0.0 112.98 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.48 14.87 11.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.911 1.284 . . . . 0.0 113.298 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -107.41 101.3 10.67 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -157.2 167.04 31.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.4 t -64.86 120.83 13.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 117.111 -1.423 . . . . 0.0 109.799 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.04 -28.66 58.56 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.917 1.235 . . . . 0.0 114.396 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -81.04 -19.86 42.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.6 p -139.71 -23.05 0.87 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t 87.76 7.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.356 1.863 . . . . 0.0 114.467 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.94 135.23 27.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -60.21 132.34 53.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -98.21 -1.6 41.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 108.946 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.06 109.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 -65.93 0.31 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 126.069 1.795 . . . . 0.0 109.072 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -66.65 157.08 33.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.049 0.94 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.06 20.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -106.59 168.77 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.215 1.006 . . . . 0.0 109.187 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.95 152.28 42.66 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.868 1.667 . . . . 0.0 108.365 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 p -134.23 114.85 13.49 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.535 1.134 . . . . 0.0 110.6 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -142.64 143.23 32.28 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.622 1.569 . . . . 0.0 106.907 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 m120 53.76 25.32 5.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.873 0.869 . . . . 0.0 111.493 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt 73.15 3.61 4.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.119 1.768 . . . . 0.0 111.127 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.7 153.18 18.41 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.289 1.436 . . . . 0.0 109.825 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.75 122.46 55.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 109.931 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -137.13 166.49 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.795 1.283 . . . . 0.0 111.848 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.24 163.6 19.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -55.74 -55.51 31.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.052 1.341 . . . . 0.0 111.306 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -52.71 -48.87 66.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.361 -0.837 . . . . 0.0 112.886 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 m -68.62 -44.59 73.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.349 0.66 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 22.59 7.65 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 120.939 -1.1 . . . . 0.0 113.759 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m -75.3 92.62 2.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.369 1.585 . . . . 0.0 107.441 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.93 56.25 3.52 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.53 1.538 . . . . 0.0 111.612 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.76 132.96 52.57 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -85.34 63.0 7.84 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.0 p -59.35 -66.54 0.49 Allowed 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.502 -0.749 . . . . 0.0 111.863 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.04 167.79 28.38 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.598 2.359 . . . . 0.0 109.719 -176.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -92.48 6.22 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.731 1.612 . . . . 0.0 112.551 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.2 t -152.81 151.63 30.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.26 -74.49 0.44 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 106.751 -2.539 . . . . 0.0 106.751 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.3 62.06 6.8 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.9 3.067 . . . . 0.0 110.628 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 m -162.78 179.26 7.78 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.858 2.863 . . . . 0.0 107.564 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.4 100.49 5.99 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 N-CA-C 105.634 -2.987 . . . . 0.0 105.634 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.762 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -71.35 130.38 41.21 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.7 -9.98 35.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.806 0.842 . . . . 0.0 110.856 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.71 -174.27 30.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.6 p -113.55 1.1 14.87 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.152 -1.404 . . . . 0.0 113.139 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 m 3.71 89.81 0.01 OUTLIER 'General case' 0 C--O 1.24 0.579 0 C-N-CA 130.237 3.415 . . . . 0.0 112.522 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.25 -168.85 23.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.492 -0.861 . . . . 0.0 115.149 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.6 t -60.71 113.56 2.54 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 117.243 -1.36 . . . . 0.0 110.21 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.6 t -57.83 -20.36 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 120.091 1.314 . . . . 0.0 110.438 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.6 -3.76 58.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.072 1.349 . . . . 0.0 114.078 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 p -155.44 -10.53 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.408 1.913 . . . . 0.0 115.673 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m 55.17 53.32 10.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.331 2.252 . . . . 0.0 112.589 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -113.7 137.3 22.18 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 108.61 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.92 3.08 . . . . 0.0 110.113 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.44 129.83 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.65 173.56 1.25 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.69 0.396 . . . . 0.0 111.819 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.53 -174.06 3.67 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.22 19.97 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.045 1.338 . . . . 0.0 114.604 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 t -72.8 32.19 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.444 3.098 . . . . 0.0 111.494 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.25 2.63 57.89 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.583 -1.323 . . . . 0.0 113.638 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 105.96 0.73 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.335 1.067 . . . . 0.0 109.684 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -74.46 117.61 16.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -137.89 166.77 23.23 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.406 1.882 . . . . 0.0 109.991 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.2 mm -125.25 114.87 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 p -104.41 117.29 33.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.139 1.776 . . . . 0.0 107.525 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -145.58 143.48 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.209 1.004 . . . . 0.0 109.218 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 31.52 60.37 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.872 2.469 . . . . 0.0 114.372 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 65.19 5.36 3.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.916 2.487 . . . . 0.0 114.972 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -116.09 161.85 18.3 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 0.0 111.079 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -125.72 141.1 52.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.462 1.125 . . . . 0.0 110.168 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -132.58 152.42 51.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.225 1.41 . . . . 0.0 109.555 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -86.15 141.57 29.27 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.67 -55.79 4.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.021 1.328 . . . . 0.0 111.071 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -65.56 -12.68 55.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -118.15 16.56 14.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.411 0.685 . . . . 0.0 111.869 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -106.92 101.56 10.99 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.88 176.34 12.28 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.9 t -58.11 118.93 5.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 117.088 -1.434 . . . . 0.0 109.731 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.07 -11.51 12.23 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 123.968 0.793 . . . . 0.0 114.787 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -102.74 -21.52 14.06 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.093 1.357 . . . . 0.0 114.595 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.68 -14.21 0.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.993 2.59 . . . . 0.0 117.993 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 t 81.62 27.46 0.18 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.833 1.652 . . . . 0.0 114.725 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.75 128.49 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -51.3 136.51 24.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.141 1.377 . . . . 0.0 111.691 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.1 mt -112.41 3.74 17.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.561 1.144 . . . . 0.0 110.215 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.81 105.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 126.594 1.958 . . . . 0.0 108.641 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.45 36.13 92.08 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.517 -0.602 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -132.99 160.97 35.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.483 1.141 . . . . 0.0 107.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.44 124.82 30.29 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.7 171.08 14.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.125 . . . . 0.0 109.243 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 60' ' ' GLN . 5.1 mp -136.13 156.84 48.11 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.271 1.828 . . . . 0.0 106.442 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.4 p -137.46 115.4 11.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -142.48 145.79 34.07 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 48.42 41.92 17.54 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.909 1.283 . . . . 0.0 111.465 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.397 5.0 ptpp? 61.43 7.87 1.95 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.189 2.995 . . . . 0.0 114.62 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.95 178.07 5.4 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.368 1.44 . . . . 0.0 110.889 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.31 122.81 60.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 109.535 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.14 160.14 35.61 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.667 -1.27 . . . . 0.0 112.811 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.91 162.43 16.91 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.654 ' HA ' HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.28 -52.73 60.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.041 1.291 . . . . 0.0 111.372 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -40.28 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.145 1.339 . . . . 0.0 113.302 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -78.46 -29.05 46.65 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.715 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.47 13.76 61.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.108 1.813 . . . . 0.0 113.342 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -84.17 79.73 9.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.6 156.21 4.83 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.4 ttm -145.22 120.03 9.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -120.82 94.81 4.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.2 t -161.1 -22.35 0.05 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.55 0.74 . . . . 0.0 112.53 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -156.31 110.04 2.72 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.9 mt -77.28 72.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.4 m -71.84 64.19 0.48 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 128.186 2.594 . . . . 0.0 109.086 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.08 73.59 0.32 Allowed Glycine 0 C--N 1.334 0.447 0 CA-C-O 117.949 -1.473 . . . . 0.0 114.344 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.6 22.7 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.28 2.653 . . . . 0.0 111.949 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.4 p -55.71 -45.4 77.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.126 1.77 . . . . 0.0 109.312 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.6 m -142.02 179.78 6.68 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 128.268 2.627 . . . . 0.0 107.443 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 N-CA-C 105.574 -3.01 . . . . 0.0 105.574 -179.851 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 t -114.57 164.95 13.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -161.77 168.66 22.79 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.133 1.373 . . . . 0.0 107.764 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.46 60.05 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 m -125.7 116.35 21.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.242 1.017 . . . . 0.0 108.72 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 m -67.4 88.56 0.2 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.32 1.448 . . . . 0.0 109.898 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.79 -165.77 38.23 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 126.291 1.901 . . . . 0.0 108.368 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 11.4 t -58.56 125.4 23.24 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 117.619 -1.182 . . . . 0.0 108.943 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.3 -17.01 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 124.731 1.213 . . . . 0.0 112.052 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.85 9.43 22.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.239 2.216 . . . . 0.0 115.083 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -161.1 -5.3 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.426 -1.421 . . . . 0.0 114.351 178.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t 62.15 0.6 0.59 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.381 1.872 . . . . 0.0 113.755 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -82.58 156.4 68.21 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 122.359 2.345 . . . . 0.0 112.271 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.23 122.82 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.452 2.101 . . . . 0.0 108.837 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -76.33 151.26 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -66.17 139.33 58.12 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.44 -176.08 10.91 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.09 37.9 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.215 2.606 . . . . 0.0 116.274 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 t -99.0 32.08 2.79 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.702 2.401 . . . . 0.0 107.52 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.19 38.73 7.15 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 124.553 1.073 . . . . 0.0 110.566 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.94 107.58 20.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.396 1.479 . . . . 0.0 112.625 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -64.6 110.77 2.45 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.23 1.012 . . . . 0.0 110.187 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -137.41 164.65 28.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.538 1.535 . . . . 0.0 108.844 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.29 140.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -131.47 132.94 44.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.731 2.012 . . . . 0.0 106.272 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -145.57 102.74 3.73 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.703 1.601 . . . . 0.0 108.587 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.5 64.68 1.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 109.796 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 49.8 t0 42.66 67.32 0.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.468 2.707 . . . . 0.0 113.245 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.8 p -134.99 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 130.103 3.361 . . . . 0.0 106.951 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -142.53 118.06 10.34 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -131.55 131.61 43.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.305 1.042 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -66.45 154.97 38.83 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -53.03 -43.41 66.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.157 0.98 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.62 -2.69 33.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -121.12 18.68 11.61 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 0.0 114.442 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -112.38 100.08 8.51 Favored 'General case' 0 C--O 1.235 0.333 1 N-CA-C 100.193 -4.002 . . . . 0.0 100.193 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.63 160.53 40.12 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.7 t -58.9 124.23 19.15 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.444 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.88 -28.06 72.15 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 118.425 0.557 . . . . 0.0 113.362 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -78.83 -28.63 44.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.78 -10.84 1.02 Allowed 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t 72.62 87.77 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.907 1.337 . . . . 0.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.98 143.29 18.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 127.556 2.342 . . . . 0.0 104.801 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.7 t -65.55 142.71 58.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.252 1.025 . . . . 0.0 109.867 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.32 13.15 11.87 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.044 1.738 . . . . 0.0 109.658 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.9 t -76.97 -63.49 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 119.035 0.834 . . . . 0.0 108.761 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.61 11.9 6.6 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.206 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.97 159.1 44.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.665 1.732 . . . . 0.0 109.897 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.65 159.14 52.41 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -132.46 167.4 20.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.697 1.599 . . . . 0.0 108.425 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 60' ' ' GLN . 10.3 mp -125.29 159.02 32.7 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -126.72 107.84 10.53 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.991 1.716 . . . . 0.0 109.489 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -142.44 155.21 45.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m120 47.66 41.53 13.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.873 1.269 . . . . 0.0 112.197 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt 50.74 19.75 0.65 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.931 2.092 . . . . 0.0 113.882 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -123.82 176.26 6.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.494 1.918 . . . . 0.0 109.389 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.6 pt -112.92 131.67 63.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.674 1.189 . . . . 0.0 111.511 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.0 165.51 25.5 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.51 1.148 . . . . 0.0 113.69 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.72 156.64 20.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.472 ' HA ' HD13 ' A' ' 51' ' ' LEU . 74.6 mt-30 -54.9 -52.38 63.06 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.532 1.133 . . . . 0.0 109.554 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -55.07 -26.14 35.67 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.219 -1.551 . . . . 0.0 114.558 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.21 -22.97 16.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.731 1.612 . . . . 0.0 112.808 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.3 -4.38 55.13 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.492 1.044 . . . . 0.0 113.529 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.1 t -61.9 107.56 0.87 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.914 1.686 . . . . 0.0 108.023 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.47 -173.62 26.65 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 126.163 1.84 . . . . 0.0 108.999 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.24 -30.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.01 1.324 . . . . 0.0 110.114 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.6 13.42 7.28 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.608 1.963 . . . . 0.0 113.915 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.413 HG23 HG12 ' A' ' 70' ' ' ILE . 7.5 t -146.36 145.85 30.45 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.523 1.056 . . . . 0.0 108.528 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -72.75 -7.29 49.85 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.776 2.03 . . . . 0.0 115.684 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.413 HG12 HG23 ' A' ' 68' ' ' THR . 48.3 pt -64.98 153.46 8.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 122.273 1.035 . . . . 0.0 111.492 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.4 p -125.59 55.67 1.41 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.455 1.902 . . . . 0.0 106.985 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.51 156.22 39.36 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.76 124.73 9.94 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.851 1.701 . . . . 0.0 107.851 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 p -167.24 154.34 8.68 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 127.138 2.175 . . . . 0.0 105.556 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 p -159.84 100.07 1.41 Allowed 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.634 -0.667 . . . . 0.0 111.127 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 178.542 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.516 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 t -129.76 127.45 40.41 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.986 0.914 . . . . 0.0 109.581 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 t -77.84 -30.88 51.24 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.28 178.36 47.48 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 125.671 1.605 . . . . 0.0 114.154 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -133.86 154.37 51.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.16 2.584 . . . . 0.0 104.293 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 55.65 64.42 1.75 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.822 1.192 . . . . 0.0 111.346 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.79 -171.49 42.11 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 18.0 t -49.54 124.67 9.84 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.203 2.002 . . . . 0.0 108.32 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.23 -8.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 120.581 1.537 . . . . 0.0 110.964 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.07 7.16 27.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.703 2.001 . . . . 0.0 113.159 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.9 p -167.66 -5.34 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 121.225 1.829 . . . . 0.0 115.774 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.368 0.1 OUTLIER 56.06 18.79 3.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.128 2.171 . . . . 0.0 114.666 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -82.82 144.45 48.27 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.34 128.51 14.67 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.648 2.232 . . . . 0.0 110.239 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.8 mt -78.87 162.18 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t -107.97 88.33 2.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.73 169.17 52.63 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.0 tp 48.54 28.32 1.71 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.264 1.425 . . . . 0.0 112.399 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.4 m -125.83 -12.15 6.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.79 1.236 . . . . 0.0 113.204 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.07 30.67 19.53 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.12 154.76 40.45 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.656 0.782 . . . . 0.0 111.322 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -85.99 75.22 9.99 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -119.24 158.53 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.405 HG21 ' CE1' ' A' ' 36' ' ' PHE . 3.9 mp -118.85 131.67 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.08 116.11 22.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.117 2.167 . . . . 0.0 107.549 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -145.76 131.25 18.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.233 1.813 . . . . 0.0 107.172 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 36.32 63.13 0.65 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.669 1.988 . . . . 0.0 111.918 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 60.19 -3.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 128.035 2.534 . . . . 0.0 115.749 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -80.45 160.63 25.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.492 1.117 . . . . 0.0 108.179 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -136.69 113.87 10.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -118.91 149.95 40.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.584 1.154 . . . . 0.0 111.021 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -86.56 147.37 25.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.0 t -49.39 -52.78 26.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.613 1.097 . . . . 0.0 110.669 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -57.76 -31.07 66.13 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.49 -4.92 52.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.405 ' CE1' HG21 ' A' ' 24' ' ' ILE . 47.8 t80 -80.93 99.36 8.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.38 161.76 37.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.086 1.355 . . . . 0.0 112.563 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.68 145.7 55.23 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.099 1.36 . . . . 0.0 112.701 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.39 -49.27 15.74 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 123.797 0.686 . . . . 0.0 111.915 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -75.53 -23.14 56.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -133.57 -7.43 2.87 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -178.454 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 m 72.49 -0.75 3.19 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 41' ' ' CYS . 4.0 p -71.06 147.03 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 121.038 1.744 . . . . 0.0 111.251 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -71.81 149.59 45.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.583 0.628 . . . . 0.0 111.968 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.13 -6.56 13.66 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.985 0.803 . . . . 0.0 112.412 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.65 95.83 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.58 11.56 24.81 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.877 1.227 . . . . 0.0 113.175 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -127.55 141.01 51.76 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.498 1.149 . . . . 0.0 108.305 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.95 88.78 0.66 Allowed Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -85.44 168.07 14.92 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.766 0.783 . . . . 0.0 110.296 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 mp -117.68 158.89 23.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.224 1.809 . . . . 0.0 106.918 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.3 p -128.71 122.6 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -143.51 153.21 42.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 m120 47.06 36.99 4.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm 58.89 30.4 20.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.327 1.051 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -129.19 166.64 18.96 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.913 1.685 . . . . 0.0 108.921 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.82 120.8 63.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.128 1.771 . . . . 0.0 108.487 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -131.31 139.48 49.58 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.007 -1.683 . . . . 0.0 113.054 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.58 144.52 31.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 114.521 -2.657 . . . . 0.0 106.024 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -30.06 -53.16 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.791 3.236 . . . . 0.0 112.304 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -47.83 -40.31 20.86 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.953 0.797 . . . . 0.0 112.296 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 29.2 m -80.14 -44.13 20.44 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.02 14.97 5.59 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 120.954 -1.091 . . . . 0.0 113.6 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.3 t -82.61 53.99 2.51 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.65 -83.51 0.9 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 94.3 mmm -134.94 146.26 48.95 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.085 1.754 . . . . 0.0 107.923 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.96 52.78 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.038 2.135 . . . . 0.0 108.116 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.9 t -60.98 144.94 52.31 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.82 -1.175 . . . . 0.0 109.287 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.05 -177.27 6.19 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 128.355 2.662 . . . . 0.0 107.224 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.1 pt -78.05 152.15 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.1 t -71.72 -43.38 65.98 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.19 177.52 25.1 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.385 0.993 . . . . 0.0 111.544 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -76.29 -177.89 4.03 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 124.096 3.197 . . . . 0.0 109.055 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -60.4 143.14 53.89 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.6 p -63.67 122.86 17.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 109.783 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 N-CA-C 105.707 -2.957 . . . . 0.0 105.707 179.333 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.838 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 p -72.89 -84.27 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.237 1.815 . . . . 0.0 108.805 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.64 95.43 0.86 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.468 1.907 . . . . 0.0 107.747 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.93 156.84 27.11 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -84.27 102.8 12.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.841 1.257 . . . . 0.0 108.546 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.8 m -55.98 153.15 9.18 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.49 179.88 31.13 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.213 1.387 . . . . 0.0 109.753 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 18.1 t -61.28 117.24 5.37 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 116.31 -1.805 . . . . 0.0 107.761 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 29' ' ' SER . 88.0 t -52.3 -30.54 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 121.067 1.758 . . . . 0.0 112.161 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.83 -12.02 58.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 1.8 p -139.49 -13.51 1.14 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.733 1.606 . . . . 0.0 113.413 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m 52.77 56.04 8.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 128.396 2.679 . . . . 0.0 111.665 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -124.86 149.23 62.21 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 117.773 -1.108 . . . . 0.0 108.748 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.87 114.74 3.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.606 2.204 . . . . 0.0 109.042 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.76 138.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 107.542 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -66.1 150.87 48.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.544 0.611 . . . . 0.0 111.079 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.41 146.82 18.76 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp 39.17 48.89 1.62 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.064 2.146 . . . . 0.0 113.749 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.31 11.92 5.95 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.669 -1.269 . . . . 0.0 111.863 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.55 17.77 79.63 Favored Glycine 0 CA--C 1.537 1.448 0 O-C-N 121.072 -1.017 . . . . 0.0 111.058 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 110.83 3.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -71.74 71.13 0.73 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.944 0.878 . . . . 0.0 112.086 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.58 165.26 18.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.559 1.544 . . . . 0.0 109.523 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 mt -130.19 152.94 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 126.218 1.807 . . . . 0.0 106.611 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 t -131.8 131.72 43.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.557 1.543 . . . . 0.0 108.399 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -146.42 136.24 23.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.116 1.366 . . . . 0.0 107.811 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 48.15 38.12 9.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 65.51 6.47 3.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.374 1.469 . . . . 0.0 112.959 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 9' ' ' VAL . 15.4 m -102.08 160.98 14.04 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.426 2.29 . . . . 0.0 105.73 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -132.14 144.86 50.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 119.936 -1.728 . . . . 0.0 113.363 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -133.43 145.08 49.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.238 1.015 . . . . 0.0 111.327 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -80.68 157.69 25.83 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 p -53.62 -49.77 67.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.867 0.867 . . . . 0.0 111.846 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -12.64 60.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.75 4.77 24.06 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.277 1.831 . . . . 0.0 113.714 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -101.28 99.89 10.33 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -155.24 166.41 33.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -58.48 119.77 7.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 116.821 -1.561 . . . . 0.0 112.45 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.27 49.81 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.453 1.024 . . . . 0.0 112.225 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -92.0 -17.52 24.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -148.72 -4.96 0.43 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m 74.47 1.14 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.77 134.61 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.9 t -59.38 145.52 43.22 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 124.242 0.964 . . . . 0.0 110.472 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -118.33 4.6 11.85 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.137 1.775 . . . . 0.0 110.058 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.91 91.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.964 . . . . 0.0 110.524 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.51 -58.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 125.875 1.702 . . . . 0.0 111.668 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.64 148.42 42.58 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.352 0.576 . . . . 0.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.42 115.03 7.36 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 105.52 -3.032 . . . . 0.0 105.52 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -85.16 170.38 12.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 109.137 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.7 160.74 32.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.693 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.7 p -137.72 104.5 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 110.247 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -141.16 153.57 45.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.89 1.676 . . . . 0.0 107.246 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.89 31.6 3.3 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.272 1.029 . . . . 0.0 113.396 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm 60.37 21.46 11.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.005 1.722 . . . . 0.0 112.007 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -125.43 174.83 7.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.49 1.516 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -117.31 122.7 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.977 1.311 . . . . 0.0 111.037 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.78 148.23 50.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.382 1.087 . . . . 0.0 113.586 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 162.68 29.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -50.22 -52.94 31.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.586 1.085 . . . . 0.0 112.39 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.46 -45.24 69.48 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.64 1.109 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.22 -59.44 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.5 29.92 1.71 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.139 1.352 . . . . 0.0 112.959 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.2 t -64.95 104.08 0.81 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 107.642 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.0 115.08 2.83 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 127.843 2.639 . . . . 0.0 111.545 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -146.47 166.9 25.02 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.424 2.69 . . . . 0.0 105.811 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -128.05 87.2 2.57 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -79.98 69.26 6.31 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -133.99 84.8 2.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.541 1.136 . . . . 0.0 108.155 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.11 -46.31 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.9 t -78.51 -95.46 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.811 1.645 . . . . 0.0 107.513 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.8 120.69 0.54 Allowed Glycine 0 CA--C 1.526 0.755 0 O-C-N 120.632 -1.293 . . . . 0.0 110.86 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -80.01 -4.65 13.41 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.229 2.619 . . . . 0.0 114.019 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t -68.4 170.92 8.05 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 120.191 1.36 . . . . 0.0 111.909 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 p -151.73 163.75 38.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.858 1.663 . . . . 0.0 108.428 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 N-CA-C 105.947 -2.861 . . . . 0.0 105.947 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.4 m -59.42 108.26 0.69 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.799 1.64 . . . . 0.0 111.0 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m -80.94 -15.48 56.15 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.156 0.435 . . . . 0.0 109.85 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.53 -178.08 48.19 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.209 2.338 . . . . 0.0 108.116 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 p -59.15 114.8 2.79 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.737 1.215 . . . . 0.0 110.056 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.4 t -151.85 131.56 13.17 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.61 167.01 11.66 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.453 1.501 . . . . 0.0 111.174 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 10.2 t -57.67 120.72 8.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.418 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.76 -2.4 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 125.605 1.562 . . . . 0.0 112.337 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.99 6.09 10.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.957 2.103 . . . . 0.0 113.022 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.7 p -159.02 -7.37 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 119.282 -2.136 . . . . 0.0 114.625 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.8 m 58.38 12.94 2.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.63 1.572 . . . . 0.0 114.036 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -81.31 148.75 63.95 Favored Pre-proline 0 C--N 1.346 0.435 0 O-C-N 120.117 -1.614 . . . . 0.0 108.138 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.59 117.54 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.901 3.067 . . . . 0.0 109.122 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.2 mt -74.65 139.51 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -53.65 -41.1 66.42 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.55 -90.87 0.31 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.457 ' H ' HD22 ' A' ' 18' ' ' LEU . 3.6 mm? -43.03 -41.83 3.61 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 128.612 2.765 . . . . 0.0 114.215 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 m -66.59 -17.51 64.86 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.22 21.56 54.51 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 120.691 -1.256 . . . . 0.0 112.628 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.35 153.2 12.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.873 0.869 . . . . 0.0 109.987 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 7.1 mmpt? -76.88 111.07 12.03 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.684 -0.635 . . . . 0.0 111.233 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.99 164.13 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.484 1.514 . . . . 0.0 107.877 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.23 137.78 52.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.14 112.15 18.32 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.265 1.826 . . . . 0.0 106.751 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -146.47 150.23 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 42.04 32.88 0.33 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.6 t70 56.68 40.67 29.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 123.699 1.714 . . . . 0.0 111.454 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 56.5 m -131.73 164.37 26.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 130.525 3.53 . . . . 0.0 106.804 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -132.65 133.77 44.0 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.327 1.051 . . . . 0.0 111.858 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 30.6 m-90 -132.38 161.54 33.34 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.527 1.131 . . . . 0.0 109.419 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -97.28 166.7 11.43 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.1 p -55.92 -30.76 62.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.338 1.055 . . . . 0.0 112.282 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -103.57 4.8 36.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.251 1.42 . . . . 0.0 112.256 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.01 6.59 9.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.313 1.045 . . . . 0.0 112.349 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -101.85 100.28 10.59 Favored 'General case' 0 N--CA 1.453 -0.298 1 N-CA-C 99.524 -4.25 . . . . 0.0 99.524 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -145.04 157.41 44.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 t -51.53 118.28 3.22 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -27.3 38.67 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 119.849 1.204 . . . . 0.0 112.872 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.6 -22.59 26.14 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.4 p -143.45 -6.72 0.8 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m 76.92 10.31 2.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.71 141.36 15.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.1 t -66.11 151.33 47.13 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.4 mt -118.18 -1.72 11.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.433 1.093 . . . . 0.0 111.374 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.29 -57.43 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.445 1.098 . . . . 0.0 112.286 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.76 17.15 2.85 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.05 -0.861 . . . . 0.0 113.947 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -150.92 -167.66 2.88 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.437 1.618 . . . . 0.0 110.722 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.96 165.31 21.92 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -140.82 171.48 14.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 109.766 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 60' ' ' GLN . 6.7 mp -129.53 165.53 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.407 1.083 . . . . 0.0 109.291 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 p -137.65 111.51 8.28 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.983 0.513 . . . . 0.0 109.735 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -142.46 148.36 37.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.161 1.784 . . . . 0.0 106.48 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 46.08 33.98 1.9 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.093 2.157 . . . . 0.0 112.478 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp 59.7 9.99 1.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.752 1.621 . . . . 0.0 113.039 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -93.41 -173.56 3.25 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.769 2.028 . . . . 0.0 107.466 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.2 pt -135.75 124.05 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.06 1.744 . . . . 0.0 109.397 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -135.38 148.04 49.25 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 120.745 -1.222 . . . . 0.0 114.183 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.72 155.68 39.66 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HA ' HD13 ' A' ' 51' ' ' LEU . 56.6 mt-30 -51.36 -52.75 42.87 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.934 1.243 . . . . 0.0 110.263 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -56.83 -25.79 56.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.2 m -97.51 -18.23 19.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 114.075 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.62 -5.63 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t -59.98 112.24 1.8 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.032 2.533 . . . . 0.0 105.963 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.95 -77.42 1.21 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -158.92 165.81 33.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.911 1.684 . . . . 0.0 108.323 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -115.92 0.7 13.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.976 1.31 . . . . 0.0 108.752 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.298 2.0 p 61.46 10.13 3.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.307 2.243 . . . . 0.0 113.2 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -93.98 133.42 37.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 mt -120.92 8.37 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.809 1.243 . . . . 0.0 109.321 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m -65.12 152.69 42.92 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -2.05 82.73 0.0 OUTLIER Glycine 0 CA--C 1.532 1.155 0 C-N-CA 128.509 2.956 . . . . 0.0 114.427 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -57.93 108.34 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.204 2.603 . . . . 0.0 110.874 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.4 t -124.8 -168.23 1.79 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.083 1.753 . . . . 0.0 108.274 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 65.7 p -132.13 -172.25 2.84 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.853 1.261 . . . . 0.0 110.423 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.951 0 N-CA-C 106.304 -2.718 . . . . 0.0 106.304 179.044 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.444 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 m -152.45 160.49 43.26 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.897 1.279 . . . . 0.0 107.979 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 t -112.89 104.12 12.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.78 -81.79 1.24 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . 0.263 31.4 p 51.17 29.49 4.86 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.961 1.705 . . . . 0.0 111.629 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -72.48 -173.76 1.21 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.938 2.495 . . . . 0.0 108.979 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -142.4 -119.85 1.51 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 49.2 t -66.53 106.89 1.9 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.743 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -50.55 -35.16 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.784 1.174 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.39 1.0 50.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.227 2.211 . . . . 0.0 116.427 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -153.16 -12.98 0.15 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.101 1.773 . . . . 0.0 112.798 178.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m 55.41 51.13 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 131.169 3.788 . . . . 0.0 113.388 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.59 149.18 44.47 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.71 1.204 . . . . 0.0 110.098 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.4 122.6 6.62 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 123.306 2.671 . . . . 0.0 112.097 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.8 mt -80.72 163.04 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.621 2.368 . . . . 0.0 105.2 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -65.93 -80.04 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.27 84.58 0.19 Allowed Glycine 0 C--N 1.338 0.691 0 O-C-N 120.616 -1.303 . . . . 0.0 110.79 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.1 mt 58.95 11.74 2.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.502 1.521 . . . . 0.0 112.84 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 m -67.38 -15.45 63.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.939 2.096 . . . . 0.0 113.706 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.28 6.15 18.46 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.27 161.2 27.77 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.599 1.2 . . . . 0.0 109.207 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -85.93 106.5 17.17 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -131.59 163.97 26.89 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.659 0.784 . . . . 0.0 111.477 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.18 138.66 53.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.877 2.071 . . . . 0.0 105.892 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.6 121.0 23.64 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.12 1.368 . . . . 0.0 107.584 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -145.31 130.74 18.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 53.16 39.27 29.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.125 0.97 . . . . 0.0 111.532 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 68.26 -0.72 2.06 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.879 1.672 . . . . 0.0 113.039 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 t -73.91 165.75 24.58 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.103 2.161 . . . . 0.0 110.059 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -132.81 110.69 10.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.662 0.785 . . . . 0.0 112.141 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -118.03 129.81 55.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.61 154.47 40.74 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -49.87 -49.85 47.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.425 1.09 . . . . 0.0 110.967 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.35 -4.76 41.16 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.207 -1.558 . . . . 0.0 114.224 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.0 m -121.56 17.71 11.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.96 101.54 9.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.14 166.44 30.81 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.0 t -55.83 112.15 1.1 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.247 -1.359 . . . . 0.0 109.548 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.04 -25.3 30.99 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.208 0.909 . . . . 0.0 114.921 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -90.35 -20.96 22.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.35 -22.8 1.5 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m 77.47 78.51 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.251 1.024 . . . . 0.0 109.738 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.34 134.68 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 t -54.2 135.43 44.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.933 1.293 . . . . 0.0 112.461 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.39 9.72 15.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.547 1.939 . . . . 0.0 109.222 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.19 111.23 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 126.11 1.764 . . . . 0.0 112.711 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.47 43.4 94.03 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-O 119.331 -0.705 . . . . 0.0 113.666 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -139.07 153.21 48.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 134.34 46.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.99 171.77 9.0 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.144 1.378 . . . . 0.0 108.058 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.99 155.31 30.49 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 112.88 6.49 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -143.12 150.26 39.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 54.72 23.08 4.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.134 0.879 . . . . 0.0 112.528 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 70.54 8.45 6.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.792 2.437 . . . . 0.0 113.065 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.81 150.94 25.83 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.431 1.092 . . . . 0.0 108.587 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.8 pt -102.63 129.87 53.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.226 1.411 . . . . 0.0 110.025 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.92 160.69 36.9 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.669 -1.269 . . . . 0.0 112.444 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 161.39 19.69 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -51.98 -51.55 56.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.21 1.368 . . . . 0.0 111.57 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -53.49 -38.59 63.82 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.419 -0.8 . . . . 0.0 112.402 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -75.59 -53.26 8.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.27 1.04 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.548 1.07 . . . . 0.0 113.924 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -30.69 70.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.134 1.467 . . . . 0.0 111.303 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.32 -178.23 39.92 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.433 ' HG3' ' H ' ' A' ' 67' ' ' ASP . 22.8 ptt? -125.48 -60.21 1.34 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.418 1.487 . . . . 0.0 108.05 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' H ' ' HG3' ' A' ' 66' ' ' MET . 67.5 m-20 48.35 27.47 1.37 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.022 2.529 . . . . 0.0 112.882 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 p -66.09 113.73 4.7 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.977 2.111 . . . . 0.0 110.555 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -81.92 149.39 28.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.007 2.123 . . . . 0.0 110.498 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.1 pt -150.76 159.71 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 127.47 2.308 . . . . 0.0 108.388 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -80.28 179.5 7.64 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.718 0.807 . . . . 0.0 109.252 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.75 149.68 17.15 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.31 4.46 1.98 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.035 2.49 . . . . 0.0 113.754 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -125.26 -0.15 7.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.858 2.463 . . . . 0.0 111.009 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.8 t -168.29 84.61 0.18 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.855 0 CA-C-O 116.108 -2.495 . . . . 0.0 108.274 -179.466 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.979 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -85.57 108.01 17.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.657 1.583 . . . . 0.0 108.255 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -136.86 130.7 32.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.4 1.0 . . . . 0.0 111.808 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.56 -111.18 2.9 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.519 2.009 . . . . 0.0 110.695 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 t -104.9 112.51 25.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.032 1.333 . . . . 0.0 111.462 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.2 m -155.6 74.54 0.88 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.36 1.864 . . . . 0.0 110.469 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.33 178.39 15.3 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.464 1.03 . . . . 0.0 110.709 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.489 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.5 t -79.13 121.97 25.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.96 -23.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.249 0.931 . . . . 0.0 111.61 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.2 1.28 57.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.804 1.642 . . . . 0.0 115.207 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.1 p -162.6 -7.79 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.776 1.625 . . . . 0.0 115.128 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.28 97.1 p 53.83 26.82 6.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.103 2.561 . . . . 0.0 114.149 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -83.88 154.16 64.29 Favored Pre-proline 0 C--O 1.237 0.436 0 O-C-N 120.765 -1.21 . . . . 0.0 108.459 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.34 120.12 5.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.366 2.71 . . . . 0.0 107.185 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -70.55 144.07 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 p -76.8 176.4 8.54 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.429 0.692 . . . . 0.0 111.212 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.47 -179.08 43.98 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.27 19.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.789 2.036 . . . . 0.0 115.175 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 t -67.26 32.55 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 129.202 3.001 . . . . 0.0 114.2 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.26 1.61 55.77 Favored Glycine 0 CA--C 1.522 0.5 0 O-C-N 119.884 -1.76 . . . . 0.0 112.41 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.23 160.99 11.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.473 0.709 . . . . 0.0 109.8 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 127.31 20.68 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -145.06 164.95 29.64 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 126.039 1.736 . . . . 0.0 108.721 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.27 134.73 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -111.22 131.35 55.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.185 0.994 . . . . 0.0 108.834 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -146.15 138.1 25.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.091 1.756 . . . . 0.0 106.666 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 45.33 43.11 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.273 1.429 . . . . 0.0 112.235 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 69.45 -17.55 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 129.766 3.226 . . . . 0.0 113.616 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 56.6 m -73.94 164.15 26.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.325 1.45 . . . . 0.0 108.969 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.21 135.94 52.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.082 1.353 . . . . 0.0 111.115 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 18.3 m-90 -132.89 131.43 40.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.359 0.664 . . . . 0.0 111.664 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -65.48 154.38 38.73 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 p -49.58 -53.19 25.18 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.298 1.408 . . . . 0.0 112.613 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.49 -26.38 67.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.05 1.06 56.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 116.955 -1.498 . . . . 0.0 114.162 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -100.74 100.4 11.07 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 102.406 -3.183 . . . . 0.0 102.406 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -153.19 166.09 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 t -61.13 120.11 9.68 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-O 117.329 -1.319 . . . . 0.0 109.99 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.08 -24.38 54.53 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 121.989 0.772 . . . . 0.0 113.412 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -85.81 -18.83 31.82 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.16 -8.81 0.34 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 82.63 -0.99 1.33 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.474 1.488 . . . . 0.0 114.791 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.44 136.13 26.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 121.246 1.839 . . . . 0.0 108.024 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -54.35 136.2 43.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.082 1.353 . . . . 0.0 109.609 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.1 -0.37 15.65 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.773 0.829 . . . . 0.0 110.686 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.8 t -54.18 116.51 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 127.409 2.284 . . . . 0.0 109.505 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.68 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.532 1.152 0 C-N-CA 128.776 3.084 . . . . 0.0 117.617 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -9.38 56.96 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.23 147.09 16.94 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -146.34 172.26 13.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.575 1.55 . . . . 0.0 110.563 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.0 mp -119.13 154.95 32.45 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.9 p -130.11 102.46 6.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.241 0.963 . . . . 0.0 109.213 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.61 155.66 48.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.323 1.849 . . . . 0.0 107.595 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 52.35 21.77 1.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.004 1.321 . . . . 0.0 112.935 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt 62.49 22.02 12.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.038 1.735 . . . . 0.0 112.047 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -112.95 -169.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.893 2.477 . . . . 0.0 108.691 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.1 123.82 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 120.423 -1.423 . . . . 0.0 110.003 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -131.95 152.01 51.36 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 122.92 1.343 . . . . 0.0 114.607 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.76 150.28 42.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.545 ' HA ' HD13 ' A' ' 51' ' ' LEU . 5.0 mt-30 -46.23 -51.83 13.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.337 1.426 . . . . 0.0 110.502 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -51.53 61.47 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.135 0.879 . . . . 0.0 111.017 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.78 -29.01 68.85 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.35 -25.28 51.83 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.021 -1.433 . . . . 0.0 111.535 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m -61.97 -51.79 66.64 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.936 1.368 . . . . 0.0 109.802 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.59 -166.74 53.52 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.3 mmt -146.44 76.76 1.45 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -69.73 4.73 1.78 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.909 0.484 . . . . 0.0 112.12 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.3 p 56.92 49.1 14.63 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 128.027 2.531 . . . . 0.0 111.059 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -63.05 148.46 47.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.84 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.1 pt -115.85 18.69 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.849 1.659 . . . . 0.0 111.456 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -28.65 69.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.914 0.886 . . . . 0.0 113.029 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 112.8 -86.78 0.43 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.412 -1.216 . . . . 0.0 112.409 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.23 134.67 23.4 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.586 2.191 . . . . 0.0 112.646 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.4 t -158.58 162.49 37.35 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.923 1.289 . . . . 0.0 107.829 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.7 p -72.77 88.47 1.31 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.093 -1.005 . . . . 0.0 109.025 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.793 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m -147.44 126.99 13.25 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 t -135.09 76.93 1.65 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.51 -4.02 2.73 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.285 1.421 . . . . 0.0 112.691 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t -139.13 155.02 48.18 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.799 1.64 . . . . 0.0 107.751 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.3 p -140.79 -8.95 1.05 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.514 1.926 . . . . 0.0 112.7 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.45 -149.56 8.96 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 125.92 1.724 . . . . 0.0 109.856 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 8.0 t -53.26 127.54 24.9 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.178 -1.391 . . . . 0.0 107.954 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -51.51 -24.64 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 120.048 1.294 . . . . 0.0 113.883 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.67 9.29 25.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.493 1.917 . . . . 0.0 115.126 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -154.2 -11.07 0.14 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.96 -1.712 . . . . 0.0 114.132 179.026 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 p 58.99 2.93 0.28 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.057 2.543 . . . . 0.0 114.812 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -72.04 147.69 91.19 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 120.597 -1.315 . . . . 0.0 110.684 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.55 113.65 3.7 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.355 2.703 . . . . 0.0 110.58 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.63 149.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.46 21.38 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.18 -175.71 31.77 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.749 1.194 . . . . 0.0 112.11 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.56 15.82 0.17 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.722 1.609 . . . . 0.0 113.605 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -66.89 -0.14 2.87 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.833 1.653 . . . . 0.0 112.827 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.57 11.65 11.39 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 120.559 -1.338 . . . . 0.0 115.04 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.13 146.05 55.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.881 1.341 . . . . 0.0 107.659 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -78.7 106.22 10.54 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -135.44 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.827 2.051 . . . . 0.0 111.807 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.0 mm -120.05 147.37 23.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.89 117.9 19.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.375 1.07 . . . . 0.0 109.603 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.82 138.74 25.89 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 48.57 42.74 19.51 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.727 1.611 . . . . 0.0 110.597 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 61.87 2.45 0.76 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.272 2.229 . . . . 0.0 112.545 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.6 m -84.35 164.84 18.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.631 1.572 . . . . 0.0 108.875 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 117.83 24.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.403 1.081 . . . . 0.0 111.47 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -120.72 136.73 54.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.26 155.52 28.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.1 t -57.34 -46.03 83.69 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.341 0.973 . . . . 0.0 108.487 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -1.24 3.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.64 -6.47 6.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.913 1.285 . . . . 0.0 113.275 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -89.99 100.29 13.13 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -149.08 176.5 10.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.5 t -65.53 119.93 11.97 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.49 -1.243 . . . . 0.0 112.694 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.07 -10.8 16.14 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.468 1.508 . . . . 0.0 112.977 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -106.05 -23.49 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.133 1.466 . . . . 0.0 114.525 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.433 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -141.41 -3.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.294 15.4 m 70.83 15.44 6.85 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.433 HG12 ' SG ' ' A' ' 41' ' ' CYS . 7.5 p -73.64 134.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 t -58.0 139.63 54.09 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.802 0.728 . . . . 0.0 110.679 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -111.06 3.55 18.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.045 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.32 122.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.52 29.47 69.82 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.622 -1.099 . . . . 0.0 112.438 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -139.8 150.45 44.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.356 1.578 . . . . 0.0 110.958 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.28 108.35 2.54 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.506 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -102.83 171.85 7.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.363 1.865 . . . . 0.0 108.945 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -129.15 163.61 25.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.117 1.767 . . . . 0.0 107.256 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.479 HG22 HG22 ' A' ' 57' ' ' ILE . 21.9 p -135.39 117.4 15.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.396 0.544 . . . . 0.0 111.567 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -143.7 156.49 44.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.301 1.84 . . . . 0.0 107.386 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.5 m120 57.3 29.08 16.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.925 0.89 . . . . 0.0 112.018 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm 64.18 16.09 9.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.437 1.495 . . . . 0.0 110.57 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -120.1 177.97 4.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.993 1.717 . . . . 0.0 106.994 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 52' ' ' THR . 18.5 pt -115.63 149.55 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -145.84 155.73 43.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.096 1.771 . . . . 0.0 111.482 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.3 156.42 38.46 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -57.12 -50.61 72.27 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.197 1.362 . . . . 0.0 110.871 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -55.42 -24.91 33.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.516 1.126 . . . . 0.0 113.847 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.382 85.7 m -97.24 -17.07 20.06 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.572 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.02 -20.29 18.94 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.387 -1.229 . . . . 0.0 111.54 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 m -39.88 110.24 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.081 2.152 . . . . 0.0 113.518 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.36 -175.55 44.25 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 106.167 -2.773 . . . . 0.0 106.167 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.2 132.86 4.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -123.76 14.95 9.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.2 p -57.26 -34.07 68.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.021 0.928 . . . . 0.0 109.261 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -166.83 176.97 6.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.152 2.181 . . . . 0.0 107.801 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.7 mt -131.48 -43.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 129.791 3.237 . . . . 0.0 106.613 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.99 167.03 3.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.916 2.086 . . . . 0.0 111.977 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -98.23 175.43 29.53 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.29 10.99 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.883 3.055 . . . . 0.0 113.308 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.0 p -147.1 131.98 18.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.742 1.617 . . . . 0.0 107.483 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -146.06 135.63 23.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.894 0 N-CA-C 106.677 -2.569 . . . . 0.0 106.677 -179.263 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.851 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -146.02 91.21 2.05 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m -74.19 92.07 2.19 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.36 88.03 0.07 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 m -68.14 -16.07 63.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.14 1.776 . . . . 0.0 113.212 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.0 m -127.43 169.99 13.03 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.374 1.47 . . . . 0.0 107.301 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.16 -175.69 54.99 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 8.9 t -62.57 119.55 9.42 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.358 -1.782 . . . . 0.0 108.607 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.7 t -54.55 -25.84 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 121.113 1.779 . . . . 0.0 111.165 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.66 -1.77 58.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.294 1.837 . . . . 0.0 115.284 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 6.4 p -158.88 -2.54 0.08 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 121.235 1.834 . . . . 0.0 114.481 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 p 58.35 7.27 0.66 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.838 3.255 . . . . 0.0 114.071 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -70.38 136.68 86.36 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.11 122.67 10.5 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 123.066 2.51 . . . . 0.0 108.504 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.51 151.98 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.0 t -70.3 165.78 21.57 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.067 -1.021 . . . . 0.0 109.115 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.14 -140.41 6.32 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.764 1.173 . . . . 0.0 111.111 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 tt -75.53 71.34 2.45 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 123.468 1.604 . . . . 0.0 107.66 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.6 m -128.04 -5.16 5.6 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 127.067 2.147 . . . . 0.0 109.498 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.62 39.22 10.91 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.07 111.45 2.2 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.684 1.193 . . . . 0.0 108.564 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 108.25 12.45 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -145.67 165.16 29.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.744 1.617 . . . . 0.0 107.125 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.89 122.38 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 126.984 2.114 . . . . 0.0 106.202 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -106.05 106.79 17.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.97 139.85 38.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 48.86 43.92 21.74 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.379 0.672 . . . . 0.0 109.591 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 42.87 43.32 3.43 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.086 2.555 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 50.7 m -134.16 149.77 51.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.898 1.679 . . . . 0.0 108.712 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.07 118.81 32.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.419 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 2.7 m-90 -131.36 123.23 27.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -66.24 145.34 55.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -45.04 -54.76 6.27 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.422 1.489 . . . . 0.0 111.376 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -67.29 -17.57 64.83 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.09 17.55 20.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.73 101.39 12.78 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -139.48 165.05 28.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.95 113.59 2.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.077 1.751 . . . . 0.0 109.009 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.83 -24.92 21.26 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 120.167 1.349 . . . . 0.0 115.539 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -84.92 -20.33 30.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 114.762 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.71 -25.88 0.68 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.298 5.6 p 91.57 17.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.671 2.388 . . . . 0.0 115.596 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.47 143.72 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 120.582 -1.324 . . . . 0.0 108.043 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -59.35 140.65 55.89 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.821 0.848 . . . . 0.0 110.631 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.22 -1.01 10.35 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.252 1.421 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.1 t -49.69 115.93 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 126.33 1.852 . . . . 0.0 110.402 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -3.74 27.24 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.043 -1.421 . . . . 0.0 115.33 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -89.34 162.1 15.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.948 2.374 . . . . 0.0 110.179 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.87 1.54 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -85.38 171.88 11.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.916 0.887 . . . . 0.0 109.762 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.53 126.7 52.56 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.911 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -95.55 107.35 19.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.787 2.035 . . . . 0.0 110.15 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -144.17 155.04 43.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 44.99 46.18 9.05 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.173 1.389 . . . . 0.0 112.333 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.346 7.5 ptmm? 48.97 24.99 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.709 2.004 . . . . 0.0 114.321 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -127.23 177.94 6.36 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.977 1.711 . . . . 0.0 107.781 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.04 123.62 65.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 125.611 1.564 . . . . 0.0 110.984 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.42 152.01 51.03 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.948 0.88 . . . . 0.0 113.31 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.9 163.36 27.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -53.91 -55.87 22.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 110.854 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -55.28 -27.08 44.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.672 1.189 . . . . 0.0 113.468 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.91 -19.29 18.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.724 1.21 . . . . 0.0 113.077 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.49 -3.61 56.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.088 1.804 . . . . 0.0 112.015 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 t -68.72 177.39 2.54 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.741 1.217 . . . . 0.0 107.952 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.97 -65.72 0.09 OUTLIER Glycine 0 C--N 1.333 0.379 0 CA-C-O 119.176 -0.791 . . . . 0.0 112.269 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 23.1 mmt -104.78 88.67 2.96 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 117.794 0.797 . . . . 0.0 109.485 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.2 91.67 3.2 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -158.53 172.51 18.17 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.318 2.247 . . . . 0.0 108.231 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -82.13 -177.93 6.82 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 126.181 1.792 . . . . 0.0 111.033 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -85.19 167.72 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 120.867 -1.146 . . . . 0.0 109.469 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.7 t -117.24 7.69 13.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.653 1.181 . . . . 0.0 112.5 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.36 144.45 15.77 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.64 137.26 62.9 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.835 1.69 . . . . 0.0 110.043 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -164.42 179.34 6.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.655 1.582 . . . . 0.0 107.331 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.5 m -79.83 81.32 6.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 179.511 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.633 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -130.47 81.67 2.02 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.201 1.001 . . . . 0.0 108.398 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.6 t -82.99 -32.44 26.99 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.848 1.659 . . . . 0.0 109.553 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.78 -178.89 28.78 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 p -149.68 49.85 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.08 1.44 . . . . 0.0 114.401 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.6 p -107.48 68.5 0.72 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -111.97 -167.56 17.97 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.44 1.495 . . . . 0.0 112.627 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -71.48 109.58 5.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.858 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -43.73 -39.93 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 121.539 1.972 . . . . 0.0 111.743 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -8.47 53.11 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -156.96 -4.88 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.098 1.317 . . . . 0.0 114.326 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 p 62.92 8.01 2.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 130.815 3.646 . . . . 0.0 114.597 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -70.64 152.93 95.21 Favored Pre-proline 0 N--CA 1.468 0.454 0 O-C-N 120.38 -1.45 . . . . 0.0 109.892 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.24 127.63 16.15 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.84 1.694 . . . . 0.0 109.054 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.97 142.96 16.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.9 m -59.94 154.0 19.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.734 0.814 . . . . 0.0 109.898 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.08 -81.79 0.82 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.916 0.77 . . . . 0.0 111.333 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 tt -145.55 77.31 1.51 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.486 1.114 . . . . 0.0 108.343 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.7 t -129.67 20.22 5.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.985 0.914 . . . . 0.0 112.961 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.01 5.52 84.96 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.457 -1.191 . . . . 0.0 114.25 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.63 154.0 37.7 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.305 1.042 . . . . 0.0 109.336 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -103.43 117.24 34.02 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.118 0.967 . . . . 0.0 109.469 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -134.05 120.44 20.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 mm -83.46 152.73 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -130.01 107.02 9.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.671 1.588 . . . . 0.0 108.897 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -128.22 123.82 35.17 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.815 1.246 . . . . 0.0 108.803 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 50.69 15.48 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.264 1.026 . . . . 0.0 109.001 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 62.62 -6.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 127.57 2.348 . . . . 0.0 115.97 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.3 t -89.06 149.68 23.11 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -116.04 136.45 53.02 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.474 0.709 . . . . 0.0 111.548 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -130.26 138.56 50.58 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.776 1.23 . . . . 0.0 108.35 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -71.09 152.32 43.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -43.87 -62.48 1.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.751 1.22 . . . . 0.0 113.101 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 21.0 mp0 -61.34 -22.46 64.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.887 2.075 . . . . 0.0 114.164 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 m -90.5 -28.27 18.66 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.026 1.331 . . . . 0.0 112.725 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -72.09 101.73 2.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.456 1.48 . . . . 0.0 108.703 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 4.6 m-80 -139.87 164.02 31.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.294 1.038 . . . . 0.0 112.95 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 35.2 t -59.15 116.74 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 116.287 -1.816 . . . . 0.0 108.474 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.42 34.01 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 120.865 1.666 . . . . 0.0 114.132 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -84.93 -18.66 33.94 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 38' ' ' CYS . 0.8 OUTLIER -140.43 -13.74 1.0 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -177.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' HB3' ' A' ' 37' ' ' ASN 0.358 86.9 p 62.46 60.04 1.44 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.203 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 ' SG ' ' A' ' 41' ' ' CYS . 10.0 p -117.65 137.01 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -58.38 125.56 23.83 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 124.037 0.836 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.1 mt -101.91 14.71 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.172 1.389 . . . . 0.0 109.111 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.64 126.9 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.21 -49.77 1.55 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 126.049 1.785 . . . . 0.0 115.987 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -63.23 154.18 32.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.904 0.882 . . . . 0.0 112.238 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.09 161.59 54.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.59 163.29 36.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.935 1.294 . . . . 0.0 109.778 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.03 152.7 29.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.695 1.998 . . . . 0.0 106.573 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.3 p -129.77 123.16 30.32 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -144.17 154.72 43.44 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.583 0.753 . . . . 0.0 109.183 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 41.89 42.31 2.2 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.783 1.174 . . . . 0.0 111.649 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 62.42 7.12 2.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.552 1.941 . . . . 0.0 114.805 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -106.31 173.12 6.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.861 2.064 . . . . 0.0 111.088 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.8 135.12 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.588 1.955 . . . . 0.0 110.737 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -139.65 155.35 47.46 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 120.787 -1.195 . . . . 0.0 113.256 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 157.49 32.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -52.31 -54.47 31.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.241 1.017 . . . . 0.0 110.161 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -52.67 -46.35 67.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.124 0.875 . . . . 0.0 111.256 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.332 1.3 m -61.29 -41.27 96.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.381 0.992 . . . . 0.0 111.73 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.49 -4.14 89.42 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.582 1.083 . . . . 0.0 113.553 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t -70.55 92.29 0.83 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.326 1.85 . . . . 0.0 110.592 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.98 -162.52 28.34 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -151.13 150.23 30.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -102.37 115.77 31.25 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.85 161.13 27.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.428 0.691 . . . . 0.0 112.329 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -117.24 27.7 8.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.099 2.56 . . . . 0.0 112.13 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.2 mt -66.04 110.05 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.701 1.6 . . . . 0.0 107.543 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 m -62.32 -6.2 3.02 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.6 93.63 1.34 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.302 0.956 . . . . 0.0 111.442 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.32 150.65 71.15 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 119.559 1.679 . . . . 0.0 109.44 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 t -71.52 92.68 1.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 t -151.8 -175.21 5.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.039 1.736 . . . . 0.0 107.769 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.263 1.916 1 C-N-CA 133.132 5.158 . . . . 0.0 103.504 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.747 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 p -149.01 99.07 2.92 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -73.8 79.66 1.59 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.482 1.113 . . . . 0.0 110.297 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.83 169.98 20.7 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 123.756 0.693 . . . . 0.0 112.305 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -153.59 80.06 1.16 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.376 1.07 . . . . 0.0 110.204 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -53.02 -62.36 1.71 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.794 1.238 . . . . 0.0 111.933 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.98 -175.38 52.29 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.644 0.64 . . . . 0.0 113.063 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -58.61 112.36 1.58 Allowed 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 115.794 -2.051 . . . . 0.0 108.282 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.9 t -41.81 -36.33 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 122.312 2.324 . . . . 0.0 112.785 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.55 -13.93 58.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.77 -3.62 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 120.877 1.671 . . . . 0.0 115.431 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 m 59.49 8.03 1.12 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 130.18 3.392 . . . . 0.0 115.083 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -58.79 153.09 44.43 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 120.0 1.273 . . . . 0.0 110.315 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.0 122.9 9.21 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.82 1.68 . . . . 0.0 108.526 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mm -74.12 144.13 12.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -64.43 169.61 4.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.121 0.568 . . . . 0.0 110.842 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.12 -137.72 9.71 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.4 mt -76.08 80.32 2.92 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.676 0.79 . . . . 0.0 108.892 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 t -128.7 -16.35 4.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.51 1.124 . . . . 0.0 112.253 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.98 34.07 7.43 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 160.24 29.72 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -110.11 95.19 5.43 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -129.5 165.18 22.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.407 1.883 . . . . 0.0 108.675 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.0 mm -116.37 151.46 18.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 m -131.27 117.83 19.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -145.43 130.6 18.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 55.66 23.62 6.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 111.231 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . 0.272 2.3 m-20 72.49 -0.68 3.21 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 130.004 3.322 . . . . 0.0 113.482 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -81.8 164.01 21.96 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.02 135.15 51.95 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.382 -1.448 . . . . 0.0 114.153 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 3.6 m-90 -132.07 125.91 32.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -73.84 154.54 39.44 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -49.97 -55.08 16.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.598 1.09 . . . . 0.0 109.178 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -65.66 -3.28 4.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.97 1.708 . . . . 0.0 115.554 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . 0.282 1.7 m -119.31 -3.01 10.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.58 -1.676 . . . . 0.0 114.369 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -91.04 102.54 15.3 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.181 1.392 . . . . 0.0 108.583 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -154.12 172.13 18.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.5 122.81 18.05 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 117.019 -1.467 . . . . 0.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -27.1 65.12 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.762 1.164 . . . . 0.0 113.524 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -75.81 -20.51 58.14 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.17 -12.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.272 18.0 m 85.92 10.6 0.25 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.726 1.61 . . . . 0.0 115.119 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.67 131.95 32.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 m -56.63 136.09 54.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.552 1.141 . . . . 0.0 111.611 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.1 mt -103.21 -1.11 29.48 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.79 142.04 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 20.85 73.63 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.628 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -152.94 148.21 26.85 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.039 1.419 . . . . 0.0 109.768 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.0 152.71 44.3 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -135.73 171.65 14.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.92 1.36 . . . . 0.0 111.652 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.08 145.45 24.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.1 p -134.45 103.39 5.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.619 1.168 . . . . 0.0 109.47 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -140.58 152.36 45.41 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 53.23 17.15 0.94 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.05 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.3 mttt 86.56 -0.1 0.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 129.313 3.045 . . . . 0.0 112.282 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -89.55 -179.04 5.71 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.504 1.521 . . . . 0.0 109.619 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.0 pt -131.44 136.01 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.512 2.325 . . . . 0.0 106.509 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -148.56 157.26 43.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 123.126 1.441 . . . . 0.0 113.199 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 153.81 39.79 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -66.34 -38.38 87.5 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.918 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -54.24 -26.74 30.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.25 1.42 . . . . 0.0 113.916 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.0 m -97.29 -45.08 6.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.208 1.803 . . . . 0.0 109.123 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.03 11.4 57.54 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.99 153.69 24.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.969 1.385 . . . . 0.0 108.524 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.42 6.86 56.3 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.892 -0.949 . . . . 0.0 112.971 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.1 mtt -64.26 86.31 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.054 2.542 . . . . 0.0 112.749 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.19 66.09 6.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.144 2.577 . . . . 0.0 105.205 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.7 t -79.4 -3.04 44.52 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.2 170.83 9.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.881 0.764 . . . . 0.0 109.213 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.5 mt -79.19 84.83 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 101.449 -3.537 . . . . 0.0 101.449 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.5 t -98.58 -167.43 1.5 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 129.095 2.958 . . . . 0.0 110.443 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.21 -73.31 0.03 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.156 1.836 . . . . 0.0 108.987 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.18 78.74 2.19 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.162 3.241 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.3 p -61.49 -31.0 70.96 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 127.187 2.195 . . . . 0.0 111.601 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 4.82 81.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 131.367 3.867 . . . . 0.0 113.875 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 -179.656 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.643 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -66.49 168.22 9.46 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.492 0.717 . . . . 0.0 110.839 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.5 -61.0 1.29 Allowed 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.8 131.87 1.41 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -160.35 92.4 0.98 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -64.7 -61.0 2.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.82 -167.99 14.66 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 121.733 -0.604 . . . . 0.0 112.362 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.9 t -59.87 121.4 11.66 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 117.275 -1.345 . . . . 0.0 108.636 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -52.21 -29.76 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.727 1.148 . . . . 0.0 111.346 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.4 -4.05 59.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 p -153.48 -7.08 0.17 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.156 1.343 . . . . 0.0 114.084 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 54.02 37.83 27.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.435 2.294 . . . . 0.0 112.642 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -100.05 151.91 37.66 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.47 137.57 30.87 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 O-C-N 124.554 1.818 . . . . 0.0 108.55 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.94 121.22 60.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 t -58.64 -44.49 90.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.094 0.558 . . . . 0.0 110.48 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.74 -75.03 1.89 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 pp -45.36 -31.57 1.69 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.703 2.801 . . . . 0.0 114.974 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.8 t -67.76 -10.44 52.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.393 0.677 . . . . 0.0 110.604 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.95 37.29 13.17 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.34 147.71 20.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.228 1.411 . . . . 0.0 110.935 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -80.41 115.57 20.01 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.006 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.73 164.22 30.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.03 0.443 . . . . 0.0 111.85 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.2 mm -121.3 125.81 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.3 m -103.39 102.93 12.88 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -124.9 136.92 54.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 40.38 46.23 1.99 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.401 1.881 . . . . 0.0 112.697 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 51.05 35.63 13.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.075 1.75 . . . . 0.0 113.127 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -126.09 164.73 20.25 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 126.419 1.888 . . . . 0.0 107.206 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -109.73 131.57 54.94 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -132.21 133.14 43.82 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 108.324 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -73.76 147.1 43.81 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -49.21 -55.5 12.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.936 1.244 . . . . 0.0 110.189 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.92 -5.18 2.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.928 1.291 . . . . 0.0 113.994 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 m -118.65 -1.26 11.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 113.566 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -94.59 100.78 12.68 Favored 'General case' 0 N--CA 1.45 -0.46 1 N-CA-C 99.417 -4.29 . . . . 0.0 99.417 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 75.5 m-20 -145.59 164.3 32.13 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.709 -177.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.9 t -58.12 122.03 12.1 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 116.795 -1.574 . . . . 0.0 108.975 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.89 -25.56 30.82 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 123.985 0.803 . . . . 0.0 113.816 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -90.87 -18.37 24.93 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -143.87 -15.95 0.61 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 37' ' ' ASN 0.3 1.1 p 84.78 8.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.2 142.55 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 120.54 1.518 . . . . 0.0 110.158 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -64.81 105.16 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.514 1.925 . . . . 0.0 107.429 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.3 mt -88.54 -9.0 53.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.0 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.1 t -42.56 111.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.404 1.882 . . . . 0.0 112.4 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 12.51 63.02 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.28 -1.845 . . . . 0.0 117.304 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -110.39 167.73 9.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 121.432 2.616 . . . . 0.0 112.161 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 136.2 46.13 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -144.42 171.17 14.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.242 1.017 . . . . 0.0 110.905 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.42 160.66 33.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.954 0.902 . . . . 0.0 110.793 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 p -132.58 104.83 6.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.995 0.918 . . . . 0.0 109.653 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -142.37 152.45 42.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.18 31.89 7.3 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.499 1.52 . . . . 0.0 112.77 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.17 6.67 3.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.369 2.267 . . . . 0.0 113.014 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -108.53 176.84 4.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.698 1.599 . . . . 0.0 109.8 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -112.68 121.46 65.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.64 138.26 52.09 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 157.24 37.1 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -46.39 -54.43 9.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.353 1.061 . . . . 0.0 111.654 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -58.96 -31.33 68.63 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.1 -12.46 21.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 113.656 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.91 -24.31 20.49 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -81.16 99.29 8.47 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 101.91 -3.366 . . . . 0.0 101.91 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.96 -169.45 36.57 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 56.3 mtp 46.73 46.6 15.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.434 1.094 . . . . 0.0 110.835 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.98 44.08 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.668 2.787 . . . . 0.0 113.201 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.1 t -136.53 171.76 14.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.071 1.748 . . . . 0.0 108.566 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -138.06 8.19 2.72 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.088 2.155 . . . . 0.0 109.409 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.2 pt -135.9 151.61 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.292 1.037 . . . . 0.0 109.199 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.2 m -117.78 34.13 5.3 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.064 1.345 . . . . 0.0 109.27 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.73 95.99 1.02 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.06 -17.77 28.0 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.338 2.025 . . . . 0.0 112.833 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.7 p -158.67 171.19 20.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.846 2.458 . . . . 0.0 106.836 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 m -136.46 3.53 2.81 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.31 1.444 . . . . 0.0 110.908 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.635 1 C-N-CA 130.918 4.104 . . . . 0.0 105.717 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.36 -69.93 0.73 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 p -155.34 157.16 36.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.93 157.06 10.53 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.7 t -144.2 121.78 11.79 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 t -161.86 -71.15 0.06 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.2 162.3 43.58 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.095 -0.836 . . . . 0.0 112.955 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 t -44.61 120.47 2.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.824 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.03 -32.31 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 120.63 1.559 . . . . 0.0 110.685 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.92 2.66 37.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 p -166.24 -3.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 119.19 -2.194 . . . . 0.0 114.707 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.54 10.21 2.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.763 3.225 . . . . 0.0 114.238 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -67.36 145.66 98.55 Favored Pre-proline 0 N--CA 1.47 0.565 0 O-C-N 120.122 -1.611 . . . . 0.0 109.402 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 137.68 45.45 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 O-C-N 124.35 1.711 . . . . 0.0 109.149 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -87.98 157.09 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.719 1.608 . . . . 0.0 107.216 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m -70.75 -25.31 62.85 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.05 -118.65 7.63 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.287 0.949 . . . . 0.0 111.708 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 1.4 pt? -69.27 53.16 0.1 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.639 2.376 . . . . 0.0 115.524 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -130.05 -30.09 2.02 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.873 0.869 . . . . 0.0 111.491 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.12 0.33 25.36 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.336 0.969 . . . . 0.0 114.437 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.47 151.44 32.73 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.056 1.342 . . . . 0.0 113.093 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -80.2 120.37 24.21 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.004 0.921 . . . . 0.0 109.584 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -145.77 146.73 31.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mm -88.77 120.74 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 p -107.38 110.22 22.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -139.46 137.77 35.86 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 42.4 54.91 4.24 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.842 1.657 . . . . 0.0 112.114 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.92 13.89 0.61 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.851 1.661 . . . . 0.0 114.111 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -113.03 163.74 14.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.945 2.098 . . . . 0.0 108.949 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -120.95 131.94 54.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.938 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -124.61 138.28 54.32 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.113 1.365 . . . . 0.0 107.535 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -76.0 144.74 40.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.5 t -51.53 -51.53 54.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -61.9 -11.24 12.05 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 114.156 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.2 m -123.66 11.31 9.13 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.624 1.17 . . . . 0.0 113.382 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.99 101.16 13.19 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 101.231 -3.618 . . . . 0.0 101.231 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -141.35 168.82 18.86 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.89 121.04 13.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 116.424 -1.751 . . . . 0.0 108.287 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.82 -32.26 58.83 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 120.919 1.69 . . . . 0.0 113.45 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -82.67 -22.32 34.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.38 -7.92 1.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.393 83.7 p 66.64 29.94 8.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -86.9 147.07 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -58.06 134.96 56.88 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 111.484 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 mt -112.12 1.69 16.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.708 1.203 . . . . 0.0 110.818 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.82 107.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.342 2.657 . . . . 0.0 110.636 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.69 -17.57 3.44 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.968 1.747 . . . . 0.0 115.482 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 112.62 22.77 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -40.88 142.06 0.87 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.243 1.401 . . . . 0.0 111.149 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -135.66 170.55 15.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.04 162.12 13.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.287 1.435 . . . . 0.0 108.052 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 p -141.92 102.92 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -130.33 154.94 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 m120 48.95 36.02 7.7 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.852 1.261 . . . . 0.0 112.728 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm 55.76 21.76 4.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.491 1.116 . . . . 0.0 112.181 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -117.36 -178.54 3.48 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.165 1.786 . . . . 0.0 109.609 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 pt -123.34 122.7 65.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.805 1.642 . . . . 0.0 110.461 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -136.16 140.02 43.3 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.205 -0.934 . . . . 0.0 111.486 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.79 163.33 27.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -42.84 -62.79 0.92 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.226 1.81 . . . . 0.0 111.975 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -52.63 -41.03 63.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.877 0.871 . . . . 0.0 112.825 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.4 -46.99 58.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.551 0.614 . . . . 0.0 110.068 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.57 -3.01 46.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.987 0.803 . . . . 0.0 113.506 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 t -66.54 8.99 0.19 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.973 2.109 . . . . 0.0 112.588 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.98 68.75 3.44 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.0 tpt -71.71 127.83 33.84 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -63.57 8.28 0.08 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.119 1.368 . . . . 0.0 114.325 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -66.17 -31.18 71.87 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.014 1.326 . . . . 0.0 112.352 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -68.08 164.08 21.0 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.2 mt -38.34 117.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 128.78 2.832 . . . . 0.0 110.737 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 p -73.24 175.19 7.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.104 1.362 . . . . 0.0 110.813 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.39 171.15 47.49 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.46 130.82 31.36 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.465 2.11 . . . . 0.0 110.52 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 m -92.0 -158.09 0.56 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.399 1.479 . . . . 0.0 109.199 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.4 m -69.35 -2.8 11.83 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.292 -0.88 . . . . 0.0 111.361 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 1 C-N-CA 133.074 5.131 . . . . 0.0 105.213 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.049 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 p -124.86 167.02 15.23 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.361 1.08 . . . . 0.0 109.596 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 p -122.75 159.59 27.7 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.433 0.693 . . . . 0.0 109.943 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.24 10.45 86.2 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.469 -0.628 . . . . 0.0 112.88 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.7 p -70.92 30.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.736 1.614 . . . . 0.0 113.658 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.4 t -141.07 5.04 1.89 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.523 -1.361 . . . . 0.0 111.231 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.62 -166.92 37.58 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 119.551 1.069 . . . . 0.0 110.483 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.35 124.54 18.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.291 -1.814 . . . . 0.0 107.989 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -7.96 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 120.694 1.588 . . . . 0.0 112.319 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.28 4.96 25.19 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.026 1.73 . . . . 0.0 114.076 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 p -166.22 -4.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.286 61.6 p 54.83 12.83 0.63 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.6 3.16 . . . . 0.0 114.824 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.07 150.28 97.54 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.71 125.5 11.71 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.484 1.456 . . . . 0.0 108.665 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mm -68.32 148.19 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 135.97 45.45 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.29 -119.87 0.19 Allowed Glycine 0 CA--C 1.523 0.588 0 O-C-N 124.801 1.313 . . . . 0.0 111.763 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.67 69.78 6.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.105 0.962 . . . . 0.0 108.686 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 m -128.21 -4.39 5.55 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.71 2.404 . . . . 0.0 112.135 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.54 26.14 64.13 Favored Glycine 0 CA--C 1.535 1.304 0 O-C-N 120.343 -1.473 . . . . 0.0 114.005 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.72 158.56 33.98 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.237 1.015 . . . . 0.0 109.924 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -95.04 122.61 37.87 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -145.15 164.96 29.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.932 2.093 . . . . 0.0 107.177 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -115.15 139.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 p -130.89 120.08 23.11 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.475 1.51 . . . . 0.0 107.921 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -145.37 150.53 36.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.303 1.841 . . . . 0.0 106.526 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 36.04 50.52 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.111 2.165 . . . . 0.0 114.081 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t0 53.89 39.74 30.77 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 113.189 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' ' CZ3' ' A' ' 31' ' ' TRP . 27.6 t -134.22 164.71 26.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.07 1.748 . . . . 0.0 109.972 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -119.11 124.1 46.03 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.89 1.676 . . . . 0.0 111.605 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' A' ' 29' ' ' SER . 9.6 m-90 -130.71 123.99 30.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.796 1.284 . . . . 0.0 110.296 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -68.49 155.5 39.8 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -53.51 30.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.106 1.363 . . . . 0.0 112.589 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.1 -30.49 71.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.597 1.09 . . . . 0.0 113.607 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -84.81 0.08 52.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 117.416 -1.278 . . . . 0.0 113.457 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -98.77 100.5 11.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -155.85 170.28 22.45 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.0 115.42 4.05 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 115.713 -2.089 . . . . 0.0 106.493 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.11 -29.34 51.9 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 121.444 1.929 . . . . 0.0 112.902 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -75.55 -22.49 57.0 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.87 -13.9 0.83 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 118.621 2.823 . . . . 0.0 118.621 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.276 3.0 m 79.67 12.22 1.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.92 136.09 26.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.1 t -58.59 138.36 56.92 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.446 0.641 . . . . 0.0 109.87 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.47 2.04 20.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.577 1.551 . . . . 0.0 110.079 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.82 109.57 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.05 1.34 . . . . 0.0 110.441 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.19 -44.66 2.96 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.749 2.118 . . . . 0.0 113.409 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -64.76 160.93 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.854 1.327 . . . . 0.0 111.864 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.58 123.55 16.53 Favored Glycine 0 C--O 1.241 0.531 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -110.16 166.1 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.762 1.225 . . . . 0.0 109.561 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.82 147.98 47.12 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.45 103.82 6.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.956 1.302 . . . . 0.0 107.659 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -142.75 156.4 44.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 127.096 2.159 . . . . 0.0 106.441 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 57.86 21.68 7.83 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 62.81 23.08 13.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.045 1.338 . . . . 0.0 109.72 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -126.75 -178.84 4.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 127.443 2.297 . . . . 0.0 107.614 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 pt -130.56 134.5 62.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.986 0.898 . . . . 0.0 109.868 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -134.24 162.43 32.18 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 123.012 1.387 . . . . 0.0 114.138 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.23 161.51 23.93 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -54.16 -54.87 33.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.02 0.827 . . . . 0.0 111.08 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -56.41 -27.7 57.23 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.527 -1.358 . . . . 0.0 114.553 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 m -97.59 -18.4 18.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.612 1.165 . . . . 0.0 113.297 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.31 -23.85 10.05 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.815 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 t -57.83 117.64 4.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.823 1.649 . . . . 0.0 108.571 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.67 144.69 16.7 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 107.204 -2.358 . . . . 0.0 107.204 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.1 mtm -147.12 147.56 30.69 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -59.92 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.242 1.817 . . . . 0.0 110.671 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.91 160.02 22.2 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.135 1.774 . . . . 0.0 109.045 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -70.68 159.09 35.08 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 122.252 -0.28 . . . . 0.0 111.539 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.58 173.12 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.181 0.993 . . . . 0.0 110.221 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.2 t -73.85 0.91 11.83 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.21 100.49 0.34 Allowed Glycine 0 C--O 1.224 -0.493 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.39 20.57 0.1 OUTLIER 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 124.496 3.464 . . . . 0.0 115.61 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 t -80.27 67.32 6.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 t -116.95 78.42 1.21 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.245 0 C-N-CA 126.676 2.084 . . . . 0.0 108.168 -179.6 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.548 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t -159.63 171.71 19.1 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.765 0.826 . . . . 0.0 109.5 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 m -158.43 174.42 15.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.279 2.232 . . . . 0.0 107.46 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.63 165.28 14.53 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.587 1.089 . . . . 0.0 111.597 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -92.34 156.95 16.9 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.619 1.568 . . . . 0.0 110.724 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.4 t -69.78 139.37 53.24 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.23 -150.34 19.98 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 121.193 -0.942 . . . . 0.0 112.419 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 4.6 t -57.75 116.44 3.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.62 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.42 -14.0 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.783 0.833 . . . . 0.0 112.241 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.95 -0.71 38.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.368 1.467 . . . . 0.0 113.678 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -152.62 -11.21 0.17 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.792 -1.818 . . . . 0.0 114.917 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 2.9 p 49.91 53.51 12.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.615 1.966 . . . . 0.0 112.667 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -114.81 140.3 25.25 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.37 124.32 12.74 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.986 2.457 . . . . 0.0 110.454 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.74 135.76 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.007 1.723 . . . . 0.0 106.538 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t -78.59 178.81 7.52 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.966 0.907 . . . . 0.0 109.816 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.25 179.56 53.17 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.2 10.32 0.12 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.508 1.523 . . . . 0.0 112.734 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 t -69.84 22.72 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.36 2.264 . . . . 0.0 112.575 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.95 2.4 23.7 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 125.404 1.478 . . . . 0.0 111.875 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 100.67 12.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.926 1.863 . . . . 0.0 106.515 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -73.47 131.7 42.09 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.29 164.57 31.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.482 1.513 . . . . 0.0 109.495 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.73 102.12 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.364 1.465 . . . . 0.0 109.061 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.3 m -82.19 114.67 20.86 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -145.83 147.7 32.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.279 0.945 . . . . 0.0 108.638 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 36.96 58.08 1.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.096 1.759 . . . . 0.0 111.537 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 p30 48.62 25.03 0.87 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.105 1.762 . . . . 0.0 114.968 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 t -128.49 165.46 20.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 127.911 2.484 . . . . 0.0 108.524 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.9 109.77 11.54 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.516 -0.74 . . . . 0.0 110.632 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -103.54 150.96 23.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.343 1.068 . . . . 0.0 108.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' A' ' 8' ' ' CYS . 25.9 m170 -82.5 152.5 26.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -57.52 -37.02 72.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.781 1.173 . . . . 0.0 108.923 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.8 -17.4 63.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 112.763 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.45 27.82 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -113.1 100.31 8.51 Favored 'General case' 0 C--O 1.237 0.436 1 N-CA-C 99.023 -4.436 . . . . 0.0 99.023 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -145.38 173.11 12.28 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.16 107.39 1.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.457 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.2 -31.34 26.5 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 119.57 1.077 . . . . 0.0 115.413 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -77.4 -23.86 50.59 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.42 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -135.26 -23.68 1.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -178.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t 74.37 85.13 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.632 1.573 . . . . 0.0 109.909 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.42 HG12 ' SG ' ' A' ' 41' ' ' CYS . 11.1 p -151.57 136.59 10.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 129.872 3.269 . . . . 0.0 104.682 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -54.54 146.45 16.31 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.659 1.219 . . . . 0.0 113.045 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -120.01 1.94 10.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 109.098 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.36 103.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 125.659 1.583 . . . . 0.0 107.178 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 5.89 86.87 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.272 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -112.86 87.7 2.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.249 1.524 . . . . 0.0 107.969 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -20.67 109.79 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 128.501 2.953 . . . . 0.0 113.139 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -111.14 165.02 12.25 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.378 1.071 . . . . 0.0 112.752 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.9 mp -105.58 151.15 24.69 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.913 1.685 . . . . 0.0 107.734 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -124.4 109.05 12.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.103 1.361 . . . . 0.0 108.677 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -142.49 152.76 43.01 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m120 45.78 32.52 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.479 1.912 . . . . 0.0 111.354 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.06 -9.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.782 2.833 . . . . 0.0 112.813 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.97 -176.02 5.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.971 2.108 . . . . 0.0 110.747 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.05 126.18 21.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 127.619 2.368 . . . . 0.0 110.589 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -139.58 155.77 47.27 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.464 -1.397 . . . . 0.0 113.689 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.17 154.67 41.64 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.554 ' HA ' HD13 ' A' ' 51' ' ' LEU . 25.2 tm0? -53.15 -51.69 61.16 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.248 1.019 . . . . 0.0 111.283 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -52.54 -46.06 66.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.018 1.281 . . . . 0.0 111.272 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.5 m -65.45 -47.03 77.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.469 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -17.08 73.43 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.041 0.837 . . . . 0.0 112.743 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t -85.59 63.63 8.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.229 1.412 . . . . 0.0 108.44 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.25 175.54 22.71 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 124.891 1.234 . . . . 0.0 110.058 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.0 ptm -71.64 119.94 16.52 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -65.83 130.04 41.87 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.2 p -133.24 -27.25 1.61 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -85.52 87.66 7.42 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 120.426 1.467 . . . . 0.0 107.249 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.6 pt -69.73 -4.87 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 118.096 -0.955 . . . . 0.0 112.379 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.6 p -79.42 143.8 34.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 120.113 1.324 . . . . 0.0 111.049 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 148.33 92.7 0.11 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-O 118.575 -1.125 . . . . 0.0 111.172 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.98 164.21 36.53 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 119.977 1.888 . . . . 0.0 109.89 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 m -86.19 116.02 24.12 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.1 m -135.95 164.72 27.33 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 N-CA-C 107.333 -2.307 . . . . 0.0 107.333 178.731 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.486 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -102.66 170.29 8.11 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.307 1.043 . . . . 0.0 110.965 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.92 135.82 1.45 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.943 1.697 . . . . 0.0 107.06 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.14 91.06 1.69 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 105.866 -2.894 . . . . 0.0 105.866 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.8 m -71.63 61.29 0.36 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.342 1.857 . . . . 0.0 111.844 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.38 125.99 28.4 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 121.447 -0.783 . . . . 0.0 109.579 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.08 -177.24 17.63 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.268 1.413 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.8 125.3 24.39 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 116.732 -1.604 . . . . 0.0 107.39 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -57.94 -27.28 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 120.841 1.655 . . . . 0.0 109.015 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.22 12.12 14.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.982 2.913 . . . . 0.0 116.831 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -171.7 -7.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 118.609 -2.557 . . . . 0.0 114.229 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 58.28 9.85 1.13 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.644 2.778 . . . . 0.0 114.658 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -72.74 154.92 91.19 Favored Pre-proline 0 CA--C 1.517 -0.299 0 O-C-N 120.868 -1.145 . . . . 0.0 110.662 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.61 146.34 84.18 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.364 2.042 . . . . 0.0 108.871 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.4 mt -109.32 122.0 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.772 2.429 . . . . 0.0 106.772 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m -112.18 114.33 27.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.494 1.118 . . . . 0.0 108.603 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.64 89.16 0.49 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 105.278 -3.129 . . . . 0.0 105.278 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.5 tp -156.99 -50.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.661 1.584 . . . . 0.0 109.526 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 m -73.81 -23.23 59.64 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.357 -0.839 . . . . 0.0 110.486 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.62 36.13 1.47 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.924 1.249 . . . . 0.0 112.01 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.12 118.78 8.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.098 0.959 . . . . 0.0 109.264 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -65.8 132.08 47.85 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.28 165.35 28.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 111.297 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -128.99 146.28 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.808 1.643 . . . . 0.0 107.765 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -132.81 119.06 19.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.75 143.89 48.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 37.2 56.14 1.31 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.07 1.748 . . . . 0.0 114.178 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t0 55.14 24.59 6.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.678 1.191 . . . . 0.0 112.806 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 14.7 m -127.69 131.49 49.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.777 1.631 . . . . 0.0 109.949 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -90.73 130.28 36.74 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.393 0.677 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 2.6 m-90 -131.09 133.32 45.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.501 1.143 . . . . 0.0 110.873 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.39 154.35 41.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 p -61.22 -36.24 79.39 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -74.07 4.25 5.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.746 1.618 . . . . 0.0 113.12 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -139.97 21.75 2.45 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.445 1.021 . . . . 0.0 113.002 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -109.34 99.76 8.96 Favored 'General case' 0 C--O 1.237 0.443 1 N-CA-C 98.356 -4.683 . . . . 0.0 98.356 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -152.63 176.16 12.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.8 t -59.69 111.64 1.51 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.891 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.82 13.22 0.09 OUTLIER Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.165 1.84 . . . . 0.0 115.348 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -128.03 -18.64 4.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.411 2.684 . . . . 0.0 112.757 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 -17.43 0.82 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 m 84.36 1.43 0.87 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.224 1.81 . . . . 0.0 115.463 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.81 126.44 28.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 t -52.05 142.81 15.22 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.475 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -115.81 -2.5 12.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.809 1.244 . . . . 0.0 110.924 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.17 126.12 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.647 0.779 . . . . 0.0 109.356 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.36 69.48 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.016 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -131.45 167.25 19.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 121.128 2.464 . . . . 0.0 112.547 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.97 127.73 33.45 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.01 171.49 14.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.732 1.213 . . . . 0.0 110.015 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.7 mp -121.52 156.55 32.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.885 1.674 . . . . 0.0 109.188 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 p -137.45 102.59 4.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.28 147.64 47.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 108.757 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.7 m120 52.81 23.78 2.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.775 2.03 . . . . 0.0 114.322 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? 78.61 12.4 1.52 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.043 2.137 . . . . 0.0 111.784 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -105.78 -178.39 3.64 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.748 -1.22 . . . . 0.0 109.4 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -128.45 122.17 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.714 1.606 . . . . 0.0 108.395 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -138.08 157.28 46.65 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 123.111 1.434 . . . . 0.0 114.794 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.45 155.52 37.93 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.539 ' HA ' HD13 ' A' ' 51' ' ' LEU . 12.6 tt0 -47.26 -52.92 14.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.765 0.711 . . . . 0.0 111.557 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -58.57 7.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.534 0.734 . . . . 0.0 112.171 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.11 -23.11 44.71 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.619 -1.181 . . . . 0.0 113.728 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.36 -24.13 10.53 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 120.213 1.37 . . . . 0.0 112.355 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.0 t -86.95 89.07 7.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.93 87.32 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.3 mmt -78.45 89.18 4.42 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -81.11 71.61 8.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 p -128.54 71.24 1.39 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.775 1.23 . . . . 0.0 110.975 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.52 -11.61 59.12 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.797 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.8 mt -67.01 92.53 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 129.348 3.059 . . . . 0.0 106.913 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.3 t -150.8 165.06 34.68 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.718 1.207 . . . . 0.0 108.609 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.25 65.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.464 2.459 . . . . 0.0 107.952 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.91 166.78 26.63 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.483 2.122 . . . . 0.0 111.609 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.4 p -144.4 177.9 8.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.709 1.604 . . . . 0.0 108.351 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.5 t -79.29 -178.35 6.17 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.263 1.911 1 C-N-CA 133.197 5.189 . . . . 0.0 103.458 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.983 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -71.78 97.94 1.87 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.8 m -144.55 168.6 19.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.402 1.481 . . . . 0.0 109.174 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.47 -6.49 57.51 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 117.769 -1.573 . . . . 0.0 116.444 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 p -172.35 111.21 0.26 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-N 120.442 2.121 . . . . 0.0 111.579 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.1 m -61.2 126.96 29.24 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.99 -174.0 32.37 Favored Glycine 0 N--CA 1.446 -0.681 0 O-C-N 121.761 -0.587 . . . . 0.0 112.552 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 11.6 t -61.89 126.04 25.94 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.89 -20.23 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 119.336 0.971 . . . . 0.0 111.493 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.73 3.62 45.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 115.487 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -155.94 -9.69 0.11 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.023 -1.673 . . . . 0.0 113.723 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m 53.38 29.06 8.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.533 1.933 . . . . 0.0 111.675 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -89.41 151.09 45.82 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.802 -1.186 . . . . 0.0 108.178 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 118.37 5.64 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.273 1.982 . . . . 0.0 110.027 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mm -65.29 162.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.514 1.526 . . . . 0.0 107.632 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.32 147.34 37.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.83 -21.67 0.63 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.554 1.55 . . . . 0.0 113.065 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.34 -46.71 83.0 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.431 2.115 . . . . 0.0 109.02 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.3 m -73.44 7.43 2.32 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.578 1.951 . . . . 0.0 112.17 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.9 38.12 82.46 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 120.367 -1.458 . . . . 0.0 111.679 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 141.45 58.04 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.161 0.584 . . . . 0.0 111.898 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -72.74 110.32 6.99 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.348 1.059 . . . . 0.0 111.939 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -142.32 164.51 29.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.558 1.943 . . . . 0.0 106.644 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.59 130.34 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.234 1.814 . . . . 0.0 106.427 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.7 124.11 38.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.05 122.56 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 40.92 59.02 2.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.998 1.719 . . . . 0.0 112.848 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 63.66 12.23 6.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.265 2.226 . . . . 0.0 114.913 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 158.51 28.79 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.547 -1.346 . . . . 0.0 110.629 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.24 133.26 56.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.588 0.709 . . . . 0.0 110.855 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -123.88 126.8 47.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -67.08 148.79 51.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.11 -51.64 23.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.098 0.863 . . . . 0.0 112.438 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.22 -13.33 61.87 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -102.64 -12.68 17.53 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -80.43 101.52 9.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.24 168.57 19.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.2 t -65.23 114.91 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 116.663 -1.637 . . . . 0.0 110.049 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.82 -18.62 25.96 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.498 1.045 . . . . 0.0 115.528 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.13 -17.37 23.85 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.0 -20.21 0.5 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 118.601 2.815 . . . . 0.0 118.601 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 m 77.14 80.54 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.536 1.062 . . . . 0.0 109.888 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.64 141.57 18.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 126.832 2.053 . . . . 0.0 105.749 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -58.56 121.7 11.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.79 1.306 . . . . 0.0 113.626 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.4 mt -99.37 1.73 44.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.072 0.949 . . . . 0.0 109.659 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.68 140.71 19.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 -62.19 3.84 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.252 1.406 . . . . 0.0 112.777 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 164.81 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.849 0.859 . . . . 0.0 112.494 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.3 156.44 39.39 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.433 ' C ' HD12 ' A' ' 51' ' ' LEU . 30.9 p90 -137.93 168.48 19.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.586 1.154 . . . . 0.0 107.946 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.433 HD12 ' C ' ' A' ' 50' ' ' PHE . 6.8 mp -122.61 161.01 24.56 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.7 p -127.41 115.82 19.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.247 1.419 . . . . 0.0 107.607 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -143.17 150.59 39.6 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 51.39 24.72 2.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.896 1.678 . . . . 0.0 114.107 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt 73.79 9.99 4.76 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.751 2.02 . . . . 0.0 111.277 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -110.68 -178.01 3.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.06 2.144 . . . . 0.0 110.136 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.3 pt -123.96 126.99 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.892 0.877 . . . . 0.0 110.465 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -130.28 163.32 27.04 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.468 -1.395 . . . . 0.0 113.254 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.21 156.98 19.44 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -57.36 -47.05 82.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 119.257 0.935 . . . . 0.0 110.136 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -52.25 -37.43 55.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.75 -1.219 . . . . 0.0 113.541 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.77 -35.6 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.234 1.014 . . . . 0.0 110.622 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.79 33.32 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.104 1.335 . . . . 0.0 110.005 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -64.99 141.21 58.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 118.783 1.291 . . . . 0.0 110.739 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.22 178.2 20.86 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 69.1 mtm -88.11 -27.74 21.73 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.013 0.525 . . . . 0.0 109.688 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.05 33.98 13.1 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.414 1.885 . . . . 0.0 111.615 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 t -160.36 176.51 11.6 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.595 2.358 . . . . 0.0 104.882 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 35.02 48.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 127.999 2.519 . . . . 0.0 113.623 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.565 HD12 ' H ' ' A' ' 70' ' ' ILE . 3.9 mp -61.97 -18.7 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.472 1.509 . . . . 0.0 110.892 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 m -157.81 118.57 3.48 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.041 -1.662 . . . . 0.0 109.002 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.94 173.24 15.01 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.747 1.642 . . . . 0.0 109.795 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.09 43.8 1.46 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.489 3.46 . . . . 0.0 112.279 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.9 m 54.67 41.79 31.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.499 1.12 . . . . 0.0 111.029 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.6 m -50.57 -36.19 33.46 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.463 2.305 . . . . 0.0 115.465 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -179.552 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.65 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.3 m -60.97 126.3 26.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 117.378 0.589 . . . . 0.0 109.426 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -52.14 138.51 25.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.626 1.17 . . . . 0.0 110.41 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.09 116.94 9.46 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 124.432 1.015 . . . . 0.0 111.636 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -31.93 72.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.248 1.019 . . . . 0.0 111.743 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -168.33 169.27 10.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.715 2.006 . . . . 0.0 107.256 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.67 -167.53 42.62 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 115.325 0.89 . . . . 0.0 115.325 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 15.0 t -50.52 117.28 2.34 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.582 -1.199 . . . . 0.0 107.948 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -54.97 -27.34 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 120.94 1.7 . . . . 0.0 110.83 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.86 -3.69 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.673 1.989 . . . . 0.0 115.175 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -152.62 -10.25 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.446 1.476 . . . . 0.0 114.24 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m 60.3 10.32 2.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.517 3.527 . . . . 0.0 115.642 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -75.67 151.54 84.84 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 120.911 1.687 . . . . 0.0 112.403 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -66.94 139.43 51.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.817 2.344 . . . . 0.0 109.019 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.76 156.71 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.415 2.286 . . . . 0.0 108.68 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -98.13 -9.3 26.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.321 1.049 . . . . 0.0 111.146 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.02 -122.41 11.7 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.017 1.77 . . . . 0.0 112.813 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.9 mt -53.22 -16.17 1.16 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.629 1.972 . . . . 0.0 114.293 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 m -66.89 -8.89 32.44 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.103 0.961 . . . . 0.0 110.279 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.8 28.91 2.78 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.33 1.443 . . . . 0.0 113.053 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.64 147.05 37.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.343 1.071 . . . . 0.0 108.279 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -86.0 82.0 8.28 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -130.83 164.58 24.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.51 0.724 . . . . 0.0 111.077 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 mm -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 128.837 2.855 . . . . 0.0 105.932 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.34 102.96 15.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -135.49 127.22 29.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.403 1.002 . . . . 0.0 110.632 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 50.24 45.44 25.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.38 1.072 . . . . 0.0 109.227 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.91 -17.55 0.25 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 129.735 3.214 . . . . 0.0 114.325 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 m -73.64 164.53 26.52 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.133 0.879 . . . . 0.0 109.3 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -128.95 107.73 9.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -109.05 125.57 52.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 111.12 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -60.47 150.08 32.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -55.33 -42.42 73.77 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.72 -3.82 20.56 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.2 -1.46 11.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 128.959 2.904 . . . . 0.0 113.909 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.98 102.57 15.14 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -152.77 174.59 13.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.27 120.47 11.63 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 117.264 -1.35 . . . . 0.0 110.075 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.14 -12.27 29.8 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.627 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.37 -19.67 16.18 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.52 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -141.98 -10.59 0.88 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 81.11 1.22 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.52 HG12 ' SG ' ' A' ' 41' ' ' CYS . 11.8 p -65.23 138.9 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.218 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -55.33 134.25 50.01 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.313 1.045 . . . . 0.0 111.773 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 mt -117.99 4.75 12.09 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.69 -1.148 . . . . 0.0 109.695 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 46' ' ' VAL . 22.9 t -36.76 103.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.482 1.913 . . . . 0.0 112.525 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 -25.17 0.9 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 129.064 3.221 . . . . 0.0 115.928 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -55.0 138.27 44.21 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.662 1.985 . . . . 0.0 112.128 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.14 121.73 27.14 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -116.36 172.6 7.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.866 2.067 . . . . 0.0 111.719 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.01 148.12 33.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.0 p -126.52 117.26 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.11 143.93 32.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 50.6 28.74 3.64 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.981 1.264 . . . . 0.0 113.958 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm 64.85 22.72 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.734 1.214 . . . . 0.0 111.145 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -110.2 178.57 4.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.129 2.172 . . . . 0.0 106.751 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.81 122.95 55.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 109.532 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -131.55 154.58 48.67 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 122.893 1.33 . . . . 0.0 113.197 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 164.51 19.75 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -59.02 -54.44 47.1 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.925 0.784 . . . . 0.0 111.135 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -50.52 -30.18 12.33 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.4 m -93.96 -30.72 14.6 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.231 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.55 7.53 59.67 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.96 1.255 . . . . 0.0 115.356 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -53.53 -38.64 63.98 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.455 1.628 . . . . 0.0 113.276 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.04 178.22 30.25 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.5 ptp -132.02 169.55 16.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -143.71 58.85 1.38 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.5 p -75.67 -11.33 59.98 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.963 1.305 . . . . 0.0 111.616 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -67.94 163.47 22.05 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.1 mt 53.52 54.94 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -70.54 92.58 0.85 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.27 2.228 . . . . 0.0 108.254 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.43 113.1 0.24 Allowed Glycine 0 CA--C 1.531 1.041 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.39 47.05 1.96 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 123.726 2.951 . . . . 0.0 112.102 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.2 m -142.79 142.44 31.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.97 2.908 . . . . 0.0 106.518 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.1 m -91.12 86.98 6.37 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 CA-C-O 117.931 -1.483 . . . . 0.0 110.052 -179.831 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.896 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -142.03 -174.12 4.01 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.985 -0.715 . . . . 0.0 110.76 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 t 65.19 10.61 6.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.065 1.746 . . . . 0.0 113.73 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.84 175.75 19.86 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.967 1.258 . . . . 0.0 111.634 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 m -114.06 164.7 13.48 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.531 1.133 . . . . 0.0 110.498 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 m -146.97 156.63 43.2 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.761 1.225 . . . . 0.0 109.225 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.87 178.3 52.31 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.103 1.335 . . . . 0.0 112.743 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 12.4 t -52.13 115.38 1.68 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.737 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 29' ' ' SER . 80.2 t -54.94 -24.36 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 121.287 1.858 . . . . 0.0 112.481 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.96 -0.57 56.81 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.666 1.186 . . . . 0.0 113.841 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.8 p -156.71 -11.37 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.268 1.849 . . . . 0.0 115.075 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t 52.44 57.63 6.23 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.004 2.522 . . . . 0.0 111.598 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -117.84 147.11 40.46 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.883 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.55 114.03 2.94 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.013 3.142 . . . . 0.0 113.537 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -82.95 162.09 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -64.71 154.2 37.38 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 120.69 -1.256 . . . . 0.0 110.657 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.5 54.33 3.25 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 124.563 1.078 . . . . 0.0 114.524 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mp 58.98 5.53 0.53 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.839 2.456 . . . . 0.0 115.875 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 t -67.33 17.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 127.483 2.313 . . . . 0.0 115.87 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.64 22.73 5.31 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 119.624 -1.922 . . . . 0.0 113.859 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.73 161.02 30.02 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.737 -0.861 . . . . 0.0 109.712 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -104.2 100.92 10.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.39 165.72 26.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.544 1.938 . . . . 0.0 109.294 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mm -116.52 150.37 18.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -131.38 135.08 46.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -145.21 111.38 5.61 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.43 56.81 6.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.143 0.973 . . . . 0.0 109.682 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 -16.89 0.09 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 130.013 3.325 . . . . 0.0 115.191 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' HG21 ' A' ' 9' ' ' VAL . 72.7 m -80.08 145.64 32.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -119.87 141.69 49.34 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.976 0.893 . . . . 0.0 112.528 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.8 m-90 -132.86 162.9 30.33 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.145 1.378 . . . . 0.0 111.143 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -79.78 148.43 31.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.4 t -60.55 -8.94 3.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.728 2.011 . . . . 0.0 115.042 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.96 -36.74 5.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.001 1.721 . . . . 0.0 108.83 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.26 18.28 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.866 1.667 . . . . 0.0 114.913 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -113.2 101.35 9.34 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -148.57 174.72 11.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -61.19 121.05 11.56 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.503 1.521 . . . . 0.0 109.779 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.49 -25.75 58.55 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 118.133 0.424 . . . . 0.0 113.069 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -87.45 -18.8 29.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.63 -9.92 0.41 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 119.082 2.993 . . . . 0.0 119.082 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 83.44 3.23 0.94 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.37 133.69 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.445 1.475 . . . . 0.0 107.303 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.0 t -57.36 144.67 35.2 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.684 0.754 . . . . 0.0 109.852 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.21 -6.56 14.1 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.325 . . . . 0.0 110.197 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.82 120.24 10.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.73 84.83 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 116.163 -2.465 . . . . 0.0 115.923 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -135.21 169.47 17.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.635 2.717 . . . . 0.0 112.204 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.25 123.54 25.92 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -116.62 167.88 10.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.19 159.81 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.8 p -132.3 112.06 11.9 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.919 0.762 . . . . 0.0 109.504 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -142.7 156.12 44.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.632 1.573 . . . . 0.0 107.341 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.9 m120 52.5 30.73 8.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.349 1.06 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.7 27.43 14.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.03 1.332 . . . . 0.0 110.708 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -125.63 175.55 7.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.192 2.197 . . . . 0.0 110.24 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.39 126.4 69.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 127.715 2.406 . . . . 0.0 110.021 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -134.03 163.52 29.37 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 161.2 16.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -50.23 -56.39 11.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.772 1.229 . . . . 0.0 111.215 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -49.8 -33.63 17.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 113.249 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.2 -54.85 5.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.369 0.668 . . . . 0.0 109.319 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.72 26.62 4.62 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 115.621 1.008 . . . . 0.0 115.621 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.16 29.39 0.08 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.578 1.689 . . . . 0.0 112.776 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.21 -172.63 30.94 Favored Glycine 0 CA--C 1.522 0.525 0 O-C-N 120.804 -1.185 . . . . 0.0 111.458 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -71.25 168.16 17.89 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.332 2.253 . . . . 0.0 110.34 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -81.95 60.42 4.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.222 1.011 . . . . 0.0 110.532 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.3 p -64.15 98.3 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.654 1.582 . . . . 0.0 110.118 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -153.75 150.58 28.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.4 mm -84.25 88.11 2.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 m -58.78 155.42 12.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.935 0.398 . . . . 0.0 110.452 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.09 -176.66 14.62 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.85 -14.3 43.25 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.179 1.919 . . . . 0.0 112.44 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.4 m -63.68 98.92 0.2 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.667 1.187 . . . . 0.0 109.518 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 t -124.09 -177.0 3.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.375 1.87 . . . . 0.0 110.464 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.425 0 C-N-CA 126.412 1.958 . . . . 0.0 108.918 179.844 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.997 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -43.0 118.49 1.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 116.197 -1.859 . . . . 0.0 110.423 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.15 -31.36 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 121.753 2.069 . . . . 0.0 112.025 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.68 -5.37 59.31 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -157.95 -7.66 0.08 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 0.1 OUTLIER 61.77 14.34 6.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 130.164 3.386 . . . . 0.0 114.914 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -78.25 147.04 71.97 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 120.453 -1.404 . . . . 0.0 108.646 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.16 120.32 6.93 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.259 2.639 . . . . 0.0 110.07 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mm -66.53 140.45 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.237 0.419 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.58 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.9 tttm . . . . . 0 C--O 1.237 0.433 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -134.43 164.28 27.8 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.499 0.72 . . . . 0.0 110.514 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mm -122.43 145.96 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 127.271 2.229 . . . . 0.0 106.283 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -126.83 102.82 7.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -121.95 127.62 50.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 52.85 43.59 31.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.968 0.907 . . . . 0.0 108.781 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 56.91 0.51 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.007 2.523 . . . . 0.0 114.41 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 m -85.39 156.46 20.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.932 1.693 . . . . 0.0 107.831 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.99 130.31 51.63 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -132.3 145.09 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.647 1.179 . . . . 0.0 109.026 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -98.39 161.26 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 p -53.09 -55.02 27.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.938 0.895 . . . . 0.0 111.651 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.29 -4.05 9.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.054 1.341 . . . . 0.0 112.98 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.48 14.87 11.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.911 1.284 . . . . 0.0 113.298 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -107.41 101.3 10.67 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -157.2 167.04 31.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.4 t -64.86 120.83 13.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 117.111 -1.423 . . . . 0.0 109.799 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.04 -28.66 58.56 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.917 1.235 . . . . 0.0 114.396 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -81.04 -19.86 42.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.6 p -139.71 -23.05 0.87 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t 87.76 7.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.356 1.863 . . . . 0.0 114.467 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.94 135.23 27.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -60.21 132.34 53.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -98.21 -1.6 41.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 108.946 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.06 109.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 -65.93 0.31 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 126.069 1.795 . . . . 0.0 109.072 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -66.65 157.08 33.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.049 0.94 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.06 20.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -106.59 168.77 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.215 1.006 . . . . 0.0 109.187 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.95 152.28 42.66 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.868 1.667 . . . . 0.0 108.365 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 p -134.23 114.85 13.49 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.535 1.134 . . . . 0.0 110.6 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.446 ' HG2' HD22 ' A' ' 54' ' ' ASN . 31.8 tt0 -142.64 143.23 32.28 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.622 1.569 . . . . 0.0 106.907 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.446 HD22 ' HG2' ' A' ' 53' ' ' GLN . 8.8 m-80 53.76 25.32 5.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.873 0.869 . . . . 0.0 111.493 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt 73.15 3.61 4.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.119 1.768 . . . . 0.0 111.127 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.7 153.18 18.41 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.289 1.436 . . . . 0.0 109.825 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.75 122.46 55.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 109.931 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -137.13 166.49 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.795 1.283 . . . . 0.0 111.848 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.24 163.6 19.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -55.74 -55.51 31.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.052 1.341 . . . . 0.0 111.306 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -52.71 -48.87 66.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.361 -0.837 . . . . 0.0 112.886 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 m -68.62 -44.59 73.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.349 0.66 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 22.59 7.65 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 120.939 -1.1 . . . . 0.0 113.759 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 CA--C 1.53 0.178 0 CA-C-N 119.369 1.585 . . . . 0.0 107.441 179.325 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.522 0 N-CA-C 115.149 0.82 . . . . 0.0 115.149 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.6 t -60.71 113.56 2.54 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 117.243 -1.36 . . . . 0.0 110.21 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.6 t -57.83 -20.36 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 120.091 1.314 . . . . 0.0 110.438 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.6 -3.76 58.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.072 1.349 . . . . 0.0 114.078 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 p -155.44 -10.53 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.408 1.913 . . . . 0.0 115.673 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m 55.17 53.32 10.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.331 2.252 . . . . 0.0 112.589 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -113.7 137.3 22.18 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 108.61 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.92 3.08 . . . . 0.0 110.113 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.44 129.83 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 122.69 0.396 . . . . 0.0 111.819 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.286 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -137.89 166.77 23.23 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.406 1.882 . . . . 0.0 109.991 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.2 mm -125.25 114.87 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 p -104.41 117.29 33.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.139 1.776 . . . . 0.0 107.525 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -145.58 143.48 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.209 1.004 . . . . 0.0 109.218 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 31.52 60.37 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.872 2.469 . . . . 0.0 114.372 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 65.19 5.36 3.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.916 2.487 . . . . 0.0 114.972 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -116.09 161.85 18.3 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 0.0 111.079 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -125.72 141.1 52.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.462 1.125 . . . . 0.0 110.168 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -132.58 152.42 51.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.225 1.41 . . . . 0.0 109.555 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -86.15 141.57 29.27 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.67 -55.79 4.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.021 1.328 . . . . 0.0 111.071 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -65.56 -12.68 55.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -118.15 16.56 14.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.411 0.685 . . . . 0.0 111.869 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -106.92 101.56 10.99 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.88 176.34 12.28 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.9 t -58.11 118.93 5.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 117.088 -1.434 . . . . 0.0 109.731 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.07 -11.51 12.23 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 123.968 0.793 . . . . 0.0 114.787 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -102.74 -21.52 14.06 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.093 1.357 . . . . 0.0 114.595 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.68 -14.21 0.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.993 2.59 . . . . 0.0 117.993 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 t 81.62 27.46 0.18 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.833 1.652 . . . . 0.0 114.725 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.75 128.49 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -51.3 136.51 24.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.141 1.377 . . . . 0.0 111.691 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.1 mt -112.41 3.74 17.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.561 1.144 . . . . 0.0 110.215 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.81 105.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 126.594 1.958 . . . . 0.0 108.641 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.45 36.13 92.08 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.517 -0.602 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -132.99 160.97 35.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.483 1.141 . . . . 0.0 107.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.44 124.82 30.29 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.7 171.08 14.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.125 . . . . 0.0 109.243 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 60' ' ' GLN . 5.1 mp -136.13 156.84 48.11 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.271 1.828 . . . . 0.0 106.442 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.4 p -137.46 115.4 11.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -142.48 145.79 34.07 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 48.42 41.92 17.54 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.909 1.283 . . . . 0.0 111.465 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.397 5.0 ptpp? 61.43 7.87 1.95 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.189 2.995 . . . . 0.0 114.62 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.95 178.07 5.4 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.368 1.44 . . . . 0.0 110.889 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.31 122.81 60.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 109.535 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.14 160.14 35.61 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.667 -1.27 . . . . 0.0 112.811 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.91 162.43 16.91 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.654 ' HA ' HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.28 -52.73 60.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.041 1.291 . . . . 0.0 111.372 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -40.28 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.145 1.339 . . . . 0.0 113.302 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -78.46 -29.05 46.65 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.715 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.47 13.76 61.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.108 1.813 . . . . 0.0 113.342 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.702 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 11.4 t -58.56 125.4 23.24 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 117.619 -1.182 . . . . 0.0 108.943 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.3 -17.01 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 124.731 1.213 . . . . 0.0 112.052 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.85 9.43 22.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.239 2.216 . . . . 0.0 115.083 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -161.1 -5.3 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.426 -1.421 . . . . 0.0 114.351 178.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t 62.15 0.6 0.59 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.381 1.872 . . . . 0.0 113.755 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -82.58 156.4 68.21 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 122.359 2.345 . . . . 0.0 112.271 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.23 122.82 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.452 2.101 . . . . 0.0 108.837 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -76.33 151.26 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.235 0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.292 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 tptm . . . . . 0 C--O 1.238 0.473 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -137.41 164.65 28.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.538 1.535 . . . . 0.0 108.844 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.29 140.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -131.47 132.94 44.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.731 2.012 . . . . 0.0 106.272 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -145.57 102.74 3.73 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.703 1.601 . . . . 0.0 108.587 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.5 64.68 1.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 109.796 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 49.8 t0 42.66 67.32 0.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.468 2.707 . . . . 0.0 113.245 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.8 p -134.99 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 130.103 3.361 . . . . 0.0 106.951 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -142.53 118.06 10.34 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -131.55 131.61 43.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.305 1.042 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -66.45 154.97 38.83 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -53.03 -43.41 66.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.157 0.98 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.62 -2.69 33.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -121.12 18.68 11.61 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 0.0 114.442 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -112.38 100.08 8.51 Favored 'General case' 0 C--O 1.235 0.333 1 N-CA-C 100.193 -4.002 . . . . 0.0 100.193 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.63 160.53 40.12 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.7 t -58.9 124.23 19.15 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.444 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.88 -28.06 72.15 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 118.425 0.557 . . . . 0.0 113.362 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -78.83 -28.63 44.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.78 -10.84 1.02 Allowed 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t 72.62 87.77 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.907 1.337 . . . . 0.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.98 143.29 18.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 127.556 2.342 . . . . 0.0 104.801 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.7 t -65.55 142.71 58.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.252 1.025 . . . . 0.0 109.867 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.32 13.15 11.87 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.044 1.738 . . . . 0.0 109.658 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.9 t -76.97 -63.49 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 119.035 0.834 . . . . 0.0 108.761 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.61 11.9 6.6 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.206 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.97 159.1 44.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.665 1.732 . . . . 0.0 109.897 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.65 159.14 52.41 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -132.46 167.4 20.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.697 1.599 . . . . 0.0 108.425 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 60' ' ' GLN . 10.3 mp -125.29 159.02 32.7 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -126.72 107.84 10.53 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.991 1.716 . . . . 0.0 109.489 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -142.44 155.21 45.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m120 47.66 41.53 13.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.873 1.269 . . . . 0.0 112.197 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt 50.74 19.75 0.65 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.931 2.092 . . . . 0.0 113.882 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -123.82 176.26 6.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.494 1.918 . . . . 0.0 109.389 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.6 pt -112.92 131.67 63.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.674 1.189 . . . . 0.0 111.511 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.0 165.51 25.5 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.51 1.148 . . . . 0.0 113.69 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.72 156.64 20.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.472 ' HA ' HD13 ' A' ' 51' ' ' LEU . 74.6 mt-30 -54.9 -52.38 63.06 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.532 1.133 . . . . 0.0 109.554 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -55.07 -26.14 35.67 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.219 -1.551 . . . . 0.0 114.558 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.21 -22.97 16.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.731 1.612 . . . . 0.0 112.808 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.3 -4.38 55.13 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.492 1.044 . . . . 0.0 113.529 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.451 -0.423 0 C-N-CA 125.914 1.686 . . . . 0.0 108.023 -179.774 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.429 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 18.0 t -49.54 124.67 9.84 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.203 2.002 . . . . 0.0 108.32 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.23 -8.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 120.581 1.537 . . . . 0.0 110.964 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.07 7.16 27.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.703 2.001 . . . . 0.0 113.159 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.9 p -167.66 -5.34 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 121.225 1.829 . . . . 0.0 115.774 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.368 0.1 OUTLIER 56.06 18.79 3.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.128 2.171 . . . . 0.0 114.666 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -82.82 144.45 48.27 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.34 128.51 14.67 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.648 2.232 . . . . 0.0 110.239 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.8 mt -78.87 162.18 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.6 mttm . . . . . 0 C--O 1.237 0.441 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -119.24 158.53 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.405 HG21 ' CE1' ' A' ' 36' ' ' PHE . 3.9 mp -118.85 131.67 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.08 116.11 22.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.117 2.167 . . . . 0.0 107.549 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -145.76 131.25 18.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.233 1.813 . . . . 0.0 107.172 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 36.32 63.13 0.65 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.669 1.988 . . . . 0.0 111.918 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 60.19 -3.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 128.035 2.534 . . . . 0.0 115.749 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -80.45 160.63 25.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.492 1.117 . . . . 0.0 108.179 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -136.69 113.87 10.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -118.91 149.95 40.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.584 1.154 . . . . 0.0 111.021 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -86.56 147.37 25.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.0 t -49.39 -52.78 26.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.613 1.097 . . . . 0.0 110.669 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -57.76 -31.07 66.13 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.49 -4.92 52.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.405 ' CE1' HG21 ' A' ' 24' ' ' ILE . 47.8 t80 -80.93 99.36 8.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.38 161.76 37.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.086 1.355 . . . . 0.0 112.563 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.68 145.7 55.23 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.099 1.36 . . . . 0.0 112.701 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.39 -49.27 15.74 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 123.797 0.686 . . . . 0.0 111.915 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -75.53 -23.14 56.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -133.57 -7.43 2.87 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -178.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 m 72.49 -0.75 3.19 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 41' ' ' CYS . 4.0 p -71.06 147.03 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 121.038 1.744 . . . . 0.0 111.251 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -71.81 149.59 45.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.583 0.628 . . . . 0.0 111.968 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.13 -6.56 13.66 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.985 0.803 . . . . 0.0 112.412 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.65 95.83 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.58 11.56 24.81 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.877 1.227 . . . . 0.0 113.175 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -127.55 141.01 51.76 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.498 1.149 . . . . 0.0 108.305 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.95 88.78 0.66 Allowed Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -85.44 168.07 14.92 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.766 0.783 . . . . 0.0 110.296 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 mp -117.68 158.89 23.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.224 1.809 . . . . 0.0 106.918 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.3 p -128.71 122.6 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -143.51 153.21 42.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 m120 47.06 36.99 4.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm 58.89 30.4 20.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.327 1.051 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -129.19 166.64 18.96 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.913 1.685 . . . . 0.0 108.921 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.82 120.8 63.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.128 1.771 . . . . 0.0 108.487 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -131.31 139.48 49.58 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.007 -1.683 . . . . 0.0 113.054 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.58 144.52 31.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 114.521 -2.657 . . . . 0.0 106.024 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -30.06 -53.16 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.791 3.236 . . . . 0.0 112.304 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -47.83 -40.31 20.86 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.953 0.797 . . . . 0.0 112.296 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 29.2 m -80.14 -44.13 20.44 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.02 14.97 5.59 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 120.954 -1.091 . . . . 0.0 113.6 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.445 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.576 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 18.1 t -61.28 117.24 5.37 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 116.31 -1.805 . . . . 0.0 107.761 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 29' ' ' SER . 88.0 t -52.3 -30.54 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 121.067 1.758 . . . . 0.0 112.161 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.83 -12.02 58.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 1.8 p -139.49 -13.51 1.14 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.733 1.606 . . . . 0.0 113.413 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m 52.77 56.04 8.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 128.396 2.679 . . . . 0.0 111.665 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -124.86 149.23 62.21 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 117.773 -1.108 . . . . 0.0 108.748 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.87 114.74 3.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.606 2.204 . . . . 0.0 109.042 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.76 138.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 107.542 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 CA--C 1.535 0.392 0 CA-C-N 118.544 0.611 . . . . 0.0 111.079 179.345 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 121.944 0.878 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.58 165.26 18.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.559 1.544 . . . . 0.0 109.523 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 mt -130.19 152.94 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 126.218 1.807 . . . . 0.0 106.611 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 t -131.8 131.72 43.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.557 1.543 . . . . 0.0 108.399 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -146.42 136.24 23.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.116 1.366 . . . . 0.0 107.811 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 48.15 38.12 9.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 65.51 6.47 3.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.374 1.469 . . . . 0.0 112.959 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 9' ' ' VAL . 15.4 m -102.08 160.98 14.04 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.426 2.29 . . . . 0.0 105.73 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -132.14 144.86 50.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 119.936 -1.728 . . . . 0.0 113.363 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -133.43 145.08 49.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.238 1.015 . . . . 0.0 111.327 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -80.68 157.69 25.83 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 p -53.62 -49.77 67.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.867 0.867 . . . . 0.0 111.846 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -12.64 60.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.75 4.77 24.06 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.277 1.831 . . . . 0.0 113.714 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -101.28 99.89 10.33 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -155.24 166.41 33.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -58.48 119.77 7.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 116.821 -1.561 . . . . 0.0 112.45 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.27 49.81 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.453 1.024 . . . . 0.0 112.225 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -92.0 -17.52 24.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -148.72 -4.96 0.43 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m 74.47 1.14 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.77 134.61 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.9 t -59.38 145.52 43.22 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 124.242 0.964 . . . . 0.0 110.472 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -118.33 4.6 11.85 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.137 1.775 . . . . 0.0 110.058 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.91 91.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.964 . . . . 0.0 110.524 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.51 -58.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 125.875 1.702 . . . . 0.0 111.668 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.64 148.42 42.58 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.352 0.576 . . . . 0.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.42 115.03 7.36 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 105.52 -3.032 . . . . 0.0 105.52 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -85.16 170.38 12.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 109.137 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.7 160.74 32.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.693 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.7 p -137.72 104.5 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 110.247 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -141.16 153.57 45.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.89 1.676 . . . . 0.0 107.246 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.89 31.6 3.3 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.272 1.029 . . . . 0.0 113.396 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm 60.37 21.46 11.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.005 1.722 . . . . 0.0 112.007 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -125.43 174.83 7.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.49 1.516 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -117.31 122.7 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.977 1.311 . . . . 0.0 111.037 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.78 148.23 50.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.382 1.087 . . . . 0.0 113.586 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 162.68 29.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -50.22 -52.94 31.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.586 1.085 . . . . 0.0 112.39 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.46 -45.24 69.48 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.64 1.109 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.22 -59.44 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.5 29.92 1.71 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.139 1.352 . . . . 0.0 112.959 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 107.642 -179.278 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.757 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 10.2 t -57.67 120.72 8.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.418 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.76 -2.4 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 125.605 1.562 . . . . 0.0 112.337 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.99 6.09 10.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.957 2.103 . . . . 0.0 113.022 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.7 p -159.02 -7.37 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 119.282 -2.136 . . . . 0.0 114.625 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.8 m 58.38 12.94 2.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.63 1.572 . . . . 0.0 114.036 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -81.31 148.75 63.95 Favored Pre-proline 0 C--N 1.346 0.435 0 O-C-N 120.117 -1.614 . . . . 0.0 108.138 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.59 117.54 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.901 3.067 . . . . 0.0 109.122 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.2 mt -74.65 139.51 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.614 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 7.1 mmpt? . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.267 0.556 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.99 164.13 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.484 1.514 . . . . 0.0 107.877 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.23 137.78 52.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.14 112.15 18.32 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.265 1.826 . . . . 0.0 106.751 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -146.47 150.23 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 42.04 32.88 0.33 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.6 t70 56.68 40.67 29.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 123.699 1.714 . . . . 0.0 111.454 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 56.5 m -131.73 164.37 26.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 130.525 3.53 . . . . 0.0 106.804 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -132.65 133.77 44.0 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.327 1.051 . . . . 0.0 111.858 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 30.6 m-90 -132.38 161.54 33.34 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.527 1.131 . . . . 0.0 109.419 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -97.28 166.7 11.43 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.1 p -55.92 -30.76 62.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.338 1.055 . . . . 0.0 112.282 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -103.57 4.8 36.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.251 1.42 . . . . 0.0 112.256 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.01 6.59 9.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.313 1.045 . . . . 0.0 112.349 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -101.85 100.28 10.59 Favored 'General case' 0 N--CA 1.453 -0.298 1 N-CA-C 99.524 -4.25 . . . . 0.0 99.524 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -145.04 157.41 44.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 t -51.53 118.28 3.22 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -27.3 38.67 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 119.849 1.204 . . . . 0.0 112.872 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.6 -22.59 26.14 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.4 p -143.45 -6.72 0.8 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m 76.92 10.31 2.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.71 141.36 15.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.1 t -66.11 151.33 47.13 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.4 mt -118.18 -1.72 11.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.433 1.093 . . . . 0.0 111.374 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.29 -57.43 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.445 1.098 . . . . 0.0 112.286 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.76 17.15 2.85 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.05 -0.861 . . . . 0.0 113.947 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -150.92 -167.66 2.88 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.437 1.618 . . . . 0.0 110.722 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.96 165.31 21.92 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -140.82 171.48 14.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 109.766 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 60' ' ' GLN . 6.7 mp -129.53 165.53 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.407 1.083 . . . . 0.0 109.291 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 p -137.65 111.51 8.28 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.983 0.513 . . . . 0.0 109.735 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -142.46 148.36 37.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.161 1.784 . . . . 0.0 106.48 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 46.08 33.98 1.9 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.093 2.157 . . . . 0.0 112.478 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp 59.7 9.99 1.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.752 1.621 . . . . 0.0 113.039 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -93.41 -173.56 3.25 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.769 2.028 . . . . 0.0 107.466 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.2 pt -135.75 124.05 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.06 1.744 . . . . 0.0 109.397 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -135.38 148.04 49.25 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 120.745 -1.222 . . . . 0.0 114.183 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.72 155.68 39.66 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HA ' HD13 ' A' ' 51' ' ' LEU . 56.6 mt-30 -51.36 -52.75 42.87 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.934 1.243 . . . . 0.0 110.263 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -56.83 -25.79 56.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.2 m -97.51 -18.23 19.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 114.075 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.62 -5.63 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.536 0.41 0 C-N-CA 128.032 2.533 . . . . 0.0 105.963 178.737 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 49.2 t -66.53 106.89 1.9 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.743 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -50.55 -35.16 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.784 1.174 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.39 1.0 50.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.227 2.211 . . . . 0.0 116.427 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -153.16 -12.98 0.15 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.101 1.773 . . . . 0.0 112.798 178.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m 55.41 51.13 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 131.169 3.788 . . . . 0.0 113.388 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.59 149.18 44.47 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.71 1.204 . . . . 0.0 110.098 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.4 122.6 6.62 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 123.306 2.671 . . . . 0.0 112.097 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.8 mt -80.72 163.04 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.621 2.368 . . . . 0.0 105.2 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.116 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -131.59 163.97 26.89 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.659 0.784 . . . . 0.0 111.477 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.18 138.66 53.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.877 2.071 . . . . 0.0 105.892 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.6 121.0 23.64 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.12 1.368 . . . . 0.0 107.584 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -145.31 130.74 18.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 53.16 39.27 29.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.125 0.97 . . . . 0.0 111.532 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 68.26 -0.72 2.06 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.879 1.672 . . . . 0.0 113.039 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 t -73.91 165.75 24.58 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.103 2.161 . . . . 0.0 110.059 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -132.81 110.69 10.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.662 0.785 . . . . 0.0 112.141 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -118.03 129.81 55.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.61 154.47 40.74 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -49.87 -49.85 47.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.425 1.09 . . . . 0.0 110.967 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.35 -4.76 41.16 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.207 -1.558 . . . . 0.0 114.224 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.0 m -121.56 17.71 11.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.96 101.54 9.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.14 166.44 30.81 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.0 t -55.83 112.15 1.1 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.247 -1.359 . . . . 0.0 109.548 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.04 -25.3 30.99 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.208 0.909 . . . . 0.0 114.921 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -90.35 -20.96 22.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.35 -22.8 1.5 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m 77.47 78.51 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.251 1.024 . . . . 0.0 109.738 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.34 134.68 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 t -54.2 135.43 44.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.933 1.293 . . . . 0.0 112.461 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.39 9.72 15.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.547 1.939 . . . . 0.0 109.222 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.19 111.23 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 126.11 1.764 . . . . 0.0 112.711 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.47 43.4 94.03 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-O 119.331 -0.705 . . . . 0.0 113.666 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -139.07 153.21 48.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 134.34 46.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.99 171.77 9.0 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.144 1.378 . . . . 0.0 108.058 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.99 155.31 30.49 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 112.88 6.49 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -143.12 150.26 39.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 54.72 23.08 4.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.134 0.879 . . . . 0.0 112.528 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 70.54 8.45 6.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.792 2.437 . . . . 0.0 113.065 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.81 150.94 25.83 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.431 1.092 . . . . 0.0 108.587 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.8 pt -102.63 129.87 53.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.226 1.411 . . . . 0.0 110.025 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.92 160.69 36.9 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.669 -1.269 . . . . 0.0 112.444 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 161.39 19.69 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -51.98 -51.55 56.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.21 1.368 . . . . 0.0 111.57 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -53.49 -38.59 63.82 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.419 -0.8 . . . . 0.0 112.402 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -75.59 -53.26 8.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.27 1.04 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.548 1.07 . . . . 0.0 113.924 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.361 0 CA-C-N 119.134 1.467 . . . . 0.0 111.303 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.796 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.489 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.5 t -79.13 121.97 25.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.96 -23.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.249 0.931 . . . . 0.0 111.61 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.2 1.28 57.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.804 1.642 . . . . 0.0 115.207 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.1 p -162.6 -7.79 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.776 1.625 . . . . 0.0 115.128 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.28 97.1 p 53.83 26.82 6.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.103 2.561 . . . . 0.0 114.149 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -83.88 154.16 64.29 Favored Pre-proline 0 C--O 1.237 0.436 0 O-C-N 120.765 -1.21 . . . . 0.0 108.459 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.34 120.12 5.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.366 2.71 . . . . 0.0 107.185 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -70.55 144.07 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 C--O 1.234 0.282 0 C-N-CA 123.429 0.692 . . . . 0.0 111.212 -179.847 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -145.06 164.95 29.64 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 126.039 1.736 . . . . 0.0 108.721 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.27 134.73 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -111.22 131.35 55.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.185 0.994 . . . . 0.0 108.834 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -146.15 138.1 25.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.091 1.756 . . . . 0.0 106.666 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 45.33 43.11 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.273 1.429 . . . . 0.0 112.235 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 69.45 -17.55 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 129.766 3.226 . . . . 0.0 113.616 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 56.6 m -73.94 164.15 26.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.325 1.45 . . . . 0.0 108.969 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.21 135.94 52.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.082 1.353 . . . . 0.0 111.115 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 18.3 m-90 -132.89 131.43 40.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.359 0.664 . . . . 0.0 111.664 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -65.48 154.38 38.73 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 p -49.58 -53.19 25.18 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.298 1.408 . . . . 0.0 112.613 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.49 -26.38 67.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.05 1.06 56.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 116.955 -1.498 . . . . 0.0 114.162 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -100.74 100.4 11.07 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 102.406 -3.183 . . . . 0.0 102.406 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -153.19 166.09 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 t -61.13 120.11 9.68 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-O 117.329 -1.319 . . . . 0.0 109.99 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.08 -24.38 54.53 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 121.989 0.772 . . . . 0.0 113.412 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -85.81 -18.83 31.82 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.16 -8.81 0.34 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 82.63 -0.99 1.33 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.474 1.488 . . . . 0.0 114.791 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.44 136.13 26.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 121.246 1.839 . . . . 0.0 108.024 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -54.35 136.2 43.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.082 1.353 . . . . 0.0 109.609 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.1 -0.37 15.65 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.773 0.829 . . . . 0.0 110.686 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.8 t -54.18 116.51 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 127.409 2.284 . . . . 0.0 109.505 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.68 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.532 1.152 0 C-N-CA 128.776 3.084 . . . . 0.0 117.617 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -9.38 56.96 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.23 147.09 16.94 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -146.34 172.26 13.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.575 1.55 . . . . 0.0 110.563 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.0 mp -119.13 154.95 32.45 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.9 p -130.11 102.46 6.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.241 0.963 . . . . 0.0 109.213 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.61 155.66 48.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.323 1.849 . . . . 0.0 107.595 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 52.35 21.77 1.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.004 1.321 . . . . 0.0 112.935 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt 62.49 22.02 12.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.038 1.735 . . . . 0.0 112.047 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -112.95 -169.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.893 2.477 . . . . 0.0 108.691 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.1 123.82 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 120.423 -1.423 . . . . 0.0 110.003 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -131.95 152.01 51.36 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 122.92 1.343 . . . . 0.0 114.607 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.76 150.28 42.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.545 ' HA ' HD13 ' A' ' 51' ' ' LEU . 5.0 mt-30 -46.23 -51.83 13.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.337 1.426 . . . . 0.0 110.502 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -51.53 61.47 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.135 0.879 . . . . 0.0 111.017 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.78 -29.01 68.85 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.35 -25.28 51.83 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.021 -1.433 . . . . 0.0 111.535 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 C--N 1.343 0.283 0 CA-C-N 118.936 1.368 . . . . 0.0 109.802 179.636 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.426 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 8.0 t -53.26 127.54 24.9 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.178 -1.391 . . . . 0.0 107.954 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -51.51 -24.64 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 120.048 1.294 . . . . 0.0 113.883 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.67 9.29 25.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.493 1.917 . . . . 0.0 115.126 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -154.2 -11.07 0.14 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.96 -1.712 . . . . 0.0 114.132 179.026 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 p 58.99 2.93 0.28 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.057 2.543 . . . . 0.0 114.812 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -72.04 147.69 91.19 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 120.597 -1.315 . . . . 0.0 110.684 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.55 113.65 3.7 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.355 2.703 . . . . 0.0 110.58 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.63 149.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm . . . . . 0 C--O 1.239 0.531 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -135.44 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.827 2.051 . . . . 0.0 111.807 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.0 mm -120.05 147.37 23.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.89 117.9 19.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.375 1.07 . . . . 0.0 109.603 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.82 138.74 25.89 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 48.57 42.74 19.51 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.727 1.611 . . . . 0.0 110.597 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 61.87 2.45 0.76 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.272 2.229 . . . . 0.0 112.545 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.6 m -84.35 164.84 18.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.631 1.572 . . . . 0.0 108.875 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 117.83 24.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.403 1.081 . . . . 0.0 111.47 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -120.72 136.73 54.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.26 155.52 28.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.1 t -57.34 -46.03 83.69 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.341 0.973 . . . . 0.0 108.487 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -1.24 3.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.64 -6.47 6.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.913 1.285 . . . . 0.0 113.275 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -89.99 100.29 13.13 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -149.08 176.5 10.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.5 t -65.53 119.93 11.97 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.49 -1.243 . . . . 0.0 112.694 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.07 -10.8 16.14 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.468 1.508 . . . . 0.0 112.977 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -106.05 -23.49 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.133 1.466 . . . . 0.0 114.525 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.433 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -141.41 -3.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.294 15.4 m 70.83 15.44 6.85 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.433 HG12 ' SG ' ' A' ' 41' ' ' CYS . 7.5 p -73.64 134.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 t -58.0 139.63 54.09 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.802 0.728 . . . . 0.0 110.679 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -111.06 3.55 18.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.045 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.32 122.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.52 29.47 69.82 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.622 -1.099 . . . . 0.0 112.438 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -139.8 150.45 44.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.356 1.578 . . . . 0.0 110.958 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.28 108.35 2.54 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.506 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -102.83 171.85 7.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.363 1.865 . . . . 0.0 108.945 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -129.15 163.61 25.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.117 1.767 . . . . 0.0 107.256 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.479 HG22 HG22 ' A' ' 57' ' ' ILE . 21.9 p -135.39 117.4 15.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.396 0.544 . . . . 0.0 111.567 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -143.7 156.49 44.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.301 1.84 . . . . 0.0 107.386 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.5 m120 57.3 29.08 16.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.925 0.89 . . . . 0.0 112.018 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm 64.18 16.09 9.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.437 1.495 . . . . 0.0 110.57 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -120.1 177.97 4.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.993 1.717 . . . . 0.0 106.994 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 52' ' ' THR . 18.5 pt -115.63 149.55 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -145.84 155.73 43.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.096 1.771 . . . . 0.0 111.482 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.3 156.42 38.46 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -57.12 -50.61 72.27 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.197 1.362 . . . . 0.0 110.871 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -55.42 -24.91 33.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.516 1.126 . . . . 0.0 113.847 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.382 85.7 m -97.24 -17.07 20.06 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.572 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.02 -20.29 18.94 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.387 -1.229 . . . . 0.0 111.54 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 CA--C 1.533 0.294 0 C-N-CA 127.081 2.152 . . . . 0.0 113.518 -179.409 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 8.9 t -62.57 119.55 9.42 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.358 -1.782 . . . . 0.0 108.607 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.7 t -54.55 -25.84 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 121.113 1.779 . . . . 0.0 111.165 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.66 -1.77 58.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.294 1.837 . . . . 0.0 115.284 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 6.4 p -158.88 -2.54 0.08 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 121.235 1.834 . . . . 0.0 114.481 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 p 58.35 7.27 0.66 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.838 3.255 . . . . 0.0 114.071 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -70.38 136.68 86.36 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.11 122.67 10.5 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 123.066 2.51 . . . . 0.0 108.504 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.51 151.98 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 CA--C 1.542 0.65 0 O-C-N 121.067 -1.021 . . . . 0.0 109.115 179.649 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.627 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -145.67 165.16 29.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.744 1.617 . . . . 0.0 107.125 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.89 122.38 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 126.984 2.114 . . . . 0.0 106.202 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -106.05 106.79 17.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.97 139.85 38.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 48.86 43.92 21.74 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.379 0.672 . . . . 0.0 109.591 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 42.87 43.32 3.43 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.086 2.555 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 50.7 m -134.16 149.77 51.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.898 1.679 . . . . 0.0 108.712 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.07 118.81 32.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.419 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 2.7 m-90 -131.36 123.23 27.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -66.24 145.34 55.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -45.04 -54.76 6.27 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.422 1.489 . . . . 0.0 111.376 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -67.29 -17.57 64.83 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.09 17.55 20.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.73 101.39 12.78 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -139.48 165.05 28.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.95 113.59 2.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.077 1.751 . . . . 0.0 109.009 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.83 -24.92 21.26 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 120.167 1.349 . . . . 0.0 115.539 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -84.92 -20.33 30.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 114.762 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.71 -25.88 0.68 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.298 5.6 p 91.57 17.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.671 2.388 . . . . 0.0 115.596 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.47 143.72 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 120.582 -1.324 . . . . 0.0 108.043 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -59.35 140.65 55.89 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.821 0.848 . . . . 0.0 110.631 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.22 -1.01 10.35 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.252 1.421 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.1 t -49.69 115.93 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 126.33 1.852 . . . . 0.0 110.402 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -3.74 27.24 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.043 -1.421 . . . . 0.0 115.33 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -89.34 162.1 15.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.948 2.374 . . . . 0.0 110.179 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.87 1.54 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -85.38 171.88 11.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.916 0.887 . . . . 0.0 109.762 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.53 126.7 52.56 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.911 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -95.55 107.35 19.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.787 2.035 . . . . 0.0 110.15 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -144.17 155.04 43.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 44.99 46.18 9.05 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.173 1.389 . . . . 0.0 112.333 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.346 7.5 ptmm? 48.97 24.99 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.709 2.004 . . . . 0.0 114.321 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -127.23 177.94 6.36 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.977 1.711 . . . . 0.0 107.781 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.04 123.62 65.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 125.611 1.564 . . . . 0.0 110.984 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.42 152.01 51.03 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.948 0.88 . . . . 0.0 113.31 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.9 163.36 27.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -53.91 -55.87 22.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 110.854 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -55.28 -27.08 44.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.672 1.189 . . . . 0.0 113.468 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.91 -19.29 18.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.724 1.21 . . . . 0.0 113.077 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.49 -3.61 56.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.088 1.804 . . . . 0.0 112.015 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 t . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 124.741 1.217 . . . . 0.0 107.952 178.631 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.871 0 CA-C-O 121.383 0.435 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -71.48 109.58 5.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.858 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -43.73 -39.93 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 121.539 1.972 . . . . 0.0 111.743 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -8.47 53.11 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -156.96 -4.88 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.098 1.317 . . . . 0.0 114.326 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 p 62.92 8.01 2.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 130.815 3.646 . . . . 0.0 114.597 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -70.64 152.93 95.21 Favored Pre-proline 0 N--CA 1.468 0.454 0 O-C-N 120.38 -1.45 . . . . 0.0 109.892 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.24 127.63 16.15 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.84 1.694 . . . . 0.0 109.054 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.97 142.96 16.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 CA--C 1.537 0.455 0 C-N-CA 123.734 0.814 . . . . 0.0 109.898 -179.856 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.6 mptt . . . . . 0 C--O 1.237 0.406 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -134.05 120.44 20.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 mm -83.46 152.73 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -130.01 107.02 9.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.671 1.588 . . . . 0.0 108.897 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -128.22 123.82 35.17 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.815 1.246 . . . . 0.0 108.803 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 50.69 15.48 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.264 1.026 . . . . 0.0 109.001 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 62.62 -6.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 127.57 2.348 . . . . 0.0 115.97 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.3 t -89.06 149.68 23.11 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -116.04 136.45 53.02 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.474 0.709 . . . . 0.0 111.548 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -130.26 138.56 50.58 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.776 1.23 . . . . 0.0 108.35 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -71.09 152.32 43.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -43.87 -62.48 1.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.751 1.22 . . . . 0.0 113.101 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 21.0 mp0 -61.34 -22.46 64.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.887 2.075 . . . . 0.0 114.164 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 m -90.5 -28.27 18.66 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.026 1.331 . . . . 0.0 112.725 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -72.09 101.73 2.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.456 1.48 . . . . 0.0 108.703 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 4.6 m-80 -139.87 164.02 31.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.294 1.038 . . . . 0.0 112.95 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 35.2 t -59.15 116.74 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 116.287 -1.816 . . . . 0.0 108.474 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.42 34.01 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 120.865 1.666 . . . . 0.0 114.132 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -84.93 -18.66 33.94 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 38' ' ' CYS . 0.8 OUTLIER -140.43 -13.74 1.0 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -177.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' HB3' ' A' ' 37' ' ' ASN 0.358 86.9 p 62.46 60.04 1.44 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 ' SG ' ' A' ' 41' ' ' CYS . 10.0 p -117.65 137.01 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -58.38 125.56 23.83 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 124.037 0.836 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.1 mt -101.91 14.71 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.172 1.389 . . . . 0.0 109.111 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.64 126.9 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.21 -49.77 1.55 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 126.049 1.785 . . . . 0.0 115.987 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -63.23 154.18 32.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.904 0.882 . . . . 0.0 112.238 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.09 161.59 54.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.59 163.29 36.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.935 1.294 . . . . 0.0 109.778 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.03 152.7 29.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.695 1.998 . . . . 0.0 106.573 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.3 p -129.77 123.16 30.32 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -144.17 154.72 43.44 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.583 0.753 . . . . 0.0 109.183 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 41.89 42.31 2.2 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.783 1.174 . . . . 0.0 111.649 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 62.42 7.12 2.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.552 1.941 . . . . 0.0 114.805 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -106.31 173.12 6.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.861 2.064 . . . . 0.0 111.088 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.8 135.12 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.588 1.955 . . . . 0.0 110.737 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -139.65 155.35 47.46 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 120.787 -1.195 . . . . 0.0 113.256 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 157.49 32.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -52.31 -54.47 31.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.241 1.017 . . . . 0.0 110.161 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -52.67 -46.35 67.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.124 0.875 . . . . 0.0 111.256 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.332 1.3 m -61.29 -41.27 96.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.381 0.992 . . . . 0.0 111.73 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.49 -4.14 89.42 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.582 1.083 . . . . 0.0 113.553 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.236 0.373 0 C-N-CA 126.326 1.85 . . . . 0.0 110.592 -179.344 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.753 0 CA-C-O 121.395 0.442 . . . . 0.0 113.063 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -58.61 112.36 1.58 Allowed 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 115.794 -2.051 . . . . 0.0 108.282 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.9 t -41.81 -36.33 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 122.312 2.324 . . . . 0.0 112.785 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.55 -13.93 58.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.77 -3.62 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 120.877 1.671 . . . . 0.0 115.431 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 m 59.49 8.03 1.12 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 130.18 3.392 . . . . 0.0 115.083 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -58.79 153.09 44.43 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 120.0 1.273 . . . . 0.0 110.315 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.0 122.9 9.21 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.82 1.68 . . . . 0.0 108.526 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mm -74.12 144.13 12.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 123.121 0.568 . . . . 0.0 110.842 179.791 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -129.5 165.18 22.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.407 1.883 . . . . 0.0 108.675 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.0 mm -116.37 151.46 18.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 m -131.27 117.83 19.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -145.43 130.6 18.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 55.66 23.62 6.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 111.231 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . 0.272 2.3 m-20 72.49 -0.68 3.21 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 130.004 3.322 . . . . 0.0 113.482 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -81.8 164.01 21.96 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.02 135.15 51.95 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.382 -1.448 . . . . 0.0 114.153 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 3.6 m-90 -132.07 125.91 32.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -73.84 154.54 39.44 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -49.97 -55.08 16.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.598 1.09 . . . . 0.0 109.178 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -65.66 -3.28 4.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.97 1.708 . . . . 0.0 115.554 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . 0.282 1.7 m -119.31 -3.01 10.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.58 -1.676 . . . . 0.0 114.369 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -91.04 102.54 15.3 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.181 1.392 . . . . 0.0 108.583 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -154.12 172.13 18.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.5 122.81 18.05 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 117.019 -1.467 . . . . 0.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -27.1 65.12 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.762 1.164 . . . . 0.0 113.524 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -75.81 -20.51 58.14 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.17 -12.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.272 18.0 m 85.92 10.6 0.25 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.726 1.61 . . . . 0.0 115.119 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.67 131.95 32.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 m -56.63 136.09 54.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.552 1.141 . . . . 0.0 111.611 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.1 mt -103.21 -1.11 29.48 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.79 142.04 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 20.85 73.63 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.628 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -152.94 148.21 26.85 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.039 1.419 . . . . 0.0 109.768 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.0 152.71 44.3 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -135.73 171.65 14.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.92 1.36 . . . . 0.0 111.652 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.08 145.45 24.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.1 p -134.45 103.39 5.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.619 1.168 . . . . 0.0 109.47 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -140.58 152.36 45.41 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 53.23 17.15 0.94 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.05 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.3 mttt 86.56 -0.1 0.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 129.313 3.045 . . . . 0.0 112.282 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -89.55 -179.04 5.71 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.504 1.521 . . . . 0.0 109.619 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.0 pt -131.44 136.01 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.512 2.325 . . . . 0.0 106.509 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -148.56 157.26 43.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 123.126 1.441 . . . . 0.0 113.199 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 153.81 39.79 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -66.34 -38.38 87.5 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.918 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -54.24 -26.74 30.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.25 1.42 . . . . 0.0 113.916 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.0 m -97.29 -45.08 6.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.208 1.803 . . . . 0.0 109.123 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.03 11.4 57.54 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 CA-C-N 118.969 1.385 . . . . 0.0 108.524 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.032 0 CA-C-O 121.639 0.577 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.9 t -59.87 121.4 11.66 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 117.275 -1.345 . . . . 0.0 108.636 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -52.21 -29.76 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.727 1.148 . . . . 0.0 111.346 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.4 -4.05 59.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 p -153.48 -7.08 0.17 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.156 1.343 . . . . 0.0 114.084 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 54.02 37.83 27.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.435 2.294 . . . . 0.0 112.642 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -100.05 151.91 37.66 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.47 137.57 30.87 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 O-C-N 124.554 1.818 . . . . 0.0 108.55 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.94 121.22 60.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 123.094 0.558 . . . . 0.0 110.48 -179.868 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.433 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.73 164.22 30.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.03 0.443 . . . . 0.0 111.85 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.2 mm -121.3 125.81 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.3 m -103.39 102.93 12.88 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -124.9 136.92 54.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 40.38 46.23 1.99 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.401 1.881 . . . . 0.0 112.697 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 51.05 35.63 13.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.075 1.75 . . . . 0.0 113.127 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -126.09 164.73 20.25 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 126.419 1.888 . . . . 0.0 107.206 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -109.73 131.57 54.94 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -132.21 133.14 43.82 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 108.324 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -73.76 147.1 43.81 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -49.21 -55.5 12.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.936 1.244 . . . . 0.0 110.189 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.92 -5.18 2.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.928 1.291 . . . . 0.0 113.994 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 m -118.65 -1.26 11.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 113.566 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -94.59 100.78 12.68 Favored 'General case' 0 N--CA 1.45 -0.46 1 N-CA-C 99.417 -4.29 . . . . 0.0 99.417 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 75.5 m-20 -145.59 164.3 32.13 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.709 -177.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.9 t -58.12 122.03 12.1 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 116.795 -1.574 . . . . 0.0 108.975 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.89 -25.56 30.82 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 123.985 0.803 . . . . 0.0 113.816 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -90.87 -18.37 24.93 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -143.87 -15.95 0.61 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 37' ' ' ASN 0.3 1.1 p 84.78 8.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.2 142.55 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 120.54 1.518 . . . . 0.0 110.158 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -64.81 105.16 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.514 1.925 . . . . 0.0 107.429 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.3 mt -88.54 -9.0 53.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.0 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.1 t -42.56 111.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.404 1.882 . . . . 0.0 112.4 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 12.51 63.02 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.28 -1.845 . . . . 0.0 117.304 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -110.39 167.73 9.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 121.432 2.616 . . . . 0.0 112.161 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 136.2 46.13 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -144.42 171.17 14.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.242 1.017 . . . . 0.0 110.905 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.42 160.66 33.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.954 0.902 . . . . 0.0 110.793 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 p -132.58 104.83 6.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.995 0.918 . . . . 0.0 109.653 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -142.37 152.45 42.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.18 31.89 7.3 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.499 1.52 . . . . 0.0 112.77 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.17 6.67 3.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.369 2.267 . . . . 0.0 113.014 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -108.53 176.84 4.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.698 1.599 . . . . 0.0 109.8 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -112.68 121.46 65.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.64 138.26 52.09 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 157.24 37.1 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -46.39 -54.43 9.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.353 1.061 . . . . 0.0 111.654 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -58.96 -31.33 68.63 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.1 -12.46 21.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 113.656 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.91 -24.31 20.49 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 101.91 -3.366 . . . . 0.0 101.91 177.666 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.95 0 CA-C-O 119.095 -0.836 . . . . 0.0 112.955 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 t -44.61 120.47 2.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.824 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.03 -32.31 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 120.63 1.559 . . . . 0.0 110.685 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.92 2.66 37.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 p -166.24 -3.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 119.19 -2.194 . . . . 0.0 114.707 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.54 10.21 2.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.763 3.225 . . . . 0.0 114.238 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -67.36 145.66 98.55 Favored Pre-proline 0 N--CA 1.47 0.565 0 O-C-N 120.122 -1.611 . . . . 0.0 109.402 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 137.68 45.45 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 O-C-N 124.35 1.711 . . . . 0.0 109.149 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -87.98 157.09 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.719 1.608 . . . . 0.0 107.216 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.233 0.215 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -178.27 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt . . . . . 0 C--O 1.238 0.449 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -145.77 146.73 31.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mm -88.77 120.74 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 p -107.38 110.22 22.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -139.46 137.77 35.86 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 42.4 54.91 4.24 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.842 1.657 . . . . 0.0 112.114 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.92 13.89 0.61 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.851 1.661 . . . . 0.0 114.111 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -113.03 163.74 14.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.945 2.098 . . . . 0.0 108.949 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -120.95 131.94 54.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.938 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -124.61 138.28 54.32 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.113 1.365 . . . . 0.0 107.535 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -76.0 144.74 40.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.5 t -51.53 -51.53 54.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -61.9 -11.24 12.05 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 114.156 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.2 m -123.66 11.31 9.13 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.624 1.17 . . . . 0.0 113.382 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.99 101.16 13.19 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 101.231 -3.618 . . . . 0.0 101.231 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -141.35 168.82 18.86 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.89 121.04 13.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 116.424 -1.751 . . . . 0.0 108.287 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.82 -32.26 58.83 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 120.919 1.69 . . . . 0.0 113.45 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -82.67 -22.32 34.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.38 -7.92 1.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.393 83.7 p 66.64 29.94 8.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -86.9 147.07 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -58.06 134.96 56.88 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 111.484 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 mt -112.12 1.69 16.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.708 1.203 . . . . 0.0 110.818 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.82 107.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.342 2.657 . . . . 0.0 110.636 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.69 -17.57 3.44 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.968 1.747 . . . . 0.0 115.482 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 112.62 22.77 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -40.88 142.06 0.87 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.243 1.401 . . . . 0.0 111.149 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -135.66 170.55 15.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.04 162.12 13.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.287 1.435 . . . . 0.0 108.052 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 p -141.92 102.92 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -130.33 154.94 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 m120 48.95 36.02 7.7 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.852 1.261 . . . . 0.0 112.728 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm 55.76 21.76 4.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.491 1.116 . . . . 0.0 112.181 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -117.36 -178.54 3.48 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.165 1.786 . . . . 0.0 109.609 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 pt -123.34 122.7 65.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.805 1.642 . . . . 0.0 110.461 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -136.16 140.02 43.3 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.205 -0.934 . . . . 0.0 111.486 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.79 163.33 27.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -42.84 -62.79 0.92 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.226 1.81 . . . . 0.0 111.975 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -52.63 -41.03 63.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.877 0.871 . . . . 0.0 112.825 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.4 -46.99 58.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.551 0.614 . . . . 0.0 110.068 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.57 -3.01 46.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.987 0.803 . . . . 0.0 113.506 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.544 0.74 0 C-N-CA 126.973 2.109 . . . . 0.0 112.588 179.756 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.35 124.54 18.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.291 -1.814 . . . . 0.0 107.989 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -7.96 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 120.694 1.588 . . . . 0.0 112.319 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.28 4.96 25.19 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.026 1.73 . . . . 0.0 114.076 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 p -166.22 -4.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.286 61.6 p 54.83 12.83 0.63 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.6 3.16 . . . . 0.0 114.824 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.07 150.28 97.54 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.71 125.5 11.71 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.484 1.456 . . . . 0.0 108.665 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mm -68.32 148.19 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.13 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 pttm . . . . . 0 C--O 1.237 0.4 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -145.15 164.96 29.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.932 2.093 . . . . 0.0 107.177 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -115.15 139.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 p -130.89 120.08 23.11 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.475 1.51 . . . . 0.0 107.921 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -145.37 150.53 36.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.303 1.841 . . . . 0.0 106.526 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 36.04 50.52 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.111 2.165 . . . . 0.0 114.081 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t0 53.89 39.74 30.77 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 113.189 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' ' CZ3' ' A' ' 31' ' ' TRP . 27.6 t -134.22 164.71 26.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.07 1.748 . . . . 0.0 109.972 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -119.11 124.1 46.03 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.89 1.676 . . . . 0.0 111.605 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' A' ' 29' ' ' SER . 9.6 m-90 -130.71 123.99 30.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.796 1.284 . . . . 0.0 110.296 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -68.49 155.5 39.8 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -53.51 30.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.106 1.363 . . . . 0.0 112.589 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.1 -30.49 71.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.597 1.09 . . . . 0.0 113.607 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -84.81 0.08 52.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 117.416 -1.278 . . . . 0.0 113.457 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -98.77 100.5 11.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -155.85 170.28 22.45 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.0 115.42 4.05 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 115.713 -2.089 . . . . 0.0 106.493 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.11 -29.34 51.9 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 121.444 1.929 . . . . 0.0 112.902 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -75.55 -22.49 57.0 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.87 -13.9 0.83 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 118.621 2.823 . . . . 0.0 118.621 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.276 3.0 m 79.67 12.22 1.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.92 136.09 26.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.1 t -58.59 138.36 56.92 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.446 0.641 . . . . 0.0 109.87 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.47 2.04 20.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.577 1.551 . . . . 0.0 110.079 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.82 109.57 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.05 1.34 . . . . 0.0 110.441 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.19 -44.66 2.96 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.749 2.118 . . . . 0.0 113.409 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -64.76 160.93 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.854 1.327 . . . . 0.0 111.864 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.58 123.55 16.53 Favored Glycine 0 C--O 1.241 0.531 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -110.16 166.1 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.762 1.225 . . . . 0.0 109.561 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.82 147.98 47.12 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.45 103.82 6.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.956 1.302 . . . . 0.0 107.659 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -142.75 156.4 44.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 127.096 2.159 . . . . 0.0 106.441 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 57.86 21.68 7.83 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 62.81 23.08 13.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.045 1.338 . . . . 0.0 109.72 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -126.75 -178.84 4.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 127.443 2.297 . . . . 0.0 107.614 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 pt -130.56 134.5 62.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.986 0.898 . . . . 0.0 109.868 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -134.24 162.43 32.18 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 123.012 1.387 . . . . 0.0 114.138 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.23 161.51 23.93 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -54.16 -54.87 33.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.02 0.827 . . . . 0.0 111.08 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -56.41 -27.7 57.23 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.527 -1.358 . . . . 0.0 114.553 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 m -97.59 -18.4 18.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.612 1.165 . . . . 0.0 113.297 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.31 -23.85 10.05 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.815 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 t . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 125.823 1.649 . . . . 0.0 108.571 179.722 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 CA-C-O 119.728 -0.485 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 4.6 t -57.75 116.44 3.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.62 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.42 -14.0 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.783 0.833 . . . . 0.0 112.241 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.95 -0.71 38.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.368 1.467 . . . . 0.0 113.678 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -152.62 -11.21 0.17 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.792 -1.818 . . . . 0.0 114.917 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 2.9 p 49.91 53.51 12.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.615 1.966 . . . . 0.0 112.667 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -114.81 140.3 25.25 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.37 124.32 12.74 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.986 2.457 . . . . 0.0 110.454 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.74 135.76 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.007 1.723 . . . . 0.0 106.538 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 123.966 0.907 . . . . 0.0 109.816 179.608 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 C--O 1.24 0.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.29 164.57 31.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.482 1.513 . . . . 0.0 109.495 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.73 102.12 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.364 1.465 . . . . 0.0 109.061 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.3 m -82.19 114.67 20.86 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -145.83 147.7 32.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.279 0.945 . . . . 0.0 108.638 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 36.96 58.08 1.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.096 1.759 . . . . 0.0 111.537 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 p30 48.62 25.03 0.87 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.105 1.762 . . . . 0.0 114.968 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 t -128.49 165.46 20.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 127.911 2.484 . . . . 0.0 108.524 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.9 109.77 11.54 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.516 -0.74 . . . . 0.0 110.632 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -103.54 150.96 23.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.343 1.068 . . . . 0.0 108.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' A' ' 8' ' ' CYS . 25.9 m170 -82.5 152.5 26.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -57.52 -37.02 72.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.781 1.173 . . . . 0.0 108.923 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.8 -17.4 63.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 112.763 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.45 27.82 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -113.1 100.31 8.51 Favored 'General case' 0 C--O 1.237 0.436 1 N-CA-C 99.023 -4.436 . . . . 0.0 99.023 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -145.38 173.11 12.28 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.16 107.39 1.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.457 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.2 -31.34 26.5 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 119.57 1.077 . . . . 0.0 115.413 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -77.4 -23.86 50.59 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.42 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -135.26 -23.68 1.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -178.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t 74.37 85.13 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.632 1.573 . . . . 0.0 109.909 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.42 HG12 ' SG ' ' A' ' 41' ' ' CYS . 11.1 p -151.57 136.59 10.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 129.872 3.269 . . . . 0.0 104.682 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -54.54 146.45 16.31 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.659 1.219 . . . . 0.0 113.045 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -120.01 1.94 10.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 109.098 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.36 103.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 125.659 1.583 . . . . 0.0 107.178 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 5.89 86.87 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.272 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -112.86 87.7 2.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.249 1.524 . . . . 0.0 107.969 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -20.67 109.79 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 128.501 2.953 . . . . 0.0 113.139 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -111.14 165.02 12.25 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.378 1.071 . . . . 0.0 112.752 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.9 mp -105.58 151.15 24.69 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.913 1.685 . . . . 0.0 107.734 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -124.4 109.05 12.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.103 1.361 . . . . 0.0 108.677 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -142.49 152.76 43.01 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 45.78 32.52 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.479 1.912 . . . . 0.0 111.354 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.06 -9.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.782 2.833 . . . . 0.0 112.813 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.97 -176.02 5.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.971 2.108 . . . . 0.0 110.747 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.05 126.18 21.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 127.619 2.368 . . . . 0.0 110.589 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -139.58 155.77 47.27 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.464 -1.397 . . . . 0.0 113.689 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.17 154.67 41.64 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.554 ' HA ' HD13 ' A' ' 51' ' ' LEU . 25.2 tm0? -53.15 -51.69 61.16 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.248 1.019 . . . . 0.0 111.283 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -52.54 -46.06 66.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.018 1.281 . . . . 0.0 111.272 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.5 m -65.45 -47.03 77.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.469 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -17.08 73.43 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.041 0.837 . . . . 0.0 112.743 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.445 -0.7 0 C-N-CA 125.229 1.412 . . . . 0.0 108.44 179.919 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.8 125.3 24.39 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 116.732 -1.604 . . . . 0.0 107.39 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -57.94 -27.28 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 120.841 1.655 . . . . 0.0 109.015 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.22 12.12 14.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.982 2.913 . . . . 0.0 116.831 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -171.7 -7.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 118.609 -2.557 . . . . 0.0 114.229 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 58.28 9.85 1.13 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.644 2.778 . . . . 0.0 114.658 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -72.74 154.92 91.19 Favored Pre-proline 0 CA--C 1.517 -0.299 0 O-C-N 120.868 -1.145 . . . . 0.0 110.662 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.61 146.34 84.18 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.364 2.042 . . . . 0.0 108.871 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.4 mt -109.32 122.0 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.772 2.429 . . . . 0.0 106.772 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m . . . . . 0 N--CA 1.445 -0.683 0 C-N-CA 124.494 1.118 . . . . 0.0 108.603 -179.873 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--O 1.239 0.517 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.28 165.35 28.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 111.297 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -128.99 146.28 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.808 1.643 . . . . 0.0 107.765 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -132.81 119.06 19.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.75 143.89 48.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 37.2 56.14 1.31 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.07 1.748 . . . . 0.0 114.178 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t0 55.14 24.59 6.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.678 1.191 . . . . 0.0 112.806 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 14.7 m -127.69 131.49 49.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.777 1.631 . . . . 0.0 109.949 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -90.73 130.28 36.74 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.393 0.677 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 2.6 m-90 -131.09 133.32 45.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.501 1.143 . . . . 0.0 110.873 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.39 154.35 41.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 p -61.22 -36.24 79.39 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -74.07 4.25 5.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.746 1.618 . . . . 0.0 113.12 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -139.97 21.75 2.45 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.445 1.021 . . . . 0.0 113.002 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -109.34 99.76 8.96 Favored 'General case' 0 C--O 1.237 0.443 1 N-CA-C 98.356 -4.683 . . . . 0.0 98.356 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -152.63 176.16 12.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.8 t -59.69 111.64 1.51 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.891 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.82 13.22 0.09 OUTLIER Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.165 1.84 . . . . 0.0 115.348 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -128.03 -18.64 4.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.411 2.684 . . . . 0.0 112.757 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 -17.43 0.82 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 m 84.36 1.43 0.87 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.224 1.81 . . . . 0.0 115.463 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.81 126.44 28.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 t -52.05 142.81 15.22 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.475 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -115.81 -2.5 12.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.809 1.244 . . . . 0.0 110.924 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.17 126.12 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.647 0.779 . . . . 0.0 109.356 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.36 69.48 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.016 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -131.45 167.25 19.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 121.128 2.464 . . . . 0.0 112.547 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.97 127.73 33.45 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.01 171.49 14.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.732 1.213 . . . . 0.0 110.015 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.7 mp -121.52 156.55 32.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.885 1.674 . . . . 0.0 109.188 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 p -137.45 102.59 4.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.28 147.64 47.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 108.757 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 52.81 23.78 2.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.775 2.03 . . . . 0.0 114.322 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? 78.61 12.4 1.52 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.043 2.137 . . . . 0.0 111.784 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -105.78 -178.39 3.64 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.748 -1.22 . . . . 0.0 109.4 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -128.45 122.17 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.714 1.606 . . . . 0.0 108.395 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -138.08 157.28 46.65 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 123.111 1.434 . . . . 0.0 114.794 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.45 155.52 37.93 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.539 ' HA ' HD13 ' A' ' 51' ' ' LEU . 12.6 tt0 -47.26 -52.92 14.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.765 0.711 . . . . 0.0 111.557 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -58.57 7.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.534 0.734 . . . . 0.0 112.171 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.11 -23.11 44.71 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.619 -1.181 . . . . 0.0 113.728 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.36 -24.13 10.53 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 120.213 1.37 . . . . 0.0 112.355 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 179.776 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.681 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 11.6 t -61.89 126.04 25.94 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.89 -20.23 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 119.336 0.971 . . . . 0.0 111.493 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.73 3.62 45.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 115.487 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -155.94 -9.69 0.11 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.023 -1.673 . . . . 0.0 113.723 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m 53.38 29.06 8.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.533 1.933 . . . . 0.0 111.675 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -89.41 151.09 45.82 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.802 -1.186 . . . . 0.0 108.178 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 118.37 5.64 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.273 1.982 . . . . 0.0 110.027 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mm -65.29 162.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.514 1.526 . . . . 0.0 107.632 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm . . . . . 0 C--O 1.24 0.554 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -142.32 164.51 29.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.558 1.943 . . . . 0.0 106.644 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.59 130.34 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.234 1.814 . . . . 0.0 106.427 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.7 124.11 38.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.05 122.56 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 40.92 59.02 2.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.998 1.719 . . . . 0.0 112.848 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 63.66 12.23 6.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.265 2.226 . . . . 0.0 114.913 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 158.51 28.79 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.547 -1.346 . . . . 0.0 110.629 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.24 133.26 56.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.588 0.709 . . . . 0.0 110.855 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -123.88 126.8 47.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -67.08 148.79 51.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.11 -51.64 23.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.098 0.863 . . . . 0.0 112.438 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.22 -13.33 61.87 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -102.64 -12.68 17.53 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -80.43 101.52 9.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.24 168.57 19.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.2 t -65.23 114.91 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 116.663 -1.637 . . . . 0.0 110.049 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.82 -18.62 25.96 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.498 1.045 . . . . 0.0 115.528 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.13 -17.37 23.85 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.0 -20.21 0.5 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 118.601 2.815 . . . . 0.0 118.601 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 m 77.14 80.54 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.536 1.062 . . . . 0.0 109.888 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.64 141.57 18.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 126.832 2.053 . . . . 0.0 105.749 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -58.56 121.7 11.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.79 1.306 . . . . 0.0 113.626 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.4 mt -99.37 1.73 44.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.072 0.949 . . . . 0.0 109.659 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.68 140.71 19.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 -62.19 3.84 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.252 1.406 . . . . 0.0 112.777 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 164.81 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.849 0.859 . . . . 0.0 112.494 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.3 156.44 39.39 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.433 ' C ' HD12 ' A' ' 51' ' ' LEU . 30.9 p90 -137.93 168.48 19.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.586 1.154 . . . . 0.0 107.946 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.433 HD12 ' C ' ' A' ' 50' ' ' PHE . 6.8 mp -122.61 161.01 24.56 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.7 p -127.41 115.82 19.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.247 1.419 . . . . 0.0 107.607 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -143.17 150.59 39.6 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 51.39 24.72 2.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.896 1.678 . . . . 0.0 114.107 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt 73.79 9.99 4.76 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.751 2.02 . . . . 0.0 111.277 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -110.68 -178.01 3.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.06 2.144 . . . . 0.0 110.136 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.3 pt -123.96 126.99 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.892 0.877 . . . . 0.0 110.465 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -130.28 163.32 27.04 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.468 -1.395 . . . . 0.0 113.254 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.21 156.98 19.44 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -57.36 -47.05 82.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 119.257 0.935 . . . . 0.0 110.136 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -52.25 -37.43 55.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.75 -1.219 . . . . 0.0 113.541 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.77 -35.6 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.234 1.014 . . . . 0.0 110.622 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.79 33.32 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.104 1.335 . . . . 0.0 110.005 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.449 -0.522 0 CA-C-N 118.783 1.291 . . . . 0.0 110.739 -177.895 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 N-CA-C 115.325 0.89 . . . . 0.0 115.325 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 15.0 t -50.52 117.28 2.34 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.582 -1.199 . . . . 0.0 107.948 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -54.97 -27.34 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 120.94 1.7 . . . . 0.0 110.83 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.86 -3.69 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.673 1.989 . . . . 0.0 115.175 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -152.62 -10.25 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.446 1.476 . . . . 0.0 114.24 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m 60.3 10.32 2.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.517 3.527 . . . . 0.0 115.642 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -75.67 151.54 84.84 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 120.911 1.687 . . . . 0.0 112.403 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -66.94 139.43 51.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.817 2.344 . . . . 0.0 109.019 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.76 156.71 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.415 2.286 . . . . 0.0 108.68 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 124.321 1.049 . . . . 0.0 111.146 178.523 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 C--O 1.236 0.362 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -130.83 164.58 24.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.51 0.724 . . . . 0.0 111.077 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 mm -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 128.837 2.855 . . . . 0.0 105.932 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.34 102.96 15.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -135.49 127.22 29.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.403 1.002 . . . . 0.0 110.632 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 50.24 45.44 25.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.38 1.072 . . . . 0.0 109.227 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.91 -17.55 0.25 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 129.735 3.214 . . . . 0.0 114.325 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 m -73.64 164.53 26.52 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.133 0.879 . . . . 0.0 109.3 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -128.95 107.73 9.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -109.05 125.57 52.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 111.12 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -60.47 150.08 32.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -55.33 -42.42 73.77 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.72 -3.82 20.56 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.2 -1.46 11.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 128.959 2.904 . . . . 0.0 113.909 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.98 102.57 15.14 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -152.77 174.59 13.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.27 120.47 11.63 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 117.264 -1.35 . . . . 0.0 110.075 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.14 -12.27 29.8 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.627 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.37 -19.67 16.18 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.52 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -141.98 -10.59 0.88 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 81.11 1.22 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.52 HG12 ' SG ' ' A' ' 41' ' ' CYS . 11.8 p -65.23 138.9 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.218 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -55.33 134.25 50.01 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.313 1.045 . . . . 0.0 111.773 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 mt -117.99 4.75 12.09 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.69 -1.148 . . . . 0.0 109.695 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 46' ' ' VAL . 22.9 t -36.76 103.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.482 1.913 . . . . 0.0 112.525 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 -25.17 0.9 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 129.064 3.221 . . . . 0.0 115.928 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -55.0 138.27 44.21 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.662 1.985 . . . . 0.0 112.128 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.14 121.73 27.14 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -116.36 172.6 7.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.866 2.067 . . . . 0.0 111.719 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.01 148.12 33.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.0 p -126.52 117.26 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.11 143.93 32.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 50.6 28.74 3.64 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.981 1.264 . . . . 0.0 113.958 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm 64.85 22.72 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.734 1.214 . . . . 0.0 111.145 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -110.2 178.57 4.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.129 2.172 . . . . 0.0 106.751 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.81 122.95 55.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 109.532 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -131.55 154.58 48.67 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 122.893 1.33 . . . . 0.0 113.197 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 164.51 19.75 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -59.02 -54.44 47.1 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.925 0.784 . . . . 0.0 111.135 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -50.52 -30.18 12.33 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.4 m -93.96 -30.72 14.6 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.231 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.55 7.53 59.67 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.96 1.255 . . . . 0.0 115.356 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.234 0.246 0 CA-C-N 119.455 1.628 . . . . 0.0 113.276 -179.05 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 CA-C-O 120.127 -0.263 . . . . 0.0 112.743 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 12.4 t -52.13 115.38 1.68 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.737 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 29' ' ' SER . 80.2 t -54.94 -24.36 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 121.287 1.858 . . . . 0.0 112.481 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.96 -0.57 56.81 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.666 1.186 . . . . 0.0 113.841 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.8 p -156.71 -11.37 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.268 1.849 . . . . 0.0 115.075 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t 52.44 57.63 6.23 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.004 2.522 . . . . 0.0 111.598 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -117.84 147.11 40.46 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.883 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.55 114.03 2.94 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.013 3.142 . . . . 0.0 113.537 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -82.95 162.09 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 CA--C 1.529 0.159 0 O-C-N 120.69 -1.256 . . . . 0.0 110.657 179.171 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.39 165.72 26.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.544 1.938 . . . . 0.0 109.294 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mm -116.52 150.37 18.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -131.38 135.08 46.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -145.21 111.38 5.61 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.43 56.81 6.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.143 0.973 . . . . 0.0 109.682 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 -16.89 0.09 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 130.013 3.325 . . . . 0.0 115.191 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' HG21 ' A' ' 9' ' ' VAL . 72.7 m -80.08 145.64 32.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -119.87 141.69 49.34 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.976 0.893 . . . . 0.0 112.528 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.8 m-90 -132.86 162.9 30.33 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.145 1.378 . . . . 0.0 111.143 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -79.78 148.43 31.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.4 t -60.55 -8.94 3.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.728 2.011 . . . . 0.0 115.042 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.96 -36.74 5.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.001 1.721 . . . . 0.0 108.83 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.26 18.28 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.866 1.667 . . . . 0.0 114.913 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -113.2 101.35 9.34 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -148.57 174.72 11.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -61.19 121.05 11.56 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.503 1.521 . . . . 0.0 109.779 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.49 -25.75 58.55 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 118.133 0.424 . . . . 0.0 113.069 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -87.45 -18.8 29.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.63 -9.92 0.41 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 119.082 2.993 . . . . 0.0 119.082 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 83.44 3.23 0.94 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.37 133.69 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.445 1.475 . . . . 0.0 107.303 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.0 t -57.36 144.67 35.2 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.684 0.754 . . . . 0.0 109.852 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.21 -6.56 14.1 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.325 . . . . 0.0 110.197 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.82 120.24 10.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.73 84.83 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 116.163 -2.465 . . . . 0.0 115.923 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -135.21 169.47 17.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.635 2.717 . . . . 0.0 112.204 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.25 123.54 25.92 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -116.62 167.88 10.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.19 159.81 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.8 p -132.3 112.06 11.9 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.919 0.762 . . . . 0.0 109.504 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -142.7 156.12 44.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.632 1.573 . . . . 0.0 107.341 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.9 m120 52.5 30.73 8.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.349 1.06 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.7 27.43 14.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.03 1.332 . . . . 0.0 110.708 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -125.63 175.55 7.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.192 2.197 . . . . 0.0 110.24 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.39 126.4 69.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 127.715 2.406 . . . . 0.0 110.021 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -134.03 163.52 29.37 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 161.2 16.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -50.23 -56.39 11.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.772 1.229 . . . . 0.0 111.215 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -49.8 -33.63 17.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 113.249 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.2 -54.85 5.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.369 0.668 . . . . 0.0 109.319 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.72 26.62 4.62 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 115.621 1.008 . . . . 0.0 115.621 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.734 0 CA-C-N 119.578 1.689 . . . . 0.0 112.776 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.959 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m -62.73 -6.22 3.44 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -71.07 -13.57 62.02 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.85 -178.96 48.81 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 120.544 1.52 . . . . 0.0 112.061 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.7 t -108.76 175.56 5.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.394 1.478 . . . . 0.0 109.012 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -158.69 179.46 9.09 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.451 1.5 . . . . 0.0 110.876 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.76 176.53 19.43 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.752 1.644 . . . . 0.0 110.488 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 t -43.0 118.49 1.28 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 116.197 -1.859 . . . . 0.0 110.423 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.15 -31.36 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 121.753 2.069 . . . . 0.0 112.025 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.68 -5.37 59.31 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -157.95 -7.66 0.08 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 0.1 OUTLIER 61.77 14.34 6.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 130.164 3.386 . . . . 0.0 114.914 -178.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -78.25 147.04 71.97 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 120.453 -1.404 . . . . 0.0 108.646 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.16 120.32 6.93 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.259 2.639 . . . . 0.0 110.07 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mm -66.53 140.45 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 p -82.23 79.56 8.68 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 14.29 -101.55 0.01 OUTLIER Glycine 0 C--N 1.335 0.507 1 C-N-CA 131.118 4.199 . . . . 0.0 114.388 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mp -127.11 30.14 5.48 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.218 1.807 . . . . 0.0 107.176 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.1 m -67.12 -7.35 22.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.216 1.806 . . . . 0.0 113.123 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.98 9.88 15.16 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.045 -1.034 . . . . 0.0 113.735 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.71 159.69 30.84 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.791 1.296 . . . . 0.0 109.461 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -97.11 109.09 21.92 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -134.43 164.28 27.8 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.499 0.72 . . . . 0.0 110.514 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mm -122.43 145.96 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 127.271 2.229 . . . . 0.0 106.283 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -126.83 102.82 7.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -121.95 127.62 50.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 52.85 43.59 31.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.968 0.907 . . . . 0.0 108.781 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 56.91 0.51 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.007 2.523 . . . . 0.0 114.41 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 m -85.39 156.46 20.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.932 1.693 . . . . 0.0 107.831 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.99 130.31 51.63 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -132.3 145.09 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.647 1.179 . . . . 0.0 109.026 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -98.39 161.26 13.78 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 p -53.09 -55.02 27.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.938 0.895 . . . . 0.0 111.651 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.29 -4.05 9.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.054 1.341 . . . . 0.0 112.98 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -121.48 14.87 11.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.911 1.284 . . . . 0.0 113.298 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -107.41 101.3 10.67 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -157.2 167.04 31.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.4 t -64.86 120.83 13.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 117.111 -1.423 . . . . 0.0 109.799 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.04 -28.66 58.56 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.917 1.235 . . . . 0.0 114.396 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -81.04 -19.86 42.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.6 p -139.71 -23.05 0.87 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t 87.76 7.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.356 1.863 . . . . 0.0 114.467 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.94 135.23 27.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -60.21 132.34 53.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -98.21 -1.6 41.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.673 0.789 . . . . 0.0 108.946 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.06 109.49 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.23 -65.93 0.31 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 126.069 1.795 . . . . 0.0 109.072 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -66.65 157.08 33.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.049 0.94 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.06 20.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -106.59 168.77 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.215 1.006 . . . . 0.0 109.187 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.95 152.28 42.66 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.868 1.667 . . . . 0.0 108.365 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.0 p -134.23 114.85 13.49 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.535 1.134 . . . . 0.0 110.6 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.446 ' HG2' HD22 ' A' ' 54' ' ' ASN . 31.8 tt0 -142.64 143.23 32.28 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.622 1.569 . . . . 0.0 106.907 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.446 HD22 ' HG2' ' A' ' 53' ' ' GLN . 8.8 m-80 53.76 25.32 5.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.873 0.869 . . . . 0.0 111.493 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt 73.15 3.61 4.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.119 1.768 . . . . 0.0 111.127 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.7 153.18 18.41 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.289 1.436 . . . . 0.0 109.825 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.75 122.46 55.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 126.551 1.94 . . . . 0.0 109.931 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -137.13 166.49 23.6 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.795 1.283 . . . . 0.0 111.848 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -84.24 163.6 19.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -55.74 -55.51 31.42 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.052 1.341 . . . . 0.0 111.306 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -52.71 -48.87 66.33 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.361 -0.837 . . . . 0.0 112.886 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 m -68.62 -44.59 73.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.349 0.66 . . . . 0.0 110.184 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 22.59 7.65 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 120.939 -1.1 . . . . 0.0 113.759 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m -75.3 92.62 2.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.369 1.585 . . . . 0.0 107.441 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.93 56.25 3.52 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.53 1.538 . . . . 0.0 111.612 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.76 132.96 52.57 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -85.34 63.0 7.84 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.0 p -59.35 -66.54 0.49 Allowed 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.502 -0.749 . . . . 0.0 111.863 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.04 167.79 28.38 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.598 2.359 . . . . 0.0 109.719 -176.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -92.48 6.22 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.731 1.612 . . . . 0.0 112.551 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.2 t -152.81 151.63 30.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.26 -74.49 0.44 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 106.751 -2.539 . . . . 0.0 106.751 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.3 62.06 6.8 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.9 3.067 . . . . 0.0 110.628 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 m -162.78 179.26 7.78 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.858 2.863 . . . . 0.0 107.564 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.4 100.49 5.99 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 N-CA-C 105.634 -2.987 . . . . 0.0 105.634 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.762 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -71.35 130.38 41.21 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.7 -9.98 35.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.806 0.842 . . . . 0.0 110.856 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.71 -174.27 30.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.6 p -113.55 1.1 14.87 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.152 -1.404 . . . . 0.0 113.139 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 m 3.71 89.81 0.01 OUTLIER 'General case' 0 C--O 1.24 0.579 0 C-N-CA 130.237 3.415 . . . . 0.0 112.522 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.25 -168.85 23.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.492 -0.861 . . . . 0.0 115.149 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.6 t -60.71 113.56 2.54 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 117.243 -1.36 . . . . 0.0 110.21 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.6 t -57.83 -20.36 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 120.091 1.314 . . . . 0.0 110.438 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.6 -3.76 58.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.072 1.349 . . . . 0.0 114.078 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 8.0 p -155.44 -10.53 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.408 1.913 . . . . 0.0 115.673 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m 55.17 53.32 10.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.331 2.252 . . . . 0.0 112.589 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -113.7 137.3 22.18 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 108.61 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.92 3.08 . . . . 0.0 110.113 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.44 129.83 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.65 173.56 1.25 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.69 0.396 . . . . 0.0 111.819 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.53 -174.06 3.67 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.22 19.97 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.045 1.338 . . . . 0.0 114.604 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 t -72.8 32.19 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.444 3.098 . . . . 0.0 111.494 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.25 2.63 57.89 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.583 -1.323 . . . . 0.0 113.638 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 105.96 0.73 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.335 1.067 . . . . 0.0 109.684 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -74.46 117.61 16.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -137.89 166.77 23.23 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.406 1.882 . . . . 0.0 109.991 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.2 mm -125.25 114.87 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 p -104.41 117.29 33.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.139 1.776 . . . . 0.0 107.525 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -145.58 143.48 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.209 1.004 . . . . 0.0 109.218 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 31.52 60.37 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.872 2.469 . . . . 0.0 114.372 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 65.19 5.36 3.0 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.916 2.487 . . . . 0.0 114.972 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -116.09 161.85 18.3 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 0.0 111.079 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -125.72 141.1 52.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.462 1.125 . . . . 0.0 110.168 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -132.58 152.42 51.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.225 1.41 . . . . 0.0 109.555 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -86.15 141.57 29.27 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.67 -55.79 4.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.021 1.328 . . . . 0.0 111.071 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -65.56 -12.68 55.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.3 m -118.15 16.56 14.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.411 0.685 . . . . 0.0 111.869 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -106.92 101.56 10.99 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.88 176.34 12.28 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.9 t -58.11 118.93 5.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 117.088 -1.434 . . . . 0.0 109.731 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.07 -11.51 12.23 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 123.968 0.793 . . . . 0.0 114.787 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -102.74 -21.52 14.06 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.093 1.357 . . . . 0.0 114.595 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.68 -14.21 0.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 117.993 2.59 . . . . 0.0 117.993 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 t 81.62 27.46 0.18 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.833 1.652 . . . . 0.0 114.725 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.75 128.49 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -51.3 136.51 24.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.141 1.377 . . . . 0.0 111.691 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.1 mt -112.41 3.74 17.11 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.561 1.144 . . . . 0.0 110.215 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.81 105.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 126.594 1.958 . . . . 0.0 108.641 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.45 36.13 92.08 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.517 -0.602 . . . . 0.0 112.154 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -132.99 160.97 35.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.483 1.141 . . . . 0.0 107.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.44 124.82 30.29 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -133.7 171.08 14.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.511 1.125 . . . . 0.0 109.243 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 60' ' ' GLN . 5.1 mp -136.13 156.84 48.11 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.271 1.828 . . . . 0.0 106.442 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.4 p -137.46 115.4 11.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -142.48 145.79 34.07 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 48.42 41.92 17.54 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.909 1.283 . . . . 0.0 111.465 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.397 5.0 ptpp? 61.43 7.87 1.95 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 129.189 2.995 . . . . 0.0 114.62 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -96.95 178.07 5.4 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.368 1.44 . . . . 0.0 110.889 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.31 122.81 60.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 109.535 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.14 160.14 35.61 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 120.667 -1.27 . . . . 0.0 112.811 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.91 162.43 16.91 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.654 ' HA ' HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.28 -52.73 60.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.041 1.291 . . . . 0.0 111.372 178.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -40.28 61.29 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.145 1.339 . . . . 0.0 113.302 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -78.46 -29.05 46.65 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.715 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.47 13.76 61.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.108 1.813 . . . . 0.0 113.342 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 t -84.17 79.73 9.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.6 156.21 4.83 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.4 ttm -145.22 120.03 9.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -120.82 94.81 4.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.2 t -161.1 -22.35 0.05 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.55 0.74 . . . . 0.0 112.53 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -156.31 110.04 2.72 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.9 mt -77.28 72.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.4 m -71.84 64.19 0.48 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 128.186 2.594 . . . . 0.0 109.086 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.08 73.59 0.32 Allowed Glycine 0 C--N 1.334 0.447 0 CA-C-O 117.949 -1.473 . . . . 0.0 114.344 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.6 22.7 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.28 2.653 . . . . 0.0 111.949 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.4 p -55.71 -45.4 77.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.126 1.77 . . . . 0.0 109.312 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.6 m -142.02 179.78 6.68 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 128.268 2.627 . . . . 0.0 107.443 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.188 0 N-CA-C 105.574 -3.01 . . . . 0.0 105.574 -179.851 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 t -114.57 164.95 13.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -161.77 168.66 22.79 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.133 1.373 . . . . 0.0 107.764 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.46 60.05 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 m -125.7 116.35 21.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.242 1.017 . . . . 0.0 108.72 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 m -67.4 88.56 0.2 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.32 1.448 . . . . 0.0 109.898 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.79 -165.77 38.23 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 126.291 1.901 . . . . 0.0 108.368 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 11.4 t -58.56 125.4 23.24 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 117.619 -1.182 . . . . 0.0 108.943 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.3 -17.01 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 124.731 1.213 . . . . 0.0 112.052 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.85 9.43 22.48 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.239 2.216 . . . . 0.0 115.083 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -161.1 -5.3 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.426 -1.421 . . . . 0.0 114.351 178.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t 62.15 0.6 0.59 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.381 1.872 . . . . 0.0 113.755 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -82.58 156.4 68.21 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 122.359 2.345 . . . . 0.0 112.271 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.23 122.82 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.452 2.101 . . . . 0.0 108.837 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -76.33 151.26 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 t -66.17 139.33 58.12 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.44 -176.08 10.91 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.09 37.9 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.215 2.606 . . . . 0.0 116.274 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 t -99.0 32.08 2.79 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.702 2.401 . . . . 0.0 107.52 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.19 38.73 7.15 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 124.553 1.073 . . . . 0.0 110.566 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.94 107.58 20.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.396 1.479 . . . . 0.0 112.625 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -64.6 110.77 2.45 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.23 1.012 . . . . 0.0 110.187 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -137.41 164.65 28.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.538 1.535 . . . . 0.0 108.844 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.5 mm -123.29 140.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -131.47 132.94 44.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.731 2.012 . . . . 0.0 106.272 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -145.57 102.74 3.73 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.703 1.601 . . . . 0.0 108.587 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.5 64.68 1.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.47 1.108 . . . . 0.0 109.796 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 49.8 t0 42.66 67.32 0.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 128.468 2.707 . . . . 0.0 113.245 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.8 p -134.99 165.68 24.77 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 130.103 3.361 . . . . 0.0 106.951 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -142.53 118.06 10.34 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -131.55 131.61 43.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.305 1.042 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -66.45 154.97 38.83 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -53.03 -43.41 66.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.157 0.98 . . . . 0.0 111.285 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.62 -2.69 33.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.7 m -121.12 18.68 11.61 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.35 1.46 . . . . 0.0 114.442 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -112.38 100.08 8.51 Favored 'General case' 0 C--O 1.235 0.333 1 N-CA-C 100.193 -4.002 . . . . 0.0 100.193 176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.63 160.53 40.12 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.7 t -58.9 124.23 19.15 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.444 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.88 -28.06 72.15 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 118.425 0.557 . . . . 0.0 113.362 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -78.83 -28.63 44.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.78 -10.84 1.02 Allowed 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t 72.62 87.77 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.907 1.337 . . . . 0.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.98 143.29 18.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 127.556 2.342 . . . . 0.0 104.801 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.7 t -65.55 142.71 58.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.252 1.025 . . . . 0.0 109.867 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.32 13.15 11.87 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.044 1.738 . . . . 0.0 109.658 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.9 t -76.97 -63.49 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 119.035 0.834 . . . . 0.0 108.761 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.61 11.9 6.6 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.765 -1.019 . . . . 0.0 115.206 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.97 159.1 44.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.665 1.732 . . . . 0.0 109.897 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.65 159.14 52.41 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -132.46 167.4 20.03 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.697 1.599 . . . . 0.0 108.425 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 60' ' ' GLN . 10.3 mp -125.29 159.02 32.7 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.2 p -126.72 107.84 10.53 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.991 1.716 . . . . 0.0 109.489 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -142.44 155.21 45.07 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m120 47.66 41.53 13.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.873 1.269 . . . . 0.0 112.197 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt 50.74 19.75 0.65 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.931 2.092 . . . . 0.0 113.882 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -123.82 176.26 6.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.494 1.918 . . . . 0.0 109.389 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.6 pt -112.92 131.67 63.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.674 1.189 . . . . 0.0 111.511 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -136.0 165.51 25.5 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 122.51 1.148 . . . . 0.0 113.69 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.72 156.64 20.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.472 ' HA ' HD13 ' A' ' 51' ' ' LEU . 74.6 mt-30 -54.9 -52.38 63.06 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.532 1.133 . . . . 0.0 109.554 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -55.07 -26.14 35.67 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.219 -1.551 . . . . 0.0 114.558 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.21 -22.97 16.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.731 1.612 . . . . 0.0 112.808 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.3 -4.38 55.13 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.492 1.044 . . . . 0.0 113.529 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.1 t -61.9 107.56 0.87 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.914 1.686 . . . . 0.0 108.023 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.47 -173.62 26.65 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 126.163 1.84 . . . . 0.0 108.999 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -140.24 -30.97 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.01 1.324 . . . . 0.0 110.114 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.6 13.42 7.28 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.608 1.963 . . . . 0.0 113.915 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.413 HG23 HG12 ' A' ' 70' ' ' ILE . 7.5 t -146.36 145.85 30.45 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.523 1.056 . . . . 0.0 108.528 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -72.75 -7.29 49.85 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.776 2.03 . . . . 0.0 115.684 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.413 HG12 HG23 ' A' ' 68' ' ' THR . 48.3 pt -64.98 153.46 8.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 122.273 1.035 . . . . 0.0 111.492 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.4 p -125.59 55.67 1.41 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.455 1.902 . . . . 0.0 106.985 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.51 156.22 39.36 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.76 124.73 9.94 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.851 1.701 . . . . 0.0 107.851 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 p -167.24 154.34 8.68 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 127.138 2.175 . . . . 0.0 105.556 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 p -159.84 100.07 1.41 Allowed 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.634 -0.667 . . . . 0.0 111.127 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 178.542 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.516 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 t -129.76 127.45 40.41 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.986 0.914 . . . . 0.0 109.581 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 t -77.84 -30.88 51.24 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.28 178.36 47.48 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 125.671 1.605 . . . . 0.0 114.154 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 m -133.86 154.37 51.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.16 2.584 . . . . 0.0 104.293 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 55.65 64.42 1.75 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.822 1.192 . . . . 0.0 111.346 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.79 -171.49 42.11 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 18.0 t -49.54 124.67 9.84 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 120.203 2.002 . . . . 0.0 108.32 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.23 -8.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 120.581 1.537 . . . . 0.0 110.964 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.07 7.16 27.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.703 2.001 . . . . 0.0 113.159 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.9 p -167.66 -5.34 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 121.225 1.829 . . . . 0.0 115.774 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.368 0.1 OUTLIER 56.06 18.79 3.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.128 2.171 . . . . 0.0 114.666 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -82.82 144.45 48.27 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.34 128.51 14.67 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.648 2.232 . . . . 0.0 110.239 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.8 mt -78.87 162.18 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 t -107.97 88.33 2.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.73 169.17 52.63 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.0 tp 48.54 28.32 1.71 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.264 1.425 . . . . 0.0 112.399 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.4 m -125.83 -12.15 6.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.79 1.236 . . . . 0.0 113.204 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.07 30.67 19.53 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.12 154.76 40.45 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.656 0.782 . . . . 0.0 111.322 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -85.99 75.22 9.99 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -119.24 158.53 25.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.405 HG21 ' CE1' ' A' ' 36' ' ' PHE . 3.9 mp -118.85 131.67 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.08 116.11 22.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.117 2.167 . . . . 0.0 107.549 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -145.76 131.25 18.73 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.233 1.813 . . . . 0.0 107.172 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 36.32 63.13 0.65 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.669 1.988 . . . . 0.0 111.918 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 60.19 -3.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 128.035 2.534 . . . . 0.0 115.749 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -80.45 160.63 25.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.492 1.117 . . . . 0.0 108.179 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -136.69 113.87 10.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -118.91 149.95 40.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.584 1.154 . . . . 0.0 111.021 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -86.56 147.37 25.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.0 t -49.39 -52.78 26.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.613 1.097 . . . . 0.0 110.669 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -57.76 -31.07 66.13 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.49 -4.92 52.86 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.405 ' CE1' HG21 ' A' ' 24' ' ' ILE . 47.8 t80 -80.93 99.36 8.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.38 161.76 37.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.086 1.355 . . . . 0.0 112.563 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.68 145.7 55.23 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.099 1.36 . . . . 0.0 112.701 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.39 -49.27 15.74 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 123.797 0.686 . . . . 0.0 111.915 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -75.53 -23.14 56.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -133.57 -7.43 2.87 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -178.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 m 72.49 -0.75 3.19 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 41' ' ' CYS . 4.0 p -71.06 147.03 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 121.038 1.744 . . . . 0.0 111.251 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -71.81 149.59 45.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.583 0.628 . . . . 0.0 111.968 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.13 -6.56 13.66 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.985 0.803 . . . . 0.0 112.412 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.65 95.83 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.58 11.56 24.81 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.877 1.227 . . . . 0.0 113.175 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -127.55 141.01 51.76 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.498 1.149 . . . . 0.0 108.305 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.95 88.78 0.66 Allowed Glycine 0 C--N 1.331 0.281 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -85.44 168.07 14.92 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.766 0.783 . . . . 0.0 110.296 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 mp -117.68 158.89 23.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.224 1.809 . . . . 0.0 106.918 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.3 p -128.71 122.6 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -143.51 153.21 42.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 m120 47.06 36.99 4.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm 58.89 30.4 20.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.327 1.051 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -129.19 166.64 18.96 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.913 1.685 . . . . 0.0 108.921 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.82 120.8 63.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 126.128 1.771 . . . . 0.0 108.487 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -131.31 139.48 49.58 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.007 -1.683 . . . . 0.0 113.054 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.58 144.52 31.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 114.521 -2.657 . . . . 0.0 106.024 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -30.06 -53.16 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.791 3.236 . . . . 0.0 112.304 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -47.83 -40.31 20.86 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.953 0.797 . . . . 0.0 112.296 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 29.2 m -80.14 -44.13 20.44 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.02 14.97 5.59 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 120.954 -1.091 . . . . 0.0 113.6 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.3 t -82.61 53.99 2.51 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.65 -83.51 0.9 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 94.3 mmm -134.94 146.26 48.95 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.085 1.754 . . . . 0.0 107.923 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.96 52.78 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.038 2.135 . . . . 0.0 108.116 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.9 t -60.98 144.94 52.31 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.82 -1.175 . . . . 0.0 109.287 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.05 -177.27 6.19 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 128.355 2.662 . . . . 0.0 107.224 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.1 pt -78.05 152.15 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.1 t -71.72 -43.38 65.98 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.19 177.52 25.1 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.385 0.993 . . . . 0.0 111.544 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -76.29 -177.89 4.03 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 124.096 3.197 . . . . 0.0 109.055 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -60.4 143.14 53.89 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.6 p -63.67 122.86 17.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 109.783 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.212 0 N-CA-C 105.707 -2.957 . . . . 0.0 105.707 179.333 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.838 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 p -72.89 -84.27 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.237 1.815 . . . . 0.0 108.805 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.64 95.43 0.86 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.468 1.907 . . . . 0.0 107.747 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.93 156.84 27.11 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -84.27 102.8 12.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.841 1.257 . . . . 0.0 108.546 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.8 m -55.98 153.15 9.18 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.49 179.88 31.13 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.213 1.387 . . . . 0.0 109.753 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 18.1 t -61.28 117.24 5.37 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 116.31 -1.805 . . . . 0.0 107.761 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 29' ' ' SER . 88.0 t -52.3 -30.54 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 121.067 1.758 . . . . 0.0 112.161 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.83 -12.02 58.69 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 1.8 p -139.49 -13.51 1.14 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.733 1.606 . . . . 0.0 113.413 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m 52.77 56.04 8.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 128.396 2.679 . . . . 0.0 111.665 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -124.86 149.23 62.21 Favored Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 117.773 -1.108 . . . . 0.0 108.748 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.87 114.74 3.82 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.606 2.204 . . . . 0.0 109.042 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.76 138.76 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 107.542 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -66.1 150.87 48.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.544 0.611 . . . . 0.0 111.079 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.41 146.82 18.76 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mp 39.17 48.89 1.62 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.064 2.146 . . . . 0.0 113.749 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.31 11.92 5.95 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 120.669 -1.269 . . . . 0.0 111.863 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.55 17.77 79.63 Favored Glycine 0 CA--C 1.537 1.448 0 O-C-N 121.072 -1.017 . . . . 0.0 111.058 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 110.83 3.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -71.74 71.13 0.73 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.944 0.878 . . . . 0.0 112.086 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.58 165.26 18.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.559 1.544 . . . . 0.0 109.523 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 mt -130.19 152.94 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 126.218 1.807 . . . . 0.0 106.611 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 t -131.8 131.72 43.13 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.557 1.543 . . . . 0.0 108.399 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -146.42 136.24 23.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.116 1.366 . . . . 0.0 107.811 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 48.15 38.12 9.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 112.605 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 65.51 6.47 3.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.374 1.469 . . . . 0.0 112.959 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 9' ' ' VAL . 15.4 m -102.08 160.98 14.04 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.426 2.29 . . . . 0.0 105.73 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -132.14 144.86 50.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 119.936 -1.728 . . . . 0.0 113.363 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -133.43 145.08 49.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.238 1.015 . . . . 0.0 111.327 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -80.68 157.69 25.83 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 p -53.62 -49.77 67.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.867 0.867 . . . . 0.0 111.846 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -12.64 60.52 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.75 4.77 24.06 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.277 1.831 . . . . 0.0 113.714 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -101.28 99.89 10.33 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -155.24 166.41 33.64 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -58.48 119.77 7.61 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 116.821 -1.561 . . . . 0.0 112.45 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.27 49.81 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-N 119.453 1.024 . . . . 0.0 112.225 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -92.0 -17.52 24.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -148.72 -4.96 0.43 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m 74.47 1.14 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.77 134.61 29.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.9 t -59.38 145.52 43.22 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 124.242 0.964 . . . . 0.0 110.472 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -118.33 4.6 11.85 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.137 1.775 . . . . 0.0 110.058 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.91 91.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.111 0.964 . . . . 0.0 110.524 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.51 -58.98 0.69 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 125.875 1.702 . . . . 0.0 111.668 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -61.64 148.42 42.58 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.352 0.576 . . . . 0.0 110.687 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.42 115.03 7.36 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 105.52 -3.032 . . . . 0.0 105.52 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -85.16 170.38 12.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 109.137 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.7 160.74 32.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.693 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.7 p -137.72 104.5 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 110.247 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -141.16 153.57 45.41 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.89 1.676 . . . . 0.0 107.246 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.89 31.6 3.3 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.272 1.029 . . . . 0.0 113.396 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.4 mmtm 60.37 21.46 11.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.005 1.722 . . . . 0.0 112.007 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -125.43 174.83 7.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.49 1.516 . . . . 0.0 109.579 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -117.31 122.7 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.977 1.311 . . . . 0.0 111.037 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.78 148.23 50.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.382 1.087 . . . . 0.0 113.586 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.67 162.68 29.07 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -50.22 -52.94 31.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.586 1.085 . . . . 0.0 112.39 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.46 -45.24 69.48 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.64 1.109 . . . . 0.0 111.5 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.22 -59.44 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.5 29.92 1.71 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.139 1.352 . . . . 0.0 112.959 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.2 t -64.95 104.08 0.81 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 107.642 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -50.0 115.08 2.83 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 127.843 2.639 . . . . 0.0 111.545 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -146.47 166.9 25.02 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.424 2.69 . . . . 0.0 105.811 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -128.05 87.2 2.57 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -79.98 69.26 6.31 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -133.99 84.8 2.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.541 1.136 . . . . 0.0 108.155 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.11 -46.31 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.9 t -78.51 -95.46 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.811 1.645 . . . . 0.0 107.513 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.8 120.69 0.54 Allowed Glycine 0 CA--C 1.526 0.755 0 O-C-N 120.632 -1.293 . . . . 0.0 110.86 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -80.01 -4.65 13.41 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.229 2.619 . . . . 0.0 114.019 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t -68.4 170.92 8.05 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 120.191 1.36 . . . . 0.0 111.909 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.3 p -151.73 163.75 38.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.858 1.663 . . . . 0.0 108.428 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 N-CA-C 105.947 -2.861 . . . . 0.0 105.947 179.203 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.4 m -59.42 108.26 0.69 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.799 1.64 . . . . 0.0 111.0 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m -80.94 -15.48 56.15 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.156 0.435 . . . . 0.0 109.85 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.53 -178.08 48.19 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.209 2.338 . . . . 0.0 108.116 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 p -59.15 114.8 2.79 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.737 1.215 . . . . 0.0 110.056 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.4 t -151.85 131.56 13.17 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.61 167.01 11.66 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 125.453 1.501 . . . . 0.0 111.174 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 10.2 t -57.67 120.72 8.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.418 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.76 -2.4 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 125.605 1.562 . . . . 0.0 112.337 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.99 6.09 10.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.957 2.103 . . . . 0.0 113.022 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.7 p -159.02 -7.37 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 O-C-N 119.282 -2.136 . . . . 0.0 114.625 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.8 m 58.38 12.94 2.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.63 1.572 . . . . 0.0 114.036 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -81.31 148.75 63.95 Favored Pre-proline 0 C--N 1.346 0.435 0 O-C-N 120.117 -1.614 . . . . 0.0 108.138 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.59 117.54 5.18 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.901 3.067 . . . . 0.0 109.122 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.2 mt -74.65 139.51 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -53.65 -41.1 66.42 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.55 -90.87 0.31 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.457 ' H ' HD22 ' A' ' 18' ' ' LEU . 3.6 mm? -43.03 -41.83 3.61 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 128.612 2.765 . . . . 0.0 114.215 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 m -66.59 -17.51 64.86 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.22 21.56 54.51 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 120.691 -1.256 . . . . 0.0 112.628 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.35 153.2 12.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.873 0.869 . . . . 0.0 109.987 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 7.1 mmpt? -76.88 111.07 12.03 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.684 -0.635 . . . . 0.0 111.233 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.99 164.13 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.484 1.514 . . . . 0.0 107.877 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.23 137.78 52.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 p -121.14 112.15 18.32 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.265 1.826 . . . . 0.0 106.751 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -146.47 150.23 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 42.04 32.88 0.33 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.6 t70 56.68 40.67 29.13 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 123.699 1.714 . . . . 0.0 111.454 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 56.5 m -131.73 164.37 26.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 130.525 3.53 . . . . 0.0 106.804 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -132.65 133.77 44.0 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.327 1.051 . . . . 0.0 111.858 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 30.6 m-90 -132.38 161.54 33.34 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.527 1.131 . . . . 0.0 109.419 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -97.28 166.7 11.43 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.1 p -55.92 -30.76 62.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.338 1.055 . . . . 0.0 112.282 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -103.57 4.8 36.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.251 1.42 . . . . 0.0 112.256 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.01 6.59 9.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.313 1.045 . . . . 0.0 112.349 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -101.85 100.28 10.59 Favored 'General case' 0 N--CA 1.453 -0.298 1 N-CA-C 99.524 -4.25 . . . . 0.0 99.524 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -145.04 157.41 44.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.1 t -51.53 118.28 3.22 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.2 -27.3 38.67 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 119.849 1.204 . . . . 0.0 112.872 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -86.6 -22.59 26.14 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.4 p -143.45 -6.72 0.8 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m 76.92 10.31 2.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.71 141.36 15.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.1 t -66.11 151.33 47.13 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.4 mt -118.18 -1.72 11.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.433 1.093 . . . . 0.0 111.374 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.29 -57.43 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.445 1.098 . . . . 0.0 112.286 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.76 17.15 2.85 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.05 -0.861 . . . . 0.0 113.947 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -150.92 -167.66 2.88 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.437 1.618 . . . . 0.0 110.722 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.96 165.31 21.92 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -140.82 171.48 14.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 109.766 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 60' ' ' GLN . 6.7 mp -129.53 165.53 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.407 1.083 . . . . 0.0 109.291 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 p -137.65 111.51 8.28 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 122.983 0.513 . . . . 0.0 109.735 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -142.46 148.36 37.61 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.161 1.784 . . . . 0.0 106.48 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 46.08 33.98 1.9 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.093 2.157 . . . . 0.0 112.478 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp 59.7 9.99 1.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.752 1.621 . . . . 0.0 113.039 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -93.41 -173.56 3.25 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.769 2.028 . . . . 0.0 107.466 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.2 pt -135.75 124.05 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.06 1.744 . . . . 0.0 109.397 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -135.38 148.04 49.25 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 120.745 -1.222 . . . . 0.0 114.183 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.72 155.68 39.66 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HA ' HD13 ' A' ' 51' ' ' LEU . 56.6 mt-30 -51.36 -52.75 42.87 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.934 1.243 . . . . 0.0 110.263 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -56.83 -25.79 56.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.2 m -97.51 -18.23 19.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 114.075 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.62 -5.63 68.82 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 t -59.98 112.24 1.8 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.032 2.533 . . . . 0.0 105.963 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.95 -77.42 1.21 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -158.92 165.81 33.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.911 1.684 . . . . 0.0 108.323 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -115.92 0.7 13.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.976 1.31 . . . . 0.0 108.752 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.298 2.0 p 61.46 10.13 3.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.307 2.243 . . . . 0.0 113.2 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -93.98 133.42 37.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 mt -120.92 8.37 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.809 1.243 . . . . 0.0 109.321 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m -65.12 152.69 42.92 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -2.05 82.73 0.0 OUTLIER Glycine 0 CA--C 1.532 1.155 0 C-N-CA 128.509 2.956 . . . . 0.0 114.427 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -57.93 108.34 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.204 2.603 . . . . 0.0 110.874 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.4 t -124.8 -168.23 1.79 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.083 1.753 . . . . 0.0 108.274 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 65.7 p -132.13 -172.25 2.84 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.853 1.261 . . . . 0.0 110.423 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.951 0 N-CA-C 106.304 -2.718 . . . . 0.0 106.304 179.044 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.444 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 m -152.45 160.49 43.26 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.897 1.279 . . . . 0.0 107.979 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 t -112.89 104.12 12.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.78 -81.79 1.24 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . 0.263 31.4 p 51.17 29.49 4.86 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.961 1.705 . . . . 0.0 111.629 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -72.48 -173.76 1.21 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.938 2.495 . . . . 0.0 108.979 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -142.4 -119.85 1.51 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 49.2 t -66.53 106.89 1.9 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.743 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -50.55 -35.16 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 119.784 1.174 . . . . 0.0 110.189 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.39 1.0 50.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.227 2.211 . . . . 0.0 116.427 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -153.16 -12.98 0.15 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.101 1.773 . . . . 0.0 112.798 178.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m 55.41 51.13 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 131.169 3.788 . . . . 0.0 113.388 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.59 149.18 44.47 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.71 1.204 . . . . 0.0 110.098 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.4 122.6 6.62 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 123.306 2.671 . . . . 0.0 112.097 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.8 mt -80.72 163.04 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 127.621 2.368 . . . . 0.0 105.2 177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -65.93 -80.04 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.27 84.58 0.19 Allowed Glycine 0 C--N 1.338 0.691 0 O-C-N 120.616 -1.303 . . . . 0.0 110.79 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.1 mt 58.95 11.74 2.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.502 1.521 . . . . 0.0 112.84 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.8 m -67.38 -15.45 63.69 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.939 2.096 . . . . 0.0 113.706 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.28 6.15 18.46 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.27 161.2 27.77 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.599 1.2 . . . . 0.0 109.207 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -85.93 106.5 17.17 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -131.59 163.97 26.89 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.659 0.784 . . . . 0.0 111.477 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.18 138.66 53.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.877 2.071 . . . . 0.0 105.892 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.6 121.0 23.64 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.12 1.368 . . . . 0.0 107.584 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -145.31 130.74 18.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 53.16 39.27 29.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.125 0.97 . . . . 0.0 111.532 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 68.26 -0.72 2.06 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.879 1.672 . . . . 0.0 113.039 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.1 t -73.91 165.75 24.58 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.103 2.161 . . . . 0.0 110.059 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -132.81 110.69 10.52 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.662 0.785 . . . . 0.0 112.141 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -118.03 129.81 55.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.61 154.47 40.74 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -49.87 -49.85 47.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.425 1.09 . . . . 0.0 110.967 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.35 -4.76 41.16 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.207 -1.558 . . . . 0.0 114.224 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.0 m -121.56 17.71 11.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.96 101.54 9.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -151.14 166.44 30.81 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.0 t -55.83 112.15 1.1 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 117.247 -1.359 . . . . 0.0 109.548 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.04 -25.3 30.99 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.208 0.909 . . . . 0.0 114.921 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -90.35 -20.96 22.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.35 -22.8 1.5 Allowed 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 118.62 2.822 . . . . 0.0 118.62 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m 77.47 78.51 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.251 1.024 . . . . 0.0 109.738 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.34 134.68 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.6 t -54.2 135.43 44.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.933 1.293 . . . . 0.0 112.461 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.0 mt -115.39 9.72 15.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.547 1.939 . . . . 0.0 109.222 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.19 111.23 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 126.11 1.764 . . . . 0.0 112.711 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.47 43.4 94.03 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-O 119.331 -0.705 . . . . 0.0 113.666 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -139.07 153.21 48.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.77 134.34 46.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.99 171.77 9.0 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.144 1.378 . . . . 0.0 108.058 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.99 155.31 30.49 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 112.88 6.49 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -143.12 150.26 39.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 54.72 23.08 4.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.134 0.879 . . . . 0.0 112.528 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt 70.54 8.45 6.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.792 2.437 . . . . 0.0 113.065 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.81 150.94 25.83 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.431 1.092 . . . . 0.0 108.587 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.8 pt -102.63 129.87 53.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.226 1.411 . . . . 0.0 110.025 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -133.92 160.69 36.9 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.669 -1.269 . . . . 0.0 112.444 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 161.39 19.69 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 103.976 -2.602 . . . . 0.0 103.976 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -51.98 -51.55 56.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.21 1.368 . . . . 0.0 111.57 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -53.49 -38.59 63.82 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.419 -0.8 . . . . 0.0 112.402 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -75.59 -53.26 8.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.27 1.04 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.548 1.07 . . . . 0.0 113.924 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -30.69 70.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.134 1.467 . . . . 0.0 111.303 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.32 -178.23 39.92 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.433 ' HG3' ' H ' ' A' ' 67' ' ' ASP . 22.8 ptt? -125.48 -60.21 1.34 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.418 1.487 . . . . 0.0 108.05 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' H ' ' HG3' ' A' ' 66' ' ' MET . 67.5 m-20 48.35 27.47 1.37 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.022 2.529 . . . . 0.0 112.882 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 p -66.09 113.73 4.7 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.977 2.111 . . . . 0.0 110.555 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -81.92 149.39 28.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.007 2.123 . . . . 0.0 110.498 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 22.1 pt -150.76 159.71 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 127.47 2.308 . . . . 0.0 108.388 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -80.28 179.5 7.64 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.718 0.807 . . . . 0.0 109.252 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.75 149.68 17.15 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.31 4.46 1.98 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.035 2.49 . . . . 0.0 113.754 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -125.26 -0.15 7.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.858 2.463 . . . . 0.0 111.009 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.8 t -168.29 84.61 0.18 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.855 0 CA-C-O 116.108 -2.495 . . . . 0.0 108.274 -179.466 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.979 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -85.57 108.01 17.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.657 1.583 . . . . 0.0 108.255 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -136.86 130.7 32.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.4 1.0 . . . . 0.0 111.808 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.56 -111.18 2.9 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.519 2.009 . . . . 0.0 110.695 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 t -104.9 112.51 25.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.032 1.333 . . . . 0.0 111.462 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.2 m -155.6 74.54 0.88 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.36 1.864 . . . . 0.0 110.469 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.33 178.39 15.3 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.464 1.03 . . . . 0.0 110.709 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.489 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 7.5 t -79.13 121.97 25.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 117.632 -1.175 . . . . 0.0 109.618 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.96 -23.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 119.249 0.931 . . . . 0.0 111.61 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.2 1.28 57.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.804 1.642 . . . . 0.0 115.207 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 14.1 p -162.6 -7.79 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.776 1.625 . . . . 0.0 115.128 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.28 97.1 p 53.83 26.82 6.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.103 2.561 . . . . 0.0 114.149 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -83.88 154.16 64.29 Favored Pre-proline 0 C--O 1.237 0.436 0 O-C-N 120.765 -1.21 . . . . 0.0 108.459 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.34 120.12 5.18 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.366 2.71 . . . . 0.0 107.185 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -70.55 144.07 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 p -76.8 176.4 8.54 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.429 0.692 . . . . 0.0 111.212 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.47 -179.08 43.98 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.27 19.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.789 2.036 . . . . 0.0 115.175 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.4 t -67.26 32.55 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 129.202 3.001 . . . . 0.0 114.2 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.26 1.61 55.77 Favored Glycine 0 CA--C 1.522 0.5 0 O-C-N 119.884 -1.76 . . . . 0.0 112.41 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.23 160.99 11.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.473 0.709 . . . . 0.0 109.8 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 127.31 20.68 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -145.06 164.95 29.64 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 126.039 1.736 . . . . 0.0 108.721 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.27 134.73 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -111.22 131.35 55.19 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.185 0.994 . . . . 0.0 108.834 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -146.15 138.1 25.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.091 1.756 . . . . 0.0 106.666 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 45.33 43.11 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.273 1.429 . . . . 0.0 112.235 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 69.45 -17.55 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 129.766 3.226 . . . . 0.0 113.616 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 56.6 m -73.94 164.15 26.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.325 1.45 . . . . 0.0 108.969 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.21 135.94 52.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.082 1.353 . . . . 0.0 111.115 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 18.3 m-90 -132.89 131.43 40.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.359 0.664 . . . . 0.0 111.664 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -65.48 154.38 38.73 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 p -49.58 -53.19 25.18 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.298 1.408 . . . . 0.0 112.613 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -61.49 -26.38 67.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.05 1.06 56.26 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 116.955 -1.498 . . . . 0.0 114.162 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -100.74 100.4 11.07 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 102.406 -3.183 . . . . 0.0 102.406 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -153.19 166.09 33.61 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 t -61.13 120.11 9.68 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-O 117.329 -1.319 . . . . 0.0 109.99 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.08 -24.38 54.53 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 121.989 0.772 . . . . 0.0 113.412 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -85.81 -18.83 31.82 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.16 -8.81 0.34 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 82.63 -0.99 1.33 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.474 1.488 . . . . 0.0 114.791 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.44 136.13 26.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 121.246 1.839 . . . . 0.0 108.024 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -54.35 136.2 43.96 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.082 1.353 . . . . 0.0 109.609 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.1 -0.37 15.65 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.773 0.829 . . . . 0.0 110.686 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.8 t -54.18 116.51 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 127.409 2.284 . . . . 0.0 109.505 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.68 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.532 1.152 0 C-N-CA 128.776 3.084 . . . . 0.0 117.617 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -9.38 56.96 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.23 147.09 16.94 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -146.34 172.26 13.76 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.575 1.55 . . . . 0.0 110.563 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.0 mp -119.13 154.95 32.45 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.9 p -130.11 102.46 6.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.241 0.963 . . . . 0.0 109.213 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.61 155.66 48.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.323 1.849 . . . . 0.0 107.595 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 52.35 21.77 1.82 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.004 1.321 . . . . 0.0 112.935 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt 62.49 22.02 12.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.038 1.735 . . . . 0.0 112.047 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -112.95 -169.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.893 2.477 . . . . 0.0 108.691 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.1 123.82 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 120.423 -1.423 . . . . 0.0 110.003 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -131.95 152.01 51.36 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 122.92 1.343 . . . . 0.0 114.607 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.76 150.28 42.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.545 ' HA ' HD13 ' A' ' 51' ' ' LEU . 5.0 mt-30 -46.23 -51.83 13.64 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.337 1.426 . . . . 0.0 110.502 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -51.53 61.47 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.135 0.879 . . . . 0.0 111.017 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.78 -29.01 68.85 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.35 -25.28 51.83 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.021 -1.433 . . . . 0.0 111.535 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m -61.97 -51.79 66.64 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.936 1.368 . . . . 0.0 109.802 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.59 -166.74 53.52 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.3 mmt -146.44 76.76 1.45 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -69.73 4.73 1.78 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.909 0.484 . . . . 0.0 112.12 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.3 p 56.92 49.1 14.63 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 128.027 2.531 . . . . 0.0 111.059 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -63.05 148.46 47.73 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.84 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.1 pt -115.85 18.69 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.849 1.659 . . . . 0.0 111.456 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -28.65 69.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.914 0.886 . . . . 0.0 113.029 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 112.8 -86.78 0.43 Allowed Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.412 -1.216 . . . . 0.0 112.409 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.23 134.67 23.4 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.586 2.191 . . . . 0.0 112.646 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.4 t -158.58 162.49 37.35 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.923 1.289 . . . . 0.0 107.829 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.7 p -72.77 88.47 1.31 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.093 -1.005 . . . . 0.0 109.025 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.793 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m -147.44 126.99 13.25 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 t -135.09 76.93 1.65 Allowed 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.51 -4.02 2.73 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.285 1.421 . . . . 0.0 112.691 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t -139.13 155.02 48.18 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.799 1.64 . . . . 0.0 107.751 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.3 p -140.79 -8.95 1.05 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.514 1.926 . . . . 0.0 112.7 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.45 -149.56 8.96 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 125.92 1.724 . . . . 0.0 109.856 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 8.0 t -53.26 127.54 24.9 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 117.178 -1.391 . . . . 0.0 107.954 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -51.51 -24.64 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 120.048 1.294 . . . . 0.0 113.883 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.67 9.29 25.02 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.493 1.917 . . . . 0.0 115.126 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -154.2 -11.07 0.14 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.96 -1.712 . . . . 0.0 114.132 179.026 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 p 58.99 2.93 0.28 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.057 2.543 . . . . 0.0 114.812 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -72.04 147.69 91.19 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 120.597 -1.315 . . . . 0.0 110.684 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.55 113.65 3.7 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 123.355 2.703 . . . . 0.0 110.58 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.3 mt -67.63 149.9 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.46 21.38 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.18 -175.71 31.77 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.749 1.194 . . . . 0.0 112.11 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.56 15.82 0.17 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.722 1.609 . . . . 0.0 113.605 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -66.89 -0.14 2.87 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.833 1.653 . . . . 0.0 112.827 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.57 11.65 11.39 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 120.559 -1.338 . . . . 0.0 115.04 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.13 146.05 55.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.881 1.341 . . . . 0.0 107.659 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -78.7 106.22 10.54 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -135.44 166.67 22.63 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.827 2.051 . . . . 0.0 111.807 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.0 mm -120.05 147.37 23.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.89 117.9 19.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.375 1.07 . . . . 0.0 109.603 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.82 138.74 25.89 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 48.57 42.74 19.51 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.727 1.611 . . . . 0.0 110.597 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 61.87 2.45 0.76 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.272 2.229 . . . . 0.0 112.545 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.6 m -84.35 164.84 18.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.631 1.572 . . . . 0.0 108.875 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.62 117.83 24.37 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.403 1.081 . . . . 0.0 111.47 -177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -120.72 136.73 54.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.26 155.52 28.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.1 t -57.34 -46.03 83.69 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.341 0.973 . . . . 0.0 108.487 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -1.24 3.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -126.64 -6.47 6.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.913 1.285 . . . . 0.0 113.275 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -89.99 100.29 13.13 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 102.913 -2.995 . . . . 0.0 102.913 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -149.08 176.5 10.41 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.5 t -65.53 119.93 11.97 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 117.49 -1.243 . . . . 0.0 112.694 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.07 -10.8 16.14 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.468 1.508 . . . . 0.0 112.977 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -106.05 -23.49 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.133 1.466 . . . . 0.0 114.525 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.433 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -141.41 -3.4 1.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.294 15.4 m 70.83 15.44 6.85 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.433 HG12 ' SG ' ' A' ' 41' ' ' CYS . 7.5 p -73.64 134.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 t -58.0 139.63 54.09 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.802 0.728 . . . . 0.0 110.679 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -111.06 3.55 18.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.741 1.216 . . . . 0.0 110.045 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.32 122.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.52 29.47 69.82 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.622 -1.099 . . . . 0.0 112.438 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -139.8 150.45 44.74 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.356 1.578 . . . . 0.0 110.958 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.28 108.35 2.54 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.918 -0.934 . . . . 0.0 112.506 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -102.83 171.85 7.17 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.363 1.865 . . . . 0.0 108.945 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -129.15 163.61 25.14 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.117 1.767 . . . . 0.0 107.256 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.479 HG22 HG22 ' A' ' 57' ' ' ILE . 21.9 p -135.39 117.4 15.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.396 0.544 . . . . 0.0 111.567 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -143.7 156.49 44.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.301 1.84 . . . . 0.0 107.386 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.5 m120 57.3 29.08 16.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.925 0.89 . . . . 0.0 112.018 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm 64.18 16.09 9.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.437 1.495 . . . . 0.0 110.57 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -120.1 177.97 4.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.993 1.717 . . . . 0.0 106.994 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 52' ' ' THR . 18.5 pt -115.63 149.55 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -145.84 155.73 43.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.096 1.771 . . . . 0.0 111.482 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.3 156.42 38.46 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -57.12 -50.61 72.27 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.197 1.362 . . . . 0.0 110.871 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -55.42 -24.91 33.0 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.516 1.126 . . . . 0.0 113.847 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.382 85.7 m -97.24 -17.07 20.06 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.242 1.817 . . . . 0.0 111.572 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.02 -20.29 18.94 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 118.387 -1.229 . . . . 0.0 111.54 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 m -39.88 110.24 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.081 2.152 . . . . 0.0 113.518 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.36 -175.55 44.25 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 106.167 -2.773 . . . . 0.0 106.167 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.2 132.86 4.91 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -123.76 14.95 9.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.2 p -57.26 -34.07 68.25 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.021 0.928 . . . . 0.0 109.261 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -166.83 176.97 6.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.152 2.181 . . . . 0.0 107.801 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 30.7 mt -131.48 -43.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 129.791 3.237 . . . . 0.0 106.613 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.99 167.03 3.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.916 2.086 . . . . 0.0 111.977 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -98.23 175.43 29.53 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.29 10.99 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.883 3.055 . . . . 0.0 113.308 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.0 p -147.1 131.98 18.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.742 1.617 . . . . 0.0 107.483 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -146.06 135.63 23.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.894 0 N-CA-C 106.677 -2.569 . . . . 0.0 106.677 -179.263 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.851 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -146.02 91.21 2.05 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 m -74.19 92.07 2.19 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.36 88.03 0.07 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 m -68.14 -16.07 63.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.14 1.776 . . . . 0.0 113.212 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.0 m -127.43 169.99 13.03 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.374 1.47 . . . . 0.0 107.301 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.16 -175.69 54.99 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 8.9 t -62.57 119.55 9.42 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.358 -1.782 . . . . 0.0 108.607 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.7 t -54.55 -25.84 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 121.113 1.779 . . . . 0.0 111.165 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.66 -1.77 58.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.294 1.837 . . . . 0.0 115.284 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 6.4 p -158.88 -2.54 0.08 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 121.235 1.834 . . . . 0.0 114.481 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 p 58.35 7.27 0.66 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.838 3.255 . . . . 0.0 114.071 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -70.38 136.68 86.36 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.11 122.67 10.5 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 123.066 2.51 . . . . 0.0 108.504 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.51 151.98 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.0 t -70.3 165.78 21.57 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.067 -1.021 . . . . 0.0 109.115 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.14 -140.41 6.32 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.764 1.173 . . . . 0.0 111.111 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 tt -75.53 71.34 2.45 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 123.468 1.604 . . . . 0.0 107.66 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.6 m -128.04 -5.16 5.6 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 127.067 2.147 . . . . 0.0 109.498 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.62 39.22 10.91 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.07 111.45 2.2 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.684 1.193 . . . . 0.0 108.564 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 108.25 12.45 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -145.67 165.16 29.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.744 1.617 . . . . 0.0 107.125 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.89 122.38 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 126.984 2.114 . . . . 0.0 106.202 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.9 t -106.05 106.79 17.46 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.97 139.85 38.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 48.86 43.92 21.74 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.379 0.672 . . . . 0.0 109.591 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 42.87 43.32 3.43 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.086 2.555 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 50.7 m -134.16 149.77 51.06 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.898 1.679 . . . . 0.0 108.712 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.07 118.81 32.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.419 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 2.7 m-90 -131.36 123.23 27.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -66.24 145.34 55.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.5 m -45.04 -54.76 6.27 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.422 1.489 . . . . 0.0 111.376 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -67.29 -17.57 64.83 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.09 17.55 20.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.73 101.39 12.78 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -139.48 165.05 28.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.95 113.59 2.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.077 1.751 . . . . 0.0 109.009 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.83 -24.92 21.26 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 120.167 1.349 . . . . 0.0 115.539 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -84.92 -20.33 30.86 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 114.762 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -141.71 -25.88 0.68 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 118.507 2.78 . . . . 0.0 118.507 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.298 5.6 p 91.57 17.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.671 2.388 . . . . 0.0 115.596 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.47 143.72 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 120.582 -1.324 . . . . 0.0 108.043 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -59.35 140.65 55.89 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.821 0.848 . . . . 0.0 110.631 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.22 -1.01 10.35 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.252 1.421 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.1 t -49.69 115.93 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 126.33 1.852 . . . . 0.0 110.402 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.99 -3.74 27.24 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.043 -1.421 . . . . 0.0 115.33 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -89.34 162.1 15.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.948 2.374 . . . . 0.0 110.179 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.87 1.54 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -85.38 171.88 11.5 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.916 0.887 . . . . 0.0 109.762 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.53 126.7 52.56 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.911 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.9 p -95.55 107.35 19.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.787 2.035 . . . . 0.0 110.15 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -144.17 155.04 43.75 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 44.99 46.18 9.05 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.173 1.389 . . . . 0.0 112.333 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.346 7.5 ptmm? 48.97 24.99 0.96 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.709 2.004 . . . . 0.0 114.321 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -127.23 177.94 6.36 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.977 1.711 . . . . 0.0 107.781 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.04 123.62 65.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 125.611 1.564 . . . . 0.0 110.984 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -131.42 152.01 51.03 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.948 0.88 . . . . 0.0 113.31 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.9 163.36 27.98 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -53.91 -55.87 22.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.563 1.145 . . . . 0.0 110.854 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -55.28 -27.08 44.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.672 1.189 . . . . 0.0 113.468 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.91 -19.29 18.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.724 1.21 . . . . 0.0 113.077 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.49 -3.61 56.32 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.088 1.804 . . . . 0.0 112.015 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.8 t -68.72 177.39 2.54 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.741 1.217 . . . . 0.0 107.952 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.97 -65.72 0.09 OUTLIER Glycine 0 C--N 1.333 0.379 0 CA-C-O 119.176 -0.791 . . . . 0.0 112.269 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 23.1 mmt -104.78 88.67 2.96 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 117.794 0.797 . . . . 0.0 109.485 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -76.2 91.67 3.2 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -158.53 172.51 18.17 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.318 2.247 . . . . 0.0 108.231 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -82.13 -177.93 6.82 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 126.181 1.792 . . . . 0.0 111.033 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -85.19 167.72 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 120.867 -1.146 . . . . 0.0 109.469 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.7 t -117.24 7.69 13.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.653 1.181 . . . . 0.0 112.5 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.36 144.45 15.77 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.64 137.26 62.9 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.835 1.69 . . . . 0.0 110.043 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -164.42 179.34 6.8 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.655 1.582 . . . . 0.0 107.331 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.5 m -79.83 81.32 6.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 179.511 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.633 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -130.47 81.67 2.02 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.201 1.001 . . . . 0.0 108.398 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.6 t -82.99 -32.44 26.99 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.848 1.659 . . . . 0.0 109.553 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.78 -178.89 28.78 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 107.556 -2.218 . . . . 0.0 107.556 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 p -149.68 49.85 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.08 1.44 . . . . 0.0 114.401 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.6 p -107.48 68.5 0.72 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -111.97 -167.56 17.97 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.44 1.495 . . . . 0.0 112.627 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -71.48 109.58 5.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.858 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -43.73 -39.93 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 121.539 1.972 . . . . 0.0 111.743 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -8.47 53.11 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -156.96 -4.88 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.098 1.317 . . . . 0.0 114.326 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 p 62.92 8.01 2.93 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 130.815 3.646 . . . . 0.0 114.597 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -70.64 152.93 95.21 Favored Pre-proline 0 N--CA 1.468 0.454 0 O-C-N 120.38 -1.45 . . . . 0.0 109.892 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.24 127.63 16.15 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 121.84 1.694 . . . . 0.0 109.054 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.3 mm -65.97 142.96 16.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.9 m -59.94 154.0 19.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.734 0.814 . . . . 0.0 109.898 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.08 -81.79 0.82 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.916 0.77 . . . . 0.0 111.333 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 tt -145.55 77.31 1.51 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.486 1.114 . . . . 0.0 108.343 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.7 t -129.67 20.22 5.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.985 0.914 . . . . 0.0 112.961 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.01 5.52 84.96 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.457 -1.191 . . . . 0.0 114.25 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.63 154.0 37.7 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.305 1.042 . . . . 0.0 109.336 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -103.43 117.24 34.02 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.118 0.967 . . . . 0.0 109.469 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -134.05 120.44 20.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 mm -83.46 152.73 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 p -130.01 107.02 9.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.671 1.588 . . . . 0.0 108.897 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -128.22 123.82 35.17 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.815 1.246 . . . . 0.0 108.803 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 50.69 15.48 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.264 1.026 . . . . 0.0 109.001 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 62.62 -6.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 127.57 2.348 . . . . 0.0 115.97 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.3 t -89.06 149.68 23.11 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -116.04 136.45 53.02 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.474 0.709 . . . . 0.0 111.548 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -130.26 138.56 50.58 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.776 1.23 . . . . 0.0 108.35 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -71.09 152.32 43.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -43.87 -62.48 1.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.751 1.22 . . . . 0.0 113.101 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 21.0 mp0 -61.34 -22.46 64.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.887 2.075 . . . . 0.0 114.164 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 m -90.5 -28.27 18.66 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.026 1.331 . . . . 0.0 112.725 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -72.09 101.73 2.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.456 1.48 . . . . 0.0 108.703 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 4.6 m-80 -139.87 164.02 31.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.294 1.038 . . . . 0.0 112.95 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 35.2 t -59.15 116.74 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 116.287 -1.816 . . . . 0.0 108.474 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.17 -28.42 34.01 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 120.865 1.666 . . . . 0.0 114.132 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -84.93 -18.66 33.94 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 38' ' ' CYS . 0.8 OUTLIER -140.43 -13.74 1.0 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -177.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' HB3' ' A' ' 37' ' ' ASN 0.358 86.9 p 62.46 60.04 1.44 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 ' SG ' ' A' ' 41' ' ' CYS . 10.0 p -117.65 137.01 52.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -58.38 125.56 23.83 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 124.037 0.836 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.1 mt -101.91 14.71 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.172 1.389 . . . . 0.0 109.111 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.64 126.9 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.21 -49.77 1.55 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 126.049 1.785 . . . . 0.0 115.987 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -63.23 154.18 32.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.904 0.882 . . . . 0.0 112.238 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.09 161.59 54.14 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.59 163.29 36.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.935 1.294 . . . . 0.0 109.778 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -113.03 152.7 29.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.695 1.998 . . . . 0.0 106.573 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.3 p -129.77 123.16 30.32 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -144.17 154.72 43.44 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 123.583 0.753 . . . . 0.0 109.183 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 41.89 42.31 2.2 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.783 1.174 . . . . 0.0 111.649 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 62.42 7.12 2.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.552 1.941 . . . . 0.0 114.805 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -106.31 173.12 6.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.861 2.064 . . . . 0.0 111.088 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.8 135.12 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 126.588 1.955 . . . . 0.0 110.737 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -139.65 155.35 47.46 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 120.787 -1.195 . . . . 0.0 113.256 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 157.49 32.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -52.31 -54.47 31.11 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.241 1.017 . . . . 0.0 110.161 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -52.67 -46.35 67.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.124 0.875 . . . . 0.0 111.256 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . 0.332 1.3 m -61.29 -41.27 96.68 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.381 0.992 . . . . 0.0 111.73 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.49 -4.14 89.42 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.582 1.083 . . . . 0.0 113.553 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t -70.55 92.29 0.83 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.326 1.85 . . . . 0.0 110.592 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.98 -162.52 28.34 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -151.13 150.23 30.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -102.37 115.77 31.25 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.85 161.13 27.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.428 0.691 . . . . 0.0 112.329 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -117.24 27.7 8.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.099 2.56 . . . . 0.0 112.13 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.2 mt -66.04 110.05 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.701 1.6 . . . . 0.0 107.543 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 m -62.32 -6.2 3.02 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.6 93.63 1.34 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.302 0.956 . . . . 0.0 111.442 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.32 150.65 71.15 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 119.559 1.679 . . . . 0.0 109.44 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.4 t -71.52 92.68 1.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 t -151.8 -175.21 5.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.039 1.736 . . . . 0.0 107.769 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.263 1.916 1 C-N-CA 133.132 5.158 . . . . 0.0 103.504 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.747 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 p -149.01 99.07 2.92 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -73.8 79.66 1.59 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.482 1.113 . . . . 0.0 110.297 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.83 169.98 20.7 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 123.756 0.693 . . . . 0.0 112.305 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -153.59 80.06 1.16 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.376 1.07 . . . . 0.0 110.204 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -53.02 -62.36 1.71 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.794 1.238 . . . . 0.0 111.933 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.98 -175.38 52.29 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.644 0.64 . . . . 0.0 113.063 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 t -58.61 112.36 1.58 Allowed 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 115.794 -2.051 . . . . 0.0 108.282 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.9 t -41.81 -36.33 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 122.312 2.324 . . . . 0.0 112.785 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.55 -13.93 58.66 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.77 -3.62 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 120.877 1.671 . . . . 0.0 115.431 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 m 59.49 8.03 1.12 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 130.18 3.392 . . . . 0.0 115.083 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -58.79 153.09 44.43 Favored Pre-proline 0 C--O 1.237 0.426 0 CA-C-N 120.0 1.273 . . . . 0.0 110.315 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.0 122.9 9.21 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 C-N-CA 121.82 1.68 . . . . 0.0 108.526 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mm -74.12 144.13 12.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -64.43 169.61 4.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.121 0.568 . . . . 0.0 110.842 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.12 -137.72 9.71 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.4 mt -76.08 80.32 2.92 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.676 0.79 . . . . 0.0 108.892 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 t -128.7 -16.35 4.25 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.51 1.124 . . . . 0.0 112.253 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.98 34.07 7.43 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 160.24 29.72 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -110.11 95.19 5.43 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -129.5 165.18 22.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.407 1.883 . . . . 0.0 108.675 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.0 mm -116.37 151.46 18.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 m -131.27 117.83 19.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -145.43 130.6 18.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 55.66 23.62 6.35 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.363 0.665 . . . . 0.0 111.231 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . 0.272 2.3 m-20 72.49 -0.68 3.21 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 130.004 3.322 . . . . 0.0 113.482 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -81.8 164.01 21.96 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -111.02 135.15 51.95 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.382 -1.448 . . . . 0.0 114.153 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 3.6 m-90 -132.07 125.91 32.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.51 -0.744 . . . . 0.0 111.391 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -73.84 154.54 39.44 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -49.97 -55.08 16.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.598 1.09 . . . . 0.0 109.178 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -65.66 -3.28 4.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.97 1.708 . . . . 0.0 115.554 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . 0.282 1.7 m -119.31 -3.01 10.55 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 116.58 -1.676 . . . . 0.0 114.369 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -91.04 102.54 15.3 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 125.181 1.392 . . . . 0.0 108.583 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -154.12 172.13 18.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.5 122.81 18.05 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 117.019 -1.467 . . . . 0.0 110.965 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -27.1 65.12 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.762 1.164 . . . . 0.0 113.524 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -75.81 -20.51 58.14 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.17 -12.94 0.21 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.272 18.0 m 85.92 10.6 0.25 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.726 1.61 . . . . 0.0 115.119 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.67 131.95 32.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 m -56.63 136.09 54.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.552 1.141 . . . . 0.0 111.611 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.1 mt -103.21 -1.11 29.48 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.7 t -69.79 142.04 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 20.85 73.63 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.628 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -152.94 148.21 26.85 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.039 1.419 . . . . 0.0 109.768 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.0 152.71 44.3 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -135.73 171.65 14.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.92 1.36 . . . . 0.0 111.652 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -94.08 145.45 24.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.1 p -134.45 103.39 5.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.619 1.168 . . . . 0.0 109.47 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -140.58 152.36 45.41 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 53.23 17.15 0.94 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.05 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 82.3 mttt 86.56 -0.1 0.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 129.313 3.045 . . . . 0.0 112.282 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -89.55 -179.04 5.71 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.504 1.521 . . . . 0.0 109.619 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.0 pt -131.44 136.01 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.512 2.325 . . . . 0.0 106.509 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -148.56 157.26 43.34 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 123.126 1.441 . . . . 0.0 113.199 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 153.81 39.79 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -66.34 -38.38 87.5 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.315 -0.866 . . . . 0.0 110.918 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -54.24 -26.74 30.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.25 1.42 . . . . 0.0 113.916 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.0 m -97.29 -45.08 6.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.208 1.803 . . . . 0.0 109.123 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.03 11.4 57.54 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.99 153.69 24.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.969 1.385 . . . . 0.0 108.524 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.42 6.86 56.3 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.892 -0.949 . . . . 0.0 112.971 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.1 mtt -64.26 86.31 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.054 2.542 . . . . 0.0 112.749 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.19 66.09 6.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.144 2.577 . . . . 0.0 105.205 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.7 t -79.4 -3.04 44.52 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.2 170.83 9.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.881 0.764 . . . . 0.0 109.213 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.5 mt -79.19 84.83 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 101.449 -3.537 . . . . 0.0 101.449 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.5 t -98.58 -167.43 1.5 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 129.095 2.958 . . . . 0.0 110.443 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.21 -73.31 0.03 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.156 1.836 . . . . 0.0 108.987 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.18 78.74 2.19 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.162 3.241 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.3 p -61.49 -31.0 70.96 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 127.187 2.195 . . . . 0.0 111.601 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 4.82 81.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 131.367 3.867 . . . . 0.0 113.875 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 -179.656 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.643 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -66.49 168.22 9.46 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.492 0.717 . . . . 0.0 110.839 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.5 -61.0 1.29 Allowed 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.8 131.87 1.41 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -160.35 92.4 0.98 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -64.7 -61.0 2.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.82 -167.99 14.66 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 121.733 -0.604 . . . . 0.0 112.362 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.9 t -59.87 121.4 11.66 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 117.275 -1.345 . . . . 0.0 108.636 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -52.21 -29.76 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 119.727 1.148 . . . . 0.0 111.346 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.4 -4.05 59.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 p -153.48 -7.08 0.17 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.156 1.343 . . . . 0.0 114.084 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 54.02 37.83 27.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.435 2.294 . . . . 0.0 112.642 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -100.05 151.91 37.66 Favored Pre-proline 0 CA--C 1.511 -0.533 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.47 137.57 30.87 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 O-C-N 124.554 1.818 . . . . 0.0 108.55 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.2 mt -107.94 121.22 60.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.6 t -58.64 -44.49 90.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.094 0.558 . . . . 0.0 110.48 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.74 -75.03 1.89 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 pp -45.36 -31.57 1.69 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.703 2.801 . . . . 0.0 114.974 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.8 t -67.76 -10.44 52.71 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.393 0.677 . . . . 0.0 110.604 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.95 37.29 13.17 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.34 147.71 20.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.228 1.411 . . . . 0.0 110.935 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -80.41 115.57 20.01 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.73 164.22 30.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.03 0.443 . . . . 0.0 111.85 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.2 mm -121.3 125.81 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.828 -2.656 . . . . 0.0 103.828 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.3 m -103.39 102.93 12.88 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -124.9 136.92 54.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 40.38 46.23 1.99 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.401 1.881 . . . . 0.0 112.697 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 51.05 35.63 13.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.075 1.75 . . . . 0.0 113.127 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -126.09 164.73 20.25 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 126.419 1.888 . . . . 0.0 107.206 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -109.73 131.57 54.94 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -132.21 133.14 43.82 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.011 1.324 . . . . 0.0 108.324 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -73.76 147.1 43.81 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -49.21 -55.5 12.31 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.936 1.244 . . . . 0.0 110.189 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.92 -5.18 2.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.928 1.291 . . . . 0.0 113.994 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.1 m -118.65 -1.26 11.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 113.566 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -94.59 100.78 12.68 Favored 'General case' 0 N--CA 1.45 -0.46 1 N-CA-C 99.417 -4.29 . . . . 0.0 99.417 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 42' ' ' SER . 75.5 m-20 -145.59 164.3 32.13 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.675 -0.679 . . . . 0.0 112.709 -177.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.9 t -58.12 122.03 12.1 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 116.795 -1.574 . . . . 0.0 108.975 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.89 -25.56 30.82 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 123.985 0.803 . . . . 0.0 113.816 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -90.87 -18.37 24.93 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.749 2.129 . . . . 0.0 116.749 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -143.87 -15.95 0.61 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 37' ' ' ASN 0.3 1.1 p 84.78 8.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.2 142.55 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 CA-C-N 120.54 1.518 . . . . 0.0 110.158 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.7 t -64.81 105.16 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.514 1.925 . . . . 0.0 107.429 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 90.3 mt -88.54 -9.0 53.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.0 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.1 t -42.56 111.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.404 1.882 . . . . 0.0 112.4 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 12.51 63.02 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.28 -1.845 . . . . 0.0 117.304 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -110.39 167.73 9.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 121.432 2.616 . . . . 0.0 112.161 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.98 136.2 46.13 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -144.42 171.17 14.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.242 1.017 . . . . 0.0 110.905 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -130.42 160.66 33.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 123.954 0.902 . . . . 0.0 110.793 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 p -132.58 104.83 6.86 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.995 0.918 . . . . 0.0 109.653 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -142.37 152.45 42.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.18 31.89 7.3 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.499 1.52 . . . . 0.0 112.77 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.17 6.67 3.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.369 2.267 . . . . 0.0 113.014 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -108.53 176.84 4.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.698 1.599 . . . . 0.0 109.8 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.2 pt -112.68 121.46 65.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.64 138.26 52.09 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 157.24 37.1 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -46.39 -54.43 9.08 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.353 1.061 . . . . 0.0 111.654 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -58.96 -31.33 68.63 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.1 -12.46 21.79 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.277 1.831 . . . . 0.0 113.656 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.91 -24.31 20.49 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 107.318 -2.313 . . . . 0.0 107.318 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -81.16 99.29 8.47 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 101.91 -3.366 . . . . 0.0 101.91 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.96 -169.45 36.57 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 56.3 mtp 46.73 46.6 15.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.434 1.094 . . . . 0.0 110.835 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.98 44.08 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.668 2.787 . . . . 0.0 113.201 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.1 t -136.53 171.76 14.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.071 1.748 . . . . 0.0 108.566 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -138.06 8.19 2.72 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.088 2.155 . . . . 0.0 109.409 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.2 pt -135.9 151.61 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.292 1.037 . . . . 0.0 109.199 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.2 m -117.78 34.13 5.3 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.064 1.345 . . . . 0.0 109.27 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.73 95.99 1.02 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.06 -17.77 28.0 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.338 2.025 . . . . 0.0 112.833 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.7 p -158.67 171.19 20.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.846 2.458 . . . . 0.0 106.836 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 m -136.46 3.53 2.81 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.31 1.444 . . . . 0.0 110.908 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.635 1 C-N-CA 130.918 4.104 . . . . 0.0 105.717 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.36 -69.93 0.73 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 p -155.34 157.16 36.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.93 157.06 10.53 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.7 t -144.2 121.78 11.79 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 t -161.86 -71.15 0.06 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.2 162.3 43.58 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.095 -0.836 . . . . 0.0 112.955 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 t -44.61 120.47 2.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.824 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.03 -32.31 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 120.63 1.559 . . . . 0.0 110.685 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.92 2.66 37.59 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 p -166.24 -3.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 119.19 -2.194 . . . . 0.0 114.707 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.54 10.21 2.43 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.763 3.225 . . . . 0.0 114.238 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -67.36 145.66 98.55 Favored Pre-proline 0 N--CA 1.47 0.565 0 O-C-N 120.122 -1.611 . . . . 0.0 109.402 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 137.68 45.45 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 O-C-N 124.35 1.711 . . . . 0.0 109.149 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -87.98 157.09 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.719 1.608 . . . . 0.0 107.216 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m -70.75 -25.31 62.85 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.05 -118.65 7.63 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 119.287 0.949 . . . . 0.0 111.708 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' CD2' ' H ' ' A' ' 18' ' ' LEU . 1.4 pt? -69.27 53.16 0.1 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.639 2.376 . . . . 0.0 115.524 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -130.05 -30.09 2.02 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.873 0.869 . . . . 0.0 111.491 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.12 0.33 25.36 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.336 0.969 . . . . 0.0 114.437 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.47 151.44 32.73 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.056 1.342 . . . . 0.0 113.093 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -80.2 120.37 24.21 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.004 0.921 . . . . 0.0 109.584 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -145.77 146.73 31.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.5 mm -88.77 120.74 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 p -107.38 110.22 22.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -139.46 137.77 35.86 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 42.4 54.91 4.24 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.842 1.657 . . . . 0.0 112.114 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.92 13.89 0.61 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.851 1.661 . . . . 0.0 114.111 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -113.03 163.74 14.33 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.945 2.098 . . . . 0.0 108.949 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -120.95 131.94 54.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.938 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -124.61 138.28 54.32 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.113 1.365 . . . . 0.0 107.535 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -76.0 144.74 40.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.5 t -51.53 -51.53 54.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -61.9 -11.24 12.05 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 114.156 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.2 m -123.66 11.31 9.13 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.624 1.17 . . . . 0.0 113.382 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -93.99 101.16 13.19 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 101.231 -3.618 . . . . 0.0 101.231 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -141.35 168.82 18.86 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.89 121.04 13.1 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 116.424 -1.751 . . . . 0.0 108.287 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.82 -32.26 58.83 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 120.919 1.69 . . . . 0.0 113.45 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -82.67 -22.32 34.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.38 -7.92 1.51 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.393 83.7 p 66.64 29.94 8.54 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -86.9 147.07 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -58.06 134.96 56.88 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.115 0.966 . . . . 0.0 111.484 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 mt -112.12 1.69 16.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.708 1.203 . . . . 0.0 110.818 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.82 107.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 128.342 2.657 . . . . 0.0 110.636 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.69 -17.57 3.44 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.968 1.747 . . . . 0.0 115.482 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 112.62 22.77 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -40.88 142.06 0.87 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.243 1.401 . . . . 0.0 111.149 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -135.66 170.55 15.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.04 162.12 13.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.287 1.435 . . . . 0.0 108.052 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 p -141.92 102.92 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -130.33 154.94 47.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.6 m120 48.95 36.02 7.7 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.852 1.261 . . . . 0.0 112.728 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm 55.76 21.76 4.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.491 1.116 . . . . 0.0 112.181 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -117.36 -178.54 3.48 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.165 1.786 . . . . 0.0 109.609 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 pt -123.34 122.7 65.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.805 1.642 . . . . 0.0 110.461 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -136.16 140.02 43.3 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.205 -0.934 . . . . 0.0 111.486 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.79 163.33 27.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -42.84 -62.79 0.92 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.226 1.81 . . . . 0.0 111.975 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -52.63 -41.03 63.36 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.877 0.871 . . . . 0.0 112.825 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -71.4 -46.99 58.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.551 0.614 . . . . 0.0 110.068 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.57 -3.01 46.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.987 0.803 . . . . 0.0 113.506 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 t -66.54 8.99 0.19 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.973 2.109 . . . . 0.0 112.588 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.98 68.75 3.44 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.0 tpt -71.71 127.83 33.84 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -63.57 8.28 0.08 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.119 1.368 . . . . 0.0 114.325 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -66.17 -31.18 71.87 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.014 1.326 . . . . 0.0 112.352 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -68.08 164.08 21.0 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.2 mt -38.34 117.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 128.78 2.832 . . . . 0.0 110.737 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 p -73.24 175.19 7.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.104 1.362 . . . . 0.0 110.813 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.39 171.15 47.49 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.46 130.82 31.36 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.465 2.11 . . . . 0.0 110.52 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 m -92.0 -158.09 0.56 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.399 1.479 . . . . 0.0 109.199 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.4 m -69.35 -2.8 11.83 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.292 -0.88 . . . . 0.0 111.361 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 1 C-N-CA 133.074 5.131 . . . . 0.0 105.213 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.049 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.6 p -124.86 167.02 15.23 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.361 1.08 . . . . 0.0 109.596 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 p -122.75 159.59 27.7 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.433 0.693 . . . . 0.0 109.943 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.24 10.45 86.2 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.469 -0.628 . . . . 0.0 112.88 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.7 p -70.92 30.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.736 1.614 . . . . 0.0 113.658 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.4 t -141.07 5.04 1.89 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.523 -1.361 . . . . 0.0 111.231 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.62 -166.92 37.58 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 119.551 1.069 . . . . 0.0 110.483 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.35 124.54 18.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.291 -1.814 . . . . 0.0 107.989 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -7.96 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 120.694 1.588 . . . . 0.0 112.319 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.28 4.96 25.19 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.026 1.73 . . . . 0.0 114.076 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 p -166.22 -4.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.286 61.6 p 54.83 12.83 0.63 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 129.6 3.16 . . . . 0.0 114.824 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -69.07 150.28 97.54 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.71 125.5 11.71 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 121.484 1.456 . . . . 0.0 108.665 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.9 mm -68.32 148.19 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 135.97 45.45 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.29 -119.87 0.19 Allowed Glycine 0 CA--C 1.523 0.588 0 O-C-N 124.801 1.313 . . . . 0.0 111.763 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.67 69.78 6.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.105 0.962 . . . . 0.0 108.686 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 m -128.21 -4.39 5.55 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.71 2.404 . . . . 0.0 112.135 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.54 26.14 64.13 Favored Glycine 0 CA--C 1.535 1.304 0 O-C-N 120.343 -1.473 . . . . 0.0 114.005 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.72 158.56 33.98 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.237 1.015 . . . . 0.0 109.924 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -95.04 122.61 37.87 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -145.15 164.96 29.67 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.932 2.093 . . . . 0.0 107.177 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 mm -115.15 139.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 p -130.89 120.08 23.11 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.475 1.51 . . . . 0.0 107.921 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -145.37 150.53 36.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.303 1.841 . . . . 0.0 106.526 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 36.04 50.52 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.111 2.165 . . . . 0.0 114.081 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.2 t0 53.89 39.74 30.77 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.687 1.595 . . . . 0.0 113.189 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' ' CZ3' ' A' ' 31' ' ' TRP . 27.6 t -134.22 164.71 26.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.07 1.748 . . . . 0.0 109.972 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -119.11 124.1 46.03 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.89 1.676 . . . . 0.0 111.605 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' A' ' 29' ' ' SER . 9.6 m-90 -130.71 123.99 30.52 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.796 1.284 . . . . 0.0 110.296 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -68.49 155.5 39.8 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -53.51 30.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.106 1.363 . . . . 0.0 112.589 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.1 -30.49 71.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.597 1.09 . . . . 0.0 113.607 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.0 m -84.81 0.08 52.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 117.416 -1.278 . . . . 0.0 113.457 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -98.77 100.5 11.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -155.85 170.28 22.45 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.0 t -62.0 115.42 4.05 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 115.713 -2.089 . . . . 0.0 106.493 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.11 -29.34 51.9 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-N 121.444 1.929 . . . . 0.0 112.902 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -75.55 -22.49 57.0 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.6 p -141.87 -13.9 0.83 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 118.621 2.823 . . . . 0.0 118.621 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.276 3.0 m 79.67 12.22 1.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.92 136.09 26.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.1 t -58.59 138.36 56.92 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.446 0.641 . . . . 0.0 109.87 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.47 2.04 20.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.577 1.551 . . . . 0.0 110.079 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.82 109.57 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.05 1.34 . . . . 0.0 110.441 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.19 -44.66 2.96 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.749 2.118 . . . . 0.0 113.409 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -64.76 160.93 19.05 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.854 1.327 . . . . 0.0 111.864 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.58 123.55 16.53 Favored Glycine 0 C--O 1.241 0.531 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -110.16 166.1 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.762 1.225 . . . . 0.0 109.561 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.82 147.98 47.12 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.45 103.82 6.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.956 1.302 . . . . 0.0 107.659 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -142.75 156.4 44.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 127.096 2.159 . . . . 0.0 106.441 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 57.86 21.68 7.83 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 62.81 23.08 13.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.045 1.338 . . . . 0.0 109.72 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -126.75 -178.84 4.53 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 127.443 2.297 . . . . 0.0 107.614 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 pt -130.56 134.5 62.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.986 0.898 . . . . 0.0 109.868 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -134.24 162.43 32.18 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 123.012 1.387 . . . . 0.0 114.138 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.23 161.51 23.93 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -54.16 -54.87 33.78 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.02 0.827 . . . . 0.0 111.08 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -56.41 -27.7 57.23 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.527 -1.358 . . . . 0.0 114.553 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 m -97.59 -18.4 18.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.612 1.165 . . . . 0.0 113.297 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.31 -23.85 10.05 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.831 -0.983 . . . . 0.0 112.815 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 t -57.83 117.64 4.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.823 1.649 . . . . 0.0 108.571 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.67 144.69 16.7 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 107.204 -2.358 . . . . 0.0 107.204 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.1 mtm -147.12 147.56 30.69 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -59.92 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.242 1.817 . . . . 0.0 110.671 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.91 160.02 22.2 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.135 1.774 . . . . 0.0 109.045 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -70.68 159.09 35.08 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 122.252 -0.28 . . . . 0.0 111.539 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.58 173.12 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.181 0.993 . . . . 0.0 110.221 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.2 t -73.85 0.91 11.83 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.21 100.49 0.34 Allowed Glycine 0 C--O 1.224 -0.493 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.39 20.57 0.1 OUTLIER 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 124.496 3.464 . . . . 0.0 115.61 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 t -80.27 67.32 6.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 t -116.95 78.42 1.21 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.245 0 C-N-CA 126.676 2.084 . . . . 0.0 108.168 -179.6 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.548 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t -159.63 171.71 19.1 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.765 0.826 . . . . 0.0 109.5 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 m -158.43 174.42 15.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.279 2.232 . . . . 0.0 107.46 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.63 165.28 14.53 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.587 1.089 . . . . 0.0 111.597 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -92.34 156.95 16.9 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.619 1.568 . . . . 0.0 110.724 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.4 t -69.78 139.37 53.24 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.23 -150.34 19.98 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 121.193 -0.942 . . . . 0.0 112.419 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 4.6 t -57.75 116.44 3.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.62 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.42 -14.0 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.783 0.833 . . . . 0.0 112.241 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.95 -0.71 38.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.368 1.467 . . . . 0.0 113.678 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -152.62 -11.21 0.17 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.792 -1.818 . . . . 0.0 114.917 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.306 2.9 p 49.91 53.51 12.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.615 1.966 . . . . 0.0 112.667 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -114.81 140.3 25.25 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.37 124.32 12.74 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.986 2.457 . . . . 0.0 110.454 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.74 135.76 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.007 1.723 . . . . 0.0 106.538 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t -78.59 178.81 7.52 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.966 0.907 . . . . 0.0 109.816 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.25 179.56 53.17 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.2 10.32 0.12 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.508 1.523 . . . . 0.0 112.734 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 t -69.84 22.72 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.36 2.264 . . . . 0.0 112.575 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.95 2.4 23.7 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 125.404 1.478 . . . . 0.0 111.875 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 100.67 12.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.926 1.863 . . . . 0.0 106.515 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -73.47 131.7 42.09 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -145.29 164.57 31.0 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.482 1.513 . . . . 0.0 109.495 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.73 102.12 13.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.364 1.465 . . . . 0.0 109.061 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.3 m -82.19 114.67 20.86 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -145.83 147.7 32.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 119.279 0.945 . . . . 0.0 108.638 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 36.96 58.08 1.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.096 1.759 . . . . 0.0 111.537 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 p30 48.62 25.03 0.87 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.105 1.762 . . . . 0.0 114.968 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.1 t -128.49 165.46 20.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 127.911 2.484 . . . . 0.0 108.524 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.9 109.77 11.54 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.516 -0.74 . . . . 0.0 110.632 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -103.54 150.96 23.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.343 1.068 . . . . 0.0 108.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' A' ' 8' ' ' CYS . 25.9 m170 -82.5 152.5 26.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -57.52 -37.02 72.35 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.781 1.173 . . . . 0.0 108.923 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.8 -17.4 63.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.106 0.962 . . . . 0.0 112.763 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.45 27.82 5.77 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -113.1 100.31 8.51 Favored 'General case' 0 C--O 1.237 0.436 1 N-CA-C 99.023 -4.436 . . . . 0.0 99.023 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -145.38 173.11 12.28 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -176.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.16 107.39 1.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.457 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.2 -31.34 26.5 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 119.57 1.077 . . . . 0.0 115.413 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -77.4 -23.86 50.59 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.42 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -135.26 -23.68 1.46 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -178.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t 74.37 85.13 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.632 1.573 . . . . 0.0 109.909 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.42 HG12 ' SG ' ' A' ' 41' ' ' CYS . 11.1 p -151.57 136.59 10.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 129.872 3.269 . . . . 0.0 104.682 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -54.54 146.45 16.31 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.659 1.219 . . . . 0.0 113.045 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -120.01 1.94 10.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.848 2.059 . . . . 0.0 109.098 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.36 103.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 125.659 1.583 . . . . 0.0 107.178 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.86 5.89 86.87 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.272 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -112.86 87.7 2.65 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.249 1.524 . . . . 0.0 107.969 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -20.67 109.79 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 128.501 2.953 . . . . 0.0 113.139 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -111.14 165.02 12.25 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.378 1.071 . . . . 0.0 112.752 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.9 mp -105.58 151.15 24.69 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.913 1.685 . . . . 0.0 107.734 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -124.4 109.05 12.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.103 1.361 . . . . 0.0 108.677 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -142.49 152.76 43.01 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 45.78 32.52 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.479 1.912 . . . . 0.0 111.354 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.06 -9.48 1.25 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.782 2.833 . . . . 0.0 112.813 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -81.97 -176.02 5.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.971 2.108 . . . . 0.0 110.747 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.05 126.18 21.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 127.619 2.368 . . . . 0.0 110.589 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -139.58 155.77 47.27 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 120.464 -1.397 . . . . 0.0 113.689 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.17 154.67 41.64 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.554 ' HA ' HD13 ' A' ' 51' ' ' LEU . 25.2 tm0? -53.15 -51.69 61.16 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.248 1.019 . . . . 0.0 111.283 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -52.54 -46.06 66.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.018 1.281 . . . . 0.0 111.272 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.5 m -65.45 -47.03 77.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.469 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -17.08 73.43 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 119.041 0.837 . . . . 0.0 112.743 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t -85.59 63.63 8.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.229 1.412 . . . . 0.0 108.44 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.25 175.54 22.71 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 124.891 1.234 . . . . 0.0 110.058 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 24.0 ptm -71.64 119.94 16.52 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -65.83 130.04 41.87 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.2 p -133.24 -27.25 1.61 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -85.52 87.66 7.42 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 120.426 1.467 . . . . 0.0 107.249 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 23.6 pt -69.73 -4.87 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 118.096 -0.955 . . . . 0.0 112.379 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.6 p -79.42 143.8 34.68 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 120.113 1.324 . . . . 0.0 111.049 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 148.33 92.7 0.11 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-O 118.575 -1.125 . . . . 0.0 111.172 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.98 164.21 36.53 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 119.977 1.888 . . . . 0.0 109.89 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 m -86.19 116.02 24.12 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.1 m -135.95 164.72 27.33 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 N-CA-C 107.333 -2.307 . . . . 0.0 107.333 178.731 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.486 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -102.66 170.29 8.11 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.307 1.043 . . . . 0.0 110.965 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.92 135.82 1.45 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.943 1.697 . . . . 0.0 107.06 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.14 91.06 1.69 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 105.866 -2.894 . . . . 0.0 105.866 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.8 m -71.63 61.29 0.36 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.342 1.857 . . . . 0.0 111.844 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.38 125.99 28.4 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 121.447 -0.783 . . . . 0.0 109.579 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.08 -177.24 17.63 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.268 1.413 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.7 t -64.8 125.3 24.39 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 116.732 -1.604 . . . . 0.0 107.39 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -57.94 -27.28 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 120.841 1.655 . . . . 0.0 109.015 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.22 12.12 14.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 128.982 2.913 . . . . 0.0 116.831 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.7 p -171.7 -7.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 118.609 -2.557 . . . . 0.0 114.229 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 m 58.28 9.85 1.13 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.644 2.778 . . . . 0.0 114.658 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -72.74 154.92 91.19 Favored Pre-proline 0 CA--C 1.517 -0.299 0 O-C-N 120.868 -1.145 . . . . 0.0 110.662 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.61 146.34 84.18 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.364 2.042 . . . . 0.0 108.871 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.4 mt -109.32 122.0 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.772 2.429 . . . . 0.0 106.772 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.6 m -112.18 114.33 27.07 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.494 1.118 . . . . 0.0 108.603 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.64 89.16 0.49 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 105.278 -3.129 . . . . 0.0 105.278 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.5 tp -156.99 -50.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.661 1.584 . . . . 0.0 109.526 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 m -73.81 -23.23 59.64 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.357 -0.839 . . . . 0.0 110.486 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.62 36.13 1.47 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.924 1.249 . . . . 0.0 112.01 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.12 118.78 8.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.098 0.959 . . . . 0.0 109.264 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -65.8 132.08 47.85 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.28 165.35 28.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 111.297 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.8 mt -128.99 146.28 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.808 1.643 . . . . 0.0 107.765 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 t -132.81 119.06 19.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -133.75 143.89 48.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 37.2 56.14 1.31 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.07 1.748 . . . . 0.0 114.178 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t0 55.14 24.59 6.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.678 1.191 . . . . 0.0 112.806 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 31' ' ' TRP . 14.7 m -127.69 131.49 49.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.777 1.631 . . . . 0.0 109.949 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -90.73 130.28 36.74 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.393 0.677 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 29' ' ' SER . 2.6 m-90 -131.09 133.32 45.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.501 1.143 . . . . 0.0 110.873 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -68.39 154.35 41.97 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 p -61.22 -36.24 79.39 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -74.07 4.25 5.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.746 1.618 . . . . 0.0 113.12 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -139.97 21.75 2.45 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 119.445 1.021 . . . . 0.0 113.002 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -109.34 99.76 8.96 Favored 'General case' 0 C--O 1.237 0.443 1 N-CA-C 98.356 -4.683 . . . . 0.0 98.356 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -152.63 176.16 12.03 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.8 t -59.69 111.64 1.51 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.891 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.82 13.22 0.09 OUTLIER Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.165 1.84 . . . . 0.0 115.348 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -128.03 -18.64 4.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.411 2.684 . . . . 0.0 112.757 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 -17.43 0.82 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.5 m 84.36 1.43 0.87 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.224 1.81 . . . . 0.0 115.463 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.81 126.44 28.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 t -52.05 142.81 15.22 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.475 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.0 mt -115.81 -2.5 12.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.809 1.244 . . . . 0.0 110.924 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.17 126.12 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.647 0.779 . . . . 0.0 109.356 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.55 14.36 69.48 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.016 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -131.45 167.25 19.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 121.128 2.464 . . . . 0.0 112.547 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.97 127.73 33.45 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.01 171.49 14.39 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.732 1.213 . . . . 0.0 110.015 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 60' ' ' GLN . 9.7 mp -121.52 156.55 32.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.885 1.674 . . . . 0.0 109.188 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 p -137.45 102.59 4.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.28 147.64 47.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.905 1.282 . . . . 0.0 108.757 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 52.81 23.78 2.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.775 2.03 . . . . 0.0 114.322 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? 78.61 12.4 1.52 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.043 2.137 . . . . 0.0 111.784 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -105.78 -178.39 3.64 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.748 -1.22 . . . . 0.0 109.4 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 pt -128.45 122.17 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.714 1.606 . . . . 0.0 108.395 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -138.08 157.28 46.65 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 123.111 1.434 . . . . 0.0 114.794 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.45 155.52 37.93 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.539 ' HA ' HD13 ' A' ' 51' ' ' LEU . 12.6 tt0 -47.26 -52.92 14.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.765 0.711 . . . . 0.0 111.557 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -58.57 7.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.534 0.734 . . . . 0.0 112.171 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.11 -23.11 44.71 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.619 -1.181 . . . . 0.0 113.728 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.36 -24.13 10.53 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 120.213 1.37 . . . . 0.0 112.355 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.0 t -86.95 89.07 7.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.93 87.32 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.3 mmt -78.45 89.18 4.42 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -81.11 71.61 8.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 p -128.54 71.24 1.39 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.775 1.23 . . . . 0.0 110.975 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -81.52 -11.61 59.12 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.797 177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 58.8 mt -67.01 92.53 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 129.348 3.059 . . . . 0.0 106.913 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.3 t -150.8 165.06 34.68 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.718 1.207 . . . . 0.0 108.609 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.25 65.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.464 2.459 . . . . 0.0 107.952 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.91 166.78 26.63 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.483 2.122 . . . . 0.0 111.609 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 78.4 p -144.4 177.9 8.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.709 1.604 . . . . 0.0 108.351 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.5 t -79.29 -178.35 6.17 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.263 1.911 1 C-N-CA 133.197 5.189 . . . . 0.0 103.458 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.983 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -71.78 97.94 1.87 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.8 m -144.55 168.6 19.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.402 1.481 . . . . 0.0 109.174 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.47 -6.49 57.51 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 117.769 -1.573 . . . . 0.0 116.444 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 p -172.35 111.21 0.26 Allowed 'General case' 0 C--O 1.239 0.537 0 CA-C-N 120.442 2.121 . . . . 0.0 111.579 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.1 m -61.2 126.96 29.24 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.99 -174.0 32.37 Favored Glycine 0 N--CA 1.446 -0.681 0 O-C-N 121.761 -0.587 . . . . 0.0 112.552 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 11.6 t -61.89 126.04 25.94 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.89 -20.23 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 119.336 0.971 . . . . 0.0 111.493 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.73 3.62 45.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 115.487 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -155.94 -9.69 0.11 Allowed 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.023 -1.673 . . . . 0.0 113.723 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m 53.38 29.06 8.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.533 1.933 . . . . 0.0 111.675 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -89.41 151.09 45.82 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 120.802 -1.186 . . . . 0.0 108.178 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 118.37 5.64 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.273 1.982 . . . . 0.0 110.027 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.2 mm -65.29 162.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.514 1.526 . . . . 0.0 107.632 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.32 147.34 37.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.83 -21.67 0.63 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.554 1.55 . . . . 0.0 113.065 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.34 -46.71 83.0 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.431 2.115 . . . . 0.0 109.02 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.3 m -73.44 7.43 2.32 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.578 1.951 . . . . 0.0 112.17 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.9 38.12 82.46 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 120.367 -1.458 . . . . 0.0 111.679 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 141.45 58.04 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.161 0.584 . . . . 0.0 111.898 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -72.74 110.32 6.99 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.348 1.059 . . . . 0.0 111.939 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -142.32 164.51 29.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.558 1.943 . . . . 0.0 106.644 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.59 130.34 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.234 1.814 . . . . 0.0 106.427 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.7 124.11 38.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.05 122.56 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 40.92 59.02 2.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.998 1.719 . . . . 0.0 112.848 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 63.66 12.23 6.4 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.265 2.226 . . . . 0.0 114.913 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 158.51 28.79 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.547 -1.346 . . . . 0.0 110.629 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -116.24 133.26 56.22 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.588 0.709 . . . . 0.0 110.855 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -123.88 126.8 47.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -67.08 148.79 51.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.11 -51.64 23.82 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.098 0.863 . . . . 0.0 112.438 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.22 -13.33 61.87 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -102.64 -12.68 17.53 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -80.43 101.52 9.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.24 168.57 19.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 45.2 t -65.23 114.91 5.03 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 116.663 -1.637 . . . . 0.0 110.049 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.82 -18.62 25.96 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.498 1.045 . . . . 0.0 115.528 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.13 -17.37 23.85 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.0 -20.21 0.5 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 118.601 2.815 . . . . 0.0 118.601 -177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 m 77.14 80.54 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.536 1.062 . . . . 0.0 109.888 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -148.64 141.57 18.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 126.832 2.053 . . . . 0.0 105.749 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -58.56 121.7 11.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 124.79 1.306 . . . . 0.0 113.626 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.4 mt -99.37 1.73 44.61 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.072 0.949 . . . . 0.0 109.659 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.68 140.71 19.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 -62.19 3.84 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.252 1.406 . . . . 0.0 112.777 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 164.81 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.849 0.859 . . . . 0.0 112.494 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.3 156.44 39.39 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.433 ' C ' HD12 ' A' ' 51' ' ' LEU . 30.9 p90 -137.93 168.48 19.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.586 1.154 . . . . 0.0 107.946 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.433 HD12 ' C ' ' A' ' 50' ' ' PHE . 6.8 mp -122.61 161.01 24.56 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.7 p -127.41 115.82 19.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.247 1.419 . . . . 0.0 107.607 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -143.17 150.59 39.6 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.9 m120 51.39 24.72 2.27 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.896 1.678 . . . . 0.0 114.107 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt 73.79 9.99 4.76 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.751 2.02 . . . . 0.0 111.277 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -110.68 -178.01 3.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.06 2.144 . . . . 0.0 110.136 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.3 pt -123.96 126.99 73.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.892 0.877 . . . . 0.0 110.465 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -130.28 163.32 27.04 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.468 -1.395 . . . . 0.0 113.254 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.21 156.98 19.44 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -57.36 -47.05 82.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 119.257 0.935 . . . . 0.0 110.136 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -52.25 -37.43 55.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.75 -1.219 . . . . 0.0 113.541 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.77 -35.6 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.234 1.014 . . . . 0.0 110.622 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.79 33.32 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.104 1.335 . . . . 0.0 110.005 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -64.99 141.21 58.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 118.783 1.291 . . . . 0.0 110.739 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.22 178.2 20.86 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 69.1 mtm -88.11 -27.74 21.73 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.013 0.525 . . . . 0.0 109.688 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.05 33.98 13.1 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.414 1.885 . . . . 0.0 111.615 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 t -160.36 176.51 11.6 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.595 2.358 . . . . 0.0 104.882 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 35.02 48.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 127.999 2.519 . . . . 0.0 113.623 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.565 HD12 ' H ' ' A' ' 70' ' ' ILE . 3.9 mp -61.97 -18.7 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.472 1.509 . . . . 0.0 110.892 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 m -157.81 118.57 3.48 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.041 -1.662 . . . . 0.0 109.002 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.94 173.24 15.01 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.747 1.642 . . . . 0.0 109.795 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.09 43.8 1.46 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.489 3.46 . . . . 0.0 112.279 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.9 m 54.67 41.79 31.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.499 1.12 . . . . 0.0 111.029 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.6 m -50.57 -36.19 33.46 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.463 2.305 . . . . 0.0 115.465 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -179.552 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.65 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.3 m -60.97 126.3 26.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 117.378 0.589 . . . . 0.0 109.426 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -52.14 138.51 25.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.626 1.17 . . . . 0.0 110.41 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.09 116.94 9.46 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 124.432 1.015 . . . . 0.0 111.636 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -31.93 72.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.248 1.019 . . . . 0.0 111.743 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -168.33 169.27 10.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.715 2.006 . . . . 0.0 107.256 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.67 -167.53 42.62 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 115.325 0.89 . . . . 0.0 115.325 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 15.0 t -50.52 117.28 2.34 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 117.582 -1.199 . . . . 0.0 107.948 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -54.97 -27.34 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 120.94 1.7 . . . . 0.0 110.83 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.86 -3.69 58.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.673 1.989 . . . . 0.0 115.175 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -152.62 -10.25 0.18 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.446 1.476 . . . . 0.0 114.24 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m 60.3 10.32 2.33 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 130.517 3.527 . . . . 0.0 115.642 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -75.67 151.54 84.84 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 120.911 1.687 . . . . 0.0 112.403 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -66.94 139.43 51.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.817 2.344 . . . . 0.0 109.019 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.76 156.71 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.415 2.286 . . . . 0.0 108.68 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -98.13 -9.3 26.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.321 1.049 . . . . 0.0 111.146 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.02 -122.41 11.7 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.017 1.77 . . . . 0.0 112.813 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 80.9 mt -53.22 -16.17 1.16 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.629 1.972 . . . . 0.0 114.293 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 m -66.89 -8.89 32.44 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.103 0.961 . . . . 0.0 110.279 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.8 28.91 2.78 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.33 1.443 . . . . 0.0 113.053 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.64 147.05 37.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.343 1.071 . . . . 0.0 108.279 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -86.0 82.0 8.28 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -130.83 164.58 24.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.51 0.724 . . . . 0.0 111.077 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 mm -116.46 118.58 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 128.837 2.855 . . . . 0.0 105.932 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.34 102.96 15.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -135.49 127.22 29.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.403 1.002 . . . . 0.0 110.632 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 50.24 45.44 25.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.38 1.072 . . . . 0.0 109.227 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.91 -17.55 0.25 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 129.735 3.214 . . . . 0.0 114.325 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 m -73.64 164.53 26.52 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.133 0.879 . . . . 0.0 109.3 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -128.95 107.73 9.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -109.05 125.57 52.24 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 123.506 0.722 . . . . 0.0 111.12 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -60.47 150.08 32.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.4 p -55.33 -42.42 73.77 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.72 -3.82 20.56 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.2 -1.46 11.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 128.959 2.904 . . . . 0.0 113.909 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.98 102.57 15.14 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -152.77 174.59 13.85 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.27 120.47 11.63 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-O 117.264 -1.35 . . . . 0.0 110.075 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.14 -12.27 29.8 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.627 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.37 -19.67 16.18 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.52 ' SG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -141.98 -10.59 0.88 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m 81.11 1.22 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.52 HG12 ' SG ' ' A' ' 41' ' ' CYS . 11.8 p -65.23 138.9 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.218 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -55.33 134.25 50.01 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.313 1.045 . . . . 0.0 111.773 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 mt -117.99 4.75 12.09 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.69 -1.148 . . . . 0.0 109.695 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 46' ' ' VAL . 22.9 t -36.76 103.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.482 1.913 . . . . 0.0 112.525 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 -25.17 0.9 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 129.064 3.221 . . . . 0.0 115.928 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -55.0 138.27 44.21 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.662 1.985 . . . . 0.0 112.128 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.14 121.73 27.14 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -116.36 172.6 7.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.866 2.067 . . . . 0.0 111.719 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.01 148.12 33.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.0 p -126.52 117.26 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.11 143.93 32.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 50.6 28.74 3.64 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.981 1.264 . . . . 0.0 113.958 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm 64.85 22.72 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.734 1.214 . . . . 0.0 111.145 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -110.2 178.57 4.35 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.129 2.172 . . . . 0.0 106.751 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.81 122.95 55.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 109.532 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -131.55 154.58 48.67 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 122.893 1.33 . . . . 0.0 113.197 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -83.55 164.51 19.75 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -59.02 -54.44 47.1 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.925 0.784 . . . . 0.0 111.135 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -50.52 -30.18 12.33 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.4 m -93.96 -30.72 14.6 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.231 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.55 7.53 59.67 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.96 1.255 . . . . 0.0 115.356 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -53.53 -38.64 63.98 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.455 1.628 . . . . 0.0 113.276 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.04 178.22 30.25 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.5 ptp -132.02 169.55 16.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -143.71 58.85 1.38 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 76.5 p -75.67 -11.33 59.98 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.963 1.305 . . . . 0.0 111.616 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -67.94 163.47 22.05 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.1 mt 53.52 54.94 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -70.54 92.58 0.85 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.27 2.228 . . . . 0.0 108.254 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.43 113.1 0.24 Allowed Glycine 0 CA--C 1.531 1.041 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.39 47.05 1.96 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 123.726 2.951 . . . . 0.0 112.102 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.2 m -142.79 142.44 31.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.97 2.908 . . . . 0.0 106.518 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.1 m -91.12 86.98 6.37 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 CA-C-O 117.931 -1.483 . . . . 0.0 110.052 -179.831 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.896 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -142.03 -174.12 4.01 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.985 -0.715 . . . . 0.0 110.76 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 t 65.19 10.61 6.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.065 1.746 . . . . 0.0 113.73 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.84 175.75 19.86 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.967 1.258 . . . . 0.0 111.634 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 m -114.06 164.7 13.48 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.531 1.133 . . . . 0.0 110.498 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 m -146.97 156.63 43.2 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.761 1.225 . . . . 0.0 109.225 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.87 178.3 52.31 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.103 1.335 . . . . 0.0 112.743 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 12.4 t -52.13 115.38 1.68 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.737 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 29' ' ' SER . 80.2 t -54.94 -24.36 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 121.287 1.858 . . . . 0.0 112.481 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.96 -0.57 56.81 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.666 1.186 . . . . 0.0 113.841 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.8 p -156.71 -11.37 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.268 1.849 . . . . 0.0 115.075 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t 52.44 57.63 6.23 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.004 2.522 . . . . 0.0 111.598 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -117.84 147.11 40.46 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-O 117.858 -1.068 . . . . 0.0 108.883 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.55 114.03 2.94 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 124.013 3.142 . . . . 0.0 113.537 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.8 mt -82.95 162.09 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -64.71 154.2 37.38 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 120.69 -1.256 . . . . 0.0 110.657 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.5 54.33 3.25 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 124.563 1.078 . . . . 0.0 114.524 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mp 58.98 5.53 0.53 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.839 2.456 . . . . 0.0 115.875 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 t -67.33 17.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 127.483 2.313 . . . . 0.0 115.87 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.64 22.73 5.31 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 119.624 -1.922 . . . . 0.0 113.859 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.73 161.02 30.02 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.737 -0.861 . . . . 0.0 109.712 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -104.2 100.92 10.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.39 165.72 26.66 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.544 1.938 . . . . 0.0 109.294 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.6 mm -116.52 150.37 18.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -131.38 135.08 46.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -145.21 111.38 5.61 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.43 56.81 6.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.143 0.973 . . . . 0.0 109.682 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 -16.89 0.09 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 130.013 3.325 . . . . 0.0 115.191 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' HG21 ' A' ' 9' ' ' VAL . 72.7 m -80.08 145.64 32.33 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -119.87 141.69 49.34 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.976 0.893 . . . . 0.0 112.528 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 10.8 m-90 -132.86 162.9 30.33 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.145 1.378 . . . . 0.0 111.143 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -79.78 148.43 31.45 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.4 t -60.55 -8.94 3.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.728 2.011 . . . . 0.0 115.042 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.96 -36.74 5.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.001 1.721 . . . . 0.0 108.83 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.26 18.28 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.866 1.667 . . . . 0.0 114.913 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -113.2 101.35 9.34 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -148.57 174.72 11.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -61.19 121.05 11.56 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.503 1.521 . . . . 0.0 109.779 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.49 -25.75 58.55 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 118.133 0.424 . . . . 0.0 113.069 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -87.45 -18.8 29.1 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.63 -9.92 0.41 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 119.082 2.993 . . . . 0.0 119.082 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m 83.44 3.23 0.94 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.37 133.69 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.445 1.475 . . . . 0.0 107.303 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.0 t -57.36 144.67 35.2 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.684 0.754 . . . . 0.0 109.852 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.5 mt -112.21 -6.56 14.1 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.325 . . . . 0.0 110.197 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.82 120.24 10.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.73 84.83 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 116.163 -2.465 . . . . 0.0 115.923 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -135.21 169.47 17.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.635 2.717 . . . . 0.0 112.204 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.25 123.54 25.92 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -116.62 167.88 10.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.19 159.81 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.8 p -132.3 112.06 11.9 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.919 0.762 . . . . 0.0 109.504 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -142.7 156.12 44.99 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.632 1.573 . . . . 0.0 107.341 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.9 m120 52.5 30.73 8.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.349 1.06 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.7 27.43 14.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.03 1.332 . . . . 0.0 110.708 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -125.63 175.55 7.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.192 2.197 . . . . 0.0 110.24 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.39 126.4 69.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 127.715 2.406 . . . . 0.0 110.021 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -134.03 163.52 29.37 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.88 161.2 16.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -50.23 -56.39 11.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.772 1.229 . . . . 0.0 111.215 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -49.8 -33.63 17.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.513 1.125 . . . . 0.0 113.249 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.4 m -80.2 -54.85 5.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.369 0.668 . . . . 0.0 109.319 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.72 26.62 4.62 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 115.621 1.008 . . . . 0.0 115.621 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.16 29.39 0.08 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.578 1.689 . . . . 0.0 112.776 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.21 -172.63 30.94 Favored Glycine 0 CA--C 1.522 0.525 0 O-C-N 120.804 -1.185 . . . . 0.0 111.458 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -71.25 168.16 17.89 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.332 2.253 . . . . 0.0 110.34 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -81.95 60.42 4.79 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.222 1.011 . . . . 0.0 110.532 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.3 p -64.15 98.3 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.654 1.582 . . . . 0.0 110.118 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -153.75 150.58 28.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.4 mm -84.25 88.11 2.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 m -58.78 155.42 12.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.935 0.398 . . . . 0.0 110.452 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.09 -176.66 14.62 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.85 -14.3 43.25 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.179 1.919 . . . . 0.0 112.44 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.4 m -63.68 98.92 0.2 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.667 1.187 . . . . 0.0 109.518 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 t -124.09 -177.0 3.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.375 1.87 . . . . 0.0 110.464 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.425 0 C-N-CA 126.412 1.958 . . . . 0.0 108.918 179.844 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_